chrom	pos	ref	alt	start	stop	strand	variation_type	variation_id	rcv	scv	allele_id	symbol	hgvs_c	hgvs_p	molecular_consequence	clinical_significance	clinical_significance_ordered	pathogenic	likely_pathogenic	uncertain_significance	likely_benign	benign	review_status	review_status_ordered	last_evaluated	all_submitters	submitters_ordered	all_traits	all_pmids	inheritance_modes	age_of_onset	prevalence	disease_mechanism	origin	xrefs	dates_ordered	gold_stars	conflicted	Filter	AC	AC_Het	AC_Hom	AC_Adj	AN	AN_Adj	AF	AC_AFR	AC_AMR	AC_EAS	AC_FIN	AC_NFE	AC_OTH	AC_SAS	AN_AFR	AN_AMR	AN_EAS	AN_FIN	AN_NFE	AN_OTH	AN_SAS	DP	Het_AFR	Het_AMR	Het_EAS	Het_FIN	Het_NFE	Het_OTH	Het_SAS	Hom_AFR	Hom_AMR	Hom_EAS	Hom_FIN	Hom_NFE	Hom_OTH	Hom_SAS	AC_MALE	AC_FEMALE	AN_MALE	AN_FEMALE	AC_CONSANGUINEOUS	AN_CONSANGUINEOUS	Hom_CONSANGUINEOUS	AC_POPMAX	AN_POPMAX	POPMAX
1	7869953	C	G	7869953	7869953	+	Haplotype	224889	RCV000210468	SCV000266565	226735	PER3	NM_001289862.1:c.1243C>G	NP_001276791.1:p.Pro415Ala	NM_001289862.1:c.1243C>G:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 23, 2017	OMIM	OMIM	Advanced sleep phase syndrome, familial, 3;ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3 (1 family)	26903630					germline	MedGen:C4225169;OMIM:616882;Orphanet:164736	2016-10-17	0	0	PASS	705	685	5	695	121410	118078	0.005807	5	10	2	176	455	3	44	10068	11322	8528	6104	65066	862	16128	1658001	5	10	2	172	449	3	44	0	0	0	2	3	0	0	414	281	65804	52274	2	2104	0	455	65066	NFE
1	7869960	A	G	7869960	7869960	+	Haplotype	224889	RCV000210468	SCV000266565	226734	PER3	NM_001289862.1:c.1250A>G	NP_001276791.1:p.His417Arg	NM_001289862.1:c.1250A>G:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 23, 2017	OMIM	OMIM	Advanced sleep phase syndrome, familial, 3;ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3 (1 family)	26903630					germline	MedGen:C4225169;OMIM:616882;Orphanet:164736	2016-10-17	0	0	PASS	705	689	5	699	121410	118888	0.005807	5	9	2	179	457	3	44	10124	11408	8566	6188	65464	874	16264	1681881	5	9	2	175	451	3	44	0	0	0	2	3	0	0	416	283	66234	52654	2	2126	0	457	65464	NFE
1	8045031	G	A	8045031	8045031	+	Haplotype	446717	RCV000007484	SCV000027684	22107	PARK7	NM_007262.4:c.487G>A	NP_009193.2:p.Glu163Lys	NM_007262.4:c.487G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 2005	OMIM	OMIM	Parkinson disease 7;PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	16240358;20301402;23279440					germline	GeneReviews:NBK1223;Genetic Alliance:Parkinson+disease+7/9090;MedGen:C1853445;OMIM:602533.0001;OMIM:602533.0002;OMIM:602533.0003;OMIM:602533.0004;OMIM:602533.0005;OMIM:602533.0006;OMIM:606324;Orphanet:2828	2005-11-01	0	0	PASS	3	3	0	3	121412	121378	2.471e-05	1	0	0	0	2	0	0	10402	11576	8650	6614	66720	908	16508	1804699	1	0	0	0	2	0	0	0	0	0	0	0	0	0	2	1	67274	54104	0	2164	0	1	10402	AFR
1	25627552	C	G	25627552	25627552	+	Haplotype	202166;208474	RCV000184007;RCV000190496	SCV000236501;SCV000245368	198596	RHD	NM_016124.4:c.602C>G	NP_057208.2:p.Thr201Arg	NM_016124.4:c.602C>G:missense variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Colsan	Colsan	Weak RhD expression	24579654					unknown	MedGen:CN231363	0000-00-00	0	0	PASS	559	353	99	551	111802	108262	0.005	470	33	0	0	44	0	4	9962	11122	8642	5816	56538	832	15350	3711283	304	23	0	0	24	0	2	83	5	0	0	10	0	1	207	344	59774	48488	1	1978	0	470	9962	AFR
1	25628043	T	G	25628043	25628043	+	Haplotype	202166;208474	RCV000184007;RCV000190496	SCV000236501;SCV000245368	198597	RHD	NM_016124.4:c.667T>G	NP_057208.2:p.Phe223Val	NM_016124.4:c.667T>G:missense variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Colsan	Colsan	Weak RhD expression	24579654					unknown	MedGen:CN231363	0000-00-00	0	0	PASS	1331	780	266	1312	112940	108300	0.012	1081	59	21	0	95	3	53	9954	11132	8642	5816	56572	834	15350	2763318	637	47	19	0	47	3	27	222	6	1	0	24	0	13	548	764	59802	48498	14	1978	3	1081	9954	AFR
1	25628073	G	C	25628073	25628073	+	Haplotype	208474	RCV000190496	SCV000245368	204995	RHD	NM_016124.4:c.697G>C	NP_057208.2:p.Glu233Gln	NM_016124.4:c.697G>C:missense variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Colsan	Colsan	Weak RhD expression;Weak RhD expression						unknown	MedGen:CN231363	0000-00-00	0	0	PASS	200	115	36	187	113196	108308	0.001767	164	11	1	2	5	0	4	9944	11124	8642	5816	56598	834	15350	2696051	102,8,0	7,0,0	1,0,0	0,0,0	3,0,0	0,0,0	2,0,0	31	2	0	1	1	0	1	84	103	59800	48508	1	1978	0	164	9944	AFR
1	25628109	G	C	25628109	25628109	+	Haplotype	208474	RCV000190496	SCV000245368	204996	RHD	NM_016124.4:c.733G>C	NP_057208.2:p.Val245Leu	NM_016124.4:c.733G>C:missense variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Colsan	Colsan	Weak RhD expression;Weak RhD expression						unknown	MedGen:CN231363	0000-00-00	0	0	PASS	105	53	23	99	113182	108340	0.0009277	20	6	0	2	70	0	1	9958	11130	8642	5820	56606	834	15350	2692945	14	4	0	0	34	0	1	3	1	0	1	18	0	0	50	49	59828	48512	0	1978	0	20	9958	AFR
1	25628120	C	T	25628120	25628120	+	Haplotype	202166;208474	RCV000184007;RCV000190496	SCV000236501;SCV000245368	198598	RHD	NM_016124.4:c.744C>T	NP_057208.2:p.Ser248=	NM_016124.4:c.744C>T:synonymous variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Colsan	Colsan	Weak RhD expression	24579654					unknown	MedGen:CN231363	0000-00-00	0	0	PASS	129	96	16	128	113160	108332	0.00114	108	6	4	0	9	0	1	9958	11126	8642	5820	56602	834	15350	2692107	82	6	4	0	3	0	1	13	0	0	0	3	0	0	51	77	59828	48504	1	1978	0	108	9958	AFR
1	25633104	G	A	25633104	25633104	+	Haplotype	202166	RCV000184007	SCV000236501	198599	RHD	NM_016124.4:c.957G>A	NP_057208.2:p.Val319=	NM_001127691.2:c.939+3154G>A:intron variant;NM_016124.4:c.957G>A:synonymous variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Colsan	Colsan	Weak RhD expression;Weak RhD expression	24579654					unknown	MedGen:CN231363	0000-00-00	0	0	PASS	63	50	6	62	112736	108298	0.0005588	56	5	0	0	1	0	0	9964	11128	8642	5816	56564	834	15350	1962959	44	5	0	0	1	0	0	6	0	0	0	0	0	0	24	38	59794	48504	0	1978	0	56	9964	AFR
1	25633172	T	C	25633172	25633172	+	Haplotype	202166	RCV000184007	SCV000236501	198600	RHD	NM_001127691.2:c.939+3222T>C	NP_057208.2:p.Ile342Thr	NM_001127691.2:c.939+3222T>C:intron variant;NM_016124.4:c.1025T>C:missense variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Colsan	Colsan	Weak RhD expression;Weak RhD expression	24579654					unknown	MedGen:CN231363	0000-00-00	0	0	PASS	67	54	6	66	113214	108340	0.0005918	60	5	0	0	1	0	0	9964	11136	8642	5816	56598	834	15350	1963935	48	5	0	0	1	0	0	6	0	0	0	0	0	0	26	40	59822	48518	0	1978	0	60	9964	AFR
1	25633210	G	A	25633210	25633210	+	Haplotype	202166	RCV000184007	SCV000236501	198601	RHD	NM_001127691.2:c.939+3260G>A	NP_057208.2:p.Gly355Ser	NM_001127691.2:c.939+3260G>A:intron variant;NM_016124.4:c.1063G>A:missense variant	risk factor	not provided	0	0	0	0	0	no assertion criteria provided	no assertion provided	Sep 30, 2014	Colsan	Colsan	Weak RhD expression;Weak RhD expression	24579654					unknown	MedGen:CN231363	0000-00-00	0	0	PASS	79	38	18	74	112810	108270	0.0007003	0	0	0	0	74	0	0	9952	11130	8640	5816	56548	834	15350	1947992	0	0	0	0	38	0	0	0	0	0	0	18	0	0	44	30	59792	48478	0	1978	0	74	56548	NFE
1	25701876	C	T	25701876	25701876	+	Haplotype	208474	RCV000190496	SCV000245368	204997	RHD				-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Colsan	Colsan	Weak RhD expression;Weak RhD expression						unknown	MedGen:CN231363	0000-00-00	0	0	VQSRTrancheSNP99.60to99.80	1	1	0	1	121410	121410	8.237e-06	0	0	0	0	1	0	0	10406	11578	8654	6614	66738	908	16512	2298493	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	67288	54122	0	2164	0	1	66738	NFE
1	25747230	G	C	25747230	25747230	-	Haplotype	17709	RCV000019283	SCV000039571	32748	RHCE	NM_020485.5:c.48G=	NP_065231.3:p.Trp16=	NM_020485.5:c.48G=:synonymous variant	-	benign	0	0	0	0	1	no assertion for the individual variant	no assertion criteria provided	Sep 01, 1993	OMIM	OMIM	RH C/c POLYMORPHISM;RH C/c POLYMORPHISM	8220426					germline	OMIM:111700.0002	1993-09-01	0	0	PASS	48959	22275	9968	42215	120884	106024	0.405	3565	3203	1796	2825	25874	320	4632	9040	9856	8012	5856	57106	802	15352	2778155	1835,0,0	2115,0,0	1339,6,3	1469,0,0	12782,0,0	170,0,0	2565,0,1	865	544	227	678	6546	75	1033	23417	18798	58960	47064	627	2010	174	25874	57106	NFE
1	53676401	T	G	53676401	53676401	+	Haplotype	30118	RCV000023026	SCV000044317	39073	CPT2	NM_000098.2:c.1055T>G	NP_000089.1:p.Phe352Cys	NM_000098.2:c.1055T>G:missense variant	Benign/Likely benign	risk factor	0	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Aug 07, 2017	OMIM	OMIM	Encephalopathy, acute, infection-induced, 4, susceptibility to;ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4	15811315;18306170;20934285;21697855					germline	Genetic Alliance:Encephalopathy%2C+acute%2C+infection-induced%2C+4%2C+susceptibility+to/8308;MedGen:C3280160;OMIM:614212;Orphanet:263524	2011-08-01	2	0	PASS	2647	2237	205	2647	121412	121204	0.022	206	501	1770	3	81	9	77	10354	11564	8610	6614	66652	906	16504	2141211	200	469	1400	3	81	9	75	3	16	185	0	0	0	1	1202	1445	67254	53950	16	2164	1	1770	8610	EAS
1	53676448	G	A	53676448	53676448	+	Haplotype	30118	RCV000023026	SCV000044317	39074	CPT2	NM_000098.2:c.1102G>A	NP_000089.1:p.Val368Ile	NM_000098.2:c.1102G>A:missense variant	Benign	risk factor	0	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jun 14, 2016	OMIM	OMIM	Encephalopathy, acute, infection-induced, 4, susceptibility to;ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4	15811315;18306170;20934285;21697855					germline	Genetic Alliance:Encephalopathy%2C+acute%2C+infection-induced%2C+4%2C+susceptibility+to/8308;MedGen:C3280160;OMIM:614212;Orphanet:263524	2011-08-01	2	0	PASS	58689	27955	15346	58647	121412	121140	0.483	2941	4947	6325	3504	36217	408	4305	10370	11528	8634	6596	66604	908	16500	3171623	2039	2823	1663	1638	16519	194	3079	451	1062	2331	933	9849	107	613	32044	26603	67186	53954	633	2164	113	6325	8634	EAS
1	53676583	CAG	C	53676585	53676586	+	Haplotype	60702	RCV000009520;RCV000202553	SCV000029738;SCV000153666	98339	CPT2	NM_000098.2:c.1239_1240delGA	NP_000089.1:p.Lys414Thrfs	NM_000098.2:c.1239_1240delGA:frameshift variant	Pathogenic	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 30, 2017	OMIM;GeneReviews	OMIM;GeneReviews	Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED;Carnitine palmitoyltransferase II deficiency	10090476;11477613;12410208;20301431;25173338					germline	GeneReviews:NBK1253;MedGen:C1833508;OMIM:255110;Orphanet:157;Orphanet:228302;MedGen:C0342790;Office of Rare Diseases:1121;SNOMED CT:238002005	2002-11-01;2014-05-15	0	0	PASS	13	13	0	13	121412	121214	0.0001071	0	0	0	0	13	0	0	10358	11542	8650	6606	66658	906	16494	1598075	0	0	0	0	13	0	0	0	0	0	0	0	0	0	6	7	67228	53986	0	2164	0	13	66658	NFE
1	53676688	T	C	53676688	53676688	+	Haplotype	60702	RCV000009520;RCV000202553	SCV000029738;SCV000153666	23999	CPT2	NM_000098.2:c.1342T>C	NP_000089.1:p.Phe448Leu	NM_000098.2:c.1342T>C:missense variant	Conflicting interpretations of pathogenicity, other	pathogenic	2	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Nov 18, 2016	OMIM;GeneReviews	OMIM;GeneReviews	Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED;Carnitine palmitoyltransferase II deficiency	10090476;11477613;12410208;20301431;25173338					germline	GeneReviews:NBK1253;MedGen:C1833508;OMIM:255110;Orphanet:157;Orphanet:228302;MedGen:C0342790;Office of Rare Diseases:1121;SNOMED CT:238002005	2002-11-01;2014-05-15	1	1	PASS	13	13	0	13	121412	121226	0.0001071	0	0	0	0	13	0	0	10390	11538	8648	6610	66662	904	16474	1594025	0	0	0	0	13	0	0	0	0	0	0	0	0	0	6	7	67198	54028	0	2156	0	13	66662	NFE
1	55331078	C	G	55331078	55331078	-	Haplotype	4368	RCV000004616	SCV000024790	38433	DHCR24	NM_014762.3:c.918G>C	NP_055577.1:p.Lys306Asn	NM_014762.3:c.918G>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 01, 2001	OMIM	OMIM	Desmosterolosis;DESMOSTEROLOSIS	11519011					germline	GeneTests:238860;Genetic Alliance:Desmosterolosis/2221;MedGen:C1865596;OMIM:602398;Office of Rare Diseases:10283;Orphanet:35107	2001-10-01	0	0																																															
1	55331115	T	G	55331115	55331115	-	Haplotype	4368	RCV000004616	SCV000024790	19407	DHCR24	NM_014762.3:c.881A>C	NP_055577.1:p.Asn294Thr	NM_014762.3:c.881A>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 01, 2001	OMIM	OMIM	Desmosterolosis;DESMOSTEROLOSIS	11519011					germline	GeneTests:238860;Genetic Alliance:Desmosterolosis/2221;MedGen:C1865596;OMIM:602398;Office of Rare Diseases:10283;Orphanet:35107	2001-10-01	0	0																																															
1	94467548	C	G	94467548	94467548	-	Haplotype	236131	RCV000408516	SCV000281924	22923	ABCA4	NM_000350.2:c.6148G>C	NP_000341.2:p.Val2050Leu	NM_000350.2:c.6148G>C:missense variant	Conflicting interpretations of pathogenicity	likely pathogenic	0	1	0	0	0	criteria provided, conflicting interpretations	criteria provided, single submitter	Feb 17, 2017	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827	2016-01-01	1	1	PASS	334	334	0	334	121412	121350	0.002751	7	79	0	0	246	2	0	10396	11566	8640	6612	66718	908	16510	1719157	7	79	0	0	246	2	0	0	0	0	0	0	0	0	165	169	67262	54088	0	2164	0	79	11566	AMR
1	94471055	C	T	94471055	94471055	-	Haplotype	236068	RCV000408532	SCV000281790	105317	ABCA4	NM_000350.2:c.6089G>A	NP_000341.2:p.Arg2030Gln	NM_000350.2:c.6089G>A:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jun 02, 2017	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827	2016-01-01	0	0	PASS	47	45	1	47	121412	121404	0.0003871	1	4	0	2	37	0	3	10404	11576	8654	6614	66736	908	16512	4740408	1	4	0	2	37	0	1	0	0	0	0	0	0	1	22	25	67286	54118	0	2164	0	37	66736	NFE
1	94480178	G	T	94480178	94480178	-	Haplotype	236131	RCV000408516	SCV000281924	105260	ABCA4	NM_000350.2:c.5381C>A	NP_000341.2:p.Ala1794Asp	NM_000350.2:c.5381C>A:missense variant	Likely pathogenic	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jan 01, 2016	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827	2016-01-01	0	0	PASS	3	3	0	3	121412	121408	2.471e-05	0	0	0	0	3	0	0	10404	11578	8654	6614	66738	908	16512	4561854	0	0	0	0	3	0	0	0	0	0	0	0	0	0	2	1	67288	54120	0	2164	0	3	66738	NFE
1	94485181	A	C	94485181	94485181	-	Haplotype	236092	RCV000408474	SCV000281849	237656	ABCA4	NM_000350.2:c.5153T>G	NP_000341.2:p.Val1718Gly	NM_000350.2:c.5153T>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jan 01, 2016	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827	2016-01-01	0	0																																															
1	94492973	G	A	94492973	94492973	-	Haplotype	225694	RCV000211040	SCV000267675	227509	ABCA4	NM_000350.2:c.4539+2028C>T		NM_000350.2:c.4539+2028C>T:intron variant	Uncertain significance	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jan 01, 2016	Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine	Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine	Stargardt disease 1	26527198;28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827	0000-00-00	0	0																																															
1	94508356	T	A	94508356	94508356	-	Haplotype	236091	RCV000408579	SCV000281848	237681	ABCA4	NM_000350.2:c.3289A>T	NP_000341.2:p.Arg1097Ter	NM_000350.2:c.3289A>T:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jan 01, 2016	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827	2016-01-01	0	0																																															
1	94508969	G	A	94508969	94508969	-	Haplotype	7901	RCV000008358;RCV000008359	SCV000028566;SCV000028567	22933	ABCA4	NM_000350.2:c.3113C>T	NP_000341.2:p.Ala1038Val	NM_000350.2:c.3113C>T:missense variant	Pathogenic/Likely pathogenic	pathogenic	2	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Mar 21, 2017	OMIM	OMIM	Stargardt disease 1;STARGARDT DISEASE 1;Cone-rod dystrophy 3	10958761;10958763;12796258;16103129;28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827;Genetic Alliance:Cone-Rod+Dystrophy+3/1769;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1858806;OMIM:604116;Office of Rare Diseases:10653;Orphanet:1872	2005-10-01	2	0	PASS	173	173	0	173	121412	121304	0.001425	1	10	0	28	131	2	1	10384	11566	8650	6606	66700	908	16490	1863942	1	10	0	28	131	2	1	0	0	0	0	0	0	0	95	78	67264	54040	1	2164	0	131	66700	NFE
1	94517254	C	G	94517254	94517254	-	Haplotype	236091;236092	RCV000408579;RCV000408474	SCV000281848;SCV000281849	22918	ABCA4	NM_000350.2:c.2588G>C	NP_000341.2:p.Gly863Ala	NM_000350.2:c.2588G>C:missense variant	Conflicting interpretations of pathogenicity	pathogenic	2	0	0	0	0	criteria provided, conflicting interpretations	criteria provided, single submitter	Oct 19, 2017	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827	2016-01-01	1	1	PASS	603	597	2	601	121412	118484	0.004967	16	11	0	9	528	2	35	10100	11338	8428	6536	65218	884	15980	1856752	16	11	0	9	524	2	35	0	0	0	0	2	0	0	348	253	65642	52842	7	2140	0	528	65218	NFE
1	94528806	A	G	94528806	94528806	-	Haplotype	7901	RCV000008358;RCV000008359	SCV000028566;SCV000028567	22940	ABCA4	NM_000350.2:c.1622T>C	NP_000341.2:p.Leu541Pro	NM_000350.2:c.1622T>C:missense variant	Conflicting interpretations of pathogenicity	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 12, 2017	OMIM	OMIM	Stargardt disease 1;STARGARDT DISEASE 1;Cone-rod dystrophy 3	10958761;10958763;12796258;16103129;28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827;Genetic Alliance:Cone-Rod+Dystrophy+3/1769;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1858806;OMIM:604116;Office of Rare Diseases:10653;Orphanet:1872	2005-10-01	0	1	PASS	15	15	0	15	121412	121412	0.0001235	0	0	0	3	12	0	0	10406	11578	8654	6614	66740	908	16512	2835472	0	0	0	3	12	0	0	0	0	0	0	0	0	0	9	6	67288	54124	0	2164	0	12	66740	NFE
1	94576926	G	A	94576926	94576926	-	Haplotype	225694	RCV000211040	SCV000267675	227508	ABCA4	NM_000350.2:c.302+68C>T		NM_000350.2:c.302+68C>T:intron variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	-	Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine	Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine	Stargardt disease 1	26527198;28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827	0000-00-00	0	0																																															
1	94586601	T	C	94586601	94586601	-	Haplotype	236068	RCV000408532	SCV000281790	104999	ABCA4	NM_000350.2:c.1A>G	NP_000341.2:p.Met1Val	NM_000350.2:c.1A>G:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Sep 23, 2016	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827	2016-01-01	0	0																																															
1	116269619	T	C	116269619	116269619	-	Haplotype	228471	RCV000217394	SCV000271536	44436	CASQ2	NM_001232.3:c.731A>G	NP_001223.2:p.His244Arg	NM_001232.3:c.731A>G:missense variant	Conflicting interpretations of pathogenicity	uncertain significance	0	0	1	0	0	criteria provided, conflicting interpretations	criteria provided, single submitter	Jul 28, 2017	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-02-05	1	1	PASS	931	834	44	922	121412	111188	0.007668	876	40	0	0	3	2	1	9370	10680	8294	5896	61330	822	14796	1475218	788	40	0	0	3	2	1	44	0	0	0	0	0	0	331	591	61632	49556	0	2034	0	876	9370	AFR
1	116269620	G	A	116269620	116269620	-	Haplotype	228471	RCV000217394	SCV000271536	228262	CASQ2	NM_001232.3:c.730C>T	NP_001223.2:p.His244Tyr	NM_001232.3:c.730C>T:missense variant	Conflicting interpretations of pathogenicity	uncertain significance	0	0	1	0	0	no assertion for the individual variant	criteria provided, single submitter	Jul 21, 2016	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-02-05	0	1	PASS	26	26	0	26	121412	111734	0.0002141	25	1	0	0	0	0	0	9422	10730	8312	5952	61644	824	14850	1466519	25	1	0	0	0	0	0	0	0	0	0	0	0	0	12	14	61940	49794	0	2034	0	25	9422	AFR
1	155204994	C	G	155204994	155204994	-	Haplotype	4297	RCV000004533;RCV000004534;RCV000004535;RCV000004536	SCV000024707;SCV000024708;SCV000024709;SCV000024710	38385	GBA	NM_001005741.2:c.1497G>C	NP_001005741.1:p.Val499=	NM_001005741.2:c.1497G>C:synonymous variant	Benign/Likely benign	pathogenic	4	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 21, 2017	OMIM	OMIM	Gaucher's disease, type 1;GAUCHER DISEASE, TYPE I;Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease, perinatal lethal	10685993;1437405;1594045;18197057;1899336;1972019;19888064;20301446;7857677;8118460;8929950					germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+1/3002;MedGen:C1961835;OMIM:230800;Orphanet:355;Orphanet:77259;SNOMED CT:62201009;Genetic Alliance:Gaucher+Disease+Type+2/3003;MedGen:C0268250;OMIM:230900;OMIM:606463.0001;OMIM:606463.0002;OMIM:606463.0006;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0015;OMIM:606463.0017;OMIM:606463.0030;OMIM:606463.0031;OMIM:606463.0047;SNOMED CT:12246008;Genetic Alliance:Gaucher+Disease+Type+3/3004;MedGen:C0268251;OMIM:231000;OMIM:606463.0005;OMIM:606463.0007;OMIM:606463.0026;OMIM:606463.0035;OMIM:606463.0040;OMIM:606463.0043;Orphanet:77261;SNOMED CT:5963005;Genetic Alliance:Gaucher+Disease+Perinatal+Lethal/3001;MedGen:C1842704;OMIM:608013	2000-03-01	0	0	VQSRTrancheSNP99.60to99.80	36	35	0	35	121412	121388	0.0002965	2	1	9	0	16	0	7	10404	11570	8654	6612	66732	906	16510	1610263	2	1	9	0	16	0	7	0	0	0	0	0	0	0	23	12	67280	54108	1	2164	0	9	8654	EAS
1	155205008	C	G	155205008	155205008	-	Haplotype	4297	RCV000004533;RCV000004534;RCV000004535;RCV000004536	SCV000024707;SCV000024708;SCV000024709;SCV000024710	38384	GBA	NM_001005741.2:c.1483G>C	NP_001005741.1:p.Ala495Pro	NM_001005741.2:c.1483G>C:missense variant	Benign	pathogenic	4	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 24, 2012	OMIM	OMIM	Gaucher's disease, type 1;GAUCHER DISEASE, TYPE I;Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease, perinatal lethal	10685993;1437405;1594045;18197057;1899336;1972019;19888064;20301446;7857677;8118460;8929950					germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+1/3002;MedGen:C1961835;OMIM:230800;Orphanet:355;Orphanet:77259;SNOMED CT:62201009;Genetic Alliance:Gaucher+Disease+Type+2/3003;MedGen:C0268250;OMIM:230900;OMIM:606463.0001;OMIM:606463.0002;OMIM:606463.0006;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0015;OMIM:606463.0017;OMIM:606463.0030;OMIM:606463.0031;OMIM:606463.0047;SNOMED CT:12246008;Genetic Alliance:Gaucher+Disease+Type+3/3004;MedGen:C0268251;OMIM:231000;OMIM:606463.0005;OMIM:606463.0007;OMIM:606463.0026;OMIM:606463.0035;OMIM:606463.0040;OMIM:606463.0043;Orphanet:77261;SNOMED CT:5963005;Genetic Alliance:Gaucher+Disease+Perinatal+Lethal/3001;MedGen:C1842704;OMIM:608013	2000-03-01	0	0	VQSRTrancheSNP99.60to99.80	14	14	0	14	121412	121380	0.0001153	4	2	2	0	4	0	2	10402	11564	8654	6614	66732	906	16508	1609823	4	2	2	0	4	0	2	0	0	0	0	0	0	0	9	5	67276	54104	0	2164	0	4	10402	AFR
1	155205043	A	G	155205043	155205043	-	Haplotype	4297	RCV000004533;RCV000004534;RCV000004535;RCV000004536	SCV000024707;SCV000024708;SCV000024709;SCV000024710	19327	GBA	NM_001005741.2:c.1448T>C	NP_001005741.1:p.Leu483Pro	NM_001005741.2:c.1448T>C:missense variant	Pathogenic, risk factor	pathogenic	4	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Sep 23, 2016	OMIM	OMIM	Gaucher's disease, type 1;GAUCHER DISEASE, TYPE I;Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease, perinatal lethal	10685993;1437405;1594045;18197057;1899336;1972019;19888064;20301446;7857677;8118460;8929950					germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+1/3002;MedGen:C1961835;OMIM:230800;Orphanet:355;Orphanet:77259;SNOMED CT:62201009;Genetic Alliance:Gaucher+Disease+Type+2/3003;MedGen:C0268250;OMIM:230900;OMIM:606463.0001;OMIM:606463.0002;OMIM:606463.0006;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0015;OMIM:606463.0017;OMIM:606463.0030;OMIM:606463.0031;OMIM:606463.0047;SNOMED CT:12246008;Genetic Alliance:Gaucher+Disease+Type+3/3004;MedGen:C0268251;OMIM:231000;OMIM:606463.0005;OMIM:606463.0007;OMIM:606463.0026;OMIM:606463.0035;OMIM:606463.0040;OMIM:606463.0043;Orphanet:77261;SNOMED CT:5963005;Genetic Alliance:Gaucher+Disease+Perinatal+Lethal/3001;MedGen:C1842704;OMIM:608013	2000-03-01	2	0	VQSRTrancheSNP99.60to99.80	383	375	0	375	121412	121026	0.003155	12	34	11	16	261	8	33	10342	11524	8644	6602	66548	900	16466	1631058	12	34	11	16	261	8	33	0	0	0	0	0	0	0	209	166	67074	53952	6	2160	0	261	66548	NFE
1	155205518	C	G	155205518	155205518	-	Haplotype	4334	RCV000004580;RCV000004581	SCV000024754;SCV000024755	19332	GBA	NM_001005741.2:c.1342G>C	NP_001005741.1:p.Asp448His	NM_001005741.2:c.1342G>C:missense variant	Pathogenic/Likely pathogenic	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 29, 2016	OMIM	OMIM	Acute neuronopathic Gaucher's disease;GAUCHER DISEASE, TYPE II;Subacute neuronopathic Gaucher's disease	15690354;20301446					germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+2/3003;MedGen:C0268250;OMIM:230900;OMIM:606463.0001;OMIM:606463.0002;OMIM:606463.0006;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0015;OMIM:606463.0017;OMIM:606463.0030;OMIM:606463.0031;OMIM:606463.0047;SNOMED CT:12246008;Genetic Alliance:Gaucher+Disease+Type+3/3004;MedGen:C0268251;OMIM:231000;OMIM:606463.0005;OMIM:606463.0007;OMIM:606463.0026;OMIM:606463.0035;OMIM:606463.0040;OMIM:606463.0043;Orphanet:355;Orphanet:77261;SNOMED CT:5963005	2005-04-01	0	0	PASS	11	11	0	11	121410	100268	9.06e-05	1	2	0	0	8	0	0	8208	8650	7160	5568	56232	754	13696	1552739	1	2	0	0	8	0	0	0	0	0	0	0	0	0	8	3	55404	44864	0	1902	0	2	8650	AMR
1	155206167	C	T	155206167	155206167	-	Haplotype	4299	RCV000004538	SCV000024712	38432	GBA	NM_001005741.2:c.1093G>A	NP_001005741.1:p.Glu365Lys	NM_001005741.2:c.1093G>A:missense variant	Conflicting interpretations of pathogenicity, risk factor	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 28, 2017	OMIM	OMIM	Gaucher's disease, type 1;GAUCHER DISEASE, TYPE I	10079102;11903352;15146461;18197057;1864608;19888064;20301446					germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+1/3002;MedGen:C1961835;OMIM:230800;Orphanet:355;Orphanet:77259;SNOMED CT:62201009	2004-06-01	0	1	PASS	1190	1164	12	1188	121410	121320	0.009801	19	27	2	288	798	9	45	10396	11550	8650	6614	66700	906	16504	1726369	19	27	2	280	784	7	45	0	0	0	4	7	1	0	662	526	67240	54080	7	2164	0	798	66700	NFE
1	155207249	A	C	155207249	155207249	-	Haplotype	4334	RCV000004580;RCV000004581	SCV000024754;SCV000024755	19373	GBA	NM_001005741.2:c.882T>G	NP_001005741.1:p.His294Gln	NM_001005741.2:c.882T>G:missense variant	-	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 01, 2005	OMIM	OMIM	Acute neuronopathic Gaucher's disease;GAUCHER DISEASE, TYPE II;Subacute neuronopathic Gaucher's disease	15690354;20301446					germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+2/3003;MedGen:C0268250;OMIM:230900;OMIM:606463.0001;OMIM:606463.0002;OMIM:606463.0006;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0015;OMIM:606463.0017;OMIM:606463.0030;OMIM:606463.0031;OMIM:606463.0047;SNOMED CT:12246008;Genetic Alliance:Gaucher+Disease+Type+3/3004;MedGen:C0268251;OMIM:231000;OMIM:606463.0005;OMIM:606463.0007;OMIM:606463.0026;OMIM:606463.0035;OMIM:606463.0040;OMIM:606463.0043;Orphanet:355;Orphanet:77261;SNOMED CT:5963005	2005-04-01	0	0	PASS	34	34	0	34	121412	121348	0.00028	0	3	0	0	24	0	7	10404	11562	8654	6614	66702	904	16508	1875027	0	3	0	0	24	0	7	0	0	0	0	0	0	0	21	13	67254	54094	3	2164	0	7	16508	SAS
1	155208361	C	G	155208361	155208361	-	Haplotype	4299	RCV000004538	SCV000024712	19338	GBA	NM_001005741.2:c.535G>C	NP_001005741.1:p.Asp179His	NM_001005741.2:c.535G>C:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Feb 28, 2017	OMIM	OMIM	Gaucher's disease, type 1;GAUCHER DISEASE, TYPE I	10079102;11903352;15146461;18197057;1864608;19888064;20301446					germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+1/3002;MedGen:C1961835;OMIM:230800;Orphanet:355;Orphanet:77259;SNOMED CT:62201009	2004-06-01	1	0	VQSRTrancheSNP99.60to99.80	7	7	0	7	121412	117722	5.765e-05	0	0	0	0	7	0	0	9590	11004	8576	6478	65188	890	15996	1510433	0	0	0	0	7	0	0	0	0	0	0	0	0	0	3	4	65482	52240	0	2114	0	7	65188	NFE
1	156830751	C	T	156830751	156830751	+	Haplotype	12304	RCV000030667	SCV000033344	27343	NTRK1	NM_002529.3:c.25C>T	NP_002520.2:p.Gln9Ter	NM_001007792.1:c.123-3395C>T:intron variant;NM_001012331.1:c.25C>T:nonsense	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Aug 05, 2008	OMIM	OMIM	Hereditary insensitivity to pain with anhidrosis;INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	10330344;11159935;20301726					germline	GeneReviews:NBK1769;Genetic Alliance:Insensitivity+to+pain%2C+congenital%2C+with+anhidrosis/3832;MedGen:C0020074;OMIM:256800;Office of Rare Diseases:3006;Orphanet:642;SNOMED CT:62985007	2001-02-01	0	0																																															
1	156848918	C	T	156848918	156848918	+	Haplotype	12304	RCV000030667	SCV000033344	38397	NTRK1	NM_002529.3:c.1810C>T	NP_002520.2:p.His604Tyr	NM_001007792.1:c.1702C>T:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 08, 2017	OMIM	OMIM	Hereditary insensitivity to pain with anhidrosis;INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	10330344;11159935;20301726					germline	GeneReviews:NBK1769;Genetic Alliance:Insensitivity+to+pain%2C+congenital%2C+with+anhidrosis/3832;MedGen:C0020074;OMIM:256800;Office of Rare Diseases:3006;Orphanet:642;SNOMED CT:62985007	2001-02-01	0	1	PASS	5125	4832	136	5104	121412	120020	0.042	90	279	4	190	3639	37	865	9870	11536	8640	6480	66140	892	16462	1900784	90	269	4	184	3447	35	803	0	5	0	3	96	1	31	3026	2078	66852	53168	111	2160	8	3639	66140	NFE
1	156848946	G	T	156848946	156848946	+	Haplotype	12304	RCV000030667	SCV000033344	27347	NTRK1	NM_002529.3:c.1838G>T	NP_002520.2:p.Gly613Val	NM_001007792.1:c.1730G>T:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Aug 08, 2017	OMIM	OMIM	Hereditary insensitivity to pain with anhidrosis;INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	10330344;11159935;20301726					germline	GeneReviews:NBK1769;Genetic Alliance:Insensitivity+to+pain%2C+congenital%2C+with+anhidrosis/3832;MedGen:C0020074;OMIM:256800;Office of Rare Diseases:3006;Orphanet:642;SNOMED CT:62985007	2001-02-01	1	1	PASS	5116	4825	138	5101	121412	120296	0.042	95	279	4	193	3639	37	854	10074	11522	8640	6466	66232	898	16464	1888102	95	269	4	185	3443	35	794	0	5	0	4	98	1	30	3020	2081	66892	53404	109	2158	8	3639	66232	NFE
1	161276217	G	C	161276217	161276217	-	Haplotype	14182	RCV000015246	SCV000035505	38403	MPZ	NM_000530.7:c.486C>G	NP_000521.2:p.Ile162Met	NM_000530.7:c.486C>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 01, 2002	OMIM	OMIM	Charcot-Marie-Tooth disease type 2I;CHARCOT-MARIE-TOOTH DISEASE, TYPE 2I	11835375;20301462;9222756					germline	GeneReviews:NBK1285;Genetic Alliance:Charcot-Marie-Tooth+Disease+Type+2I/1300;MedGen:C1843251;OMIM:607677;Office of Rare Diseases:9197;Orphanet:99942	2002-02-01	0	0																																															
1	161276564	C	T	161276564	161276564	-	Haplotype	14180	RCV000015243	SCV000035502	38402	MPZ	NM_000530.7:c.382G>A	NP_000521.2:p.Asp128Asn	NM_000530.7:c.382G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1997	OMIM	OMIM	Dejerine-sottas syndrome, sporadic;DEJERINE-SOTTAS SYNDROME, SPORADIC	9222756					germline	MedGen:C4016265	1997-01-01	0	0																																															
1	161276600	T	G	161276600	161276600	-	Haplotype	14180	RCV000015243	SCV000035502	38401	MPZ	NM_000530.7:c.346A>C	NP_000521.2:p.Asn116His	NM_000530.7:c.346A>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1997	OMIM	OMIM	Dejerine-sottas syndrome, sporadic;DEJERINE-SOTTAS SYNDROME, SPORADIC	9222756					germline	MedGen:C4016265	1997-01-01	0	0																																															
1	161276605	A	G	161276605	161276605	-	Haplotype	14180	RCV000015243	SCV000035502	29219	MPZ	NM_000530.7:c.341T>C	NP_000521.2:p.Ile114Thr	NM_000530.7:c.341T>C:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	May 25, 2017	OMIM	OMIM	Dejerine-sottas syndrome, sporadic;DEJERINE-SOTTAS SYNDROME, SPORADIC	9222756					germline	MedGen:C4016265	1997-01-01	1	0																																															
1	161276609	C	A	161276609	161276609	-	Haplotype	208147	RCV000194363	SCV000243903	49442	MPZ	NM_000530.7:c.337G>T	NP_000521.2:p.Val113Phe	NM_000530.7:c.337G>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 26, 2015	GeneReviews	GeneReviews	Charcot-Marie-Tooth disease, demyelinating, type 1b;Charcot-Marie-Tooth disease, type IB	20301384					germline	GeneReviews:NBK1205;Genetic Alliance:Charcot-Marie-Tooth+Disease+Type+1B/1285;MedGen:C0270912;OMIM:118200;Office of Rare Diseases:1246;Orphanet:101082;SNOMED CT:42986003	2015-03-26	0	0																																															
1	161276672	C	T	161276672	161276672	-	Haplotype	14182	RCV000015246	SCV000035505	38404	MPZ	NM_000530.7:c.274G>A	NP_000521.2:p.Val92Met	NM_000530.7:c.274G>A:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 21, 2017	OMIM	OMIM	Charcot-Marie-Tooth disease type 2I;CHARCOT-MARIE-TOOTH DISEASE, TYPE 2I	11835375;20301462;9222756					germline	GeneReviews:NBK1285;Genetic Alliance:Charcot-Marie-Tooth+Disease+Type+2I/1300;MedGen:C1843251;OMIM:607677;Office of Rare Diseases:9197;Orphanet:99942	2002-02-01	0	0																																															
1	161276680	A	T	161276680	161276680	-	Haplotype	14182	RCV000015246	SCV000035505	29221	MPZ	NM_000530.7:c.266T>A	NP_000521.2:p.Ile89Asn	NM_000530.7:c.266T>A:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jul 21, 2017	OMIM	OMIM	Charcot-Marie-Tooth disease type 2I;CHARCOT-MARIE-TOOTH DISEASE, TYPE 2I	11835375;20301462;9222756					germline	GeneReviews:NBK1285;Genetic Alliance:Charcot-Marie-Tooth+Disease+Type+2I/1300;MedGen:C1843251;OMIM:607677;Office of Rare Diseases:9197;Orphanet:99942	2002-02-01	1	0																																															
1	161276705	G	A	161276705	161276705	-	Haplotype	208147	RCV000194363	SCV000243903	49438	MPZ	NM_000530.7:c.241C>T	NP_000521.2:p.His81Tyr	NM_000530.7:c.241C>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Mar 26, 2015	GeneReviews	GeneReviews	Charcot-Marie-Tooth disease, demyelinating, type 1b;Charcot-Marie-Tooth disease, type IB	20301384					germline	GeneReviews:NBK1205;Genetic Alliance:Charcot-Marie-Tooth+Disease+Type+1B/1285;MedGen:C0270912;OMIM:118200;Office of Rare Diseases:1246;Orphanet:101082;SNOMED CT:42986003	2015-03-26	0	0																																															
1	161599693	T	C	161599693	161599693	-	Haplotype	36924	RCV000030607	SCV000053285	45587	FCGR3B	NM_000570.4:c.194A>G	NP_000561.3:p.Asn65Ser	NM_000570.4:c.194A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 1989	OMIM	OMIM	Neutrophil-specific antigens na1/na2;NEUTROPHIL-SPECIFIC ANTIGENS NA1/NA2	2478590					germline	MedGen:C4017227	1989-11-01	0	0	VQSRTrancheSNP99.90to99.95	71082	28152	21003	70158	120932	119168	0.588	5574	4878	2987	3977	42904	551	9287	9786	11338	8482	6480	65886	890	16306	4489820	1836	3500	2195	1609	15222	179	3611	1869	689	396	1184	13841	186	2838	39601	30557	66260	52908	1225	2138	384	42904	65886	NFE
1	171076966	G	A	171076966	171076966	+	Haplotype	16318;217371	RCV000017711;RCV000201276;RCV000201278	SCV000037988;SCV000256060;SCV000256061	38476	FMO3	NM_006894.5:c.472G>A	NP_008825.4:p.Glu158Lys	NM_001002294.2:c.472G>A:missense variant	Benign	pathogenic;likely pathogenic	2	1	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jun 14, 2016	OMIM;GeneReviews	OMIM;GeneReviews	Trimethylaminuria, mild;TRIMETHYLAMINURIA, MILD;Trimethylaminuria	10485731;10896299;11809920;20301282;22126753;19321370				loss of function	germline	MedGen:C4016101;GeneReviews:NBK1103;Genetic Alliance:Trimethylaminuria/7223;Genetic Testing Registry (GTR):GTR000505067;Genetic Testing Registry (GTR):GTR000518973;Genetic Testing Registry (GTR):GTR000520120;MedGen:C0342739;OMIM:602079;Office of Rare Diseases:6447;SNOMED CT:237959005	1999-09-04;2015-10-01	2	0	PASS	46481	27968	9246	46460	121412	121316	0.383	4851	3546	1755	2982	27552	369	5405	10396	11532	8642	6608	66718	908	16512	6503491	2543	2446	1407	1676	16164	213	3519	1154	550	174	653	5694	78	943	25569	20891	67240	54076	799	2164	181	4851	10396	AFR
1	171077295	T	C	171077295	171077295	+	Haplotype	217371	RCV000201278	SCV000256061	214011	FMO3	NM_006894.5:c.560T>C	NP_008825.4:p.Val187Ala	NM_001002294.2:c.560T>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 01, 2015	GeneReviews	GeneReviews	Trimethylaminuria	19321370;20301282;22126753				loss of function	germline	GeneReviews:NBK1103;Genetic Alliance:Trimethylaminuria/7223;Genetic Testing Registry (GTR):GTR000505067;Genetic Testing Registry (GTR):GTR000518973;Genetic Testing Registry (GTR):GTR000520120;MedGen:C0342739;OMIM:602079;Office of Rare Diseases:6447;SNOMED CT:237959005	2015-10-01	0	0																																															
1	171083242	A	G	171083242	171083242	+	Haplotype	16318	RCV000017711;RCV000201276	SCV000037988;SCV000256060	31357	FMO3	NM_006894.5:c.923A>G	NP_008825.4:p.Glu308Gly	NM_001002294.2:c.923A>G:missense variant	Benign	pathogenic;likely pathogenic	1	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 14, 2016	OMIM;GeneReviews	OMIM;GeneReviews	Trimethylaminuria, mild;TRIMETHYLAMINURIA, MILD;Trimethylaminuria	10485731;10896299;11809920;20301282;22126753				loss of function	germline	MedGen:C4016101;GeneReviews:NBK1103;Genetic Alliance:Trimethylaminuria/7223;Genetic Testing Registry (GTR):GTR000505067;Genetic Testing Registry (GTR):GTR000518973;Genetic Testing Registry (GTR):GTR000520120;MedGen:C0342739;OMIM:602079;Office of Rare Diseases:6447;SNOMED CT:237959005	1999-09-04;2015-10-01	0	0	PASS	18539	15070	1727	18524	121404	121124	0.153	404	976	1578	1646	12982	130	808	10402	11514	8614	6604	66620	906	16464	2534269	386	892	1286	1260	10378	112	756	9	42	146	193	1302	9	26	10074	8450	67132	53992	115	2148	8	12982	66620	NFE
1	179545050	C	A	179545050	179545050	-	Haplotype	225143	RCV000210779	SCV000266491	227036	NPHS2	NM_014625.3:c.-51G>T		NM_014625.3:c.-51G>T:5 prime UTR variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Jun 14, 2016	Human Genetics Disease in Children – Taif University,Taif University	Human Genetics Disease in Children – Taif University,Taif University	Nephrotic syndrome, idiopathic, steroid-resistant						unknown	Genetic Alliance:Nephrotic+syndrome%2C+idiopathic%2C+steroid-resistant/5149;MedGen:C1868672;OMIM:600995;Office of Rare Diseases:3946;Orphanet:656	2016-01-01	1	1	PASS	17582	2585	507	3599	98206	9850	0.179	162	612	142	149	2314	16	204	738	1316	970	288	5832	54	652	298255	134	394	126	81	1670	10	170	14	109	8	34	322	3	17	2081	1518	5684	4166	23	46	5	612	1316	AMR
1	179545051	G	C	179545051	179545051	-	Haplotype	225143	RCV000210779	SCV000266491	227037	NPHS2	NM_014625.3:c.-52C>G		NM_014625.3:c.-52C>G:5 prime UTR variant	Likely benign	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 14, 2016	Human Genetics Disease in Children – Taif University,Taif University	Human Genetics Disease in Children – Taif University,Taif University	Nephrotic syndrome, idiopathic, steroid-resistant						unknown	Genetic Alliance:Nephrotic+syndrome%2C+idiopathic%2C+steroid-resistant/5149;MedGen:C1868672;OMIM:600995;Office of Rare Diseases:3946;Orphanet:656	2016-01-01	0	0	PASS	972	168	15	198	103020	10624	0.009435	174	14	0	0	10	0	0	814	1426	1014	326	6290	58	696	300665	144	14	0	0	10	0	0	15	0	0	0	0	0	0	92	106	6118	4506	0	54	0	174	814	AFR
1	183543642	T	C	183543642	183543642	-	Haplotype	2240	RCV000002328	SCV000022486	38423	NCF2	NM_000433.3:c.481A>G	NP_000424.2:p.Lys161Glu	NM_000433.3:c.481A>G:missense variant;NM_001190789.1:c.366+3092A>G:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 24, 1997	OMIM	OMIM	Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2;GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II	22876374;9070911					germline	GeneReviews:NBK99496;Genetic Alliance:Chronic+granulomatous+disease%2C+autosomal+recessive+cytochrome+b-positive%2C+type+II/7977;MedGen:C1856245;OMIM:233710;Orphanet:379	1997-02-24	0	0																																															
1	183543644	T	A	183543644	183543644	-	Haplotype	2240	RCV000002328	SCV000022486	17279	NCF2	NM_000433.3:c.479A>T	NP_000424.2:p.Asp160Val	NM_000433.3:c.479A>T:missense variant;NM_001190789.1:c.366+3090A>T:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 24, 1997	OMIM	OMIM	Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2;GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II	22876374;9070911					germline	GeneReviews:NBK99496;Genetic Alliance:Chronic+granulomatous+disease%2C+autosomal+recessive+cytochrome+b-positive%2C+type+II/7977;MedGen:C1856245;OMIM:233710;Orphanet:379	1997-02-24	0	0																																															
1	207627693	T	C	207627693	207627693	+	Haplotype	17065	RCV000018594	SCV000038877	472254	CR2	NM_001006658.2:c.-71T>C			-	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 06, 2007	OMIM	OMIM	Systemic lupus erythematosus 9;SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9	17360460					germline	Genetics Home Reference:systemic-lupus-erythematosus;MedGen:C1970455;OMIM:120650.0001;OMIM:610927	2007-03-06	0	0																																															
1	207646322	G	A	207646322	207646322	+	Haplotype	17065	RCV000018594	SCV000038877	389365	CR2	NM_001006658.2:c.1776G>A	NP_001006659.1:p.Leu592=	NM_001006658.2:c.1776G>A:synonymous variant	Benign	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 28, 2016	OMIM	OMIM	Systemic lupus erythematosus 9;SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9	17360460					germline	Genetics Home Reference:systemic-lupus-erythematosus;MedGen:C1970455;OMIM:120650.0001;OMIM:610927	2007-03-06	0	0	PASS	42517	25721	8378	42477	121402	121200	0.35	7264	2563	1871	2020	23740	336	4683	10406	11478	8636	6602	66664	904	16510	3647570	2190	2011	1439	1424	15218	208	3231	2537	276	216	298	4261	64	726	22908	19569	67164	54036	657	2164	107	7264	10406	AFR
1	207646462	G	A	207646462	207646462	+	Haplotype	17065	RCV000018594	SCV000038877	389363	CR2	NM_001006658.2:c.1916G>A	NP_001006659.1:p.Ser639Asn	NM_001006658.2:c.1916G>A:missense variant	Benign	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 28, 2016	OMIM	OMIM	Systemic lupus erythematosus 9;SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9	17360460					germline	Genetics Home Reference:systemic-lupus-erythematosus;MedGen:C1970455;OMIM:120650.0001;OMIM:610927	2007-03-06	0	0	PASS	32807	23245	4776	32797	121406	121270	0.27	3969	1854	969	1543	20619	252	3591	10406	11494	8644	6614	66698	908	16506	3956612	2445	1560	871	1217	14259	182	2711	762	147	49	163	3180	35	440	18025	14772	67214	54056	515	2164	69	3969	10406	AFR
1	209880216	C	CA	209880218	209880218	+	Haplotype	8911	RCV000009466	SCV000029684	23950	HSD11B1	NM_181755.2:c.331+53_331+54insA		NM_181755.2:c.331+53_331+54insA:intron variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 2007	OMIM	OMIM	Cortisone reductase deficiency 2;RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	12858176;15827106;16091483;16817821;17062770					germline	Genetic Alliance:CORTISONE+REDUCTASE+DEFICIENCY+2/8103;MedGen:C3553382;OMIM:614662;Orphanet:168588	2007-01-01	0	0	PASS	25131	19667	2725	25117	121410	121300	0.207	1890	2433	1895	1777	14052	194	2876	10404	11544	8630	6604	66700	908	16510	5487238	1520	1881	1451	1295	11030	146	2344	185	276	222	241	1511	24	266	13804	11313	67216	54084	364	2162	39	1895	8630	EAS
1	209880259	T	G	209880259	209880259	+	Haplotype	8911	RCV000009466	SCV000029684	76328	HSD11B1	NM_181755.2:c.332-29T>G		NM_181755.2:c.332-29T>G:intron variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 2007	OMIM	OMIM	Cortisone reductase deficiency 2;RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	12858176;15827106;16091483;16817821;17062770					germline	Genetic Alliance:CORTISONE+REDUCTASE+DEFICIENCY+2/8103;MedGen:C3553382;OMIM:614662;Orphanet:168588	2007-01-01	0	0	PASS	25088	19636	2719	25074	121412	121342	0.207	1879	2437	1897	1778	14056	192	2835	10404	11560	8634	6610	66714	908	16512	4533896	1513	1885	1453	1294	11034	146	2311	183	276	222	242	1511	23	262	13790	11284	67256	54086	363	2164	39	1897	8634	EAS
1	211093297	C	G	211093297	211093297	-	Haplotype	203434	RCV000185594	SCV000238503	181518	KCNH1	NM_172362.2:c.1147G>C	NP_758872.1:p.Val383Leu	NM_172362.2:c.1147G>C:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Jun 01, 2015	OMIM	OMIM	Zimmermann-Laband syndrome 1;ZIMMERMANN-LABAND SYNDROME 1	18541964;25915598					germline	Gene:353173;Genetic Alliance:Laband+syndrome/4062;MedGen:CN032818;OMIM:135500;Orphanet:3473	2015-06-01	0	0																																															
1	211093389	G	T	211093389	211093389	-	Haplotype	203434	RCV000185594	SCV000238503	181521	KCNH1	NM_002238.3:c.974C>A	NP_758872.1:p.Ser352Tyr	NM_172362.2:c.1055C>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Jun 01, 2015	OMIM	OMIM	Zimmermann-Laband syndrome 1;ZIMMERMANN-LABAND SYNDROME 1	18541964;25915598					germline	Gene:353173;Genetic Alliance:Laband+syndrome/4062;MedGen:CN032818;OMIM:135500;Orphanet:3473	2015-06-01	0	0																																															
1	227170697	C	T	227170697	227170697	+	Haplotype	217876	RCV000201953	SCV000256872	214530	COQ8A	NM_020247.4:c.1042C>T	NP_064632.2:p.Arg348Ter	NM_020247.4:c.1042C>T:nonsense	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 2017	Mendelics Analise Genomica	Mendelics Analise Genomica	Coenzyme Q10 deficiency, primary, 4	18319072;20580948;28125198					germline	GeneReviews:NBK410087;Genetic Alliance:Spinocerebellar+ataxia%2C+autosomal+recessive+9/9342;MedGen:C2677589;OMIM:612016;Orphanet:139485	2014-06-16	0	0	PASS	4	3	0	3	120686	58456	3.314e-05	0	0	0	0	3	0	0	4866	4702	3558	2054	31740	436	11100	775209	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0	3	33788	24668	0	1760	0	3	31740	NFE
1	227173033	G	A	227173033	227173033	+	Haplotype	217876	RCV000201953	SCV000256872	18675	COQ8A	NM_020247.4:c.1651G>A	NP_064632.2:p.Glu551Lys	NM_020247.4:c.1651G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Oct 11, 2016	Mendelics Analise Genomica	Mendelics Analise Genomica	Coenzyme Q10 deficiency, primary, 4	18319072;20580948;28125198					germline	GeneReviews:NBK410087;Genetic Alliance:Spinocerebellar+ataxia%2C+autosomal+recessive+9/9342;MedGen:C2677589;OMIM:612016;Orphanet:139485	2014-06-16	1	0	PASS	1	1	0	1	121412	119888	8.236e-06	0	0	0	0	1	0	0	10200	11516	8524	6602	65656	894	16496	3027514	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	66894	52994	0	2164	0	1	65656	NFE
1	229568534	G	A	229568534	229568534	-	Haplotype	18293	RCV000019955	SCV000040253	38498	ACTA1	NM_001100.3:c.223C>T	NP_001091.1:p.His75Tyr	NM_001100.3:c.223C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 2009	OMIM	OMIM	Nemaline myopathy 3;NEMALINE MYOPATHY 3	19553116;20301465;22510848					germline	GeneReviews:NBK1288;Genetic Alliance:Nemaline+myopathy+3/5125;MedGen:C1834336;OMIM:161800;Office of Rare Diseases:10111	2009-07-01	0	0																																															
1	229568535	C	A	229568535	229568535	-	Haplotype	18293	RCV000019955	SCV000040253	33332	ACTA1	NM_001100.3:c.222G>T	NP_001091.1:p.Glu74Asp	NM_001100.3:c.222G>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 2009	OMIM	OMIM	Nemaline myopathy 3;NEMALINE MYOPATHY 3	19553116;20301465;22510848					germline	GeneReviews:NBK1288;Genetic Alliance:Nemaline+myopathy+3/5125;MedGen:C1834336;OMIM:161800;Office of Rare Diseases:10111	2009-07-01	0	0																																															
1	231557255	C	G	231557255	231557255	-	Haplotype	156155	RCV000144173	SCV000189250	165954	EGLN1	NM_022051.2:c.380G>C	NP_071334.1:p.Cys127Ser	NM_022051.2:c.380G>C:missense variant	Benign, Affects	affects	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 14, 2016	OMIM	OMIM	Hemoglobin, high altitude adaptation;HEMOGLOBIN, HIGH ALTITUDE ADAPTATION	25129147					germline	MedGen:C1836778;OMIM:609070	2014-09-01	0	0	PASS	731	10	11	32	7818	108	0.094	10	0	9	0	11	0	2	20	4	14	2	66	0	2	13594	2	0	3	0	5	0	0	4	0	3	0	3	0	1	22	10	72	36	0	0	0	2	2	SAS
1	231557623	G	C	231557623	231557623	-	Haplotype	156155	RCV000144173	SCV000189250	227498	EGLN1	NM_022051.2:c.12C>G	NP_071334.1:p.Asp4Glu	NM_022051.2:c.12C>G:missense variant	Benign/Likely benign	affects	0	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Apr 12, 2017	OMIM	OMIM	Hemoglobin, high altitude adaptation;HEMOGLOBIN, HIGH ALTITUDE ADAPTATION	25129147					germline	MedGen:C1836778;OMIM:609070	2014-09-01	2	0	PASS	217	112	0	112	109966	34066	0.001973	0	28	65	0	3	0	16	1648	2826	2192	740	17340	250	9070	480729	0	28	65	0	3	0	16	0	0	0	0	0	0	0	65	47	21368	12698	2	1550	0	65	2192	EAS
2	45169449	G	A	45169449	45169449	+	Haplotype	441532	RCV000006470	SCV000026653	21137	SIX3	NM_005413.3:c.206G>A	NP_005404.1:p.Gly69Asp	NM_005413.3:c.206G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 01, 2006	OMIM	OMIM	Holoprosencephaly 2;HOLOPROSENCEPHALY 2	17001667;20301702					germline	GeneReviews:NBK1530;Genetic Alliance:Holoprosencephaly+2/8559;MedGen:C1834877;OMIM:157170;Orphanet:2162	2006-12-01	0	0	PASS	8	5	0	5	113408	61804	7.054e-05	0	0	0	0	5	0	0	3422	6786	4734	3012	31462	464	11924	764549	0	0	0	0	5	0	0	0	0	0	0	0	0	0	4	1	37342	24462	0	1822	0	5	31462	NFE
2	47273468	A	G	47273468	47273468	+	Haplotype	190388	RCV000170526	SCV000223091	188215	TTC7A	NM_020458.3:c.1817A>G	NP_065191.2:p.Lys606Arg	NM_001288953.1:c.1715A>G:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 24, 2017	OMIM	OMIM	Multiple gastrointestinal atresias;GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME	23830146					germline	MedGen:C0220744;OMIM:243150;OMIM:609332.0001;OMIM:609332.0002;OMIM:609332.0003;OMIM:609332.0004;OMIM:609332.0005;OMIM:609332.0006;OMIM:609332.0007;OMIM:609332.0008;OMIM:609332.0009;OMIM:609332.0010;OMIM:609332.0011;OMIM:609332.0012;OMIM:609332.0013;OMIM:609332.0014;OMIM:609332.0015;Office of Rare Diseases:3013;Orphanet:2300;Orphanet:436252;SNOMED CT:95472001	2013-09-01	0	1	PASS	250	246	2	250	121412	121278	0.002059	2	5	0	7	232	4	0	10400	11568	8652	6602	66640	904	16512	2386988	2	5	0	7	228	4	0	0	0	0	0	2	0	0	123	127	67258	54020	0	2164	0	232	66640	NFE
2	47277182	T	C	47277182	47277182	+	Haplotype	190388	RCV000170526	SCV000223091	188216	TTC7A	NM_020458.3:c.2014T>C	NP_065191.2:p.Ser672Pro	NM_001288953.1:c.1912T>C:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 24, 2017	OMIM	OMIM	Multiple gastrointestinal atresias;GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME	23830146					germline	MedGen:C0220744;OMIM:243150;OMIM:609332.0001;OMIM:609332.0002;OMIM:609332.0003;OMIM:609332.0004;OMIM:609332.0005;OMIM:609332.0006;OMIM:609332.0007;OMIM:609332.0008;OMIM:609332.0009;OMIM:609332.0010;OMIM:609332.0011;OMIM:609332.0012;OMIM:609332.0013;OMIM:609332.0014;OMIM:609332.0015;Office of Rare Diseases:3013;Orphanet:2300;Orphanet:436252;SNOMED CT:95472001	2013-09-01	0	1	PASS	247	245	1	247	121412	120956	0.002034	2	5	0	7	229	4	0	10372	11530	8642	6568	66500	900	16444	1529863	2	5	0	7	227	4	0	0	0	0	0	1	0	0	121	126	67110	53846	0	2158	0	229	66500	NFE
2	74692046	C	T	74692046	74692046	-	Haplotype	375688	RCV000114957	SCV000148867	214379	MOGS	NM_006302.2:c.329G>A	NP_006293.2:p.Arg110His	NM_006302.2:c.329G>A:missense variant	Likely pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 01, 2015	OMIM	OMIM	Congenital disorder of glycosylation type 2B;CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb	20301507;24716661					germline	Genetic Alliance:CONGENITAL+DISORDER+OF+GLYCOSYLATION%2C+TYPE+IIb/8057;MedGen:C1853736;OMIM:606056;Office of Rare Diseases:10767;Orphanet:79330	2014-04-24	0	0																																															
2	74692310	G	T	74692310	74692310	-	Haplotype	375688	RCV000114957	SCV000148867	132608	MOGS	NM_006302.2:c.65C>A	NP_006293.2:p.Ala22Glu	NM_001146158.1:c.-59+131C>A:intron variant;NM_006302.2:c.65C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 24, 2014	OMIM	OMIM	Congenital disorder of glycosylation type 2B;CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb	20301507;24716661					germline	Genetic Alliance:CONGENITAL+DISORDER+OF+GLYCOSYLATION%2C+TYPE+IIb/8057;MedGen:C1853736;OMIM:606056;Office of Rare Diseases:10767;Orphanet:79330	2014-04-24	0	0	AC_Adj0_Filter	3	0	0	0	108728	12656	2.759e-05	0	0	0	0	0	0	0	642	260	648	66	4136	114	6790	343346	0	0	0	0	0	0	0	0	0	0	0	0	0	0	.	.	8854	3802	.	1278	.	NA	NA	NA
2	86444224	T	C	86444224	86444224	-	Distinct chromosomes	157528	RCV000144873	SCV000172145	167389	REEP1	NM_001164730.1:c.626A>G	NP_001158202.1:p.Ter209Trp	NM_001164730.1:c.626A>G:stop lost;NM_001164732.1:c.370A>G:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 2013	Section of Medical Genetics, Telemark Hospital	Section of Medical Genetics, Telemark Hospital	Charcot-Marie-Tooth disease;axonal type|spasticity;Charcot-Marie-Tooth disease	20301532;25025039					tested-inconclusive	GeneReviews:NBK1358;Genetic Alliance:Charcot-Marie-Tooth+Disease/1276;Genetics Home Reference:charcot-marie-tooth-disease;MedGen:C0007959;OMIM:PS118220;Office of Rare Diseases:6034;SNOMED CT:50548001	2013-11-01	0	0																																															
2	128412067	G	A	128412067	128412067	-	Haplotype	222901	RCV000208555	SCV000264322	224616	LIMS2	NM_001161404.1:c.275C>T	NP_001154876.1:p.Pro92Leu	NM_001161404.1:c.275C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 12, 2016	OMIM	OMIM	Muscular dystrophy, limb-girdle, type 2W;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W (1 family)	25589244					germline	MedGen:C4225192;OMIM:616827	2016-08-12	0	0	PASS	4	4	0	4	121412	121318	3.295e-05	0	0	0	0	4	0	0	10402	11576	8652	6614	66658	904	16512	3031983	0	0	0	0	4	0	0	0	0	0	0	0	0	0	3	1	67274	54044	0	2164	0	4	66658	NFE
2	128412081	G	C	128412081	128412081	-	Haplotype	222901	RCV000208555	SCV000264322	224615	LIMS2	NM_001136037.2:c.342C>G	NP_001154876.1:p.Asn87Lys	NM_001161404.1:c.261C>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 12, 2016	OMIM	OMIM	Muscular dystrophy, limb-girdle, type 2W;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W (1 family)	25589244					germline	MedGen:C4225192;OMIM:616827	2016-08-12	0	0	PASS	4	4	0	4	121412	121318	3.295e-05	0	0	0	0	4	0	0	10400	11576	8652	6614	66660	904	16512	3032673	0	0	0	0	4	0	0	0	0	0	0	0	0	0	3	1	67272	54046	0	2164	0	4	66660	NFE
2	167129256	C	A	167129256	167129256	-	Haplotype	441531	RCV000023304	SCV000044595	39316	SCN9A	NM_002977.3:c.2971G>T	NP_002968.1:p.Val991Leu	NM_002977.3:c.2971G>T:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Aug 22, 2017	OMIM	OMIM	Small fiber neuropathy;NEUROPATHY, SMALL FIBER	21698661					germline	GeneTests:320010;Genetics Home Reference:small-fiber-neuropathy;MedGen:C3276709;OMIM:133020	2012-01-01	1	1	PASS	3502	2687	353	3393	120588	109198	0.029	31	2542	513	0	150	7	150	9304	11018	8238	6464	62624	794	10756	1319264	29	1862	495	0	148	7	146	1	340	9	0	1	0	2	1425	1968	59620	49578	19	1098	1	2542	11018	AMR
2	167133540	T	G	167133540	167133540	-	Haplotype	441531	RCV000023304	SCV000044595	39315	SCN9A	NM_002977.3:c.2794A>C	NP_002968.1:p.Met932Leu	NM_002977.3:c.2794A>C:missense variant	Benign/Likely benign	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 22, 2017	OMIM	OMIM	Small fiber neuropathy;NEUROPATHY, SMALL FIBER	21698661					germline	GeneTests:320010;Genetics Home Reference:small-fiber-neuropathy;MedGen:C3276709;OMIM:133020	2012-01-01	0	0	PASS	3581	2806	387	3580	121412	121398	0.029	31	2664	527	0	158	7	193	10406	11570	8652	6614	66736	908	16512	2547529	29	1918	507	0	156	7	189	1	373	10	0	1	0	2	1547	2033	67280	54118	25	2164	1	2664	11570	AMR
2	179395322	AC	A	179395323	179395323	-	Haplotype	178839	RCV000155611	SCV000205319	172806	TTN	NM_133378.4:c.98315delG	NP_001254479.2:p.Gly35340Valfs	NM_001267550.2:c.106019delG:frameshift variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Sep 27, 2013	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Autosomal recessive centronuclear myopathy	22617344;23975875;24033266					germline	Genetic Alliance:Autosomal+recessive+centronuclear+myopathy/7787;Genetics Home Reference:centronuclear-myopathy;MedGen:C0410204;OMIM:255200;Orphanet:169186;Orphanet:ORPHA169186;SNOMED CT:240081004	2013-09-27	0	0																																															
2	179434462	ATGTT	A	179434463	179434466	-	Haplotype	178839	RCV000155611	SCV000205319	172708	TTN	NM_001267550.2:c.76393_76396delAACA	NP_001254479.2:p.Asn25465Terfs	NM_001267550.2:c.76393_76396delAACA:frameshift variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Sep 27, 2013	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Autosomal recessive centronuclear myopathy	22617344;23975875;24033266					germline	Genetic Alliance:Autosomal+recessive+centronuclear+myopathy/7787;Genetics Home Reference:centronuclear-myopathy;MedGen:C0410204;OMIM:255200;Orphanet:169186;Orphanet:ORPHA169186;SNOMED CT:240081004	2013-09-27	0	0																																															
2	179472292	T	A	179472292	179472292	-	Haplotype	179465	RCV000156254	SCV000205970	56237	TTN	NM_001267550.2:c.53123A>T	NP_597676.3:p.Lys8768Ile	NM_001267550.2:c.53123A>T:missense variant	Benign/Likely benign	uncertain significance	0	0	1	0	0	criteria provided, multiple submitters, no conflicts	criteria provided, single submitter	Aug 08, 2017	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-03-04	2	0	PASS	3516	3333	91	3515	120844	120548	0.029	36	408	888	349	1695	24	115	9746	11562	8604	6614	66622	900	16500	2897017	36	390	800	327	1647	22	111	0	9	44	11	24	1	2	1794	1721	67220	53328	15	2164	1	888	8604	EAS
2	179472293	T	C	179472293	179472293	-	Haplotype	179465	RCV000156254	SCV000205970	173874	TTN	NM_001267550.2:c.53122A>G	NP_001254479.2:p.Lys17708Glu	NM_001267550.2:c.53122A>G:missense variant	Conflicting interpretations of pathogenicity	uncertain significance	0	0	1	0	0	no assertion for the individual variant	criteria provided, single submitter	Aug 31, 2016	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-03-04	0	1	PASS	41	41	0	41	120842	120534	0.0003393	0	5	0	0	33	0	3	9744	11564	8604	6614	66608	900	16500	1983098	0	5	0	0	33	0	3	0	0	0	0	0	0	0	25	16	67220	53314	1	2164	0	33	66608	NFE
2	189861915	C	T	189861915	189861915	+	Haplotype	101229	RCV000087466	SCV000120353	106974	COL3A1	NM_000090.3:c.1786C>T	NP_000081.1:p.Arg596Ter	NM_000090.3:c.1786C>T:nonsense	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 19, 2017	Collagen Diagnostic Laboratory	Collagen Diagnostic Laboratory	Ehlers-Danlos syndrome, type 4;Ehlers-Danlos syndrome, type 4	20301667;23788249;24882528;25173340;25355838;25356965;27854360					germline	GeneReviews:NBK1494;Genetic Alliance:Ehlers-Danlos+Syndrome+Vascular+Type/2491;MedGen:C0268338;OMIM:130050;Orphanet:286;SNOMED CT:17025000	0000-00-00	0	0																																															
2	189874931	G	A	189874931	189874931	+	Haplotype	101229	RCV000087466	SCV000120353	106975	COL3A1	NM_000090.3:c.3851G>A	NP_000081.1:p.Gly1284Glu	NM_000090.3:c.3851G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Collagen Diagnostic Laboratory	Collagen Diagnostic Laboratory	Ehlers-Danlos syndrome, type 4;Ehlers-Danlos syndrome, type 4	20301667;23788249;24882528;25173340;25355838;25356965;27854360					germline	GeneReviews:NBK1494;Genetic Alliance:Ehlers-Danlos+Syndrome+Vascular+Type/2491;MedGen:C0268338;OMIM:130050;Orphanet:286;SNOMED CT:17025000	0000-00-00	0	0																																															
2	201436518	CAG	C	201436522	201436523		Haplotype	375673	RCV000417144	SCV000494729	362513	CLDN14	NM_152524.5:c.1453_1454delGA	NP_689737.4:p.Glu485Lysfs	NM_152524.5:c.1453_1454delGA:frameshift variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Aug 30, 2016	Laboratory of Molecular Genetics,National Institutes of Health	Laboratory of Molecular Genetics,National Institutes of Health	Perrault Syndrome;Deafness;Primary ovarian insufficiency;Perrault Syndrome						germline	Illumina Clinical Services Laboratory,Illumina:37522;MedGen:CN239459	2016-08-30	0	0																																															
2	202574623	G	A	202574623	202574623	-	Haplotype	217879	RCV000201952	SCV000256875	214531	ALS2	NM_020919.3:c.4261C>T	NP_065970.2:p.Arg1421Ter	NM_020919.3:c.4261C>T:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 14, 2014	Mendelics Analise Genomica	Mendelics Analise Genomica	Infantile-onset ascending hereditary spastic paralysis	12919135;18394004;20301421				loss of function	germline	GeneReviews:NBK1243;Genetic Alliance:Infantile-onset+ascending+hereditary+spastic+paralysis/3819;Genetic Testing Registry (GTR):GTR000249543;Genetic Testing Registry (GTR):GTR000514976;Genetic Testing Registry (GTR):GTR000528540;MedGen:C1846588;OMIM:607225;Office of Rare Diseases:4914;Orphanet:293168	2014-07-14	0	0																																															
2	202588048	C	G	202588048	202588048	-	CompoundHeterozygote	42162	RCV000034989	SCV000058622	205072	ALS2	NM_020919.3:c.3624+5G>C		NM_020919.3:c.3624+5G>C:intron variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 10, 2011	GeneReviews	GeneReviews	Amyotrophic lateral sclerosis type 2;ALS2-Related Disorders	20018642;20301421;20301623					not provided	GeneReviews:NBK1243;Genetic Alliance:Amyotrophic+Lateral+Sclerosis+Type+2/404;MedGen:C1859807;OMIM:205100;OMIM:606352.0001;OMIM:606352.0011;OMIM:606352.0016;OMIM:606352.0017;Office of Rare Diseases:9470;Orphanet:300605	2011-02-10	0	0																																															
2	202588111	AC	A	202588112	202588112	-	CompoundHeterozygote	42162	RCV000034989	SCV000058622	51328	ALS2	NM_020919.3:c.3565delG	NP_065970.2:p.Val1189Trpfs	NM_020919.3:c.3565delG:frameshift variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 10, 2011	GeneReviews	GeneReviews	Amyotrophic lateral sclerosis type 2;ALS2-Related Disorders	20018642;20301421;20301623					not provided	GeneReviews:NBK1243;Genetic Alliance:Amyotrophic+Lateral+Sclerosis+Type+2/404;MedGen:C1859807;OMIM:205100;OMIM:606352.0001;OMIM:606352.0011;OMIM:606352.0016;OMIM:606352.0017;Office of Rare Diseases:9470;Orphanet:300605	2011-02-10	0	0																																															
2	202588148	C	A	202588148	202588148	-	CompoundHeterozygote	42138	RCV000034965	SCV000058589	205071	ALS2	NM_020919.3:c.3529G>T	NP_065970.2:p.Gly1177Ter	NM_020919.3:c.3529G>T:nonsense	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 10, 2011	GeneReviews	GeneReviews	Infantile-onset ascending hereditary spastic paralysis;ALS2-Related Disorders	18394004;20301421				loss of function	not provided	GeneReviews:NBK1243;Genetic Alliance:Infantile-onset+ascending+hereditary+spastic+paralysis/3819;Genetic Testing Registry (GTR):GTR000249543;Genetic Testing Registry (GTR):GTR000514976;Genetic Testing Registry (GTR):GTR000528540;MedGen:C1846588;OMIM:607225;Office of Rare Diseases:4914;Orphanet:293168	2011-02-10	0	0																																															
2	202611376	G	T	202611376	202611376	-	Haplotype	217879	RCV000201952	SCV000256875	214532	ALS2	NM_020919.3:c.1911C>A	NP_065970.2:p.Tyr637Ter	NM_020919.3:c.1911C>A:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 14, 2014	Mendelics Analise Genomica	Mendelics Analise Genomica	Infantile-onset ascending hereditary spastic paralysis	12919135;18394004;20301421				loss of function	germline	GeneReviews:NBK1243;Genetic Alliance:Infantile-onset+ascending+hereditary+spastic+paralysis/3819;Genetic Testing Registry (GTR):GTR000249543;Genetic Testing Registry (GTR):GTR000514976;Genetic Testing Registry (GTR):GTR000528540;MedGen:C1846588;OMIM:607225;Office of Rare Diseases:4914;Orphanet:293168	2014-07-14	0	0																																															
2	202611461	T	TCACTG	202611462	202611466	-	CompoundHeterozygote	42138	RCV000034965	SCV000058589	51304	ALS2	NM_020919.3:c.1821_1825dupCAGTG	NP_065970.2:p.Glu609Alafs	NM_020919.3:c.1821_1825dupCAGTG:frameshift variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 10, 2011	GeneReviews	GeneReviews	Infantile-onset ascending hereditary spastic paralysis;ALS2-Related Disorders	18394004;20301421				loss of function	not provided	GeneReviews:NBK1243;Genetic Alliance:Infantile-onset+ascending+hereditary+spastic+paralysis/3819;Genetic Testing Registry (GTR):GTR000249543;Genetic Testing Registry (GTR):GTR000514976;Genetic Testing Registry (GTR):GTR000528540;MedGen:C1846588;OMIM:607225;Office of Rare Diseases:4914;Orphanet:293168	2011-02-10	0	0																																															
2	228137806	G	A	228137806	228137806	+	Haplotype	397582	RCV000449541	SCV000537787	384474	COL4A3	NM_000091.4:c.1900G>A	NP_000082.2:p.Gly634Arg	NM_000091.4:c.1900G>A:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Alport syndrome, autosomal recessive	20301386;22166944					germline	GeneReviews:NBK1207;Genetic Alliance:Alport+Syndrome+Recessive+Type/337;MedGen:C1567744;OMIM:203780;Orphanet:63;Orphanet:88919	0000-00-00	0	0																																															
2	228137833	G	A	228137833	228137833	+	Haplotype	397582	RCV000449541	SCV000537787	285718	COL4A3	NM_000091.4:c.1927G>A	NP_000082.2:p.Gly643Ser	NM_000091.4:c.1927G>A:missense variant	Uncertain significance	likely pathogenic	0	1	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jun 14, 2016	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Alport syndrome, autosomal recessive	20301386;22166944					germline	GeneReviews:NBK1207;Genetic Alliance:Alport+Syndrome+Recessive+Type/337;MedGen:C1567744;OMIM:203780;Orphanet:63;Orphanet:88919	0000-00-00	1	0	VQSRTrancheSNP99.60to99.80	1	1	0	1	120784	118820	8.279e-06	0	0	0	0	1	0	0	9364	11458	8510	6586	65602	882	16418	2222275	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	66862	51958	0	2164	0	1	65602	NFE
2	233348866	G	A	233348866	233348866	-	Haplotype	235817	RCV000224367	SCV000281670	48091	ECEL1	NM_004826.3:c.1252C>T	NP_004817.2:p.Arg418Cys	NM_004826.3:c.1252C>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	criteria provided, single submitter	Feb 04, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301					inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457	2013-01-08	0	0	PASS	2	2	0	2	121406	120252	1.647e-05	1	0	0	0	1	0	0	10236	11534	8616	6582	65926	898	16460	1856008	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	2	67008	53244	0	2152	0	1	10236	AFR
2	233348866	G	T	233348866	233348866	-	Haplotype	235818	RCV000224716	SCV000281671	48089	ECEL1	NM_004826.3:c.1252C>A	NP_004817.2:p.Arg418Ser	NM_004826.3:c.1252C>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Feb 04, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301					inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457	2013-01-08	0	0																																															
2	233349179	T	A	233349179	233349179	-	Haplotype	235818	RCV000224716	SCV000281671	48090	ECEL1	NM_004826.3:c.1184+3A>T		NM_004826.3:c.1184+3A>T:intron variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Feb 04, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301					inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457	2013-01-08	0	0																																															
2	233349788	T	C	233349788	233349788	-	Haplotype	235820	RCV000224404	SCV000281673	237475	ECEL1	NM_004826.3:c.869A>G	NP_004817.2:p.Tyr290Cys	NM_004826.3:c.869A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jan 08, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301					inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457	2013-01-08	0	0																																															
2	233349963	CCCAT	AGC	233349963	233349967	-	Haplotype	235820	RCV000224404	SCV000281673	237476	ECEL1	NM_004826.3:c.797_801delATGGGinsGCT	NP_004817.2:p.Asp266Glyfs	NM_004826.3:c.797_801delATGGGinsGCT:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jan 08, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301					inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457	2013-01-08	0	0																																															
2	233350647	G	GT	233350648	233350648	-	Haplotype	235821	RCV000224209	SCV000281675	48087	ECEL1	NM_004826.3:c.716dupA	NP_004817.2:p.Tyr239Terfs	NM_004826.3:c.716dupA:frameshift variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Feb 04, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301					inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457	2013-01-08	0	0																																															
2	233350774	C	T	233350774	233350774	-	Haplotype	235817	RCV000224367	SCV000281670	48092	ECEL1	NM_004826.3:c.590G>A	NP_004817.2:p.Gly197Asp	NM_004826.3:c.590G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	criteria provided, single submitter	Feb 04, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301					inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457	2013-01-08	0	0																																															
2	233351008	CTGGCGTCCAGGT	C	233351009	233351020	-	Haplotype	235821	RCV000224209	SCV000281675	48088	ECEL1	NM_004826.3:c.344_355delACCTGGACGCCA	NP_004817.2:p.Asn115_Ala118del	NM_004826.3:c.344_355delACCTGGACGCCA:inframe_variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Feb 04, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301					inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457	2013-01-08	0	0																																															
2	241808719	T	TTCCTGGTTG	241808720	241808728	+	Haplotype	204181	RCV000186388	SCV000239738	200465	AGXT	NM_000030.2:c.299_307dupTCCTGGTTG	NP_000021.1:p.Val102_Gly103insValLeuVal	NM_000030.2:c.299_307dupTCCTGGTTG:inframe_variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 27, 2014	Clinical Biochemistry Laboratory,Health Services Laboratory	Clinical Biochemistry Laboratory,Health Services Laboratory	Primary hyperoxaluria, type I;Primary hyperoxaluria, type I	17460142;20301460;22547750				loss of function	germline	GeneReviews:NBK1283;Genetic Alliance:Primary+hyperoxaluria+type+1/5947;Genetic Testing Registry (GTR):GTR000118454;Genetic Testing Registry (GTR):GTR000507681;Genetic Testing Registry (GTR):GTR000514623;Genetic Testing Registry (GTR):GTR000515735;Genetic Testing Registry (GTR):GTR000515765;Genetic Testing Registry (GTR):GTR000521390;Genetic Testing Registry (GTR):GTR000528276;MedGen:C0268164;OMIM:259900;Office of Rare Diseases:2835;Orphanet:416;Orphanet:93598;SNOMED CT:65520001	2014-11-27	0	0																																															
2	241808729	G	A	241808729	241808729	+	Haplotype	204181	RCV000186388	SCV000239738	200466	AGXT	NM_000030.2:c.308G>A	NP_000021.1:p.Gly103Glu	NM_000030.2:c.308G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 27, 2014	Clinical Biochemistry Laboratory,Health Services Laboratory	Clinical Biochemistry Laboratory,Health Services Laboratory	Primary hyperoxaluria, type I;Primary hyperoxaluria, type I	17460142;20301460;22547750				loss of function	germline	GeneReviews:NBK1283;Genetic Alliance:Primary+hyperoxaluria+type+1/5947;Genetic Testing Registry (GTR):GTR000118454;Genetic Testing Registry (GTR):GTR000507681;Genetic Testing Registry (GTR):GTR000514623;Genetic Testing Registry (GTR):GTR000515735;Genetic Testing Registry (GTR):GTR000515765;Genetic Testing Registry (GTR):GTR000521390;Genetic Testing Registry (GTR):GTR000528276;MedGen:C0268164;OMIM:259900;Office of Rare Diseases:2835;Orphanet:416;Orphanet:93598;SNOMED CT:65520001	2014-11-27	0	0																																															
2	241815403	G	GA	241815404	241815405	+	Haplotype	204202	RCV000186409	SCV000239759	200559	AGXT	NM_000030.2:c.829_830insA	NP_000021.1:p.Ala277Aspfs	NM_000030.2:c.829_830insA:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 27, 2014	Clinical Biochemistry Laboratory,Health Services Laboratory	Clinical Biochemistry Laboratory,Health Services Laboratory	Primary hyperoxaluria, type I;Primary hyperoxaluria, type I	20301460;22547750				loss of function	germline	GeneReviews:NBK1283;Genetic Alliance:Primary+hyperoxaluria+type+1/5947;Genetic Testing Registry (GTR):GTR000118454;Genetic Testing Registry (GTR):GTR000507681;Genetic Testing Registry (GTR):GTR000514623;Genetic Testing Registry (GTR):GTR000515735;Genetic Testing Registry (GTR):GTR000515765;Genetic Testing Registry (GTR):GTR000521390;Genetic Testing Registry (GTR):GTR000528276;MedGen:C0268164;OMIM:259900;Office of Rare Diseases:2835;Orphanet:416;Orphanet:93598;SNOMED CT:65520001	2014-11-27	0	0																																															
2	241815405	C	A	241815405	241815405	+	Haplotype	204202	RCV000186409	SCV000239759	200560	AGXT	NM_000030.2:c.830C>A	NP_000021.1:p.Ala277Asp	NM_000030.2:c.830C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 27, 2014	Clinical Biochemistry Laboratory,Health Services Laboratory	Clinical Biochemistry Laboratory,Health Services Laboratory	Primary hyperoxaluria, type I;Primary hyperoxaluria, type I	20301460;22547750				loss of function	germline	GeneReviews:NBK1283;Genetic Alliance:Primary+hyperoxaluria+type+1/5947;Genetic Testing Registry (GTR):GTR000118454;Genetic Testing Registry (GTR):GTR000507681;Genetic Testing Registry (GTR):GTR000514623;Genetic Testing Registry (GTR):GTR000515735;Genetic Testing Registry (GTR):GTR000515765;Genetic Testing Registry (GTR):GTR000521390;Genetic Testing Registry (GTR):GTR000528276;MedGen:C0268164;OMIM:259900;Office of Rare Diseases:2835;Orphanet:416;Orphanet:93598;SNOMED CT:65520001	2014-11-27	0	0																																															
3	15676984	GCGGCTG	TCC	15676984	15676990	+	Haplotype	38562	RCV000021886	SCV000042553	16934	BTD	NM_000060.4:c.98_104delGCGGCTGinsTCC	NP_000051.1:p.Cys33Phefs	NM_000060.4:c.98_104delGCGGCTGinsTCC:frameshift variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Apr 19, 2017	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	14707518;15776412;20301497;22378278;22475884;9396567					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	2	0																																															
3	15677019	G	A	15677019	15677019	+	Haplotype	24975;38563	RCV000021890;RCV000021889	SCV000042558;SCV000042557	36313	BTD	NM_000060.4:c.133G>A	NP_000051.1:p.Gly45Arg	NM_000060.4:c.133G>A:missense variant	Conflicting interpretations of pathogenicity	pathogenic	2	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Nov 03, 2017	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency	10400129;15060693;15776412;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	1	1	PASS	1208	1186	11	1208	121412	121412	0.00995	30	45	0	156	891	9	77	10406	11578	8654	6614	66740	908	16512	3638704	30	43	0	156	873	9	75	0	1	0	0	9	0	1	666	542	67288	54124	13	2164	0	891	66740	NFE
3	15677045	C	A	15677045	15677045	+	Haplotype	24977	RCV000021892	SCV000042560	36316	BTD	NM_000060.4:c.159C>A	NP_000051.1:p.His53Gln	NM_000060.4:c.159C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 04, 2012	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	15776412;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0																																															
3	15677046	G	T	15677046	15677046	+	Haplotype	24977	RCV000021892	SCV000042560	36317	BTD	NM_000060.4:c.160G>T	NP_000051.1:p.Glu54Ter	NM_000060.4:c.160G>T:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 04, 2012	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	15776412;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0																																															
3	15677098	T	C	15677098	15677098	+	Haplotype	38562;38564	RCV000021886;RCV000021901	SCV000042553;SCV000042569	47043	BTD	NM_000060.4:c.212T>C	NP_000051.1:p.Leu71Pro	NM_000060.4:c.212T>C:missense variant	Conflicting interpretations of pathogenicity	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 09, 2016	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency	14707518;15776412;20301497;22378278;22475884;9396567;15060693					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	1	PASS	193	177	8	193	121412	121412	0.00159	0	1	0	0	0	0	192	10406	11578	8654	6614	66740	908	16512	3531980	0	1	0	0	0	0	176	0	0	0	0	0	0	8	151	42	67288	54124	21	2164	1	192	16512	SAS
3	15677121	C	T	15677121	15677121	+	Haplotype	38565;38566	RCV000021903;RCV000032009	SCV000042572;SCV000042573	16944	BTD	NM_000060.4:c.235C>T	NP_000051.1:p.Arg79Cys	NM_000060.4:c.235C>T:missense variant	Pathogenic	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 28, 2016	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency	10801053;15776412;16435182;20301497;22378278;22475884;10400129;9396567					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0																																															
3	15677122	G	A	15677122	15677122	+	Haplotype	38564	RCV000021901	SCV000042569	46851	BTD	NM_000060.4:c.236G>A	NP_000051.1:p.Arg79His	NM_000060.4:c.236G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 04, 2012	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	14707518;15060693;15776412;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0	PASS	1	1	0	1	121412	121410	8.236e-06	0	0	0	0	0	0	1	10406	11578	8654	6614	66738	908	16512	3521188	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	67288	54122	0	2164	0	1	16512	SAS
3	15677169	C	T	15677169	15677169	+	Haplotype	24994	RCV000021912	SCV000042581	36332	BTD	NM_000060.4:c.283C>T	NP_000051.1:p.Gln95Ter	NM_000060.4:c.283C>T:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 04, 2012	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129;15776412;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0																																															
3	15685833	G	A	15685833	15685833	+	Haplotype	38566;38568	RCV000032009;RCV000021933	SCV000042573;SCV000042602	46845	BTD	NM_000060.4:c.470G>A	NP_000051.1:p.Arg157His	NM_000060.4:c.470G>A:missense variant	Pathogenic	pathogenic	2	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	May 25, 2016	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency	10400129;10801053;15776412;16435182;20301497;22378278;22475884;9396567					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	2	0	PASS	15	15	0	15	121412	113646	0.0001235	1	2	1	0	11	0	0	9830	10524	7858	6194	62540	864	15836	1384144	1	2	1	0	11	0	0	0	0	0	0	0	0	0	7	8	63458	50188	0	2130	0	2	10524	AMR
3	15685874	G	A	15685874	15685874	+	Haplotype	25016	RCV000021936	SCV000022135;SCV000042605	36353	BTD	NM_000060.4:c.511G>A	NP_000051.1:p.Ala171Thr	NM_000060.4:c.511G>A:missense variant	Conflicting interpretations of pathogenicity	pathogenic;pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided;no assertion criteria provided	May 18, 2017	OMIM;ARUP Institute,ARUP Laboratories	OMIM;ARUP Institute,ARUP Laboratories	Biotinidase deficiency;BIOTINIDASE DEFICIENCY;Biotinidase deficiency	10400129;15776412;20301497;21228398;22378278;22475884;7509806;9375914;9654207					germline;not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2011-01-12;2012-12-04	0	1	PASS	47	47	0	47	121412	120592	0.0003871	1	2	0	0	44	0	0	10342	11484	8488	6588	66336	904	16450	1471711	1	2	0	0	44	0	0	0	0	0	0	0	0	0	27	20	66928	53664	0	2160	0	44	66336	NFE
3	15686004	A	G	15686004	15686004	+	Haplotype	25030	RCV000021952	SCV000042621	36367	BTD	NM_000060.4:c.641A>G	NP_000051.1:p.Asn214Ser	NM_000060.4:c.641A>G:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Aug 01, 2017	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129;15776412;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	1	1	PASS	6	6	0	6	121412	121412	4.942e-05	0	0	0	0	6	0	0	10406	11578	8654	6614	66740	908	16512	1487824	0	0	0	0	6	0	0	0	0	0	0	0	0	0	6	0	67288	54124	0	2164	0	6	66740	NFE
3	15686157	A	T	15686157	15686157	+	Haplotype	25042	RCV000021964	SCV000042634	36378	BTD	NM_000060.4:c.794A>T	NP_000051.1:p.His265Leu	NM_000060.4:c.794A>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Dec 04, 2012	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	12359137;20083419;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0																																															
3	15686228	G	C	15686228	15686228	+	Haplotype	38563	RCV000021889	SCV000042557	46848	BTD	NM_000060.4:c.865G>C	NP_000051.1:p.Ala289Pro	NM_000060.4:c.865G>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 04, 2012	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129;15060693;15776412;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0																																															
3	15686296	T	G	15686296	15686296	+	Haplotype	25042	RCV000021964	SCV000042634	36379	BTD	NM_000060.4:c.933T>G	NP_000051.1:p.Ser311Arg	NM_000060.4:c.933T>G:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 04, 2012	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	12359137;20083419;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0																																															
3	15686534	C	T	15686534	15686534	+	Haplotype	38571	RCV000021985	SCV000042655	46849	BTD	NM_001281724.2:c.1177C>T	NP_001268653.1:p.Pro393Ser	NM_000060.4:c.1171C>T:missense variant	Benign/Likely benign	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 18, 2017	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	11668630;15776412;20301497;22378278;22475884;9396567					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0	PASS	1698	1650	24	1698	121412	121406	0.014	56	58	0	79	1406	11	88	10404	11578	8654	6614	66736	908	16512	1782572	54	58	0	79	1360	11	88	1	0	0	0	23	0	0	912	786	67288	54118	11	2164	0	1406	66736	NFE
3	15686570	T	G	15686570	15686570	+	Haplotype	1904	RCV000001981	SCV000022139;SCV000042659	16943	BTD	NM_000060.4:c.1207T>G	NP_000051.1:p.Phe403Val	NM_000060.4:c.1207T>G:missense variant	Pathogenic	pathogenic;pathogenic	2	0	0	0	0	criteria provided, single submitter	no assertion criteria provided;no assertion criteria provided	Apr 29, 2016	OMIM;ARUP Institute,ARUP Laboratories	OMIM;ARUP Institute,ARUP Laboratories	Biotinidase deficiency;BIOTINIDASE DEFICIENCY;Biotinidase deficiency	10400129;15776412;20301497;22378278;22475884					germline;not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	1999-07-01;2012-12-04	1	0																																															
3	15686634	G	C	15686634	15686634	+	Haplotype	24975	RCV000021890	SCV000042558	36314	BTD	NM_000060.4:c.1271G>C	NP_000051.1:p.Cys424Ser	NM_000060.4:c.1271G>C:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 04, 2012	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129;15060693;15776412;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0																																															
3	15686693	G	C	15686693	15686693	+	Haplotype	1904;24994;25016;25030;38568	RCV000001981;RCV000021912;RCV000021936;RCV000021952;RCV000021933	SCV000022139;SCV000042659;SCV000042581;SCV000022135;SCV000042605;SCV000042621;SCV000042602	16939	BTD	NM_001281724.2:c.1336G>C	NP_001268653.1:p.Asp446His	NM_000060.4:c.1330G>C:missense variant	Pathogenic/Likely pathogenic	pathogenic	7	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jul 18, 2017	OMIM;ARUP Institute,ARUP Laboratories	OMIM;ARUP Institute,ARUP Laboratories	Biotinidase deficiency;BIOTINIDASE DEFICIENCY	10400129;15776412;20301497;22378278;22475884;21228398;7509806;9375914;9654207;16435182;9396567					germline;not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	1999-07-01;2012-12-04;2011-01-12	2	0	PASS	3844	3678	83	3844	121412	121398	0.032	67	176	1	357	2628	32	583	10400	11576	8654	6614	66734	908	16512	1920461	65	174	1	333	2522	32	551	1	1	0	12	53	0	16	2303	1541	67286	54112	59	2164	3	2628	66734	NFE
3	15686697	G	T	15686697	15686697	+	Haplotype	38571	RCV000021985	SCV000042655	36396	BTD	NM_000060.4:c.1334G>T	NP_000051.1:p.Gly445Val	NM_000060.4:c.1334G>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 10, 2017	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	11668630;15776412;20301497;22378278;22475884;9396567					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0																																															
3	15686724	A	C	15686724	15686724	+	Haplotype	38565	RCV000021903	SCV000042572	36326	BTD	NM_000060.4:c.1361A>C	NP_000051.1:p.Tyr454Ser	NM_000060.4:c.1361A>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 04, 2012	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10801053;15776412;16435182;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0																																															
3	33060002	G	A	33060002	33060002	-	Haplotype	208495	RCV000190508	SCV000245394	205010	GLB1	NM_000404.3:c.1285C>T	NP_000395.2:p.Pro429Ser	NM_000404.3:c.1285C>T:missense variant	Likely benign	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 18, 2017	Mendelics Analise Genomica	Mendelics Analise Genomica	Mucopolysaccharidosis, MPS-IV-B	24156116					germline	GeneReviews:NBK164500;Genetic Alliance:Morquio+syndrome+B/4877;MedGen:C0086652;OMIM:253010;Orphanet:582;SNOMED CT:238044004	2016-05-13	0	0	PASS	30	30	0	30	120894	120770	0.0002482	29	1	0	0	0	0	0	9804	11574	8626	6614	66740	900	16512	2048360	29	1	0	0	0	0	0	0	0	0	0	0	0	0	14	16	67260	53510	0	2164	0	29	9804	AFR
3	33065789	G	T	33065789	33065789	-	Haplotype	208495	RCV000190508	SCV000245394	205011	GLB1	NM_000404.3:c.1097C>A	NP_000395.2:p.Pro366His	NM_000404.3:c.1097C>A:missense variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	May 13, 2016	Mendelics Analise Genomica	Mendelics Analise Genomica	Mucopolysaccharidosis, MPS-IV-B	24156116					germline	GeneReviews:NBK164500;Genetic Alliance:Morquio+syndrome+B/4877;MedGen:C0086652;OMIM:253010;Orphanet:582;SNOMED CT:238044004	2016-05-13	0	0																																															
3	38593004	G	A	38593004	38593004	-	Haplotype	440848	RCV000009965	SCV000030186	38446	SCN5A	NM_198056.2:c.4859C>T	NP_932173.1:p.Thr1620Met	NM_000335.4:c.4856C>T:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Apr 28, 2017	OMIM	OMIM	Brugada syndrome 1;BRUGADA SYNDROME 1	10618304;19251209;20129283;20301690;21321465;21810866;23788249;25356965;27854360;9521325					germline	GeneReviews:NBK1517;MedGen:CN029323;OMIM:601144;Orphanet:130	2000-01-04	1	0	PASS	1	1	0	1	121412	120994	8.236e-06	0	0	0	0	1	0	0	10176	11574	8638	6614	66582	904	16506	2336339	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	67248	53746	0	2164	0	1	66582	NFE
3	38603947	G	A	38603947	38603947	-	Haplotype	440850	RCV000010010	SCV000030231	38448	SCN5A	NM_198056.2:c.3922C>T	NP_932173.1:p.Leu1308Phe	NM_000335.4:c.3919C>T:missense variant	Benign/Likely benign	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 31, 2017	OMIM	OMIM	Brugada syndrome 1;BRUGADA SYNDROME 1	10532948;15851227;18599870;19841300;20129283;20301690;21810866;23788249;25356965;27854360					germline	GeneReviews:NBK1517;MedGen:CN029323;OMIM:601144;Orphanet:130	2008-08-15	0	0	PASS	55	55	0	55	121092	99388	0.0004542	54	1	0	0	0	0	0	7948	8964	7182	4376	56946	690	13282	1217844	54	1	0	0	0	0	0	0	0	0	0	0	0	0	20	35	55196	44192	0	1802	0	54	7948	AFR
3	38608046	G	A	38608046	38608046	-	Haplotype	440848	RCV000009965	SCV000030186	24410	SCN5A	NM_198056.2:c.3694C>T	NP_932173.1:p.Arg1232Trp	NM_000335.4:c.3691C>T:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Sep 03, 2015	OMIM	OMIM	Brugada syndrome 1;BRUGADA SYNDROME 1	10618304;19251209;20129283;20301690;21321465;21810866;23788249;25356965;27854360;9521325					germline	GeneReviews:NBK1517;MedGen:CN029323;OMIM:601144;Orphanet:130	2000-01-04	1	1																																															
3	38645420	T	C	38645420	38645420	-	Haplotype	440849	RCV000010000	SCV000030221	38447	SCN5A	NM_198056.2:c.1673A>G	NP_932173.1:p.His558Arg	NM_000335.4:c.1673A>G:missense variant	Benign/Likely benign	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 14, 2016	OMIM	OMIM	Progressive familial heart block type 1A;PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA	10807545;11463728;11997281;12569159;12639704;14760;18378609;23788249;23994779;27854360					germline	Genetic Alliance:Progressive+familial+heart+block+type+1A/5978;Genetics Home Reference:progressive-familial-heart-block;MedGen:C1879286;OMIM:113900;OMIM:600163.0009;OMIM:600163.0017;OMIM:600163.0018;OMIM:600163.0031;Office of Rare Diseases:1093;Orphanet:871	2008-04-15	0	0	PASS	26760	20427	3143	26713	121010	120472	0.221	2818	2467	854	1337	14946	192	4099	9786	11534	8604	6606	66544	892	16506	2672730	1996	1907	778	1033	11522	146	3045	411	280	38	152	1712	23	527	15022	11691	67152	53320	562	2162	85	2818	9786	AFR
3	38645558	G	A	38645558	38645558	-	Haplotype	440849	RCV000010000	SCV000030221	24437	SCN5A	NM_198056.2:c.1535C>T	NP_932173.1:p.Thr512Ile	NM_198056.2:c.1535C>T:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Mar 27, 2016	OMIM	OMIM	Progressive familial heart block type 1A;PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA	10807545;11463728;11997281;12569159;12639704;14760;18378609;23788249;23994779;27854360					germline	Genetic Alliance:Progressive+familial+heart+block+type+1A/5978;Genetics Home Reference:progressive-familial-heart-block;MedGen:C1879286;OMIM:113900;OMIM:600163.0009;OMIM:600163.0017;OMIM:600163.0018;OMIM:600163.0031;Office of Rare Diseases:1093;Orphanet:871	2008-04-15	1	1	PASS	1	1	0	1	120884	67122	8.272e-06	0	0	0	0	1	0	0	5628	5044	4730	3180	37768	484	10288	803910	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	37270	29852	0	1566	0	1	37768	NFE
3	38655243	C	T	38655243	38655243	-	Haplotype	440850	RCV000010010	SCV000030231	24446	SCN5A	NM_001099404.1:c.703+223G>A	NP_932173.1:p.Val232Ile	NM_000335.4:c.694G>A:missense variant;NM_001099404.1:c.703+223G>A:intron variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Apr 21, 2017	OMIM	OMIM	Brugada syndrome 1;BRUGADA SYNDROME 1	10532948;15851227;18599870;19841300;20129283;20301690;21810866;23788249;25356965;27854360					germline	GeneReviews:NBK1517;MedGen:CN029323;OMIM:601144;Orphanet:130	2008-08-15	1	1	PASS	18	16	0	16	120888	51296	0.0001489	15	1	0	0	0	0	0	4748	3290	3456	2994	27054	450	9304	907327	15	1	0	0	0	0	0	0	0	0	0	0	0	0	9	7	27958	23338	0	1526	0	15	4748	AFR
3	39307162	G	A	39307162	39307162	-	Haplotype	8152	RCV000008629;RCV000008630;RCV000023109	SCV000028837;SCV000028838;SCV000044400	36774	CX3CR1	NM_001171174.1:c.935C>T	NP_001164645.1:p.Thr312Met	NM_001171174.1:c.935C>T:missense variant	-	pathogenic;protective;risk factor	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 18, 2015	OMIM	OMIM	Human immunodeficiency virus type 1, rapid progression to AIDS;HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RAPID PROGRESSION TO AIDS;Coronary artery disease, resistance to;MACULAR DEGENERATION, AGE-RELATED, 12, SUSCEPTIBILITY TO	10731151;11264153;12697743;15208270;17909628;23716478					germline	MedGen:C4016733;MedGen:C1832288;OMIM:601470.0001	2014-09-05;2015-05-18;2013-12-01	0	0	PASS	16453	13769	1342	16453	120882	120766	0.136	318	1899	202	1162	11021	113	1738	9802	11574	8626	6614	66738	900	16512	4583359	308	1553	194	962	9137	97	1518	5	173	4	100	942	8	110	9218	7235	67262	53504	206	2164	19	11021	66738	NFE
3	39307256	C	T	39307256	39307256	-	Haplotype	8152	RCV000008629;RCV000008630;RCV000023109	SCV000028837;SCV000028838;SCV000044400	23191	CX3CR1	NM_001171174.1:c.841G>A	NP_001164645.1:p.Val281Ile	NM_001171174.1:c.841G>A:missense variant	-	pathogenic;protective;risk factor	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 18, 2015	OMIM	OMIM	Human immunodeficiency virus type 1, rapid progression to AIDS;HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RAPID PROGRESSION TO AIDS;Coronary artery disease, resistance to;MACULAR DEGENERATION, AGE-RELATED, 12, SUSCEPTIBILITY TO	10731151;11264153;12697743;15208270;17909628;23716478					germline	MedGen:C4016733;MedGen:C1832288;OMIM:601470.0001	2014-09-05;2015-05-18;2013-12-01	0	0	PASS	26684	20134	3273	26680	120870	120764	0.221	1313	2676	207	1819	18225	195	2245	9798	11576	8626	6614	66738	900	16512	4301487	1145	2044	199	1327	13365	163	1891	84	316	4	246	2430	16	177	14843	11837	67260	53504	291	2164	33	18225	66738	NFE
3	42733468	T	C	42733468	42733468	+	Haplotype	228777	RCV000213109	SCV000271889	229063	KLHL40	NM_152393.3:c.1849T>C	NP_689606.2:p.Cys617Arg	NM_152393.3:c.1849T>C:missense variant	Benign	uncertain significance	0	0	1	0	0	criteria provided, multiple submitters, no conflicts	criteria provided, single submitter	Jan 05, 2016	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-12-18	2	0	PASS	99138	17290	40902	99094	121410	121324	0.817	9526	10636	8648	4727	50589	739	14229	10402	11572	8654	6586	66696	908	16506	4319513	804	834	6	1341	12241	137	1927	4361	4901	4321	1693	19174	301	6151	54546	44548	67242	54082	1842	2164	795	8648	8654	EAS
3	42733469	G	A	42733469	42733469	+	Haplotype	228777	RCV000213109	SCV000271889	229064	KLHL40	NM_152393.3:c.1850G>A	NP_689606.2:p.Cys617Tyr	NM_152393.3:c.1850G>A:missense variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	criteria provided, single submitter	Dec 18, 2015	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-12-18	0	0	PASS	5	5	0	5	121412	120944	4.118e-05	1	0	1	1	2	0	0	10380	11534	8650	6406	66620	894	16460	1868812	1	0	1	1	2	0	0	0	0	0	0	0	0	0	4	1	67084	53860	0	2162	0	1	8650	EAS
3	49160612	G	A	49160612	49160612	-	Haplotype	14535	RCV000015634	SCV000035899	38466	LAMB2	NM_002292.3:c.4177C>T	NP_002283.3:p.Leu1393Phe	NM_002292.3:c.4177C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 01, 2006	OMIM	OMIM	Nephrotic syndrome, type 5, with or without ocular abnormalities;NEPHROTIC SYNDROME, TYPE 5, WITH OCULAR ABNORMALITIES	16912710					germline	Genetic Alliance:Nephrotic+syndrome%2C+type+5%2C+with+or+without+ocular+abnormalities/8989;MedGen:C3280113;OMIM:150325.0006;OMIM:150325.0007;OMIM:150325.0008;OMIM:150325.0009;OMIM:150325.0010;OMIM:150325.0011;OMIM:614199;Orphanet:306507	2006-09-01	0	0																																															
3	49160649	G	T	49160649	49160649	-	Haplotype	14535	RCV000015634	SCV000035899	29574	LAMB2	NM_002292.3:c.4140C>A	NP_002283.3:p.Asn1380Lys	NM_002292.3:c.4140C>A:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Apr 25, 2017	OMIM	OMIM	Nephrotic syndrome, type 5, with or without ocular abnormalities;NEPHROTIC SYNDROME, TYPE 5, WITH OCULAR ABNORMALITIES	16912710					germline	Genetic Alliance:Nephrotic+syndrome%2C+type+5%2C+with+or+without+ocular+abnormalities/8989;MedGen:C3280113;OMIM:150325.0006;OMIM:150325.0007;OMIM:150325.0008;OMIM:150325.0009;OMIM:150325.0010;OMIM:150325.0011;OMIM:614199;Orphanet:306507	2006-09-01	1	0	PASS	31	31	0	31	121412	121354	0.0002553	0	0	0	0	31	0	0	10400	11574	8652	6614	66696	906	16512	2102560	0	0	0	0	31	0	0	0	0	0	0	0	0	0	16	15	67282	54072	0	2164	0	31	66696	NFE
3	52820981	A	T	52820981	52820981	+	Haplotype	14798	RCV000015921	SCV000036188	29837	ITIH1	NM_002215.3:c.1754A>T	NP_002206.2:p.Glu585Val	NM_002215.3:c.1754A>T:missense variant	-	benign	0	0	0	0	1	no assertion for the individual variant	no assertion criteria provided	Apr 01, 1995	OMIM	OMIM	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 1 POLYMORPHISM;INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 1 POLYMORPHISM	7535743					germline	OMIM:147270.0001;OMIM:147270.0002;OMIM:147270.0003	1995-04-01	0	0	PASS	42390	26166	8051	42268	121408	120000	0.349	1552	6168	3137	2371	25494	331	3215	10378	11550	8624	6562	66414	896	15576	2778730	1308	2822	1973	1509	15816	201	2537	122	1673	582	431	4839	65	339	22968	19300	66278	53722	409	1972	42	6168	11550	AMR
3	52821011	A	G	52821011	52821011	+	Haplotype	14798;14799	RCV000015921;RCV000015922	SCV000036188;SCV000036189	29838	ITIH1	NM_002215.3:c.1784A>G	NP_002206.2:p.Gln595Arg	NM_002215.3:c.1784A>G:missense variant	-	benign	0	0	0	0	2	no assertion for the individual variant	no assertion criteria provided	Apr 01, 1995	OMIM	OMIM	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 1 POLYMORPHISM	7535743					germline	OMIM:147270.0001;OMIM:147270.0002;OMIM:147270.0003	1995-04-01	0	0	PASS	48277	28332	9957	48246	121412	121240	0.398	5204	6436	3276	2402	26027	354	4547	10396	11562	8608	6606	66680	904	16484	3454479	2582	2842	1992	1520	15945	214	3237	1311	1797	642	441	5041	70	655	25831	22415	67202	54038	567	2158	82	6436	11562	AMR
3	64142981	C	T	64142981	64142981	-	Haplotype	30731	RCV000023709	SCV000045000	39689	PRICKLE2	NM_198859.3:c.457G>A	NP_942559.1:p.Val153Ile	NM_198859.3:c.457G>A:missense variant	Conflicting interpretations of pathogenicity	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 21, 2016	OMIM	OMIM	Epilepsy, progressive myoclonic 5;RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	21276947;26942291;26942292;632821					germline	Genetic Alliance:Epilepsy%2C+progressive+myoclonic+5/8335;MedGen:CN226157;OMIM:613832;Orphanet:402082	2011-02-11	0	1	PASS	130	130	0	130	121410	120294	0.001071	0	3	10	46	65	1	5	10166	11504	8596	6510	66138	892	16488	1847298	0	3	10	46	65	1	5	0	0	0	0	0	0	0	77	53	67076	53218	1	2160	0	10	8596	EAS
3	64142995	C	T	64142995	64142995	-	Haplotype	30731	RCV000023709	SCV000045000	39688	PRICKLE2	NM_198859.3:c.443G>A	NP_942559.1:p.Arg148His	NM_198859.3:c.443G>A:missense variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 20, 2015	OMIM	OMIM	Epilepsy, progressive myoclonic 5;RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	21276947;26942291;26942292;632821					germline	Genetic Alliance:Epilepsy%2C+progressive+myoclonic+5/8335;MedGen:CN226157;OMIM:613832;Orphanet:402082	2011-02-11	0	0	PASS	1	1	0	1	121412	120194	8.236e-06	0	0	0	0	1	0	0	10150	11484	8576	6476	66140	890	16478	1837907	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	67046	53148	0	2160	0	1	66140	NFE
3	114057857	C	T	114057857	114057857	-	Haplotype	253111	RCV000239523	SCV000297909	247522	ZBTB20	NM_001164342.2:c.2221G>A	NP_001157814.1:p.Gly741Arg	NM_001164342.2:c.2221G>A:missense variant;NR_121662.1:n.883G>A:non-coding transcript variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 08, 2016	OMIM	OMIM	Primrose syndrome;PRIMROSE SYNDROME	27061120					germline	Genetic Alliance:Primrose+syndrome/5964;MedGen:C0796121;OMIM:259050;Office of Rare Diseases:4488	2016-08-08	0	0	PASS	1	1	0	1	118516	110168	8.438e-06	1	0	0	0	0	0	0	10138	11484	8518	6614	63612	790	9012	1683010	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	59460	50708	0	706	0	1	10138	AFR
3	114058231	G	A	114058231	114058231	-	Haplotype	253111	RCV000239523	SCV000297909	247523	ZBTB20	NM_001164342.2:c.1847C>T	NP_001157814.1:p.Ser616Phe	NM_001164342.2:c.1847C>T:missense variant;NR_121662.1:n.509C>T:non-coding transcript variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 08, 2016	OMIM	OMIM	Primrose syndrome;PRIMROSE SYNDROME	27061120					germline	Genetic Alliance:Primrose+syndrome/5964;MedGen:C0796121;OMIM:259050;Office of Rare Diseases:4488	2016-08-08	0	0																																															
3	124454069	A	G	124454069	124454069	+	Haplotype	11906	RCV000012681	SCV000032916	26945	UMPS	NM_000373.3:c.286A>G	NP_000364.1:p.Arg96Gly	NM_000373.3:c.286A>G:missense variant;NR_033434.1:n.263-2346A>G:intron variant;NR_033437.1:n.491A>G:non-coding transcript variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 01, 1997	OMIM	OMIM	Orotic aciduria;OROTIC ACIDURIA	9042911					germline	Genetic Alliance:Orotic+aciduria+hereditary/5431;MedGen:C0268128;OMIM:258900;OMIM:258920;Orphanet:30;SNOMED CT:47641009;SNOMED CT:90093009	1997-03-01	0	0	PASS	5	5	0	5	121412	115804	4.118e-05	0	0	5	0	0	0	0	10060	11228	8376	6480	63004	872	15784	1430255	0	0	5	0	0	0	0	0	0	0	0	0	0	0	1	4	64232	51572	0	2090	0	5	8376	EAS
3	124462773	G	C	124462773	124462773	+	Haplotype	11906	RCV000012681	SCV000032916	38455	UMPS	NM_000373.3:c.1285G>C	NP_000364.1:p.Gly429Arg	NM_000373.3:c.1285G>C:missense variant;NR_033434.1:n.1237G>C:non-coding transcript variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 01, 1997	OMIM	OMIM	Orotic aciduria;OROTIC ACIDURIA	9042911					germline	Genetic Alliance:Orotic+aciduria+hereditary/5431;MedGen:C0268128;OMIM:258900;OMIM:258920;Orphanet:30;SNOMED CT:47641009;SNOMED CT:90093009	1997-03-01	0	0	PASS	7	7	0	7	121412	121404	5.765e-05	0	0	7	0	0	0	0	10406	11578	8654	6614	66734	908	16510	2056216	0	0	7	0	0	0	0	0	0	0	0	0	0	0	3	4	67286	54118	0	2164	0	7	8654	EAS
3	178936092	A	C	178936092	178936092	+	Haplotype	222469	RCV000144511	SCV000189830	28698	PIK3CA	NM_006218.3:c.1634A>C	NP_006209.2:p.Glu545Ala	NM_006218.3:c.1634A>C:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 31, 2016	OMIM	OMIM	Cowden syndrome 5;COWDEN SYNDROME 5	23246288					germline	MedGen:C3554518;OMIM:615108;Orphanet:201	2013-01-10	0	0																																															
3	178936116	GT	C	178936116	178936117	+	Haplotype	222469	RCV000144511	SCV000189830	166223	PIK3CA	NM_006218.3:c.1658_1659delGTinsC	NP_006209.2:p.Ser553Thrfs	NM_006218.3:c.1658_1659delGTinsC:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 10, 2013	OMIM	OMIM	Cowden syndrome 5;COWDEN SYNDROME 5	23246288					germline	MedGen:C3554518;OMIM:615108;Orphanet:201	2013-01-10	0	0																																															
3	193355102	T	C	193355102	193355102	+	Haplotype	5089	RCV000005394	SCV000025574	101627	OPA1	NM_015560.2:c.870+32T>C		NM_015560.2:c.870+32T>C:intron variant	Benign	risk factor	0	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Feb 22, 2013	OMIM	OMIM	Glaucoma, normal tension, susceptibility to;GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO	11810296;12073024;17188046;19581274					germline	Genetic Alliance:Glaucoma%2C+normal+tension%2C+susceptibility+to/8467;MedGen:C1847730;OMIM:606657	2010-02-01	1	0	PASS	51233	29082	11034	51150	121406	121078	0.422	4339	4552	2828	3491	29311	386	6243	10344	11544	8618	6598	66580	904	16490	3714050	2545	2752	1886	1649	16229	202	3819	897	900	471	921	6541	92	1212	28199	22951	67166	53912	788	2162	167	29311	66580	NFE
4	996555	G	C	996555	996555	+	Haplotype	11911	RCV000012686	SCV000032921	26950	IDUA	NM_000203.4:c.1225G>C	NP_000194.2:p.Gly409Arg	NM_000203.4:c.1225G>C:missense variant;NR_110313.1:n.1313G>C:non-coding transcript variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 08, 2016	OMIM	OMIM	Hurler syndrome;HURLER SYNDROME	20301341;8328452					germline	GeneReviews:NBK1162;Genetic Alliance:Mucopolysaccharidosis+type+I/4912;MedGen:C0086795;OMIM:607014	1993-08-01	0	1	PASS	70	34	0	34	18038	10336	0.003881	19	0	3	0	11	0	1	248	88	130	0	2580	116	7174	152422	19	0	3	0	11	0	1	0	0	0	0	0	0	0	16	18	7542	2794	0	1384	0	19	248	AFR
4	998181	A	T	998181	998181	+	Haplotype	11911	RCV000012686	SCV000032921	38456	IDUA	NM_000203.4:c.1962A>T	NP_000194.2:p.Ter654Cys	NM_000203.4:c.1962A>T:stop lost;NR_110313.1:n.2054A>T:non-coding transcript variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 01, 1993	OMIM	OMIM	Hurler syndrome;HURLER SYNDROME	20301341;8328452					germline	GeneReviews:NBK1162;Genetic Alliance:Mucopolysaccharidosis+type+I/4912;MedGen:C0086795;OMIM:607014	1993-08-01	0	0																																															
4	1806111	T	G	1806111	1806111	+	Haplotype	441276	RCV000017763	SCV000038041	38477	FGFR3	NM_022965.3:c.931-440T>G	NP_001156685.1:p.Leu379Arg	NM_000142.4:c.1130T>G:missense variant;NM_022965.3:c.931-440T>G:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 01, 2006	OMIM	OMIM	Achondroplasia;ACHONDROPLASIA	16411219;20301331				gain of function	germline	GeneReviews:NBK1152;GeneTests:2789;Genetic Alliance:Achondroplasia/113;Genetic Testing Registry (GTR):GTR000017792;Genetic Testing Registry (GTR):GTR000193973;Genetic Testing Registry (GTR):GTR000226127;Genetic Testing Registry (GTR):GTR000320916;Genetic Testing Registry (GTR):GTR000325183;Genetic Testing Registry (GTR):GTR000327662;Genetic Testing Registry (GTR):GTR000327663;Genetic Testing Registry (GTR):GTR000332463;Genetic Testing Registry (GTR):GTR000333529;Genetic Testing Registry (GTR):GTR000500431;Genetic Testing Registry (GTR):GTR000501373;Genetic Testing Registry (GTR):GTR000508438;Genetic Testing Registry (GTR):GTR000508854;Genetic Testing Registry (GTR):GTR000508972;Genetic Testing Registry (GTR):GTR000510685;Genetic Testing Registry (GTR):GTR000510735;Genetic Testing Registry (GTR):GTR000512698;Genetic Testing Registry (GTR):GTR000514902;Genetic Testing Registry (GTR):GTR000515562;Genetic Testing Registry (GTR):GTR000518899;Genetic Testing Registry (GTR):GTR000522269;Genetic Testing Registry (GTR):GTR000522270;Genetic Testing Registry (GTR):GTR000522271;Genetic Testing Registry (GTR):GTR000522272;Genetic Testing Registry (GTR):GTR000523319;Genetic Testing Registry (GTR):GTR000529586;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000552209;Genetic Testing Registry (GTR):GTR000552289;Genetic Testing Registry (GTR):GTR000553542;Genetic Testing Registry (GTR):GTR000556521;MedGen:C0001080;OMIM:100800;Office of Rare Diseases:8173;Orphanet:15;SNOMED CT:86268005	2006-02-01	0	0	PASS	1	1	0	1	121406	119268	8.237e-06	1	0	0	0	0	0	0	10346	11554	8626	6610	65844	890	15398	3548603	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	66076	53192	0	1918	0	1	10346	AFR
4	1806119	G	A	1806119	1806119	+	Haplotype	441276	RCV000017763	SCV000038041	31366	FGFR3	NM_022965.3:c.931-432G>A	NP_001156685.1:p.Gly382Arg	NM_000142.4:c.1138G>A:missense variant;NM_022965.3:c.931-432G>A:intron variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jun 26, 2017	OMIM	OMIM	Achondroplasia;ACHONDROPLASIA	16411219;20301331				gain of function	germline	GeneReviews:NBK1152;GeneTests:2789;Genetic Alliance:Achondroplasia/113;Genetic Testing Registry (GTR):GTR000017792;Genetic Testing Registry (GTR):GTR000193973;Genetic Testing Registry (GTR):GTR000226127;Genetic Testing Registry (GTR):GTR000320916;Genetic Testing Registry (GTR):GTR000325183;Genetic Testing Registry (GTR):GTR000327662;Genetic Testing Registry (GTR):GTR000327663;Genetic Testing Registry (GTR):GTR000332463;Genetic Testing Registry (GTR):GTR000333529;Genetic Testing Registry (GTR):GTR000500431;Genetic Testing Registry (GTR):GTR000501373;Genetic Testing Registry (GTR):GTR000508438;Genetic Testing Registry (GTR):GTR000508854;Genetic Testing Registry (GTR):GTR000508972;Genetic Testing Registry (GTR):GTR000510685;Genetic Testing Registry (GTR):GTR000510735;Genetic Testing Registry (GTR):GTR000512698;Genetic Testing Registry (GTR):GTR000514902;Genetic Testing Registry (GTR):GTR000515562;Genetic Testing Registry (GTR):GTR000518899;Genetic Testing Registry (GTR):GTR000522269;Genetic Testing Registry (GTR):GTR000522270;Genetic Testing Registry (GTR):GTR000522271;Genetic Testing Registry (GTR):GTR000522272;Genetic Testing Registry (GTR):GTR000523319;Genetic Testing Registry (GTR):GTR000529586;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000552209;Genetic Testing Registry (GTR):GTR000552289;Genetic Testing Registry (GTR):GTR000553542;Genetic Testing Registry (GTR):GTR000556521;MedGen:C0001080;OMIM:100800;Office of Rare Diseases:8173;Orphanet:15;SNOMED CT:86268005	2006-02-01	2	0																																															
4	1807123	A	G	1807123	1807123	+	Haplotype	441277	RCV000017771	SCV000038050	38478	FGFR3	NM_001163213.1:c.1460A>G	NP_001156685.1:p.Gln487Arg	NM_000142.4:c.1454A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 01, 2009	OMIM	OMIM	Thanatophoric dysplasia type 1;THANATOPHORIC DYSPLASIA, TYPE I	19449430;20301540				gain of function	germline	GeneReviews:NBK1366;Genetic Alliance:Thanatophoric+dysplasia+type+1/7051;Genetic Testing Registry (GTR):GTR000226129;Genetic Testing Registry (GTR):GTR000320916;Genetic Testing Registry (GTR):GTR000327662;Genetic Testing Registry (GTR):GTR000327663;Genetic Testing Registry (GTR):GTR000327813;Genetic Testing Registry (GTR):GTR000333529;Genetic Testing Registry (GTR):GTR000508438;Genetic Testing Registry (GTR):GTR000508854;Genetic Testing Registry (GTR):GTR000508990;Genetic Testing Registry (GTR):GTR000510735;Genetic Testing Registry (GTR):GTR000512698;Genetic Testing Registry (GTR):GTR000514902;Genetic Testing Registry (GTR):GTR000515562;Genetic Testing Registry (GTR):GTR000518899;Genetic Testing Registry (GTR):GTR000522269;Genetic Testing Registry (GTR):GTR000522270;Genetic Testing Registry (GTR):GTR000522271;Genetic Testing Registry (GTR):GTR000522272;Genetic Testing Registry (GTR):GTR000530324;Genetic Testing Registry (GTR):GTR000552289;Genetic Testing Registry (GTR):GTR000553542;MedGen:C1868678;OMIM:187600;Office of Rare Diseases:9295;Orphanet:1860;Orphanet:2655	2009-06-01	0	0																																															
4	1807371	C	A	1807371	1807371	+	Haplotype	441277	RCV000017771	SCV000038050	31376	FGFR3	NM_001163213.1:c.1626C>A	NP_001156685.1:p.Asn542Lys	NM_000142.4:c.1620C>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	May 16, 2017	OMIM	OMIM	Thanatophoric dysplasia type 1;THANATOPHORIC DYSPLASIA, TYPE I	19449430;20301540				gain of function	germline	GeneReviews:NBK1366;Genetic Alliance:Thanatophoric+dysplasia+type+1/7051;Genetic Testing Registry (GTR):GTR000226129;Genetic Testing Registry (GTR):GTR000320916;Genetic Testing Registry (GTR):GTR000327662;Genetic Testing Registry (GTR):GTR000327663;Genetic Testing Registry (GTR):GTR000327813;Genetic Testing Registry (GTR):GTR000333529;Genetic Testing Registry (GTR):GTR000508438;Genetic Testing Registry (GTR):GTR000508854;Genetic Testing Registry (GTR):GTR000508990;Genetic Testing Registry (GTR):GTR000510735;Genetic Testing Registry (GTR):GTR000512698;Genetic Testing Registry (GTR):GTR000514902;Genetic Testing Registry (GTR):GTR000515562;Genetic Testing Registry (GTR):GTR000518899;Genetic Testing Registry (GTR):GTR000522269;Genetic Testing Registry (GTR):GTR000522270;Genetic Testing Registry (GTR):GTR000522271;Genetic Testing Registry (GTR):GTR000522272;Genetic Testing Registry (GTR):GTR000530324;Genetic Testing Registry (GTR):GTR000552289;Genetic Testing Registry (GTR):GTR000553542;MedGen:C1868678;OMIM:187600;Office of Rare Diseases:9295;Orphanet:1860;Orphanet:2655	2009-06-01	2	0																																															
4	70898903	G	A	70898903	70898903	+	Haplotype	14913	RCV000016048	SCV000036315	38467	HTN3	NM_000200.2:c.122G>A	NP_000191.1:p.Arg41Gln	NM_000200.2:c.122G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1994	OMIM	OMIM	HIS2*1/HIS2*2 POLYMORPHISM;HIS2*1/HIS2*2 POLYMORPHISM	7951254					germline	OMIM:142702.0001	1994-01-01	0	0	PASS	1732	1494	119	1732	121408	121140	0.014	1576	72	1	0	15	6	62	10394	11496	8648	6596	66602	908	16496	2845320	1342	70	1	0	15	6	60	117	1	0	0	0	0	1	641	1091	67144	53996	10	2162	0	1576	10394	AFR
4	70898922	T	A	70898922	70898922	+	Haplotype	14913	RCV000016048	SCV000036315	29952	HTN3	NM_000200.2:c.141T>A	NP_000191.1:p.Tyr47Ter	NM_000200.2:c.141T>A:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1994	OMIM	OMIM	HIS2*1/HIS2*2 POLYMORPHISM;HIS2*1/HIS2*2 POLYMORPHISM	7951254					germline	OMIM:142702.0001	1994-01-01	0	0	PASS	1667	1434	116	1666	121410	121162	0.014	1574	71	0	0	12	6	3	10394	11510	8648	6596	66614	908	16492	2879207	1344	69	0	0	12	6	3	115	1	0	0	0	0	0	595	1071	67166	53996	1	2160	0	1574	10394	AFR
4	103189073	C	G	103189073	103189073	-	Haplotype	218898	RCV000203237	SCV000258313	215658	SLC39A8	NM_022154.5:c.1004G>C	NP_071437.3:p.Ser335Thr	NM_022154.5:c.1004G>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 03, 2015	OMIM	OMIM	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn;CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn	26637979					germline	MedGen:C4225234;OMIM:608732.0001;OMIM:608732.0002;OMIM:608732.0003;OMIM:608732.0004;OMIM:616721	2015-12-03	0	0																																															
4	103265723	C	T	103265723	103265723	-	Haplotype	218898	RCV000203237	SCV000258313	215659	SLC39A8	NM_022154.5:c.97G>A	NP_071437.3:p.Val33Met	NM_022154.5:c.97G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 03, 2015	OMIM	OMIM	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn;CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn	26637979					germline	MedGen:C4225234;OMIM:608732.0001;OMIM:608732.0002;OMIM:608732.0003;OMIM:608732.0004;OMIM:616721	2015-12-03	0	0	PASS	35	16	1	18	106254	15410	0.0003294	0	1	0	0	4	0	13	1114	304	546	44	5574	148	7680	327319	0	1	0	0	4	0	11	0	0	0	0	0	0	1	15	3	9980	5430	3	1456	1	1	304	AMR
4	109088743	A	G	109088743	109088743	-	Haplotype	14382	RCV000015459	SCV000035724	38464	LEF1	NM_016269.4:c.181T>C	NP_057353.1:p.Ser61Pro	NM_001166119.1:c.-1307T>C:2KB upstream variant;NM_016269.4:c.181T>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 01, 2006	OMIM	OMIM	Sebaceous tumors, somatic;SEBACEOUS TUMORS, SOMATIC	16565724					somatic	MedGen:C1835244	2006-04-01	0	0																																															
4	109088791	C	T	109088791	109088791	-	Haplotype	14382	RCV000015459	SCV000035724	29421	LEF1	NM_016269.4:c.133G>A	NP_057353.1:p.Glu45Lys	NM_001166119.1:c.-1355G>A:2KB upstream variant;NM_016269.4:c.133G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 01, 2006	OMIM	OMIM	Sebaceous tumors, somatic;SEBACEOUS TUMORS, SOMATIC	16565724					somatic	MedGen:C1835244	2006-04-01	0	0																																															
5	225549	G	C	225549	225549	+	Haplotype	190221	RCV000170440	SCV000222878	188048	SDHA	NM_004168.3:c.328G>C	NP_004159.2:p.Ala110Pro	NM_001294332.1:c.313-449G>C:intron variant;NM_004168.3:c.328G>C:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 10, 2015	Mendelics Analise Genomica	Mendelics Analise Genomica	Mitochondrial complex II deficiency;Mitochondrial complex II deficiency	10746566;22972948					germline	Genetic Alliance:Mitochondrial+complex+II+deficiency/4824;MedGen:C1855008;OMIM:252011;Office of Rare Diseases:5053;Orphanet:3208	2015-03-10	0	0																																															
5	240589	A	G	240589	240589	+	Haplotype	190221	RCV000170440	SCV000222878	188049	SDHA	NM_004168.3:c.1549A>G	NP_004159.2:p.Lys517Glu	NM_004168.3:c.1549A>G:missense variant	Uncertain significance	likely pathogenic	0	1	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jul 10, 2016	Mendelics Analise Genomica	Mendelics Analise Genomica	Mitochondrial complex II deficiency;Mitochondrial complex II deficiency	10746566;22972948					germline	Genetic Alliance:Mitochondrial+complex+II+deficiency/4824;MedGen:C1855008;OMIM:252011;Office of Rare Diseases:5053;Orphanet:3208	2015-03-10	1	0																																															
5	1266634	C	T	1266634	1266634	-	Haplotype	36946	RCV000030627	SCV000053305	45604	TERT	NM_198253.2:c.2599G>A	NP_937983.2:p.Val867Met	NM_198253.2:c.2599G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 01, 2011	OMIM	OMIM	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1;PULMONARY FIBROSIS, TELOMERE-RELATED, 1	21483807					germline	MedGen:C3553617;OMIM:187270.0001;OMIM:187270.0002;OMIM:187270.0003;OMIM:187270.0004;OMIM:187270.0005;OMIM:187270.0008;OMIM:187270.0009;OMIM:187270.0010;OMIM:187270.0015;OMIM:187270.0016;OMIM:187270.0017;OMIM:614742;Orphanet:88	2011-03-01	0	0																																															
5	1272311	C	T	1272311	1272311	-	Haplotype	36946	RCV000030627	SCV000053305	45603	TERT	NM_198253.2:c.2371G>A	NP_937983.2:p.Val791Ile	NM_198253.2:c.2371G>A:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jul 18, 2017	OMIM	OMIM	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1;PULMONARY FIBROSIS, TELOMERE-RELATED, 1	21483807					germline	MedGen:C3553617;OMIM:187270.0001;OMIM:187270.0002;OMIM:187270.0003;OMIM:187270.0004;OMIM:187270.0005;OMIM:187270.0008;OMIM:187270.0009;OMIM:187270.0010;OMIM:187270.0015;OMIM:187270.0016;OMIM:187270.0017;OMIM:614742;Orphanet:88	2011-03-01	1	0	PASS	17	16	0	16	120814	92316	0.0001407	0	0	1	0	14	0	1	7078	9146	6614	3698	52198	674	12908	1621967	0	0	1	0	14	0	1	0	0	0	0	0	0	0	10	6	52506	39810	1	1878	0	14	52198	NFE
5	41853537	A	T	41853537	41853537	-	Haplotype	8165	RCV000008643	SCV000028852	38389	OXCT1	NM_000436.3:c.398T>A	NP_000427.1:p.Val133Glu	NM_000436.3:c.398T>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1998	OMIM	OMIM	Succinyl-CoA acetoacetate transferase deficiency;SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY	9671268					germline	Genetic Alliance:Succinyl-CoA+acetoacetate+transferase+deficiency/6918;MedGen:C0342792;OMIM:245050;Office of Rare Diseases:5057;Orphanet:832;SNOMED CT:238004006	1998-01-01	0	0																																															
5	41862758	G	A	41862758	41862758	-	Haplotype	8165	RCV000008643	SCV000028852	23204	OXCT1	NM_000436.3:c.173C>T	NP_000427.1:p.Thr58Met	NM_000436.3:c.173C>T:missense variant	Benign	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jul 31, 2017	OMIM	OMIM	Succinyl-CoA acetoacetate transferase deficiency;SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY	9671268					germline	Genetic Alliance:Succinyl-CoA+acetoacetate+transferase+deficiency/6918;MedGen:C0342792;OMIM:245050;Office of Rare Diseases:5057;Orphanet:832;SNOMED CT:238004006	1998-01-01	1	0	PASS	162	160	1	162	121412	121292	0.001334	3	4	147	1	6	1	0	10402	11506	8652	6614	66714	908	16496	2311982	3	4	145	1	6	1	0	0	0	1	0	0	0	0	79	83	67224	54068	0	2162	0	147	8652	EAS
5	112043220	A	C	112043220	112043220	+	Haplotype	243004	RCV000234986	SCV000292335	244097	APC	NM_001127511.2:c.-195A>C		NM_001127511.2:c.-195A>C:5 prime UTR variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 12, 2016	OMIM	OMIM	Familial adenomatous polyposis 1;FAMILIAL ADENOMATOUS POLYPOSIS 1 OF PROXIMAL STOMACH	11598466;15604628;20301519;21368914;21813476;23788249;24310308;25356965;25452455;25645574;27087319;27854360				loss of function	germline	GeneReviews:NBK1345;Genetic Testing Registry (GTR):GTR000172265;Genetic Testing Registry (GTR):GTR000321103;Genetic Testing Registry (GTR):GTR000326160;Genetic Testing Registry (GTR):GTR000330056;Genetic Testing Registry (GTR):GTR000500363;Genetic Testing Registry (GTR):GTR000500599;Genetic Testing Registry (GTR):GTR000500894;Genetic Testing Registry (GTR):GTR000501393;Genetic Testing Registry (GTR):GTR000501394;Genetic Testing Registry (GTR):GTR000501794;Genetic Testing Registry (GTR):GTR000508954;Genetic Testing Registry (GTR):GTR000512300;Genetic Testing Registry (GTR):GTR000512645;Genetic Testing Registry (GTR):GTR000515534;Genetic Testing Registry (GTR):GTR000515885;Genetic Testing Registry (GTR):GTR000515899;Genetic Testing Registry (GTR):GTR000520026;Genetic Testing Registry (GTR):GTR000520047;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520077;Genetic Testing Registry (GTR):GTR000520394;Genetic Testing Registry (GTR):GTR000520865;Genetic Testing Registry (GTR):GTR000520868;Genetic Testing Registry (GTR):GTR000520869;Genetic Testing Registry (GTR):GTR000520870;Genetic Testing Registry (GTR):GTR000520872;Genetic Testing Registry (GTR):GTR000521915;Genetic Testing Registry (GTR):GTR000522559;Genetic Testing Registry (GTR):GTR000527982;Genetic Testing Registry (GTR):GTR000527984;Genetic Testing Registry (GTR):GTR000528912;Genetic Testing Registry (GTR):GTR000529017;Genetic Testing Registry (GTR):GTR000530028;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000530120;Genetic Testing Registry (GTR):GTR000530202;Genetic Testing Registry (GTR):GTR000552245;Genetic Testing Registry (GTR):GTR000552290;Genetic Testing Registry (GTR):GTR000552303;Genetic Testing Registry (GTR):GTR000558907;MedGen:C2713442;OMIM:175100;OMIM:611731.0021;OMIM:611731.0028;OMIM:611731.0034;OMIM:611731.0035;OMIM:611731.0036;OMIM:611731.0038;OMIM:611731.0042;OMIM:611731.0043;OMIM:611731.0049	2016-07-12	0	0																																															
5	112043289	GA	G	112043290	112043290	+	Haplotype	243004	RCV000234986	SCV000292335	244084	APC	NM_001127511.2:c.-125delA		NM_001127511.2:c.-125delA:5 prime UTR variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 12, 2016	OMIM	OMIM	Familial adenomatous polyposis 1;FAMILIAL ADENOMATOUS POLYPOSIS 1 OF PROXIMAL STOMACH	11598466;15604628;20301519;21368914;21813476;23788249;24310308;25356965;25452455;25645574;27087319;27854360				loss of function	germline	GeneReviews:NBK1345;Genetic Testing Registry (GTR):GTR000172265;Genetic Testing Registry (GTR):GTR000321103;Genetic Testing Registry (GTR):GTR000326160;Genetic Testing Registry (GTR):GTR000330056;Genetic Testing Registry (GTR):GTR000500363;Genetic Testing Registry (GTR):GTR000500599;Genetic Testing Registry (GTR):GTR000500894;Genetic Testing Registry (GTR):GTR000501393;Genetic Testing Registry (GTR):GTR000501394;Genetic Testing Registry (GTR):GTR000501794;Genetic Testing Registry (GTR):GTR000508954;Genetic Testing Registry (GTR):GTR000512300;Genetic Testing Registry (GTR):GTR000512645;Genetic Testing Registry (GTR):GTR000515534;Genetic Testing Registry (GTR):GTR000515885;Genetic Testing Registry (GTR):GTR000515899;Genetic Testing Registry (GTR):GTR000520026;Genetic Testing Registry (GTR):GTR000520047;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520077;Genetic Testing Registry (GTR):GTR000520394;Genetic Testing Registry (GTR):GTR000520865;Genetic Testing Registry (GTR):GTR000520868;Genetic Testing Registry (GTR):GTR000520869;Genetic Testing Registry (GTR):GTR000520870;Genetic Testing Registry (GTR):GTR000520872;Genetic Testing Registry (GTR):GTR000521915;Genetic Testing Registry (GTR):GTR000522559;Genetic Testing Registry (GTR):GTR000527982;Genetic Testing Registry (GTR):GTR000527984;Genetic Testing Registry (GTR):GTR000528912;Genetic Testing Registry (GTR):GTR000529017;Genetic Testing Registry (GTR):GTR000530028;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000530120;Genetic Testing Registry (GTR):GTR000530202;Genetic Testing Registry (GTR):GTR000552245;Genetic Testing Registry (GTR):GTR000552290;Genetic Testing Registry (GTR):GTR000552303;Genetic Testing Registry (GTR):GTR000558907;MedGen:C2713442;OMIM:175100;OMIM:611731.0021;OMIM:611731.0028;OMIM:611731.0034;OMIM:611731.0035;OMIM:611731.0036;OMIM:611731.0038;OMIM:611731.0042;OMIM:611731.0043;OMIM:611731.0049	2016-07-12	0	0																																															
5	135392443	C	A	135392443	135392443	+	Haplotype	7874	RCV000008323	SCV000028531	22913	TGFBI	NM_000358.2:c.1637C>A	NP_000349.1:p.Ala546Asp	NM_000358.2:c.1637C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 2004	OMIM	OMIM	Lattice corneal dystrophy Type I;CORNEAL DYSTROPHY, LATTICE TYPE I	15111592;15531312					germline	Genetic Alliance:Lattice+corneal+dystrophy+type+1/4117;Genetics Home Reference:lattice-corneal-dystrophy-type-i;MedGen:C1690006;OMIM:122200;Office of Rare Diseases:9678;Orphanet:98964;SNOMED CT:419197009	2004-11-01	0	0																																															
5	135392458	C	A	135392458	135392458	+	Haplotype	7874	RCV000008323	SCV000028531	38388	TGFBI	NM_000358.2:c.1652C>A	NP_000349.1:p.Pro551Gln	NM_000358.2:c.1652C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 2004	OMIM	OMIM	Lattice corneal dystrophy Type I;CORNEAL DYSTROPHY, LATTICE TYPE I	15111592;15531312					germline	Genetic Alliance:Lattice+corneal+dystrophy+type+1/4117;Genetics Home Reference:lattice-corneal-dystrophy-type-i;MedGen:C1690006;OMIM:122200;Office of Rare Diseases:9678;Orphanet:98964;SNOMED CT:419197009	2004-11-01	0	0																																															
5	171777409	GC	G	171777410	171777410	-	Distinct chromosomes	488055	RCV000577875	SCV000583573	15228	SH3PXD2B	NM_001017995.2:c.969delG	NP_001017995.1:p.Arg324Glyfs	NM_001017995.2:c.969delG:frameshift variant	Pathogenic	likely pathogenic	0	1	0	0	0	no assertion criteria provided	criteria provided, single submitter	Jun 01, 2017	Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine	Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine	Frank Ter Haar syndrome;Opsismodysplasia	1;20137777;29276006					unknown	Genetic Alliance:Frank+Ter+Haar+Syndrome/2915;Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;MedGen:C1855305;OMIM:249420;OMIM:258480;Office of Rare Diseases:4098;Office of Rare Diseases:5138;Orphanet:137834;Orphanet:2746;SNOMED CT:254068007	2017-06-01	0	0																																															
5	176942003	G	T	176942003	176942003	-	Haplotype	403734	RCV000465916	SCV000541081	390711	DDX41	NM_016222.3:c.712C>A	NP_057306.2:p.Pro238Thr	NM_016222.3:c.712C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	-	Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	Acute myeloid leukemia;Myelodysplasia	20963938;22138009;23970018;26944477					germline	GeneReviews:NBK47457;Genetic Testing Registry (GTR):GTR000500636;Human Phenotype Ontology:HP:0002863;Human Phenotype Ontology:HP:0004832;Human Phenotype Ontology:HP:0006730;MeSH:D015470;MedGen:C0023467;MedGen:C1851971;OMIM:601626;Orphanet:519;SNOMED CT:17788007	0000-00-00	0	0	PASS	1	1	0	1	121412	120916	8.236e-06	0	0	0	0	1	0	0	10314	11548	8642	6588	66416	906	16502	2100344	1,0,0	0,0,0	0,0,0	0,0,0	0,1,0	0,0,0	0,0,0	0	0	0	0	0	0	0	1	0	67206	53710	0	2164	0	1	66416	NFE
5	176942004	C	A	176942004	176942004	-	Haplotype	403734	RCV000465916	SCV000541081	390712	DDX41	NM_016222.3:c.711G>T	NP_057306.2:p.Leu237Phe	NM_016222.3:c.711G>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	-	Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	Acute myeloid leukemia;Myelodysplasia	20963938;22138009;23970018;26944477					germline	GeneReviews:NBK47457;Genetic Testing Registry (GTR):GTR000500636;Human Phenotype Ontology:HP:0002863;Human Phenotype Ontology:HP:0004832;Human Phenotype Ontology:HP:0006730;MeSH:D015470;MedGen:C0023467;MedGen:C1851971;OMIM:601626;Orphanet:519;SNOMED CT:17788007	0000-00-00	0	0	PASS	1	1	0	1	121412	120928	8.236e-06	0	0	0	0	1	0	0	10314	11548	8642	6588	66428	906	16502	2100632	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	67206	53722	0	2164	0	1	66428	NFE
6	10874613	A	T	10874613	10874613	-	Haplotype	375590	RCV000417072	SCV000494617	362401	GCM2	NM_004752.3:c.1136T>A	NP_004743.1:p.Leu379Gln	NM_004752.3:c.1136T>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 10, 2017	OMIM	OMIM	Hyperparathyroidism 4;HYPERPARATHYROIDISM 4	27745835					germline	MedGen:CN240514;OMIM:617343	2017-02-10	0	0																																															
6	10874998	G	C	10874998	10874998	-	Haplotype	375590	RCV000417072	SCV000494617	362400	GCM2	NM_004752.3:c.751C>G	NP_004743.1:p.Gln251Glu	NM_004752.3:c.751C>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 10, 2017	OMIM	OMIM	Hyperparathyroidism 4;HYPERPARATHYROIDISM 4	27745835					germline	MedGen:CN240514;OMIM:617343	2017-02-10	0	0																																															
6	18130918	T	C	18130918	18130918	-	Haplotype	12722	RCV000013559	SCV000033806	27764	TPMT	NM_000367.4:c.719A>G	NP_000358.1:p.Tyr240Cys	NM_000367.4:c.719A>G:missense variant	drug response, other	drug response	0	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Jul 21, 2015	OMIM	OMIM	Thiopurine methyltransferase deficiency;THIOPURINES, POOR METABOLISM OF, 1	10208641;12880540;15819814;15967990;8561894;8644731;9177237;9336428;9931345;9931346				loss of function	germline	Genetic Alliance:Thiopurine+S+methyltranferase+deficiency/54;Genetic Testing Registry (GTR):GTR000299976;Genetic Testing Registry (GTR):GTR000502252;Genetic Testing Registry (GTR):GTR000509706;Genetic Testing Registry (GTR):GTR000520079;Genetic Testing Registry (GTR):GTR000522313;Genetic Testing Registry (GTR):GTR000522314;Genetic Testing Registry (GTR):GTR000525921;Genetic Testing Registry (GTR):GTR000553222;Genetic Testing Registry (GTR):GTR000558523;MedGen:C0342801;OMIM:187680.0001;OMIM:187680.0002;OMIM:187680.0003;OMIM:187680.0004;OMIM:187680.0005;OMIM:187680.0006;OMIM:187680.0007;OMIM:610460;Office of Rare Diseases:5173;Office of Rare Diseases:9153;PharmGKB:PA356;SNOMED CT:238012003	2005-06-28	0	0	PASS	4443	4215	110	4435	121392	120882	0.037	547	555	114	224	2671	29	295	10106	11546	8640	6612	66576	900	16502	1991650	511	521	114	218	2537	27	287	18	17	0	3	67	1	4	2336	2099	67158	53724	31	2164	1	547	10106	AFR
6	18139228	C	T	18139228	18139228	-	Haplotype	12722	RCV000013559	SCV000033806	27761	TPMT	NM_000367.4:c.460G>A	NP_000358.1:p.Ala154Thr	NM_000367.4:c.460G>A:missense variant	drug response, other	drug response	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2015	OMIM	OMIM	Thiopurine methyltransferase deficiency;THIOPURINES, POOR METABOLISM OF, 1	10208641;12880540;15819814;15967990;8561894;8644731;9177237;9336428;9931345;9931346				loss of function	germline	Genetic Alliance:Thiopurine+S+methyltranferase+deficiency/54;Genetic Testing Registry (GTR):GTR000299976;Genetic Testing Registry (GTR):GTR000502252;Genetic Testing Registry (GTR):GTR000509706;Genetic Testing Registry (GTR):GTR000520079;Genetic Testing Registry (GTR):GTR000522313;Genetic Testing Registry (GTR):GTR000522314;Genetic Testing Registry (GTR):GTR000525921;Genetic Testing Registry (GTR):GTR000553222;Genetic Testing Registry (GTR):GTR000558523;MedGen:C0342801;OMIM:187680.0001;OMIM:187680.0002;OMIM:187680.0003;OMIM:187680.0004;OMIM:187680.0005;OMIM:187680.0006;OMIM:187680.0007;OMIM:610460;Office of Rare Diseases:5173;Office of Rare Diseases:9153;PharmGKB:PA356;SNOMED CT:238012003	2005-06-28	0	0	PASS	3338	3187	75	3337	121412	121380	0.027	72	515	1	203	2422	21	103	10392	11578	8654	6614	66724	908	16510	3385201	70	487	1	199	2310	21	99	1	14	0	2	56	0	2	1764	1573	67278	54102	13	2164	0	515	11578	AMR
6	32007584	T	A	32007584	32007584	+	Haplotype	31662	RCV000012947	SCV000033191	33507	CYP21A2	NM_000500.7:c.710T>A	NP_000491.4:p.Ile237Asn	NM_000500.7:c.710T>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 01, 2005	OMIM	OMIM	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, SALT-WASTING TYPE	15623806;20301350;2249999;2845408					germline	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757	2005-04-01	0	0																																															
6	32007587	T	A	32007587	32007587	+	Haplotype	31662;65613	RCV000012947;RCV000055823	SCV000033191;SCV000086807	27212	CYP21A2	NM_000500.7:c.713T>A	NP_000491.4:p.Val238Glu	NM_000500.7:c.713T>A:missense variant	-	pathogenic;pathologic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 29, 2013	OMIM;GeneReviews	OMIM;GeneReviews	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, SALT-WASTING TYPE;21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia	15623806;20301350;2249999;2845408					germline;not provided	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757	2005-04-01;2013-08-29	0	0																																															
6	32007593	T	A	32007593	32007593	+	Haplotype	31662;65613	RCV000012947;RCV000055823	SCV000033191;SCV000086807	40032	CYP21A2	NM_000500.7:c.719T>A	NP_000491.4:p.Met240Lys	NM_000500.7:c.719T>A:missense variant	-	pathogenic;pathologic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 29, 2013	OMIM;GeneReviews	OMIM;GeneReviews	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, SALT-WASTING TYPE;21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia	15623806;20301350;2249999;2845408					germline;not provided	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757	2005-04-01;2013-08-29	0	0	PASS	166	158	1	160	121406	112388	0.001367	145	10	0	0	4	0	1	9428	10866	8234	5228	62338	808	15486	1732082	143	10	0	0	4	0	1	1	0	0	0	0	0	0	60	100	62752	49636	0	2070	0	145	9428	AFR
6	32007887	G	T	32007887	32007887	+	Haplotype	12182	RCV000417198	SCV000033208	27190	CYP21A2	NM_000500.7:c.844G>T	NP_000491.4:p.Val282Leu	NM_000500.7:c.844G>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Oct 26, 2017	OMIM	OMIM	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	11093272;12915679;20301350;7629224					germline	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757	2003-08-01	2	0	VQSRTrancheSNP99.80to99.90	1240	1206	1	1208	120306	115876	0.01	46	284	18	10	811	15	24	9224	11296	8518	6608	63088	870	16272	3548695	44,0,0	284,0,0	18,0,0	10,0,0	811,1,0	15,0,0	24,0,0	1	0	0	0	0	0	0	618	590	65450	50426	4	2164	0	284	11296	AMR
6	32007959	G	GT	32007966	32007966	+	Haplotype	12182	RCV000417198	SCV000033208	76519	CYP21A2	NM_000500.7:c.923dupT	NP_000491.4:p.Leu308Phefs	NM_000500.7:c.923dupT:frameshift variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 29, 2013	OMIM	OMIM	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	11093272;12915679;20301350;7629224					germline	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757	2003-08-01	0	0																																															
6	32008198	C	T	32008198	32008198	+	Haplotype	12182	RCV000417198	SCV000033208	27208	CYP21A2	NM_000500.7:c.955C>T	NP_000491.4:p.Gln319Ter	NM_000500.7:c.955C>T:nonsense	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 03, 2015	OMIM	OMIM	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	11093272;12915679;20301350;7629224					germline	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757	2003-08-01	0	0																																															
6	32008312	C	T	32008312	32008312	+	Haplotype	12182	RCV000417198	SCV000033208	27191	CYP21A2	NM_000500.7:c.1069C>T	NP_000491.4:p.Arg357Trp	NM_000500.7:c.1069C>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jan 16, 2015	OMIM	OMIM	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	11093272;12915679;20301350;7629224					germline	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757	2003-08-01	1	0																																															
6	39877666	G	A	39877666	39877666	-	Haplotype	208497	RCV000190510	SCV000245396	205013	MOCS1	NM_001075098.3:c.1015C>T	NP_001068566.1:p.Arg339Trp	NM_001075098.3:c.1015C>T:missense variant;NR_033233.1:n.1022C>T:non-coding transcript variant	Uncertain significance	likely benign	0	0	0	1	0	criteria provided, single submitter	no assertion criteria provided	Jul 31, 2016	Mendelics Analise Genomica	Mendelics Analise Genomica	Molybdenum cofactor deficiency, complementation group A	21031595					germline	Genetics Home Reference:molybdenum-cofactor-deficiency;MedGen:C1854988;OMIM:252150;Orphanet:833	2016-05-13	1	0	PASS	52	50	1	52	121412	121344	0.0004283	0	6	0	0	33	0	13	10396	11574	8646	6614	66696	908	16510	3321124	0	6	0	0	31	0	13	0	0	0	0	1	0	0	34	18	67266	54078	0	2164	0	13	16510	SAS
6	39880653	C	T	39880653	39880653	-	Haplotype	208497	RCV000190510	SCV000245396	205014	MOCS1	NM_005943.5:c.853G>A	NP_005934.2:p.Glu285Lys	NM_001075098.3:c.853G>A:missense variant;NR_033233.1:n.860G>A:non-coding transcript variant	Uncertain significance	likely benign	0	0	0	1	0	no assertion for the individual variant	no assertion criteria provided	Jul 31, 2016	Mendelics Analise Genomica	Mendelics Analise Genomica	Molybdenum cofactor deficiency, complementation group A	21031595					germline	Genetics Home Reference:molybdenum-cofactor-deficiency;MedGen:C1854988;OMIM:252150;Orphanet:833	2016-05-13	0	0	PASS	82	80	1	82	121412	121412	0.0006754	0	7	0	0	62	1	12	10406	11578	8654	6614	66740	908	16512	5092390	0,0,0	7,1,0	0,0,0	0,0,0	60,0,0	1,0,0	12,0,0	0	0	0	0	1	0	0	51	31	67288	54124	0	2164	0	62	66740	NFE
6	49580217	C	T	49580217	49580217	-	Haplotype	13065	RCV000013940	SCV000034187	38460	RHAG	NM_000324.2:c.838G>A	NP_000315.2:p.Gly280Arg	NM_000324.2:c.838G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1999	OMIM	OMIM	Rh-null hemolytic anemia, regulator type;RH-NULL HEMOLYTIC ANEMIA, REGULATOR TYPE	9915949					germline	MedGen:C4016364	1999-01-01	0	0																																															
6	49580247	C	T	49580247	49580247	-	Haplotype	13065	RCV000013940	SCV000034187	28104	RHAG	NM_000324.2:c.808G>A	NP_000315.2:p.Val270Ile	NM_000324.2:c.808G>A:missense variant	Benign	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Mar 18, 2016	OMIM	OMIM	Rh-null hemolytic anemia, regulator type;RH-NULL HEMOLYTIC ANEMIA, REGULATOR TYPE	9915949					germline	MedGen:C4016364	1999-01-01	1	0	PASS	5269	4916	176	5268	121412	121232	0.043	740	602	525	73	1620	30	1678	10398	11524	8646	6614	66660	904	16486	2360936	686	570	489	69	1590	26	1486	27	16	18	2	15	2	96	2946	2322	67194	54038	224	2158	22	1678	16486	SAS
6	52288909	C	A	52288909	52288909	+	Haplotype	2067	RCV000002148	SCV000022306	17106	EFHC1	NM_018100.3:c.229C>A	NP_060570.2:p.Pro77Thr	NM_018100.3:c.229C>A:missense variant;NR_033327.1:n.444C>A:non-coding transcript variant	Conflicting interpretations of pathogenicity	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 24, 2017	OMIM	OMIM	Myoclonic epilepsy, juvenile 1;MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1	12439895;15258581					germline		2004-08-01	0	1	PASS	285	273	6	285	121412	121348	0.002347	264	19	0	0	2	0	0	10392	11572	8652	6614	66704	906	16508	1831897	254	17	0	0	2	0	0	5	1	0	0	0	0	0	120	165	67272	54076	0	2164	0	264	10392	AFR
6	52317574	G	A	52317574	52317574	+	Haplotype	2067	RCV000002148	SCV000022306	38421	EFHC1	NM_018100.3:c.662G>A	NP_060570.2:p.Arg221His	NM_018100.3:c.662G>A:missense variant;NR_033327.1:n.877G>A:non-coding transcript variant	Conflicting interpretations of pathogenicity	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 24, 2017	OMIM	OMIM	Myoclonic epilepsy, juvenile 1;MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1	12439895;15258581					germline		2004-08-01	0	1	PASS	284	272	6	284	121412	121402	0.002339	262	20	0	0	2	0	0	10404	11576	8654	6614	66736	908	16510	1747219	252,0,0	18,1,0	0,0,0	0,0,0	2,0,0	0,0,0	0,0,0	5	1	0	0	0	0	0	121	163	67286	54116	0	2164	0	262	10404	AFR
6	129601216	A	C	129601216	129601216	+	Haplotype	190218	RCV000170437	SCV000222875	188050	LAMA2	NM_000426.3:c.2461A>C	NP_000417.2:p.Thr821Pro	NM_000426.3:c.2461A>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 08, 2015	Mendelics Analise Genomica	Mendelics Analise Genomica	Merosin deficient congenital muscular dystrophy;Merosin deficient congenital muscular dystrophy	20301468;21078917;22420014;22675738					germline	GeneReviews:NBK1291;Genetic Alliance:Muscular+dystrophy+congenital%2C+merosin+negative/4985;MedGen:C1263858;OMIM:607855;Office of Rare Diseases:3843;Orphanet:258;SNOMED CT:111503008	2015-04-08	0	0																																															
6	129823841	T	C	129823841	129823841	+	Haplotype	190218	RCV000170437	SCV000222875	188051	LAMA2	NM_000426.3:c.8282T>C	NP_000417.2:p.Ile2761Thr	NM_000426.3:c.8282T>C:missense variant	Likely benign	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jul 14, 2017	Mendelics Analise Genomica	Mendelics Analise Genomica	Merosin deficient congenital muscular dystrophy;Merosin deficient congenital muscular dystrophy	20301468;21078917;22420014;22675738					germline	GeneReviews:NBK1291;Genetic Alliance:Muscular+dystrophy+congenital%2C+merosin+negative/4985;MedGen:C1263858;OMIM:607855;Office of Rare Diseases:3843;Orphanet:258;SNOMED CT:111503008	2015-04-08	1	0	PASS	35	35	0	35	121412	121184	0.0002883	34	1	0	0	0	0	0	10356	11538	8616	6610	66660	908	16496	1881401	34	1	0	0	0	0	0	0	0	0	0	0	0	0	13	22	67174	54010	0	2162	0	34	10356	AFR
6	146720826	GGAA	G	146720827	146720829	+	Haplotype	453266	RCV000030784	SCV000053445	45814	GRM1	NM_001278064.1:c.2652_2654delGAA	NP_001264993.1:p.Asn885del		-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 25, 2012	OMIM	OMIM	Spinocerebellar ataxia, autosomal recessive 13;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	22901947					germline	MedGen:C3553816;OMIM:614831;Orphanet:324262	2012-09-07	0	0																																															
6	146720837	T	C	146720837	146720837	+	Haplotype	453266	RCV000030784	SCV000053445	434131	GRM1	NM_001278064.1:c.2660+2T>C		NM_001278064.1:c.2660+2T>C:splice donor variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 25, 2012	OMIM	OMIM	Spinocerebellar ataxia, autosomal recessive 13;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	22901947					germline	MedGen:C3553816;OMIM:614831;Orphanet:324262	2012-09-07	0	0																																															
6	152697578	C	T	152697578	152697578	-	Haplotype	92124	RCV000077790	SCV000109616	97550	SYNE1	NM_033071.3:c.9283G>A	NP_149062.1:p.Ala3095Thr	NM_182961.3:c.9262G>A:missense variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 01, 2013	OMIM	OMIM	Intellectual functioning disability;VARIANT OF UNKNOWN SIGNIFICANCE	21956720;24123876					germline	MedGen:C0025362;SNOMED CT:228156007;SNOMED CT:91138005	2013-12-01	0	0	PASS	11	11	0	11	121408	121322	9.06e-05	0	0	1	0	8	0	2	10358	11572	8652	6606	66718	906	16510	2297582	0	0	1	0	8	0	2	0	0	0	0	0	0	0	8	3	67280	54042	1	2164	0	2	16510	SAS
6	152784621	T	C	152784621	152784621	-	Haplotype	92124	RCV000077790	SCV000109616	97551	SYNE1	NM_033071.3:c.1985A>G	NP_149062.1:p.Gln662Arg	NM_182961.3:c.1964A>G:missense variant	Benign/Likely benign	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 07, 2017	OMIM	OMIM	Intellectual functioning disability;VARIANT OF UNKNOWN SIGNIFICANCE	21956720;24123876					germline	MedGen:C0025362;SNOMED CT:228156007;SNOMED CT:91138005	2013-12-01	0	0	PASS	752	742	4	750	121388	119342	0.006195	15	76	0	91	561	6	1	10244	11294	8532	6560	65650	894	16168	1899110	15	74	0	91	555	6	1	0	1	0	0	3	0	0	395	355	66158	53184	0	2116	0	561	65650	NFE
7	87072999	G	C	87072999	87072999	-	Haplotype	217883	RCV000201938	SCV000256879	214536	ABCB4	NM_018849.2:c.1210C>G	NP_061337.1:p.Pro404Ala	NM_018849.2:c.1210C>G:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 25, 2014	Mendelics Analise Genomica	Mendelics Analise Genomica	Progressive familial intrahepatic cholestasis 3	17726488;9419367					germline	Genetic Alliance:Cholestasis%2C+Progressive+Familial+Intrahepatic+3/1351;Genetics Home Reference:progressive-familial-intrahepatic-cholestasis;MedGen:C1865643;OMIM:602347;Office of Rare Diseases:1289;Orphanet:79305	2014-07-25	0	0																																															
7	87082365	C	T	87082365	87082365	-	Haplotype	217883	RCV000201938	SCV000256879	214537	ABCB4	NM_018849.2:c.431G>A	NP_061337.1:p.Arg144Gln	NM_018849.2:c.431G>A:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 25, 2014	Mendelics Analise Genomica	Mendelics Analise Genomica	Progressive familial intrahepatic cholestasis 3	17726488;9419367					germline	Genetic Alliance:Cholestasis%2C+Progressive+Familial+Intrahepatic+3/1351;Genetics Home Reference:progressive-familial-intrahepatic-cholestasis;MedGen:C1865643;OMIM:602347;Office of Rare Diseases:1289;Orphanet:79305	2014-07-25	0	0																																															
7	107336408	A	C	107336408	107336408	+	Haplotype	4816	RCV000005085	SCV000025261	38434	SLC26A4	NM_000441.1:c.1468A>C	NP_000432.1:p.Ile490Leu	NM_000441.1:c.1468A>C:missense variant	Likely benign	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 2015	OMIM	OMIM	Enlarged vestibular aqueduct syndrome;DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	18310264;20301607;20301640;9500541					germline	GeneReviews:NBK1467;Genetic Alliance:Enlarged+Vestibular+Aqueduct+Syndrome/2542;Genetic Testing Registry (GTR):GTR000500213;MedGen:C1863752;OMIM:600791;OMIM:601093.0001;OMIM:601093.0002;OMIM:602208.0008;OMIM:602208.0009;OMIM:605646.0004;OMIM:605646.0009;OMIM:605646.0010;OMIM:605646.0011;OMIM:605646.0012;OMIM:605646.0013;OMIM:605646.0014;OMIM:605646.0015;OMIM:605646.0027;OMIM:605646.0028;OMIM:605646.0029;OMIM:605646.0030;OMIM:605646.0031;Office of Rare Diseases:8651;Orphanet:90636	2008-07-01	0	0	PASS	45	45	0	45	121412	121382	0.0003706	0	0	0	0	7	0	38	10406	11554	8650	6614	66738	908	16512	3726271	0	0	0	0	7	0	38	0	0	0	0	0	0	0	32	13	67268	54114	2	2164	0	38	16512	SAS
7	107336429	G	A	107336429	107336429	+	Haplotype	4816	RCV000005085	SCV000025261	19855	SLC26A4	NM_000441.1:c.1489G>A	NP_000432.1:p.Gly497Ser	NM_000441.1:c.1489G>A:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Mar 30, 2017	OMIM	OMIM	Enlarged vestibular aqueduct syndrome;DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	18310264;20301607;20301640;9500541					germline	GeneReviews:NBK1467;Genetic Alliance:Enlarged+Vestibular+Aqueduct+Syndrome/2542;Genetic Testing Registry (GTR):GTR000500213;MedGen:C1863752;OMIM:600791;OMIM:601093.0001;OMIM:601093.0002;OMIM:602208.0008;OMIM:602208.0009;OMIM:605646.0004;OMIM:605646.0009;OMIM:605646.0010;OMIM:605646.0011;OMIM:605646.0012;OMIM:605646.0013;OMIM:605646.0014;OMIM:605646.0015;OMIM:605646.0027;OMIM:605646.0028;OMIM:605646.0029;OMIM:605646.0030;OMIM:605646.0031;Office of Rare Diseases:8651;Orphanet:90636	2008-07-01	2	0	PASS	3	3	0	3	121412	121380	2.471e-05	0	0	1	0	2	0	0	10406	11550	8652	6614	66738	908	16512	3721465	0	0	1	0	2	0	0	0	0	0	0	0	0	0	3	0	67268	54112	0	2164	0	1	8652	EAS
7	117171029	G	A	117171029	117171029	+	Haplotype	209047	RCV000190992	SCV000245925	22148	CFTR	NM_000492.3:c.350G>A	NP_000483.3:p.Arg117His	NM_000492.3:c.350G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	practice guideline	reviewed by expert panel	Oct 31, 2017	CFTR2	CFTR2	Cystic fibrosis;Cystic fibrosis	11280952;12394352;15789152;17761616;19888064;19914443;19914445;20301428;20605539;20675678;21422883;21938795;22475884;23974870;24014130;25431289;25981758				More than 1,000 CFTR variants have been reported.  Most common pathogenic variant is p.Phe508del.;loss of function	germline	GeneReviews:NBK1250;Genetic Alliance:Cystic+Fibrosis/2071;Genetic Testing Registry (GTR):GTR000004176;Genetic Testing Registry (GTR):GTR000005248;Genetic Testing Registry (GTR):GTR000025280;Genetic Testing Registry (GTR):GTR000028916;Genetic Testing Registry (GTR):GTR000074114;Genetic Testing Registry (GTR):GTR000194834;Genetic Testing Registry (GTR):GTR000209428;Genetic Testing Registry (GTR):GTR000226639;Genetic Testing Registry (GTR):GTR000277984;Genetic Testing Registry (GTR):GTR000288561;Genetic Testing Registry (GTR):GTR000320929;Genetic Testing Registry (GTR):GTR000324499;Genetic Testing Registry (GTR):GTR000328569;Genetic Testing Registry (GTR):GTR000330969;Genetic Testing Registry (GTR):GTR000332363;Genetic Testing Registry (GTR):GTR000501120;Genetic Testing Registry (GTR):GTR000501211;Genetic Testing Registry (GTR):GTR000501918;Genetic Testing Registry (GTR):GTR000501920;Genetic Testing Registry (GTR):GTR000501921;Genetic Testing Registry (GTR):GTR000502992;Genetic Testing Registry (GTR):GTR000505699;Genetic Testing Registry (GTR):GTR000506511;Genetic Testing Registry (GTR):GTR000507003;Genetic Testing Registry (GTR):GTR000507006;Genetic Testing Registry (GTR):GTR000507010;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507950;Genetic Testing Registry (GTR):GTR000508782;Genetic Testing Registry (GTR):GTR000508810;Genetic Testing Registry (GTR):GTR000508811;Genetic Testing Registry (GTR):GTR000508812;Genetic Testing Registry (GTR):GTR000508889;Genetic Testing Registry (GTR):GTR000508890;Genetic Testing Registry (GTR):GTR000508893;Genetic Testing Registry (GTR):GTR000508894;Genetic Testing Registry (GTR):GTR000514611;Genetic Testing Registry (GTR):GTR000515757;Genetic Testing Registry (GTR):GTR000515758;Genetic Testing Registry (GTR):GTR000520059;Genetic Testing Registry (GTR):GTR000521501;Genetic Testing Registry (GTR):GTR000521905;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528606;Genetic Testing Registry (GTR):GTR000529460;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000553017;Genetic Testing Registry (GTR):GTR000556535;Genetic Testing Registry (GTR):GTR000556536;Genetic Testing Registry (GTR):GTR000558875;Genetic Testing Registry (GTR):GTR000558928;MedGen:C0010674;OMIM:219700;Office of Rare Diseases:6233;Orphanet:586;SNOMED CT:190905008	0000-00-00	4	0	PASS	185	185	0	185	121406	120360	0.001524	3	4	0	7	170	1	0	10350	11290	8612	6568	66372	902	16266	1552730	3,0,0	4,0,0	0,0,0	7,0,0	170,0,0	1,0,0	0,1,0	0	0	0	0	0	0	0	98	87	66688	53672	0	2144	0	170	66372	NFE
7	117180359	C	A	117180359	117180359	+	Haplotype	40200	RCV000007589	SCV000027790	22208	CFTR	NM_000492.3:c.1075C>A	NP_000483.3:p.Gln359Lys	NM_000492.3:c.1075C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1993	OMIM	OMIM	Cystic fibrosis;CYSTIC FIBROSIS	11280952;12394352;15789152;17761616;19888064;19914443;19914445;20301428;20605539;20675678;21422883;21938795;22475884;24014130;25431289;25981758;7679367				More than 1,000 CFTR variants have been reported.  Most common pathogenic variant is p.Phe508del.;loss of function	germline	GeneReviews:NBK1250;Genetic Alliance:Cystic+Fibrosis/2071;Genetic Testing Registry (GTR):GTR000004176;Genetic Testing Registry (GTR):GTR000005248;Genetic Testing Registry (GTR):GTR000025280;Genetic Testing Registry (GTR):GTR000028916;Genetic Testing Registry (GTR):GTR000074114;Genetic Testing Registry (GTR):GTR000194834;Genetic Testing Registry (GTR):GTR000209428;Genetic Testing Registry (GTR):GTR000226639;Genetic Testing Registry (GTR):GTR000277984;Genetic Testing Registry (GTR):GTR000288561;Genetic Testing Registry (GTR):GTR000320929;Genetic Testing Registry (GTR):GTR000324499;Genetic Testing Registry (GTR):GTR000328569;Genetic Testing Registry (GTR):GTR000330969;Genetic Testing Registry (GTR):GTR000332363;Genetic Testing Registry (GTR):GTR000501120;Genetic Testing Registry (GTR):GTR000501211;Genetic Testing Registry (GTR):GTR000501918;Genetic Testing Registry (GTR):GTR000501920;Genetic Testing Registry (GTR):GTR000501921;Genetic Testing Registry (GTR):GTR000502992;Genetic Testing Registry (GTR):GTR000505699;Genetic Testing Registry (GTR):GTR000506511;Genetic Testing Registry (GTR):GTR000507003;Genetic Testing Registry (GTR):GTR000507006;Genetic Testing Registry (GTR):GTR000507010;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507950;Genetic Testing Registry (GTR):GTR000508782;Genetic Testing Registry (GTR):GTR000508810;Genetic Testing Registry (GTR):GTR000508811;Genetic Testing Registry (GTR):GTR000508812;Genetic Testing Registry (GTR):GTR000508889;Genetic Testing Registry (GTR):GTR000508890;Genetic Testing Registry (GTR):GTR000508893;Genetic Testing Registry (GTR):GTR000508894;Genetic Testing Registry (GTR):GTR000514611;Genetic Testing Registry (GTR):GTR000515757;Genetic Testing Registry (GTR):GTR000515758;Genetic Testing Registry (GTR):GTR000520059;Genetic Testing Registry (GTR):GTR000521501;Genetic Testing Registry (GTR):GTR000521905;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528606;Genetic Testing Registry (GTR):GTR000529460;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000553017;Genetic Testing Registry (GTR):GTR000556535;Genetic Testing Registry (GTR):GTR000556536;Genetic Testing Registry (GTR):GTR000558875;Genetic Testing Registry (GTR):GTR000558928;MedGen:C0010674;OMIM:219700;Office of Rare Diseases:6233;Orphanet:586;SNOMED CT:190905008	1993-01-01	0	0																																															
7	117180363	C	A	117180363	117180363	+	Haplotype	40200	RCV000007589	SCV000027790	38441	CFTR	NM_000492.3:c.1079C>A	NP_000483.3:p.Thr360Lys	NM_000492.3:c.1079C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1993	OMIM	OMIM	Cystic fibrosis;CYSTIC FIBROSIS	11280952;12394352;15789152;17761616;19888064;19914443;19914445;20301428;20605539;20675678;21422883;21938795;22475884;24014130;25431289;25981758;7679367				More than 1,000 CFTR variants have been reported.  Most common pathogenic variant is p.Phe508del.;loss of function	germline	GeneReviews:NBK1250;Genetic Alliance:Cystic+Fibrosis/2071;Genetic Testing Registry (GTR):GTR000004176;Genetic Testing Registry (GTR):GTR000005248;Genetic Testing Registry (GTR):GTR000025280;Genetic Testing Registry (GTR):GTR000028916;Genetic Testing Registry (GTR):GTR000074114;Genetic Testing Registry (GTR):GTR000194834;Genetic Testing Registry (GTR):GTR000209428;Genetic Testing Registry (GTR):GTR000226639;Genetic Testing Registry (GTR):GTR000277984;Genetic Testing Registry (GTR):GTR000288561;Genetic Testing Registry (GTR):GTR000320929;Genetic Testing Registry (GTR):GTR000324499;Genetic Testing Registry (GTR):GTR000328569;Genetic Testing Registry (GTR):GTR000330969;Genetic Testing Registry (GTR):GTR000332363;Genetic Testing Registry (GTR):GTR000501120;Genetic Testing Registry (GTR):GTR000501211;Genetic Testing Registry (GTR):GTR000501918;Genetic Testing Registry (GTR):GTR000501920;Genetic Testing Registry (GTR):GTR000501921;Genetic Testing Registry (GTR):GTR000502992;Genetic Testing Registry (GTR):GTR000505699;Genetic Testing Registry (GTR):GTR000506511;Genetic Testing Registry (GTR):GTR000507003;Genetic Testing Registry (GTR):GTR000507006;Genetic Testing Registry (GTR):GTR000507010;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507950;Genetic Testing Registry (GTR):GTR000508782;Genetic Testing Registry (GTR):GTR000508810;Genetic Testing Registry (GTR):GTR000508811;Genetic Testing Registry (GTR):GTR000508812;Genetic Testing Registry (GTR):GTR000508889;Genetic Testing Registry (GTR):GTR000508890;Genetic Testing Registry (GTR):GTR000508893;Genetic Testing Registry (GTR):GTR000508894;Genetic Testing Registry (GTR):GTR000514611;Genetic Testing Registry (GTR):GTR000515757;Genetic Testing Registry (GTR):GTR000515758;Genetic Testing Registry (GTR):GTR000520059;Genetic Testing Registry (GTR):GTR000521501;Genetic Testing Registry (GTR):GTR000521905;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528606;Genetic Testing Registry (GTR):GTR000529460;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000553017;Genetic Testing Registry (GTR):GTR000556535;Genetic Testing Registry (GTR):GTR000556536;Genetic Testing Registry (GTR):GTR000558875;Genetic Testing Registry (GTR):GTR000558928;MedGen:C0010674;OMIM:219700;Office of Rare Diseases:6233;Orphanet:586;SNOMED CT:190905008	1993-01-01	0	0																																															
7	117243663	C	T	117243663	117243663	+	Haplotype	7239	RCV000007661	SCV000027862	22244	CFTR	NM_000492.3:c.2735C>T	NP_000483.3:p.Ser912Leu	NM_000492.3:c.2735C>T:missense variant	Benign/Likely benign	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 03, 2017	OMIM	OMIM	Cystic fibrosis;CYSTIC FIBROSIS	11280952;12394352;15744523;15789152;17761616;19888064;19914443;19914445;20301428;20605539;20675678;21422883;21938795;22475884;24014130;25431289;25981758;8528204				More than 1,000 CFTR variants have been reported.  Most common pathogenic variant is p.Phe508del.;loss of function	germline	GeneReviews:NBK1250;Genetic Alliance:Cystic+Fibrosis/2071;Genetic Testing Registry (GTR):GTR000004176;Genetic Testing Registry (GTR):GTR000005248;Genetic Testing Registry (GTR):GTR000025280;Genetic Testing Registry (GTR):GTR000028916;Genetic Testing Registry (GTR):GTR000074114;Genetic Testing Registry (GTR):GTR000194834;Genetic Testing Registry (GTR):GTR000209428;Genetic Testing Registry (GTR):GTR000226639;Genetic Testing Registry (GTR):GTR000277984;Genetic Testing Registry (GTR):GTR000288561;Genetic Testing Registry (GTR):GTR000320929;Genetic Testing Registry (GTR):GTR000324499;Genetic Testing Registry (GTR):GTR000328569;Genetic Testing Registry (GTR):GTR000330969;Genetic Testing Registry (GTR):GTR000332363;Genetic Testing Registry (GTR):GTR000501120;Genetic Testing Registry (GTR):GTR000501211;Genetic Testing Registry (GTR):GTR000501918;Genetic Testing Registry (GTR):GTR000501920;Genetic Testing Registry (GTR):GTR000501921;Genetic Testing Registry (GTR):GTR000502992;Genetic Testing Registry (GTR):GTR000505699;Genetic Testing Registry (GTR):GTR000506511;Genetic Testing Registry (GTR):GTR000507003;Genetic Testing Registry (GTR):GTR000507006;Genetic Testing Registry (GTR):GTR000507010;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507950;Genetic Testing Registry (GTR):GTR000508782;Genetic Testing Registry (GTR):GTR000508810;Genetic Testing Registry (GTR):GTR000508811;Genetic Testing Registry (GTR):GTR000508812;Genetic Testing Registry (GTR):GTR000508889;Genetic Testing Registry (GTR):GTR000508890;Genetic Testing Registry (GTR):GTR000508893;Genetic Testing Registry (GTR):GTR000508894;Genetic Testing Registry (GTR):GTR000514611;Genetic Testing Registry (GTR):GTR000515757;Genetic Testing Registry (GTR):GTR000515758;Genetic Testing Registry (GTR):GTR000520059;Genetic Testing Registry (GTR):GTR000521501;Genetic Testing Registry (GTR):GTR000521905;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528606;Genetic Testing Registry (GTR):GTR000529460;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000553017;Genetic Testing Registry (GTR):GTR000556535;Genetic Testing Registry (GTR):GTR000556536;Genetic Testing Registry (GTR):GTR000558875;Genetic Testing Registry (GTR):GTR000558928;MedGen:C0010674;OMIM:219700;Office of Rare Diseases:6233;Orphanet:586;SNOMED CT:190905008	2005-05-01	0	0	PASS	108	108	0	108	121412	121272	0.0008895	6	3	1	0	88	3	7	10406	11480	8654	6612	66702	908	16510	2276752	6	3	1	0	88	3	7	0	0	0	0	0	0	0	49	59	67208	54064	1	2164	0	88	66702	NFE
7	117282505	G	T	117282505	117282505	+	Haplotype	7239	RCV000007661	SCV000027862	22278	CFTR	NM_000492.3:c.3731G>T	NP_000483.3:p.Gly1244Val	NM_000492.3:c.3731G>T:missense variant	not provided	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 2005	OMIM	OMIM	Cystic fibrosis;CYSTIC FIBROSIS	11280952;12394352;15744523;15789152;17761616;19888064;19914443;19914445;20301428;20605539;20675678;21422883;21938795;22475884;24014130;25431289;25981758;8528204				More than 1,000 CFTR variants have been reported.  Most common pathogenic variant is p.Phe508del.;loss of function	germline	GeneReviews:NBK1250;Genetic Alliance:Cystic+Fibrosis/2071;Genetic Testing Registry (GTR):GTR000004176;Genetic Testing Registry (GTR):GTR000005248;Genetic Testing Registry (GTR):GTR000025280;Genetic Testing Registry (GTR):GTR000028916;Genetic Testing Registry (GTR):GTR000074114;Genetic Testing Registry (GTR):GTR000194834;Genetic Testing Registry (GTR):GTR000209428;Genetic Testing Registry (GTR):GTR000226639;Genetic Testing Registry (GTR):GTR000277984;Genetic Testing Registry (GTR):GTR000288561;Genetic Testing Registry (GTR):GTR000320929;Genetic Testing Registry (GTR):GTR000324499;Genetic Testing Registry (GTR):GTR000328569;Genetic Testing Registry (GTR):GTR000330969;Genetic Testing Registry (GTR):GTR000332363;Genetic Testing Registry (GTR):GTR000501120;Genetic Testing Registry (GTR):GTR000501211;Genetic Testing Registry (GTR):GTR000501918;Genetic Testing Registry (GTR):GTR000501920;Genetic Testing Registry (GTR):GTR000501921;Genetic Testing Registry (GTR):GTR000502992;Genetic Testing Registry (GTR):GTR000505699;Genetic Testing Registry (GTR):GTR000506511;Genetic Testing Registry (GTR):GTR000507003;Genetic Testing Registry (GTR):GTR000507006;Genetic Testing Registry (GTR):GTR000507010;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507950;Genetic Testing Registry (GTR):GTR000508782;Genetic Testing Registry (GTR):GTR000508810;Genetic Testing Registry (GTR):GTR000508811;Genetic Testing Registry (GTR):GTR000508812;Genetic Testing Registry (GTR):GTR000508889;Genetic Testing Registry (GTR):GTR000508890;Genetic Testing Registry (GTR):GTR000508893;Genetic Testing Registry (GTR):GTR000508894;Genetic Testing Registry (GTR):GTR000514611;Genetic Testing Registry (GTR):GTR000515757;Genetic Testing Registry (GTR):GTR000515758;Genetic Testing Registry (GTR):GTR000520059;Genetic Testing Registry (GTR):GTR000521501;Genetic Testing Registry (GTR):GTR000521905;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528606;Genetic Testing Registry (GTR):GTR000529460;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000553017;Genetic Testing Registry (GTR):GTR000556535;Genetic Testing Registry (GTR):GTR000556536;Genetic Testing Registry (GTR):GTR000558875;Genetic Testing Registry (GTR):GTR000558928;MedGen:C0010674;OMIM:219700;Office of Rare Diseases:6233;Orphanet:586;SNOMED CT:190905008	2005-05-01	0	0																																															
8	1719428	C	T	1719428	1719428	+	Haplotype	217887	RCV000201947	SCV000256883	214538	CLN8	NM_018941.3:c.208C>T	NP_061764.2:p.Arg70Cys	NM_018941.3:c.208C>T:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 18, 2014	Mendelics Analise Genomica	Mendelics Analise Genomica	Ceroid lipofuscinosis neuronal 8	16570191;20301601					germline	GeneReviews:NBK1428;MedGen:C1838570;OMIM:600143;Office of Rare Diseases:4010;Orphanet:168491;Orphanet:228354;Orphanet:79264	2014-08-18	0	0	PASS	3	3	0	3	121412	121344	2.471e-05	0	0	0	0	3	0	0	10402	11574	8654	6614	66686	906	16508	1677725	0	0	0	0	3	0	0	0	0	0	0	0	0	0	2	1	67280	54064	0	2164	0	3	66686	NFE
8	1728664	C	G	1728664	1728664	+	Haplotype	217887	RCV000201947	SCV000256883	106601	CLN8	NM_018941.3:c.792C>G	NP_061764.2:p.Asn264Lys	NM_018941.3:c.792C>G:missense variant	Pathogenic	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 18, 2014	Mendelics Analise Genomica	Mendelics Analise Genomica	Ceroid lipofuscinosis neuronal 8	16570191;20301601					germline	GeneReviews:NBK1428;MedGen:C1838570;OMIM:600143;Office of Rare Diseases:4010;Orphanet:168491;Orphanet:228354;Orphanet:79264	2014-08-18	0	0	PASS	1	1	0	1	121412	121178	8.236e-06	0	0	0	0	1	0	0	10336	11566	8648	6614	66612	906	16496	2226613	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	67250	53928	0	2164	0	1	66612	NFE
8	30922450	A	T	30922450	30922450	+	Haplotype	5453	RCV000005786	SCV000025968	20492	WRN	NM_000553.5:c.375A>T	NP_000544.2:p.Lys125Asn	NM_000553.5:c.375A>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 01, 2006	OMIM	OMIM	Werner syndrome;WERNER SYNDROME	16673358;20301687;22258520					germline	GeneReviews:NBK1514;Genetic Alliance:Werner%27s+syndrome/7471;Genetics Home Reference:werner-syndrome;MedGen:C0043119;OMIM:277700;Office of Rare Diseases:7885;Orphanet:902;SNOMED CT:51626007	2006-06-01	0	0																																															
8	30922478	A	G	30922478	30922478	+	Haplotype	5453	RCV000005786	SCV000025968	38386	WRN	NM_000553.5:c.403A>G	NP_000544.2:p.Lys135Glu	NM_000553.5:c.403A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 01, 2006	OMIM	OMIM	Werner syndrome;WERNER SYNDROME	16673358;20301687;22258520					germline	GeneReviews:NBK1514;Genetic Alliance:Werner%27s+syndrome/7471;Genetics Home Reference:werner-syndrome;MedGen:C0043119;OMIM:277700;Office of Rare Diseases:7885;Orphanet:902;SNOMED CT:51626007	2006-06-01	0	0																																															
8	38271684	G	C	38271684	38271684	-	Haplotype	16292	RCV000030930	SCV000037962	38475	FGFR1	NM_023110.2:c.2172C>G	NP_075598.2:p.Asn724Lys	NM_023110.2:c.2172C>G:missense variant	-	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 18, 2006	OMIM	OMIM	Kallmann syndrome 2;HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO	16606836;20301509				loss of function	germline	Endocrinology Clinic, Seth G.S. Medical College:FGFR1sn_4;GeneReviews:NBK1334;Genetic Alliance:Kallmann+syndrome+2/3947;Genetic Testing Registry (GTR):GTR000508944;Genetic Testing Registry (GTR):GTR000511562;Genetic Testing Registry (GTR):GTR000511608;Genetic Testing Registry (GTR):GTR000511609;Genetic Testing Registry (GTR):GTR000511610;Genetic Testing Registry (GTR):GTR000511611;Genetic Testing Registry (GTR):GTR000511612;Genetic Testing Registry (GTR):GTR000511613;Genetic Testing Registry (GTR):GTR000512869;Genetic Testing Registry (GTR):GTR000556729;Genetic Testing Registry (GTR):GTR000556731;Genetic Testing Registry (GTR):GTR000558347;MedGen:C1563720;OMIM:136350.0004;OMIM:136350.0013;OMIM:136350.0014;OMIM:136350.0015;OMIM:136350.0016;OMIM:136350.0020;OMIM:136350.0023;OMIM:136350.0024;OMIM:136350.0025;OMIM:147950;Office of Rare Diseases:3070;Orphanet:478	2006-04-18	0	0																																															
8	38271691	G	T	38271691	38271691	-	Haplotype	16292	RCV000030930	SCV000037962	31331	FGFR1	NM_023110.2:c.2165C>A	NP_075598.2:p.Pro722His	NM_023110.2:c.2165C>A:missense variant	-	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 18, 2006	OMIM	OMIM	Kallmann syndrome 2;HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO	16606836;20301509				loss of function	germline	Endocrinology Clinic, Seth G.S. Medical College:FGFR1sn_4;GeneReviews:NBK1334;Genetic Alliance:Kallmann+syndrome+2/3947;Genetic Testing Registry (GTR):GTR000508944;Genetic Testing Registry (GTR):GTR000511562;Genetic Testing Registry (GTR):GTR000511608;Genetic Testing Registry (GTR):GTR000511609;Genetic Testing Registry (GTR):GTR000511610;Genetic Testing Registry (GTR):GTR000511611;Genetic Testing Registry (GTR):GTR000511612;Genetic Testing Registry (GTR):GTR000511613;Genetic Testing Registry (GTR):GTR000512869;Genetic Testing Registry (GTR):GTR000556729;Genetic Testing Registry (GTR):GTR000556731;Genetic Testing Registry (GTR):GTR000558347;MedGen:C1563720;OMIM:136350.0004;OMIM:136350.0013;OMIM:136350.0014;OMIM:136350.0015;OMIM:136350.0016;OMIM:136350.0020;OMIM:136350.0023;OMIM:136350.0024;OMIM:136350.0025;OMIM:147950;Office of Rare Diseases:3070;Orphanet:478	2006-04-18	0	0																																															
8	143994266	A	G	143994266	143994266	-	Haplotype	16876;16877	RCV000018372;RCV000018373	SCV000038654;SCV000038655	31916	CYP11B2	NM_000498.3:c.1157T>C	NP_000489.3:p.Val386Ala	NM_000498.3:c.1157T>C:missense variant	Benign	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 14, 2016	OMIM	OMIM	Corticosterone methyloxidase type 2 deficiency;CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY;Corticosterone methyloxidase type 1 deficiency;CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY	1346492;1594605;3262827;4121586;830445;838841;9814506				loss of function	germline	Genetic Alliance:Corticosterone+methyloxidase+type+2+deficiency/8102;Genetic Testing Registry (GTR):GTR000500407;Genetics Home Reference:corticosterone-methyloxidase-deficiency;MedGen:C3463917;OMIM:610600;Orphanet:427;Genetic Alliance:Corticosterone+methyloxidase+type+1+deficiency/8101;Genetic Testing Registry (GTR):GTR000507687;MedGen:CN074214;OMIM:203400;Office of Rare Diseases:5660	1992-06-01;1998-11-01	0	0	VQSRTrancheSNP99.60to99.80	10768	9252	461	10174	121406	117846	0.089	301	565	6	560	6830	86	1826	10050	11292	8636	6358	64374	888	16248	2037682	297	543	6	532	6246	70	1558	2	11	0	14	292	8	134	6074	4100	65334	52512	291	2130	36	1826	16248	SAS
8	143996463	T	G	143996463	143996463	-	Haplotype	16877	RCV000018373	SCV000038655	38484	CYP11B2	NM_000498.3:c.594A>C	NP_000489.3:p.Glu198Asp	NM_000498.3:c.594A>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 1998	OMIM	OMIM	Corticosterone methyloxidase type 1 deficiency;CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY	9814506				loss of function	germline	Genetic Alliance:Corticosterone+methyloxidase+type+1+deficiency/8101;Genetic Testing Registry (GTR):GTR000500407;Genetic Testing Registry (GTR):GTR000507687;Genetics Home Reference:corticosterone-methyloxidase-deficiency;MedGen:CN074214;OMIM:203400;Office of Rare Diseases:5660;Orphanet:427	1998-11-01	0	0	PASS	7	7	0	7	121402	116606	5.766e-05	1	1	0	0	5	0	0	9884	11134	8458	5660	64702	830	15938	1934762	1	1	0	0	5	0	0	0	0	0	0	0	0	0	5	2	65076	51530	0	2124	0	1	9884	AFR
8	143996516	G	A	143996516	143996516	-	Haplotype	16876	RCV000018372	SCV000038654	31915	CYP11B2	NM_000498.3:c.541C>T	NP_000489.3:p.Arg181Trp	NM_000498.3:c.541C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 01, 1992	OMIM	OMIM	Corticosterone methyloxidase type 2 deficiency;CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY	1346492;1594605;3262827;4121586;830445;838841				loss of function	germline	Genetic Alliance:Corticosterone+methyloxidase+type+2+deficiency/8102;Genetic Testing Registry (GTR):GTR000500407;Genetics Home Reference:corticosterone-methyloxidase-deficiency;MedGen:C3463917;OMIM:610600;Orphanet:427	1992-06-01	0	0	PASS	4	4	0	4	121396	117390	3.295e-05	0	0	0	0	4	0	0	9978	11276	8522	5752	65006	844	16012	1943412	0	0	0	0	4	0	0	0	0	0	0	0	0	0	3	1	65480	51910	0	2118	0	4	65006	NFE
9	2115860	G	C	2115860	2115860	+	Haplotype	374221	RCV000415335	SCV000493071	361134	SMARCA2	NM_003070.4:c.3495G>C	NP_003061.3:p.Gln1165His	NM_003070.4:c.3495G>C:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Laboratory of Molecular Genetics,CHU RENNES	Laboratory of Molecular Genetics,CHU RENNES	Nicolaides-Baraitser syndrome;Nicolaides Baraitser syndrome	26468571					de novo	GeneReviews:NBK321516;Genetic Alliance:Nicolaides+Baraitser+syndrome/5221;Genetics Home Reference:nicolaides-baraitser-syndrome;MedGen:C1303073;OMIM:601358;Orphanet:3051;SNOMED CT:401046009	0000-00-00	0	0																																															
9	2123873	G	A	2123873	2123873	+	Haplotype	374221	RCV000415335	SCV000493071	361135	SMARCA2	NM_003070.4:c.3917G>A	NP_003061.3:p.Arg1306Lys	NM_003070.4:c.3917G>A:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Laboratory of Molecular Genetics,CHU RENNES	Laboratory of Molecular Genetics,CHU RENNES	Nicolaides-Baraitser syndrome;Nicolaides Baraitser syndrome	26468571					de novo	GeneReviews:NBK321516;Genetic Alliance:Nicolaides+Baraitser+syndrome/5221;Genetics Home Reference:nicolaides-baraitser-syndrome;MedGen:C1303073;OMIM:601358;Orphanet:3051;SNOMED CT:401046009	0000-00-00	0	0																																															
9	34646572	CCAGT	C	34646583	34646586	+	Haplotype	140570	RCV000128642	SCV000148002	36445	GALT	NM_000155.3:c.-67-52_-67-49delGTCA		NM_000155.3:c.-119_-116del:2KB upstream variant;NM_000155.3:c.-67-52_-67-49delGTCA:intron variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Nov 09, 2017	GeneReviews	GeneReviews	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase;Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	10408771;10424825;10649501;11216901;11286503;11754113;15633893;15841485;16838075;19224951;2011574;20301691;22475884;25473725					germline	GeneReviews:NBK1518;Genetic Alliance:Deficiency+of+UTP-hexose-1-phosphate+uridylyltransferase/8206;MedGen:C0268151;OMIM:230400;Office of Rare Diseases:2424;Orphanet:352;Orphanet:79239;SNOMED CT:124354006	2014-04-03	1	1																																															
9	34648418	C	T	34648418	34648418	+	Haplotype	3620	RCV000003804	SCV000023969	18659	GALT	NM_000155.3:c.652C>T	NP_000146.2:p.Leu218=	NM_000155.3:c.652C>T:synonymous variant	Benign/Likely benign, other	benign	0	0	0	0	1	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	May 08, 2017	OMIM	OMIM	GALT POLYMORPHISM (LOS ANGELES, D1);GALT POLYMORPHISM (LOS ANGELES, D1)	10408771;10424825;19224951;2011574;4759900;8522334;9012409					germline	OMIM:606999.0012	2009-05-01	2	0	PASS	4651	4298	176	4650	121412	121352	0.038	119	196	4	281	2247	48	1755	10402	11578	8654	6614	66684	908	16512	4236957	119	190	4	269	2141	46	1529	0	3	0	6	53	1	113	2942	1708	67274	54078	235	2164	28	1755	16512	SAS
9	34649442	A	G	34649442	34649442	+	Haplotype	140570;3620	RCV000128642;RCV000003804	SCV000148002;SCV000023969	18652	GALT	NM_000155.3:c.940A>G	NP_000146.2:p.Asn314Asp	NM_000155.3:c.940A>G:missense variant	Conflicting interpretations of pathogenicity, other	pathogenic;benign	1	0	0	0	1	criteria provided, conflicting interpretations	no assertion criteria provided	Jul 26, 2017	GeneReviews;OMIM	GeneReviews;OMIM	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase;GALT POLYMORPHISM (LOS ANGELES, D1)	10408771;10424825;10649501;11216901;11286503;11754113;15633893;15841485;16838075;19224951;2011574;20301691;22475884;25473725;4759900;8522334;9012409					germline	GeneReviews:NBK1518;Genetic Alliance:Deficiency+of+UTP-hexose-1-phosphate+uridylyltransferase/8206;MedGen:C0268151;OMIM:230400;Office of Rare Diseases:2424;Orphanet:352;Orphanet:79239;SNOMED CT:124354006;OMIM:606999.0012	2014-04-03;2009-05-01	1	1	PASS	11169	9785	692	11169	121412	121390	0.092	247	662	66	748	6304	117	3025	10406	11578	8654	6614	66722	908	16508	3340763	243	602	66	666	5662	97	2449	2	30	0	41	321	10	288	6787	4382	67280	54110	414	2164	55	3025	16508	SAS
9	37424827	TCC	T	37424829	37424830	+	Haplotype	204246	RCV000186453	SCV000239808	200618	GRHPR	NM_012203.1:c.84-13_84-12delCC		NM_012203.1:c.84-13_84-12delCC:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 27, 2014	Clinical Biochemistry Laboratory,Health Services Laboratory	Clinical Biochemistry Laboratory,Health Services Laboratory	Primary hyperoxaluria, type II;Primary hyperoxaluria, type II	14635115;20301742				loss of function	germline	GeneReviews:NBK2692;Genetic Alliance:Primary+hyperoxaluria+type+2/5948;Genetic Testing Registry (GTR):GTR000118462;Genetic Testing Registry (GTR):GTR000507682;Genetic Testing Registry (GTR):GTR000522211;Genetic Testing Registry (GTR):GTR000528276;MedGen:C0268165;OMIM:260000;Office of Rare Diseases:2836;Orphanet:416;Orphanet:93599;SNOMED CT:40951006	2014-11-27	0	0	PASS	5	5	0	5	121374	107010	4.119e-05	0	0	0	0	0	0	5	9130	9864	7878	5254	58888	738	15258	1289497	0	0	0	0	0	0	5	0	0	0	0	0	0	0	5	0	60576	46434	3	1998	0	5	15258	SAS
9	37424833	TCCCC	T	37424834	37424837	+	Haplotype	204246	RCV000186453	SCV000239808	200619	GRHPR	NM_012203.1:c.84-8_84-5delCCCC		NM_012203.1:c.84-8_84-5delCCCC:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 27, 2014	Clinical Biochemistry Laboratory,Health Services Laboratory	Clinical Biochemistry Laboratory,Health Services Laboratory	Primary hyperoxaluria, type II;Primary hyperoxaluria, type II	14635115;20301742				loss of function	germline	GeneReviews:NBK2692;Genetic Alliance:Primary+hyperoxaluria+type+2/5948;Genetic Testing Registry (GTR):GTR000118462;Genetic Testing Registry (GTR):GTR000507682;Genetic Testing Registry (GTR):GTR000522211;Genetic Testing Registry (GTR):GTR000528276;MedGen:C0268165;OMIM:260000;Office of Rare Diseases:2836;Orphanet:416;Orphanet:93599;SNOMED CT:40951006	2014-11-27	0	0	VQSRTrancheINDEL96.00to97.00	5	5	0	5	121378	110320	4.119e-05	0	0	0	0	0	0	5	9360	10312	8088	5482	60832	776	15470	1335515	0	0	0	0	0	0	5	0	0	0	0	0	0	0	5	0	62312	48008	3	2032	0	5	15470	SAS
9	101340316	T	C	101340316	101340316	-	Haplotype	3331	RCV000003495	SCV000023653	18370	GABBR2	NM_005458.7:c.360A>G	NP_005449.5:p.Ala120=	NM_005458.7:c.360A>G:synonymous variant	-	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 2005	OMIM	OMIM	Tobacco addiction, susceptibility to;NICOTINE DEPENDENCE, SUSCEPTIBILITY TO	15759211					germline	Genetic Alliance:Tobacco+addiction%2C+susceptibility+to/9410;MedGen:C1861063;OMIM:188890;OMIM:607340.0001;OMIM:607340.0002	2005-05-01	0	0	PASS	20470	16714	1873	20460	121412	121366	0.169	2412	853	1297	1286	12492	171	1949	10404	11568	8638	6614	66726	908	16508	3484073	1852	793	1069	1068	10112	135	1685	280	30	114	109	1190	18	132	11393	9067	67272	54094	273	2164	27	2412	10404	AFR
9	127262853	G	A	127262853	127262853	-	Haplotype	12809	RCV000013657;RCV000022775	SCV000033904;SCV000044064	38458	NR5A1	NM_004959.4:c.386C>T	NP_004950.2:p.Pro129Leu	NM_004959.4:c.386C>T:missense variant	-	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 08, 2010	OMIM	OMIM	Premature ovarian failure 7;PREMATURE OVARIAN FAILURE 7;Spermatogenic failure 8	19246354;20887963					germline	Genetic Alliance:Premature+ovarian+failure+7/9153;MedGen:C2751825;OMIM:612964;Genetic Alliance:Spermatogenic+failure+8/9327;MedGen:C3151406;OMIM:613957	2010-10-08	0	0	PASS	36	29	0	29	120798	111400	0.000298	25	3	0	0	1	0	0	8570	11104	8234	6136	60352	810	16194	1468996	25	3	0	0	1	0	0	0	0	0	0	0	0	0	13	16	64248	47152	0	2150	0	25	8570	AFR
9	127262871	C	G	127262871	127262871	-	Haplotype	12809	RCV000013657;RCV000022775	SCV000033904;SCV000044064	27848	NR5A1	NM_004959.4:c.368G>C	NP_004950.2:p.Gly123Ala	NM_004959.4:c.368G>C:missense variant	-	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 08, 2010	OMIM	OMIM	Premature ovarian failure 7;PREMATURE OVARIAN FAILURE 7;Spermatogenic failure 8	19246354;20887963					germline	Genetic Alliance:Premature+ovarian+failure+7/9153;MedGen:C2751825;OMIM:612964;Genetic Alliance:Spermatogenic+failure+8/9327;MedGen:C3151406;OMIM:613957	2010-10-08	0	0	PASS	34	30	0	30	120850	113852	0.0002813	26	3	0	0	1	0	0	8968	11198	8356	6352	61864	838	16276	1526675	26	3	0	0	1	0	0	0	0	0	0	0	0	0	13	17	65370	48482	0	2154	0	26	8968	AFR
9	135203105	G	A	135203105	135203105	-	Haplotype	441281	RCV000002384	SCV000022542	38425	SETX	NM_015046.5:c.3880C>T	NP_055861.3:p.Arg1294Cys	NM_015046.5:c.3880C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 23, 2006	OMIM	OMIM	Spinocerebellar ataxia autosomal recessive 1;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	16717225;20050888;20301317;20301333					germline	GeneReviews:NBK1154;Genetic Alliance:Spinocerebellar+ataxia+autosomal+recessive+1/6771;Genetics Home Reference:ataxia-with-oculomotor-apraxia;MedGen:C1853761;OMIM:606002;Office of Rare Diseases:4949;Orphanet:64753	2006-05-23	0	0	PASS	2	2	0	2	121412	121382	1.647e-05	1	0	0	0	0	0	1	10388	11576	8654	6614	66732	908	16510	3284464	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	2	67282	54100	1	2164	0	1	10388	AFR
9	135203176	G	A	135203176	135203176	-	Phase unknown	157525	RCV000144869	SCV000172140	167387	SETX	NM_015046.5:c.3809C>T	NP_055861.3:p.Pro1270Leu	NM_015046.5:c.3809C>T:missense variant	Likely benign	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 09, 2016	Section of Medical Genetics, Telemark Hospital	Section of Medical Genetics, Telemark Hospital	Charcot-Marie-Tooth disease;axonal type;Charcot-Marie-Tooth disease	20301532;25025039					tested-inconclusive	GeneReviews:NBK1358;Genetic Alliance:Charcot-Marie-Tooth+Disease/1276;Genetics Home Reference:charcot-marie-tooth-disease;MedGen:C0007959;OMIM:PS118220;Office of Rare Diseases:6034;SNOMED CT:50548001	2013-11-01	0	0	PASS	152	152	0	152	121412	121396	0.001252	1	4	0	54	84	1	8	10396	11578	8654	6614	66736	908	16510	3314337	1	4	0	54	84	1	8	0	0	0	0	0	0	0	78	74	67284	54112	3	2164	0	84	66736	NFE
9	135203908	C	CTCA	135203909	135203910		Distinct chromosomes	157528	RCV000144873	SCV000172145	167390	REEP1	NM_015046.5:c.3075_3076insTGA	NP_055861.3:p.Arg1026_Lys1360delinsTer	NM_015046.5:c.3075_3076insTGA:inframe_variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 2013	Section of Medical Genetics, Telemark Hospital	Section of Medical Genetics, Telemark Hospital	Charcot-Marie-Tooth disease;axonal type|spasticity;Charcot-Marie-Tooth disease	20301532;25025039					tested-inconclusive	GeneReviews:NBK1358;Genetic Alliance:Charcot-Marie-Tooth+Disease/1276;Genetics Home Reference:charcot-marie-tooth-disease;MedGen:C0007959;OMIM:PS118220;Office of Rare Diseases:6034;SNOMED CT:50548001	2013-11-01	0	0																																															
9	135205028	G	T	135205028	135205028	-	Haplotype	441280	RCV000002383	SCV000022541	38424	SETX	NM_015046.5:c.1957C>A	NP_055861.3:p.Gln653Lys	NM_015046.5:c.1957C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 2007	OMIM	OMIM	Spinocerebellar ataxia autosomal recessive 1;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	17096168;20050888;20301317;20301333					germline	GeneReviews:NBK1154;Genetic Alliance:Spinocerebellar+ataxia+autosomal+recessive+1/6771;Genetics Home Reference:ataxia-with-oculomotor-apraxia;MedGen:C1853761;OMIM:606002;Office of Rare Diseases:4949;Orphanet:64753	2007-01-01	0	0	PASS	210	206	2	210	121408	121292	0.00173	197	9	0	0	4	0	0	10394	11558	8650	6614	66678	904	16494	1589602	193	9	0	0	4	0	0	2	0	0	0	0	0	0	87	123	67216	54076	0	2158	0	197	10394	AFR
9	135205178	T	C	135205178	135205178	-	Haplotype	441280	RCV000002383	SCV000022541	17332	SETX	NM_015046.5:c.1807A>G	NP_055861.3:p.Asn603Asp	NM_015046.5:c.1807A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 2007	OMIM	OMIM	Spinocerebellar ataxia autosomal recessive 1;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	17096168;20050888;20301317;20301333					germline	GeneReviews:NBK1154;Genetic Alliance:Spinocerebellar+ataxia+autosomal+recessive+1/6771;Genetics Home Reference:ataxia-with-oculomotor-apraxia;MedGen:C1853761;OMIM:606002;Office of Rare Diseases:4949;Orphanet:64753	2007-01-01	0	0	PASS	143	143	0	143	121406	121194	0.001178	139	4	0	0	0	0	0	10362	11546	8640	6608	66632	904	16502	1577595	139	4	0	0	0	0	0	0	0	0	0	0	0	0	60	83	67200	53994	0	2164	0	139	10362	AFR
9	135224757	C	T	135224757	135224757	-	Phase unknown	157525	RCV000144869	SCV000172140	167386	SETX	NM_015046.5:c.59G>A	NP_055861.3:p.Arg20His	NM_015046.5:c.59G>A:missense variant	Benign/Likely benign	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 31, 2017	Section of Medical Genetics, Telemark Hospital	Section of Medical Genetics, Telemark Hospital	Charcot-Marie-Tooth disease;axonal type;Charcot-Marie-Tooth disease	20301532;25025039					tested-inconclusive	GeneReviews:NBK1358;Genetic Alliance:Charcot-Marie-Tooth+Disease/1276;Genetics Home Reference:charcot-marie-tooth-disease;MedGen:C0007959;OMIM:PS118220;Office of Rare Diseases:6034;SNOMED CT:50548001	2013-11-01	0	0	PASS	1100	1082	9	1100	121412	121382	0.00906	12	42	1	97	675	17	256	10402	11572	8652	6614	66730	906	16506	1950328	12	42	1	95	665	15	252	0	0	0	1	5	1	2	675	425	67278	54104	33	2164	1	256	16506	SAS
9	136131315	C	G	136131315	136131315	-	Haplotype	17738	RCV000019312	SCV000039601	38414	ABO	NM_020469.2:c.803G>C	NP_065202.2:p.Gly268Ala	NM_020469.2:c.803G>C:missense variant	-	association	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 18, 2015	OMIM	OMIM	ABO blood group system;ABO BLOOD GROUP SYSTEM, CIS-AB PHENOTYPE	14170898;6775529;8456556					germline	MedGen:C0000778;OMIM:110300.0001;OMIM:110300.0002;OMIM:110300.0003;OMIM:110300.0004;OMIM:110300.0005;OMIM:616093;SNOMED CT:63915006	2015-05-18	0	0	PASS	14311	11649	1121	13891	120766	106094	0.119	1532	581	1460	820	5219	103	4176	8346	10050	7512	5576	58208	774	15628	1961120	1276	547	1232	704	4797	81	3012	128	17	114	58	211	11	582	8247	5644	60104	45990	553	2126	91	4176	15628	SAS
9	136131651	G	A	136131651	136131651	-	Haplotype	17738	RCV000019312	SCV000039601	32777	ABO	NM_020469.2:c.467C>T	NP_065202.2:p.Pro156Leu	NM_020469.2:c.467C>T:missense variant	-	association	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 18, 2015	OMIM	OMIM	ABO blood group system;ABO BLOOD GROUP SYSTEM, CIS-AB PHENOTYPE	14170898;6775529;8456556					germline	MedGen:C0000778;OMIM:110300.0001;OMIM:110300.0002;OMIM:110300.0003;OMIM:110300.0004;OMIM:110300.0005;OMIM:616093;SNOMED CT:63915006	2015-05-18	0	0	PASS	10457	8899	666	10231	120650	115170	0.087	2053	394	1553	768	4827	78	558	8848	11292	8336	6536	62994	852	16312	2112206	1557	372	1263	656	4455	72	524	248	11	145	56	186	3	17	5459	4772	65902	49268	72	2164	3	2053	8848	AFR
9	136301982	C	G	136301982	136301982	+	Haplotype	5813	RCV000006169	SCV000026351	20852	ADAMTS13	NM_139025.4:c.1342C>G	NP_620594.1:p.Gln448Glu	NM_139025.4:c.1342C>G:missense variant;NR_024514.2:n.993-2504C>G:intron variant	Benign	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 14, 2016	OMIM	OMIM	Upshaw-Schulman syndrome;THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	12181489					germline	Genetic Alliance:Thrombotic+thrombocytopenic+purpura%2C+congenital/7089;Genetics Home Reference:thrombotic-thrombocytopenic-purpura;MedGen:C1268935;OMIM:274150;Office of Rare Diseases:9430;SNOMED CT:373420004	2002-09-03	0	0	PASS	40802	16727	5376	27479	118652	60658	0.344	551	2548	1059	1039	16961	182	5139	4436	4988	4230	1846	33594	426	11138	1171357	479	1632	897	603	10087	124	2905	36	458	81	218	3437	29	1117	15978	11501	34608	26050	748	1674	181	2548	4988	AMR
9	136302956	G	A	136302956	136302956	+	Haplotype	5813	RCV000006169	SCV000026351	38438	ADAMTS13	NM_139025.4:c.1523G>A	NP_620594.1:p.Cys508Tyr	NM_139025.4:c.1523G>A:missense variant;NR_024514.2:n.993-1530G>A:intron variant	not provided	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 03, 2002	OMIM	OMIM	Upshaw-Schulman syndrome;THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	12181489					germline	Genetic Alliance:Thrombotic+thrombocytopenic+purpura%2C+congenital/7089;Genetics Home Reference:thrombotic-thrombocytopenic-purpura;MedGen:C1268935;OMIM:274150;Office of Rare Diseases:9430;SNOMED CT:373420004	2002-09-03	0	0																																															
9	136501794	G	A	136501794	136501794	+	Haplotype	1752	RCV000001822	SCV000021978	16791	DBH	NM_000787.3:c.301G>A	NP_000778.3:p.Val101Met	NM_000787.3:c.301G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Oct 29, 2015	OMIM	OMIM	Dopamine beta hydroxylase deficiency;DOPAMINE BETA-HYDROXYLASE DEFICIENCY	11857564;20301647					germline	GeneReviews:NBK1474;Genetic Alliance:Dopamine+Beta+Hydroxylase+Deficiency/2316;MedGen:C0342687;OMIM:223360;Office of Rare Diseases:1903;Orphanet:230	2002-03-01	0	0	PASS	2	2	0	2	121410	119646	1.647e-05	0	0	0	0	2	0	0	10226	11468	8576	6334	65748	894	16400	1620459	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1	1	66680	52966	0	2150	0	2	65748	NFE
9	136512976	G	A	136512976	136512976	+	Haplotype	1752	RCV000001822	SCV000021978	38418	DBH	NM_000787.3:c.1033G>A	NP_000778.3:p.Asp345Asn	NM_000787.3:c.1033G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 29, 2015	OMIM	OMIM	Dopamine beta hydroxylase deficiency;DOPAMINE BETA-HYDROXYLASE DEFICIENCY	11857564;20301647					germline	GeneReviews:NBK1474;Genetic Alliance:Dopamine+Beta+Hydroxylase+Deficiency/2316;MedGen:C0342687;OMIM:223360;Office of Rare Diseases:1903;Orphanet:230	2002-03-01	0	0	PASS	3	3	0	3	121410	120698	2.471e-05	0	0	0	0	3	0	0	10322	11530	8626	6578	66302	904	16436	1768227	0	0	0	0	3	0	0	0	0	0	0	0	0	0	1	2	67046	53652	0	2160	0	3	66302	NFE
10	43609944	G	C	43609944	43609944	+	Haplotype	13906	RCV000014920	SCV000035176	28945	RET	NM_020975.4:c.1896G>C	NP_066124.1:p.Glu632Asp	NM_020975.4:c.1896G>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1994	OMIM	OMIM	Multiple endocrine neoplasia, type 2a;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	11739416;19469690;20301434;21863057;23788249;24893135;25356965;25394175;27854360;3078962;7907913;8099202;8103403;8918855					germline	GeneReviews:NBK1257;Genetic Alliance:Multiple+endocrine+neoplasia+type+2A/4956;MeSH:D018813;MedGen:C0025268;OMIM:164761.0001;OMIM:164761.0002;OMIM:164761.0003;OMIM:164761.0004;OMIM:164761.0005;OMIM:164761.0006;OMIM:164761.0007;OMIM:164761.0008;OMIM:164761.0009;OMIM:164761.0010;OMIM:164761.0011;OMIM:164761.0012;OMIM:164761.0024;OMIM:164761.0025;OMIM:164761.0033;OMIM:164761.0040;OMIM:164761.0047;OMIM:164761.0049;OMIM:171400;Orphanet:653;SNOMED CT:61808009	1994-01-01	0	0																																															
10	43609945	C	G	43609945	43609945	+	Haplotype	13906	RCV000014920	SCV000035176	38399	RET	NM_020975.4:c.1897C>G	NP_066124.1:p.Leu633Val	NM_020975.4:c.1897C>G:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Sep 13, 2016	OMIM	OMIM	Multiple endocrine neoplasia, type 2a;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	11739416;19469690;20301434;21863057;23788249;24893135;25356965;25394175;27854360;3078962;7907913;8099202;8103403;8918855					germline	GeneReviews:NBK1257;Genetic Alliance:Multiple+endocrine+neoplasia+type+2A/4956;MeSH:D018813;MedGen:C0025268;OMIM:164761.0001;OMIM:164761.0002;OMIM:164761.0003;OMIM:164761.0004;OMIM:164761.0005;OMIM:164761.0006;OMIM:164761.0007;OMIM:164761.0008;OMIM:164761.0009;OMIM:164761.0010;OMIM:164761.0011;OMIM:164761.0012;OMIM:164761.0024;OMIM:164761.0025;OMIM:164761.0033;OMIM:164761.0040;OMIM:164761.0047;OMIM:164761.0049;OMIM:171400;Orphanet:653;SNOMED CT:61808009	1994-01-01	2	0																																															
10	43609948	T	C	43609948	43609948	+	Haplotype	13906	RCV000014920	SCV000035176	28956	RET	NM_020975.4:c.1900T>C	NP_066124.1:p.Cys634Arg	NM_020975.4:c.1900T>C:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Sep 28, 2017	OMIM	OMIM	Multiple endocrine neoplasia, type 2a;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	11739416;19469690;20301434;21863057;23788249;24893135;25356965;25394175;27854360;3078962;7907913;8099202;8103403;8918855					germline	GeneReviews:NBK1257;Genetic Alliance:Multiple+endocrine+neoplasia+type+2A/4956;MeSH:D018813;MedGen:C0025268;OMIM:164761.0001;OMIM:164761.0002;OMIM:164761.0003;OMIM:164761.0004;OMIM:164761.0005;OMIM:164761.0006;OMIM:164761.0007;OMIM:164761.0008;OMIM:164761.0009;OMIM:164761.0010;OMIM:164761.0011;OMIM:164761.0012;OMIM:164761.0024;OMIM:164761.0025;OMIM:164761.0033;OMIM:164761.0040;OMIM:164761.0047;OMIM:164761.0049;OMIM:171400;Orphanet:653;SNOMED CT:61808009	1994-01-01	2	0	PASS	1	1	0	1	121412	120860	8.236e-06	0	0	1	0	0	0	0	10318	11544	8634	6566	66396	902	16500	1752626	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	67162	53698	0	2164	0	1	8634	EAS
10	43614996	G	A	43614996	43614996	+	Haplotype	13945	RCV000014972	SCV000035228	28984	RET	NM_020975.4:c.2410G>A	NP_066124.1:p.Val804Met	NM_020975.4:c.2410G>A:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jul 27, 2017	OMIM	OMIM	Multiple endocrine neoplasia, type 2b;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB	11739416;11788682;19469690;20301434;21863057;23788249;24893135;25356965;27854360;8797874;8918855					germline	GeneReviews:NBK1257;Genetic Alliance:Multiple+endocrine+neoplasia%2C+type+2B/4958;MeSH:D018814;MedGen:C0025269;OMIM:162300;OMIM:164761.0013;OMIM:164761.0043;Orphanet:653;SNOMED CT:6153000;SNOMED CT:61530001	2002-01-01	2	0	PASS	14	13	0	13	121012	63744	0.0001157	0	2	1	0	7	0	3	4400	5764	4112	2438	34992	460	11578	846710	0,0,0	2,0,0	1,0,0	0,0,0	7,1,0	0,0,0	3,0,0	0	0	0	0	0	0	0	8	5	37782	25962	0	1782	0	2	5764	AMR
10	43615632	C	G	43615632	43615632	+	Haplotype	13945	RCV000014972	SCV000035228	36303	RET	NM_020975.4:c.2711C>G	NP_066124.1:p.Ser904Cys	NM_020975.4:c.2711C>G:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Dec 04, 2012	OMIM	OMIM	Multiple endocrine neoplasia, type 2b;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB	11739416;11788682;19469690;20301434;21863057;23788249;24893135;25356965;27854360;8797874;8918855					germline	GeneReviews:NBK1257;Genetic Alliance:Multiple+endocrine+neoplasia%2C+type+2B/4958;MeSH:D018814;MedGen:C0025269;OMIM:162300;OMIM:164761.0013;OMIM:164761.0043;Orphanet:653;SNOMED CT:6153000;SNOMED CT:61530001	2002-01-01	0	0																																															
10	64573251	C	A	64573251	64573251	-	Haplotype	16751	RCV000018235	SCV000038514	38481	EGR2	NM_000399.4:c.1147G>T	NP_000390.2:p.Asp383Tyr	NM_000399.4:c.1147G>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Oct 18, 2012	OMIM	OMIM	Neuropathy, congenital hypomyelinating, autosomal dominant;NEUROPATHY, CONGENITAL HYPOMYELINATING, AUTOSOMAL DOMINANT	9537424					germline	MedGen:CN069993	1998-04-01	0	0																																															
10	64573252	A	C	64573252	64573252	-	Haplotype	16751	RCV000018235	SCV000038514	31790	EGR2	NM_000399.4:c.1146T>G	NP_000390.2:p.Ser382Arg	NM_000399.4:c.1146T>G:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 18, 2012	OMIM	OMIM	Neuropathy, congenital hypomyelinating, autosomal dominant;NEUROPATHY, CONGENITAL HYPOMYELINATING, AUTOSOMAL DOMINANT	9537424					germline	MedGen:CN069993	1998-04-01	0	0																																															
10	72643759	C	T	72643759	72643759	-	Haplotype	180130	RCV000156929	SCV000206650	178310	PCBD1	NM_000281.3:c.263G>A	NP_000272.1:p.Arg88Gln	NM_000281.3:c.263G>A:missense variant;NM_001323004.1:c.216+1150G>A:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 01, 2014	OMIM	OMIM	Hyperphenylalaninemia, BH4-deficient, D;HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	24848070;9760199					germline	Genetic Alliance:Hyperphenylalaninemia+with+primapterinuria/3595;MedGen:C1849700;OMIM:264070;Orphanet:238583	2014-10-01	0	0	PASS	28	28	0	28	121412	118246	0.0002306	23	1	0	0	3	1	0	10126	11268	8596	6252	65652	858	15494	1839186	23	1	0	0	3	1	0	0	0	0	0	0	0	0	18	10	65426	52820	0	2070	0	23	10126	AFR
10	72645611	C	A	72645611	72645611	-	Haplotype	180130	RCV000156929	SCV000206650	178311	PCBD1	NM_000281.3:c.79G>T	NP_000272.1:p.Glu27Ter	NM_000281.3:c.79G>T:nonsense;NM_001289797.1:c.-69G>T:5 prime UTR variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 01, 2014	OMIM	OMIM	Hyperphenylalaninemia, BH4-deficient, D;HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	24848070;9760199					germline	Genetic Alliance:Hyperphenylalaninemia+with+primapterinuria/3595;MedGen:C1849700;OMIM:264070;Orphanet:238583	2014-10-01	0	0																																															
10	96073100	T	C	96073100	96073100	+	Haplotype	266012	RCV000256386	SCV000323171	260792	PLCE1	NM_016341.3:c.6093T>C	NP_057425.3:p.Thr2031=	NM_016341.3:c.6093T>C:synonymous variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	-	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Nephrotic syndrome, type 3						germline	Genetic Alliance:Nephrotic+syndrome%2C+type+3/8988;MedGen:C1853124;OMIM:610725;Orphanet:656	0000-00-00	0	0																																															
10	96084728	G	A	96084728	96084728	+	Haplotype	266012	RCV000256386	SCV000323171	260793	PLCE1	NM_016341.3:c.6800G>A	NP_057425.3:p.Arg2267Gln	NM_016341.3:c.6800G>A:missense variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	-	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Nephrotic syndrome, type 3						germline	Genetic Alliance:Nephrotic+syndrome%2C+type+3/8988;MedGen:C1853124;OMIM:610725;Orphanet:656	0000-00-00	0	0																																															
10	96702047	C	T	96702047	96702047	+	Haplotype	177709	RCV000154312	SCV000203973	23448	CYP2C9	NM_000771.3:c.430C>T	NP_000762.2:p.Arg144Cys	NM_000771.3:c.430C>T:missense variant	drug response	drug response	0	0	0	0	0	reviewed by expert panel	no assertion criteria provided	Aug 28, 2017	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Warfarin response;Warfarin Metabolism	18281915;18281922;24251364;26186657					germline	Genetic Alliance:Warfarin+response/9469;MedGen:CN078029;OMIM:122700;OMIM:122720.0001;OMIM:122720.0005;OMIM:608547.0002;OMIM:608547.0003;OMIM:608547.0004;OMIM:608547.0005;OMIM:608547.0007;PharmGKB:PA451906	2006-11-20	3	0	PASS	11093	9790	651	11092	121402	121310	0.091	245	760	3	774	8464	86	760	10406	11516	8624	6614	66730	908	16512	4138752	239	720	3	666	7372	80	710	3	20	0	54	546	3	25	6336	4756	67234	54076	115	2164	10	8464	66730	NFE
10	96741053	A	C	96741053	96741053	+	Haplotype	163021	RCV000150378	SCV000197513	23447	CYP2C9	NM_000771.3:c.1075A>C	NP_000762.2:p.Ile359Leu	NM_000771.3:c.1075A>C:missense variant	drug response	drug response	0	0	0	0	0	reviewed by expert panel	no assertion criteria provided	Jul 10, 2015	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Warfarin response;Warfarin Metabolism	18281915;18281922;24251364;26186657					germline	Genetic Alliance:Warfarin+response/9469;MedGen:CN078029;OMIM:122700;OMIM:122720.0001;OMIM:122720.0005;OMIM:608547.0002;OMIM:608547.0003;OMIM:608547.0004;OMIM:608547.0005;OMIM:608547.0007;PharmGKB:PA451906	2006-11-20	3	0	PASS	7727	7053	336	7725	121410	121260	0.064	131	411	292	372	4591	60	1868	10404	11480	8642	6604	66710	908	16512	3913954	127	391	280	340	4249	54	1612	2	10	6	16	171	3	128	4704	3021	67196	54064	248	2164	27	1868	16512	SAS
10	120790050	G	A	120790050	120790050	+	Haplotype	65392	RCV000055619	SCV000083844	76326	NANOS1	NM_199461.3:c.737G>A	NP_955631.1:p.Arg246His	NM_199461.3:c.737G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 01, 2013	OMIM	OMIM	Spermatogenic failure 12;SPERMATOGENIC FAILURE 12	23315541					germline	MedGen:C3809427;OMIM:615413	2013-03-01	0	0																																															
10	120790139	CG	TA	120790139	120790140	+	Haplotype	65392	RCV000055619	SCV000083844	76327	NANOS1	NM_199461.3:c.826_827delCGinsTA	NP_955631.1:p.Arg276Tyr	NM_199461.3:c.826_827delCGinsTA:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 01, 2013	OMIM	OMIM	Spermatogenic failure 12;SPERMATOGENIC FAILURE 12	23315541					germline	MedGen:C3809427;OMIM:615413	2013-03-01	0	0																																															
10	135339605	G	C	135339605	135339605	+	Haplotype	16887	RCV000018383	SCV000038665	136523	CYP2E1	NM_000773.3:c.-1295G>C		NM_000773.3:c.-1295G>C:2KB upstream variant	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 20, 2016	OMIM	OMIM	CYP2E1*5B ALLELE;CYP2E1*5B ALLELE	10543395;1778977;19444287					germline	OMIM:124040.0001	2016-04-20	0	0																																															
10	135339845	C	T	135339845	135339845	+	Haplotype	16887	RCV000018383	SCV000038665	136524	CYP2E1	NM_000773.3:c.-1055C>T		NM_000773.3:c.-1055C>T:2KB upstream variant	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 20, 2016	OMIM	OMIM	CYP2E1*5B ALLELE;CYP2E1*5B ALLELE	10543395;1778977;19444287					germline	OMIM:124040.0001	2016-04-20	0	0																																															
11	2593319	G	A	2593319	2593319	+	Haplotype	444879	RCV000003296	SCV000023454	18157	KCNQ1	NM_000218.2:c.760G>A	NP_000209.2:p.Val254Met	NM_000218.2:c.760G>A:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jul 29, 2017	OMIM	OMIM	Long QT syndrome 1;LONG QT SYNDROME 1	10973849;12820704;14678125;1475667;14756674;20301308;21810866;23788249;25356965;27854360;8528244;9386136					germline	GeneReviews:NBK1129;Genetic Alliance:Long+QT+syndrome+1/4297;MedGen:C0035828;OMIM:192500;Office of Rare Diseases:3284;Orphanet:101016;Orphanet:768;SNOMED CT:20852007	2004-03-01	2	0																																															
11	2608920	G	A	2608920	2608920	+	Haplotype	444879	RCV000003296	SCV000023454	38428	KCNQ1	NM_181798.1:c.868G>A	NP_000209.2:p.Val417Met	NM_000218.2:c.1249G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 01, 2004	OMIM	OMIM	Long QT syndrome 1;LONG QT SYNDROME 1	10973849;12820704;14678125;1475667;14756674;20301308;21810866;23788249;25356965;27854360;8528244;9386136					germline	GeneReviews:NBK1129;Genetic Alliance:Long+QT+syndrome+1/4297;MedGen:C0035828;OMIM:192500;Office of Rare Diseases:3284;Orphanet:101016;Orphanet:768;SNOMED CT:20852007	2004-03-01	0	0																																															
11	5246839	T	A	5246839	5246839	-	Haplotype	446749	RCV000016884	SCV000037154	38409	HBB	NM_000518.4:c.433A>T	NP_000509.1:p.Lys145Ter	NM_000518.4:c.433A>T:nonsense	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN KOCHI;HEMOGLOBIN KOCHI	15768550					germline	OMIM:141900.0532	2016-07-20	0	0																																															
11	5246844	G	A	5246844	5246844	-	Haplotype	446738	RCV000016580	SCV000036849	38472	HBB	NM_000518.4:c.428C>T	NP_000509.1:p.Ala143Val	NM_000518.4:c.428C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1992	OMIM	OMIM	HEMOGLOBIN S (TRAVIS);HEMOGLOBIN S (TRAVIS)	1634360;19257					germline	OMIM:141900.0247	1992-01-01	0	0																																															
11	5246848	G	C	5246848	5246848	-	Haplotype	446749	RCV000016884	SCV000037154	30656	HBB	NM_000518.4:c.424C>G	NP_000509.1:p.Leu142Val	NM_000518.4:c.424C>G:missense variant	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN KOCHI;HEMOGLOBIN KOCHI	15768550					germline	OMIM:141900.0532	2016-07-20	0	0																																															
11	5246905	A	G	5246905	5246905	-	Haplotype	446744	RCV000016848	SCV000037118	30619	HBB	NM_000518.4:c.367T>C	NP_000509.1:p.Phe123Leu	NM_000518.4:c.367T>C:missense variant	other	other	0	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN CASABLANCA;HEMOGLOBIN CASABLANCA	10870883					germline	OMIM:141900.0493	2016-07-20	0	0																																															
11	5246908	C	G	5246908	5246908	-	Haplotype	446739;446740;446745	RCV000016617;RCV000016758;RCV000016858	SCV000036886;SCV000037028;SCV000037128	30191	HBB	NM_000518.4:c.364G>C	NP_000509.1:p.Glu122Gln	NM_000518.4:c.364G>C:missense variant	Conflicting interpretations of pathogenicity, other	other	0	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Jun 26, 2017	OMIM	OMIM	HEMOGLOBIN T (CAMBODIA);HEMOGLOBIN CLEVELAND;HEMOGLOBIN D (AGRI)	1177278;1244906;12709369;15108284;16370495;16540414;19440680;19460936;20437613;20704537;20838957;21119755;2930724;4613830;640855;893136;1787096;11570725					germline	OMIM:141900.0276;OMIM:141900.0407;OMIM:141900.0502	2016-07-20	1	1	PASS	85	83	1	85	121412	121384	0.0007001	0	3	0	0	9	2	71	10406	11570	8636	6612	66740	908	16512	2931244	0,0,0	3,0,0	0,0,0	0,0,0	9,0,0	2,1,0	69,0,0	0	0	0	0	0	0	1	69	16	67278	54106	15	2164	0	71	16512	SAS
11	5246908	C	T	5246908	5246908	-	Haplotype	446736;446746	RCV000016577;RCV000016863	SCV000036846;SCV000037133	30331	HBB	NM_000518.4:c.364G>A	NP_000509.1:p.Glu122Lys	NM_000518.4:c.364G>A:missense variant	Pathogenic, other	pathogenic;other	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jun 26, 2017	OMIM	OMIM	Sickle cell-Hemoglobin O Arab disease;HEMOGLOBIN S (OMAN);HEMOGLOBIN O (TIBESTI)	10203101;1112610;11179419;14282052;15108284;15502081;15543018;15710580;15710581;1732017;18254282;19783722;20704537;20854120;25052315;2930724;3859465;5481775;5915974;6716421;8195007;893136;9049622;9834244;11939508					germline	MedGen:C1264000;OMIM:141900.0245;SNOMED CT:127048005;OMIM:141900.0507	1999-04-01;2016-07-20	2	0	PASS	1	1	0	1	121412	121384	8.236e-06	0	0	0	0	0	1	0	10406	11570	8636	6612	66740	908	16512	2931244	0,0,0	3,0,0	0,0,0	0,0,0	9,0,0	2,1,0	69,0,0	0	0	0	0	0	0	0	1	0	67278	54106	0	2164	0	NA	NA	NA
11	5246913	C	T	5246913	5246913	-	Haplotype	446732;446733	RCV000016336;RCV000016486	SCV000036604;SCV000036754	38469	HBB	NM_000518.4:c.359G>A	NP_000509.1:p.Gly120Asp	NM_000518.4:c.359G>A:missense variant	Likely benign	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 26, 2017	OMIM	OMIM	HEMOGLOBIN FANNIN-LUBBOCK;HEMOGLOBIN MASUDA	20942;7852084;2634673					germline	OMIM:141900.0075;OMIM:141900.0172	2017-02-27;2016-07-20	0	0	PASS	5	5	0	5	121412	121386	4.118e-05	0	5	0	0	0	0	0	10406	11568	8644	6612	66736	908	16512	2925070	0	5	0	0	0	0	0	0	0	0	0	0	0	0	1	4	67276	54110	0	2164	0	5	11568	AMR
11	5246929	G	T	5246929	5246929	-	Haplotype	446733	RCV000016486	SCV000036754	30525	HBB	NM_000518.4:c.343C>A	NP_000509.1:p.Leu115Met	NM_000518.4:c.343C>A:missense variant	other	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 27, 2017	OMIM	OMIM	HEMOGLOBIN MASUDA;HEMOGLOBIN MASUDA	2634673					germline	OMIM:141900.0172	2016-07-20	0	0	PASS	3	3	0	3	121412	121380	2.471e-05	0	0	3	0	0	0	0	10404	11572	8634	6612	66738	908	16512	2924542	0	0	3	0	0	0	0	0	0	0	0	0	0	0	0	3	67276	54104	0	2164	0	3	8634	EAS
11	5246938	C	G	5246938	5246938	-	Haplotype	446732	RCV000016336	SCV000036604	30204	HBB	NM_000518.4:c.334G>C	NP_000509.1:p.Val112Leu	NM_000518.4:c.334G>C:missense variant	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 27, 2017	OMIM	OMIM	HEMOGLOBIN FANNIN-LUBBOCK;HEMOGLOBIN FANNIN-LUBBOCK	20942;7852084					germline	OMIM:141900.0075	2017-02-27	0	0																																															
11	5247827	C	T	5247827	5247827	-	Haplotype	446743	RCV000016807	SCV000037077	30280	HBB	NM_000518.4:c.295G>A	NP_000509.1:p.Val99Met	NM_000518.4:c.295G>A:missense variant	Pathogenic	other	0	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Apr 24, 2017	OMIM	OMIM	HEMOGLOBIN MEDICINE LAKE;HEMOGLOBIN MEDICINE LAKE	7860732					germline	OMIM:141900.0452	2016-07-20	1	0																																															
11	5247836	T	C	5247836	5247836	-	Haplotype	446729	RCV000016251	SCV000036519	30317	HBB	NM_000518.4:c.286A>G	NP_000509.1:p.Lys96Glu	NM_000518.4:c.286A>G:missense variant	Likely benign, other	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 10, 2017	OMIM	OMIM	HEMOGLOBIN ARLINGTON PARK;HEMOGLOBIN ARLINGTON PARK	893139					germline	OMIM:141900.0010	2016-07-20	0	0																																															
11	5247842	A	G	5247842	5247842	-	Haplotype	446740	RCV000016758	SCV000037028	30336	HBB	NM_000518.4:c.280T>C	NP_000509.1:p.Cys94Arg	NM_000518.4:c.280T>C:missense variant	other	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN CLEVELAND;HEMOGLOBIN CLEVELAND	1177278;1244906;12709369;15108284;16370495;16540414;1787096;19440680;19460936;20437613;20704537;20838957;21119755;2930724;4613830;640855;893136					germline	OMIM:141900.0407	2016-07-20	0	0																																															
11	5247844	T	G	5247844	5247844	-	Haplotype	446742	RCV000016780	SCV000037050	30326	HBB	NM_000518.4:c.278A>C	NP_000509.1:p.His93Pro	NM_000518.4:c.278A>C:missense variant	other	other	0	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN DUINO;HEMOGLOBIN DUINO	1511986					germline	OMIM:141900.0427	2016-07-20	0	0																																															
11	5247851	C	T	5247851	5247851	-	Haplotype	446747	RCV000016877	SCV000037147	30130	HBB	NM_000518.4:c.271G>A	NP_000509.1:p.Glu91Lys	NM_000518.4:c.271G>A:missense variant	other	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN S (CAMEROON);HEMOGLOBIN S (CAMEROON)	15182055					germline	OMIM:141900.0521	2004-05-01	0	0																																															
11	5247863	C	G	5247863	5247863	-	Haplotype	446734	RCV000016553	SCV000036821	30650	HBB	NM_000518.4:c.259G>C	NP_000509.1:p.Ala87Pro	NM_000518.4:c.259G>C:missense variant	other	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN POISSY;HEMOGLOBIN POISSY	3841063					germline	OMIM:141900.0223	2016-07-20	0	0																																															
11	5247902	C	T	5247902	5247902	-	Haplotype	446730	RCV000016286	SCV000036554	30283	HBB	NM_000518.4:c.220G>A	NP_000509.1:p.Asp74Asn	NM_000518.4:c.220G>A:missense variant	Likely benign, other	other	0	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Mar 23, 2017	OMIM	OMIM	HEMOGLOBIN ZIGUINCHOR;HEMOGLOBIN C (GEORGETOWN)	13943409;5069596;5490239;5928902					germline	OMIM:141900.0039;OMIM:141900.0040	2017-02-27	1	0	PASS	1	1	0	1	121412	121394	8.236e-06	1	0	0	0	0	0	0	10406	11572	8642	6614	66740	908	16512	3121960	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	67282	54112	0	2164	0	1	10406	AFR
11	5247917	G	A	5247917	5247917	-	Haplotype	446748	RCV000016879	SCV000037149	30652	HBB	NM_000518.4:c.205C>T	NP_000509.1:p.Leu69Phe	NM_000518.4:c.205C>T:missense variant	other	other	0	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Feb 27, 2017	OMIM	OMIM	HEMOGLOBIN JAMAICA PLAIN;HEMOGLOBIN JAMAICA PLAIN	15470216;6166632					germline	OMIM:141900.0523	2017-02-27	0	0																																															
11	5247925	T	A	5247925	5247925	-	Haplotype	446744	RCV000016848	SCV000037118	30250	HBB	NM_000518.4:c.197A>T	NP_000509.1:p.Lys66Met	NM_000518.4:c.197A>T:missense variant	other	other	0	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Feb 27, 2017	OMIM	OMIM	HEMOGLOBIN CASABLANCA;HEMOGLOBIN CASABLANCA	10870883					germline	OMIM:141900.0493	2016-07-20	0	0																																															
11	5247946	G	C	5247946	5247946	-	Haplotype	446731	RCV000030905	SCV000036556	30437	HBB	NM_000518.4:c.176C>G	NP_000509.1:p.Pro59Arg	NM_000518.4:c.176C>G:missense variant	Pathogenic	other	0	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN ZIGUINCHOR;HEMOGLOBIN C (ZIGUINCHOR)	1225575;893143					germline	OMIM:141900.0039;OMIM:141900.0040	2016-07-20	0	0																																															
11	5247953	C	G	5247953	5247953	-	Haplotype	446734	RCV000016553	SCV000036821	30227	HBB	NM_000518.4:c.169G>C	NP_000509.1:p.Gly57Arg	NM_000518.4:c.169G>C:missense variant	other	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 27, 2017	OMIM	OMIM	HEMOGLOBIN POISSY;HEMOGLOBIN POISSY	3841063					germline	OMIM:141900.0223	2016-07-20	0	0																																															
11	5247965	C	T	5247965	5247965	-	Haplotype	446741	RCV000016759	SCV000037029	30341	HBB	NM_000518.4:c.157G>A	NP_000509.1:p.Asp53Asn	NM_000518.4:c.157G>A:missense variant	Conflicting interpretations of pathogenicity	other	0	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Jun 27, 2017	OMIM	OMIM	HEMOGLOBIN GRENOBLE;HEMOGLOBIN GRENOBLE	10335988;15008267;16178917;18932067;2079433;5097135;640855					germline	OMIM:141900.0408	2016-07-20	1	1																																															
11	5247968	G	A	5247968	5247968	-	Haplotype	446741	RCV000016759	SCV000037029	30536	HBB	NM_000518.4:c.154C>T	NP_000509.1:p.Pro52Ser	NM_000518.4:c.154C>T:missense variant	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN GRENOBLE;HEMOGLOBIN GRENOBLE	10335988;15008267;16178917;18932067;2079433;5097135;640855					germline	OMIM:141900.0408	2016-07-20	0	0																																															
11	5248024	A	T	5248024	5248024	-	Haplotype	446743	RCV000016807	SCV000037077	30572	HBB	NM_000518.4:c.98T>A	NP_000509.1:p.Leu33Gln	NM_000518.4:c.98T>A:missense variant	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN MEDICINE LAKE;HEMOGLOBIN MEDICINE LAKE	7860732					germline	OMIM:141900.0452	2016-07-20	0	0																																															
11	5248173	C	T	5248173	5248173	-	Haplotype	446739	RCV000016617	SCV000036886	30200	HBB	NM_000518.4:c.79G>A	NP_000509.1:p.Glu27Lys	NM_000518.4:c.79G>A:missense variant	Pathogenic, other, protective	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 23, 2017	OMIM	OMIM	HEMOGLOBIN T (CAMBODIA);HEMOGLOBIN T (CAMBODIA)	1177278;1244906;12709369;15108284;16370495;16540414;19440680;19460936;20437613;20704537;20838957;21119755;2930724;4613830;640855;893136					germline	OMIM:141900.0276	2016-07-20	0	0	PASS	35	35	0	35	121412	121356	0.0002883	0	1	10	0	0	0	24	10406	11560	8620	6614	66736	908	16512	3349237	0	1	10	0	0	0	24	0	0	0	0	0	0	0	22	13	67266	54090	1	2164	0	24	16512	SAS
11	5248182	C	T	5248182	5248182	-	Haplotype	446735	RCV000016576	SCV000036845	38470	HBB	NM_000518.4:c.70G>A	NP_000509.1:p.Val24Ile	NM_000518.4:c.70G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 01, 1997	OMIM	OMIM	HEMOGLOBIN S (ANTILLES);HEMOGLOBIN S (ANTILLES)	2189492;3467311;9166865					germline	OMIM:141900.0244	1997-06-01	0	0																																															
11	5248218	C	T	5248218	5248218	-	Haplotype	446746	RCV000016863	SCV000037133	30228	HBB	NM_000518.4:c.34G>A	NP_000509.1:p.Val12Ile	NM_000518.4:c.34G>A:missense variant	Uncertain significance, other	other	0	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Nov 12, 2016	OMIM	OMIM	HEMOGLOBIN O (TIBESTI);HEMOGLOBIN O (TIBESTI)	1112610;11179419;11939508;14282052;15108284;15502081;15543018;15710580;15710581;1732017;18254282;19783722;20704537;20854120;2930724;3859465;5481775;5915974;6716421;8195007;893136;9049622;9834244					germline	OMIM:141900.0507	2016-07-20	1	0	PASS	6	6	0	6	121410	121356	4.942e-05	1	0	0	0	5	0	0	10406	11560	8618	6614	66738	908	16512	3350085	1	0	0	0	5	0	0	0	0	0	0	0	0	0	3	3	67262	54094	0	2164	0	1	10406	AFR
11	5248223	G	T	5248223	5248223	-	Haplotype	446745	RCV000016858	SCV000037128	30658	HBB	NM_000518.4:c.29C>A	NP_000509.1:p.Ser10Tyr	NM_000518.4:c.29C>A:missense variant	other	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN D (AGRI);HEMOGLOBIN D (AGRI)	11570725;1177278;1244906;12709369;15108284;16370495;16540414;19440680;19460936;20437613;20704537;20838957;21119755;2930724;4613830;640855;893136					germline	OMIM:141900.0502	2016-07-20	0	0																																															
11	5248232	T	A	5248232	5248232	-	Haplotype	446730;446731;446735;446736;446737;446738;446747;446748	RCV000016286;RCV000030905;RCV000016576;RCV000016577;RCV000016579;RCV000016580;RCV000016877;RCV000016879	SCV000036554;SCV000036556;SCV000036845;SCV000036846;SCV000036848;SCV000036849;SCV000037147;SCV000037149	30372	HBB	NM_000518.4:c.20A>T	NP_000509.1:p.Glu7Val	NM_000518.4:c.20A>T:missense variant	Pathogenic, other, protective	other;pathogenic	5	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 11, 2017	OMIM	OMIM	HEMOGLOBIN ZIGUINCHOR;HEMOGLOBIN C (GEORGETOWN);HEMOGLOBIN C (ZIGUINCHOR);HEMOGLOBIN S (ANTILLES);Sickle cell-Hemoglobin O Arab disease;HEMOGLOBIN S (OMAN);HEMOGLOBIN S (PROVIDENCE);HEMOGLOBIN S (TRAVIS);HEMOGLOBIN S (CAMEROON);HEMOGLOBIN JAMAICA PLAIN	13943409;5069596;5490239;5928902;1225575;893143;2189492;3467311;9166865;10203101;1112610;11179419;14282052;15108284;15502081;15543018;15710580;15710581;1732017;18254282;19783722;20704537;20854120;25052315;2930724;3859465;5481775;5915974;6716421;8195007;893136;9049622;9834244;3191036;1634360;19257;15182055;15470216;6166632					germline	OMIM:141900.0039;OMIM:141900.0040;OMIM:141900.0244;MedGen:C1264000;OMIM:141900.0245;SNOMED CT:127048005;OMIM:141900.0246;OMIM:141900.0247;OMIM:141900.0521;OMIM:141900.0523	2017-02-27;2016-07-20;1997-06-01;1999-04-01;1988-10-01;1992-01-01;2004-05-01	0	0	PASS	533	530	1	532	121404	121340	0.00439	505	12	0	0	6	0	9	10404	11548	8620	6614	66734	908	16512	3368359	503	12	0	0	6	0	9	1	0	0	0	0	0	0	209	323	67256	54084	0	2164	0	505	10404	AFR
11	5248233	C	T	5248233	5248233	-	Haplotype	446729	RCV000016251	SCV000036519	30165	HBB	NM_000518.4:c.19G>A	NP_000509.1:p.Glu7Lys	NM_000518.4:c.19G>A:missense variant	Pathogenic, protective	other	0	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jun 27, 2017	OMIM	OMIM	HEMOGLOBIN ARLINGTON PARK;HEMOGLOBIN ARLINGTON PARK	893139					germline	OMIM:141900.0010	2016-07-20	2	0	PASS	149	149	0	149	121410	121340	0.001227	145	3	0	0	1	0	0	10404	11550	8620	6612	66736	908	16510	3370372	145,0,0	3,0,0	0,0,0	0,0,0	1,0,0	0,0,0	0,1,0	0	0	0	0	0	0	0	52	97	67256	54084	0	2164	0	145	10404	AFR
11	5269623	G	C	5269623	5269623	-	Haplotype	446751	RCV000016180	SCV000036448	38468	HBG1	NM_000559.2:c.410C>G	NP_000550.2:p.Ala137Gly	NM_000559.2:c.410C>G:missense variant	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 15, 2011	OMIM	OMIM	HEMOGLOBIN F (CHARLOTTE);HEMOGLOBIN F (CHARLOTTE)	1714434					germline	OMIM:142200.0032	2011-07-15	0	0	VQSRTrancheSNP99.80to99.90	7401	6128	2	6132	121410	114060	0.061	628	286	141	268	3482	44	1283	9700	11116	8348	6082	62442	848	15524	2738769	624	286	141	268	3482	44	1283	2	0	0	0	0	0	0	3583	2549	63144	50916	186	2044	0	1283	15524	SAS
11	5269624	C	A	5269624	5269624	-	Haplotype	446752	RCV000016185	SCV000036453	30080	HBG1	NM_000559.2:c.409G>T	NP_000550.2:p.Ala137Ser	NM_000559.2:c.409G>T:missense variant	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 18, 2016	OMIM	OMIM	HEMOGLOBIN F (PORTO TORRES);HEMOGLOBIN F (PORTO TORRES)	15666429					germline	OMIM:142200.0037	2016-08-18	0	0	PASS	2	2	0	2	121410	121298	1.647e-05	0	0	0	0	2	0	0	10398	11550	8620	6612	66704	908	16506	1754906	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1	1	67234	54064	0	2164	0	2	66704	NFE
11	5270686	G	A	5270686	5270686	-	Haplotype	446751;446752	RCV000016180;RCV000016185	SCV000036448;SCV000036453	30044	HBG1	NM_000559.2:c.227C>T	NP_000550.2:p.Thr76Ile	NM_000559.2:c.227C>T:missense variant	Benign, other	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 18, 2016	OMIM	OMIM	HEMOGLOBIN F (CHARLOTTE);HEMOGLOBIN F (PORTO TORRES)	1714434;15666429					germline	OMIM:142200.0032;OMIM:142200.0037	2011-07-15;2016-08-18	0	0	PASS	20785	313	1683	3679	71654	44856	0.29	2091	161	157	8	949	30	283	3976	3724	1866	3410	25824	316	5740	685261	147	21	15	4	107	0	19	972	70	71	2	421	15	132	1410	2269	24586	20270	41	694	19	2091	3976	AFR
11	36596373	C	T	36596373	36596373	+	Haplotype	13157	RCV000014043	SCV000034290	28196	RAG1	NM_000448.2:c.1519C>T	NP_000439.1:p.Arg507Trp	NM_000448.2:c.1519C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 08, 2008	OMIM	OMIM	Combined cellular and humoral immune defects with granulomas;COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	18463379					germline	Genetic Alliance:Combined+cellular+and+humoral+immune+defects+with+granulomas/8008;MedGen:C2673536;OMIM:233650	2008-05-08	0	0																																															
11	36597064	G	A	36597064	36597064	+	Haplotype	13157	RCV000014043	SCV000034290	28188	RAG1	NM_000448.2:c.2210G>A	NP_000439.1:p.Arg737His	NM_000448.2:c.2210G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	May 08, 2008	OMIM	OMIM	Combined cellular and humoral immune defects with granulomas;COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	18463379					germline	Genetic Alliance:Combined+cellular+and+humoral+immune+defects+with+granulomas/8008;MedGen:C2673536;OMIM:233650	2008-05-08	0	0	PASS	3	3	0	3	121412	121392	2.471e-05	1	0	0	0	2	0	0	10404	11578	8652	6612	66728	908	16510	2188433	1	0	0	0	2	0	0	0	0	0	0	0	0	0	1	2	67280	54112	0	2162	0	1	10404	AFR
11	44129522	T	G	44129522	44129522	+	Haplotype	218894	RCV000203245	SCV000258309	137950	EXT2	NM_000401.3:c.359T>G	NP_997005.1:p.Met87Arg	NM_207122.1:c.260T>G:missense variant	Likely benign	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 14, 2016	OMIM	OMIM	Seizures, scoliosis, and macrocephaly syndrome;SEIZURES, SCOLIOSIS, AND MACROCEPHALY SYNDROME (1 family)	26246518					germline	MedGen:C4225248;OMIM:616682	2015-10-01	0	0	PASS	41	41	0	41	121412	121150	0.0003377	0	3	0	0	37	1	0	10392	11528	8606	6606	66610	908	16500	1580538	0	3	0	0	37	1	0	0	0	0	0	0	0	0	22	19	67162	53988	0	2164	0	37	66610	NFE
11	44129545	C	T	44129545	44129545	+	Haplotype	218894	RCV000203245	SCV000258309	215653	EXT2	NM_000401.3:c.382C>T	NP_997005.1:p.Arg95Cys	NM_207122.1:c.283C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 01, 2015	OMIM	OMIM	Seizures, scoliosis, and macrocephaly syndrome;SEIZURES, SCOLIOSIS, AND MACROCEPHALY SYNDROME (1 family)	26246518					germline	MedGen:C4225248;OMIM:616682	2015-10-01	0	0	PASS	8	8	0	8	121412	121002	6.589e-05	3	1	0	0	3	0	1	10386	11522	8558	6600	66542	902	16492	1571207	3	1	0	0	3	0	1	0	0	0	0	0	0	0	4	4	67086	53916	0	2162	0	3	10386	AFR
11	66113551	G	A	66113551	66113551	-	Haplotype	51008	RCV000043695	SCV000071708	65678	B4GAT1	NM_006876.2:c.1217C>T	NP_006867.1:p.Ala406Val	NM_006876.2:c.1217C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 2013	OMIM	OMIM	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 13;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13	23359570					germline	MedGen:C3809042;OMIM:615287;Orphanet:899	2013-05-01	0	0	PASS	1	1	0	1	121412	121326	8.236e-06	0	0	0	0	0	0	1	10406	11578	8654	6614	66694	908	16472	2469718	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	67230	54096	0	2160	0	1	16472	SAS
11	66113600	T	C	66113600	66113600	-	Haplotype	51008	RCV000043695	SCV000071708	65679	B4GAT1	NM_006876.2:c.1168A>G	NP_006867.1:p.Asn390Asp	NM_006876.2:c.1168A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 2013	OMIM	OMIM	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 13;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13	23359570					germline	MedGen:C3809042;OMIM:615287;Orphanet:899	2013-05-01	0	0	PASS	1	1	0	1	121412	121412	8.236e-06	0	0	0	0	0	0	1	10406	11578	8654	6614	66740	908	16512	2470871	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	67288	54124	0	2164	0	1	16512	SAS
11	71936057	C	CG	71936063	71936063	+	Haplotype	235823	RCV000224773	SCV000281677	237478	INPPL1	NM_001567.3:c.35dupG	NP_001558.3:p.Ala13Argfs	NM_001567.3:c.35dupG:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 08, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Opsismodysplasia	23273567					unknown	Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;OMIM:258480;Office of Rare Diseases:4098;Orphanet:2746;SNOMED CT:254068007	2013-01-08	0	0																																															
11	71940602	G	C	71940602	71940602	+	Haplotype	235822	RCV000224420	SCV000281676	237479	INPPL1	NM_001567.3:c.753G>C	NP_001558.3:p.Gln251His	NM_001567.3:c.753G>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 08, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Opsismodysplasia	23273567					inherited	Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;OMIM:258480;Office of Rare Diseases:4098;Orphanet:2746;SNOMED CT:254068007	2013-01-08	0	0																																															
11	71940720	CAG	C	71940721	71940722	+	Haplotype	235825	RCV000224914	SCV000281680	237480	INPPL1	NM_001567.3:c.768_769delAG	NP_001558.3:p.Glu258Alafs	NM_001567.3:c.768_769delAG:frameshift variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 08, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Opsismodysplasia	23273567					inherited	Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;OMIM:258480;Office of Rare Diseases:4098;Orphanet:2746;SNOMED CT:254068007	2013-01-08	0	0	PASS	2	2	0	2	121412	121306	1.647e-05	0	0	0	1	1	0	0	10390	11572	8644	6612	66668	908	16512	1869772	0,0,0	0,0,0	0,0,0	1,0,0	1,1,0	0,0,0	0,0,0	0	0	0	0	0	0	0	0	2	67238	54068	0	2164	0	1	66668	NFE
11	71943304	G	A	71943304	71943304		Distinct chromosomes	488055	RCV000577875	SCV000583573	481067	SH3PXD2B	NM_001567.3:c.1636G>A	NP_001558.3:p.Val546Ile	NM_001567.3:c.1636G>A:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jun 01, 2017	Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine	Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine	Frank Ter Haar syndrome;Opsismodysplasia	1;20137777;29276006					unknown	Genetic Alliance:Frank+Ter+Haar+Syndrome/2915;Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;MedGen:C1855305;OMIM:249420;OMIM:258480;Office of Rare Diseases:4098;Office of Rare Diseases:5138;Orphanet:137834;Orphanet:2746;SNOMED CT:254068007	2017-06-01	0	0	AC_Adj0_Filter	1	0	0	0	112156	21678	8.916e-06	0	0	0	0	0	0	0	2902	452	782	52	9344	202	7944	561798	0	0	0	0	0	0	0	0	0	0	0	0	0	0	.	.	11350	10328	.	1460	.	NA	NA	NA
11	71943347	GTCACC	G	71943355	71943359	+	Haplotype	235823	RCV000224773	SCV000281677	237481	INPPL1	NM_001567.3:c.1687_1691delACCTC	NP_001558.3:p.Thr563Glyfs	NM_001567.3:c.1687_1691delACCTC:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 08, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Opsismodysplasia	23273567					unknown	Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;OMIM:258480;Office of Rare Diseases:4098;Orphanet:2746;SNOMED CT:254068007	2013-01-08	0	0	VQSRTrancheINDEL99.50to99.90	1	0	0	0	106694	21640	9.373e-06	0	0	0	0	0	0	0	2910	452	764	46	9330	204	7934	526595	0	0	0	0	0	0	0	0	0	0	0	0	0	0	.	.	11328	10312	.	1462	.	NA	NA	NA
11	71945660	G	A	71945660	71945660	+	Haplotype	235825	RCV000224914	SCV000281680	48075	INPPL1	NM_001567.3:c.2415+1G>A		NM_001567.3:c.2415+1G>A:splice donor variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 04, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Opsismodysplasia	23273567					inherited	Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;OMIM:258480;Office of Rare Diseases:4098;Orphanet:2746;SNOMED CT:254068007	2013-01-08	0	0																																															
11	121037361	C	T	121037361	121037361	+	Haplotype	7013	RCV000007428	SCV000027628	22052	TECTA	NM_005422.2:c.5458C>T	NP_005413.2:p.Leu1820Phe	NM_005422.2:c.5458C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 1998	OMIM	OMIM	Deafness, autosomal dominant 12;DEAFNESS, AUTOSOMAL DOMINANT 12	20301607;9590290					germline	Genetic Alliance:Deafness%2C+autosomal+dominant+12/8133;MedGen:C1832187;OMIM:601543;Orphanet:90635	1998-05-01	0	0																																															
11	121037374	G	A	121037374	121037374	+	Haplotype	7013	RCV000007428	SCV000027628	38440	TECTA	NM_005422.2:c.5471G>A	NP_005413.2:p.Gly1824Asp	NM_005422.2:c.5471G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 1998	OMIM	OMIM	Deafness, autosomal dominant 12;DEAFNESS, AUTOSOMAL DOMINANT 12	20301607;9590290					germline	Genetic Alliance:Deafness%2C+autosomal+dominant+12/8133;MedGen:C1832187;OMIM:601543;Orphanet:90635	1998-05-01	0	0	PASS	5	5	0	5	121412	121408	4.118e-05	0	0	5	0	0	0	0	10406	11578	8654	6614	66738	908	16510	2326871	0	0	5	0	0	0	0	0	0	0	0	0	0	0	2	3	67286	54122	0	2162	0	5	8654	EAS
12	57894189	G	A	57894189	57894189	+	Haplotype	189364	RCV000169765;RCV000173000	SCV000196708;SCV000224019	187252	MARS	NM_004990.3:c.1177G>A	NP_004981.2:p.Ala393Thr	NM_004990.3:c.1177G>A:missense variant	-	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 07, 2015	Institute of Human Genetics, Klinikum rechts der Isar;OMIM	Institute of Human Genetics, Klinikum rechts der Isar;OMIM	Pulmonary alveolar proteinosis;Interstitial lung and liver disease;INTERSTITIAL LUNG AND LIVER DISEASE	25913036					germline	MedGen:C0034050;SNOMED CT:10501004;MedGen:C4225400;OMIM:615486	2014-12-02;2015-05-07	0	0	PASS	24	24	0	24	121412	121410	0.0001977	4	0	19	0	0	1	0	10404	11578	8654	6614	66740	908	16512	1743668	4	0	19	0	0	1	0	0	0	0	0	0	0	0	13	11	67288	54122	0	2164	0	19	8654	EAS
12	57906083	C	T	57906083	57906083	+	Haplotype	189364	RCV000169765;RCV000173000	SCV000196708;SCV000224019	187253	MARS	NM_004990.3:c.1700C>T	NP_004981.2:p.Ser567Leu	NM_004990.3:c.1700C>T:missense variant	-	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 07, 2015	Institute of Human Genetics, Klinikum rechts der Isar;OMIM	Institute of Human Genetics, Klinikum rechts der Isar;OMIM	Pulmonary alveolar proteinosis;Interstitial lung and liver disease;INTERSTITIAL LUNG AND LIVER DISEASE	25913036					germline	MedGen:C0034050;SNOMED CT:10501004;MedGen:C4225400;OMIM:615486	2014-12-02;2015-05-07	0	0	PASS	4	4	0	4	121412	121406	3.295e-05	4	0	0	0	0	0	0	10404	11578	8654	6614	66736	908	16512	2211670	4	0	0	0	0	0	0	0	0	0	0	0	0	0	1	3	67286	54120	0	2164	0	4	10404	AFR
12	80752660	A	G	80752660	80752660	+	Haplotype	229122	RCV000217831	SCV000272283	230419	OTOGL	NM_173591.3:c.6220A>G	NP_775862.3:p.Ile2074Val	NM_173591.3:c.6220A>G:missense variant	Benign	uncertain significance	0	0	1	0	0	no assertion for the individual variant	criteria provided, single submitter	Dec 01, 2015	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-12-01	0	0	PASS	76951	1419	11113	23645	82888	25154	0.928	2940	506	584	1722	10007	254	7632	3064	530	584	1764	10918	264	8030	1107459	124	24	0	42	845	10	374	1408	241	292	840	4581	122	3629	11907	11738	12604	12550	1398	1484	662	584	584	EAS
12	80752661	T	C	80752661	80752661	+	Haplotype	229122	RCV000217831	SCV000272283	230420	OTOGL	NM_173591.3:c.6221T>C	NP_775862.3:p.Ile2074Thr	NM_173591.3:c.6221T>C:missense variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	criteria provided, single submitter	Dec 01, 2015	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-12-01	0	0	PASS	1	1	0	1	92748	22706	1.078e-05	0	0	1	0	0	0	0	2724	406	460	1654	9400	244	7818	736157	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	11308	11398	0	1450	0	1	460	EAS
12	102151032	G	A	102151032	102151032	-	Haplotype	39094	RCV000032361	SCV000056008	47698	GNPTAB	NM_024312.4:c.3392C>T	NP_077288.2:p.Ser1131Phe	NM_024312.4:c.3392C>T:missense variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 10, 2012	GeneReviews	GeneReviews	I cell disease;Mucolipidosis II	20301728					not provided	GeneReviews:NBK1828;Genetic Alliance:Mucolipidosis+II/3706;Genetics Home Reference:mucolipidosis-ii-alpha-beta;MedGen:C2673377;OMIM:252500;Office of Rare Diseases:6749;Orphanet:576	2012-05-10	0	0																																															
12	102151034	A	AG	102151035	102151036	-	Haplotype	39094	RCV000032361	SCV000056008	47699	GNPTAB	NM_024312.4:c.3388_3389insC	NP_077288.2:p.Val1130Alafs	NM_024312.4:c.3388_3389insC:frameshift variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 10, 2012	GeneReviews	GeneReviews	I cell disease;Mucolipidosis II	20301728					not provided	GeneReviews:NBK1828;Genetic Alliance:Mucolipidosis+II/3706;Genetics Home Reference:mucolipidosis-ii-alpha-beta;MedGen:C2673377;OMIM:252500;Office of Rare Diseases:6749;Orphanet:576	2012-05-10	0	0																																															
12	102155393	G	A	102155393	102155393	-	Haplotype	39093	RCV000032360	SCV000056007	47696	GNPTAB	NM_024312.4:c.2864C>T	NP_077288.2:p.Ala955Val	NM_024312.4:c.2864C>T:missense variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 10, 2012	GeneReviews	GeneReviews	I cell disease;Mucolipidosis II	20301728					not provided	GeneReviews:NBK1828;Genetic Alliance:Mucolipidosis+II/3706;Genetics Home Reference:mucolipidosis-ii-alpha-beta;MedGen:C2673377;OMIM:252500;Office of Rare Diseases:6749;Orphanet:576	2012-05-10	0	0																																															
12	102155474	T	C	102155474	102155474	-	Haplotype	39093	RCV000032360	SCV000056007	47697	GNPTAB	NM_024312.4:c.2783A>G	NP_077288.2:p.Lys928Arg	NM_024312.4:c.2783A>G:missense variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 10, 2012	GeneReviews	GeneReviews	I cell disease;Mucolipidosis II	20301728					not provided	GeneReviews:NBK1828;Genetic Alliance:Mucolipidosis+II/3706;Genetics Home Reference:mucolipidosis-ii-alpha-beta;MedGen:C2673377;OMIM:252500;Office of Rare Diseases:6749;Orphanet:576	2012-05-10	0	0																																															
12	102174357	T	G	102174357	102174357	-	Haplotype	39095	RCV000032362	SCV000056009	47700	GNPTAB	NM_024312.4:c.614A>C	NP_077288.2:p.Gln205Pro	NM_024312.4:c.614A>C:missense variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 10, 2012	GeneReviews	GeneReviews	I cell disease;Mucolipidosis II	20301728					not provided	GeneReviews:NBK1828;Genetic Alliance:Mucolipidosis+II/3706;Genetics Home Reference:mucolipidosis-ii-alpha-beta;MedGen:C2673377;OMIM:252500;Office of Rare Diseases:6749;Orphanet:576	2012-05-10	0	0																																															
12	102179816	A	T	102179816	102179816	-	Haplotype	39095	RCV000032362	SCV000056009	47701	GNPTAB	NM_024312.4:c.545T>A	NP_077288.2:p.Val182Asp	NM_024312.4:c.545T>A:missense variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 10, 2012	GeneReviews	GeneReviews	I cell disease;Mucolipidosis II	20301728					not provided	GeneReviews:NBK1828;Genetic Alliance:Mucolipidosis+II/3706;Genetics Home Reference:mucolipidosis-ii-alpha-beta;MedGen:C2673377;OMIM:252500;Office of Rare Diseases:6749;Orphanet:576	2012-05-10	0	0																																															
12	103246681	G	A	103246681	103246681	-	Haplotype	217885	RCV000201954	SCV000256881	15623	PAH	NM_000277.2:c.754C>T	NP_000268.1:p.Arg252Trp	NM_000277.2:c.754C>T:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 07, 2017	Mendelics Analise Genomica	Mendelics Analise Genomica	Phenylketonuria	20301677;21915151;24385074;24667081;2574153;9429153				loss of function	germline	GeneReviews:NBK1504;Genetic Alliance:Phenylketonuria/5714;Genetic Testing Registry (GTR):GTR000260641;Genetic Testing Registry (GTR):GTR000330994;Genetic Testing Registry (GTR):GTR000505064;Genetic Testing Registry (GTR):GTR000505124;Genetic Testing Registry (GTR):GTR000506557;Genetic Testing Registry (GTR):GTR000507953;Genetic Testing Registry (GTR):GTR000509046;Genetic Testing Registry (GTR):GTR000522527;MedGen:C0031485;OMIM:261600;Office of Rare Diseases:7383;Orphanet:716;SNOMED CT:154735006	2014-08-07	0	0	PASS	6	6	0	6	121412	121328	4.942e-05	0	0	0	0	6	0	0	10402	11554	8648	6600	66704	908	16512	3175838	0	0	0	0	6	0	0	0	0	0	0	0	0	0	3	3	67244	54084	0	2164	0	6	66704	NFE
12	103246700	C	T	103246700	103246700	-	Haplotype	402236	RCV000454199	SCV000538053	98655	PAH	NM_000277.2:c.735G>A	NP_000268.1:p.Val245=	NM_000277.2:c.735G>A:synonymous variant	Benign	likely pathogenic	0	1	0	0	0	criteria provided, multiple submitters, no conflicts	criteria provided, single submitter	Jun 14, 2016	Knight Diagnostic Laboratories,Oregon Health and Sciences University	Knight Diagnostic Laboratories,Oregon Health and Sciences University	Phenylketonuria	20301677;21915151;24385074;24667081;25741868				loss of function	germline	GeneReviews:NBK1504;Genetic Alliance:Phenylketonuria/5714;Genetic Testing Registry (GTR):GTR000260641;Genetic Testing Registry (GTR):GTR000330994;Genetic Testing Registry (GTR):GTR000505064;Genetic Testing Registry (GTR):GTR000505124;Genetic Testing Registry (GTR):GTR000506557;Genetic Testing Registry (GTR):GTR000507953;Genetic Testing Registry (GTR):GTR000509046;Genetic Testing Registry (GTR):GTR000522527;MedGen:C0031485;OMIM:261600;Office of Rare Diseases:7383;Orphanet:716;SNOMED CT:154735006	2015-08-13	2	0	PASS	35263	22186	6524	35234	121412	121256	0.29	475	2596	6506	2054	17231	273	6099	10398	11542	8628	6594	66676	908	16510	3555903	461	1978	1632	1414	12799	181	3721	7	309	2437	320	2216	46	1189	19991	15243	67216	54040	755	2164	154	6506	8628	EAS
12	103246712	GC	G	103246713	103246713	-	Haplotype	402236	RCV000454199	SCV000538053	108542	PAH	NM_000277.2:c.722delG	NP_000268.1:p.Arg241Profs	NM_000277.2:c.722delG:frameshift variant	Likely pathogenic	likely pathogenic	0	1	0	0	0	criteria provided, single submitter	criteria provided, single submitter	Aug 13, 2015	Knight Diagnostic Laboratories,Oregon Health and Sciences University	Knight Diagnostic Laboratories,Oregon Health and Sciences University	Phenylketonuria	20301677;21915151;24385074;24667081;25741868				loss of function	germline	GeneReviews:NBK1504;Genetic Alliance:Phenylketonuria/5714;Genetic Testing Registry (GTR):GTR000260641;Genetic Testing Registry (GTR):GTR000330994;Genetic Testing Registry (GTR):GTR000505064;Genetic Testing Registry (GTR):GTR000505124;Genetic Testing Registry (GTR):GTR000506557;Genetic Testing Registry (GTR):GTR000507953;Genetic Testing Registry (GTR):GTR000509046;Genetic Testing Registry (GTR):GTR000522527;MedGen:C0031485;OMIM:261600;Office of Rare Diseases:7383;Orphanet:716;SNOMED CT:154735006	2015-08-13	1	0																																															
12	103271835	C	A	103271835	103271835	-	Haplotype	217885	RCV000201954	SCV000256881	214540	PAH	NM_000277.2:c.353-507G>T		NM_000277.2:c.353-507G>T:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 07, 2014	Mendelics Analise Genomica	Mendelics Analise Genomica	Phenylketonuria	20301677;21915151;24385074;24667081;2574153;9429153				loss of function	germline	GeneReviews:NBK1504;Genetic Alliance:Phenylketonuria/5714;Genetic Testing Registry (GTR):GTR000260641;Genetic Testing Registry (GTR):GTR000330994;Genetic Testing Registry (GTR):GTR000505064;Genetic Testing Registry (GTR):GTR000505124;Genetic Testing Registry (GTR):GTR000506557;Genetic Testing Registry (GTR):GTR000507953;Genetic Testing Registry (GTR):GTR000509046;Genetic Testing Registry (GTR):GTR000522527;MedGen:C0031485;OMIM:261600;Office of Rare Diseases:7383;Orphanet:716;SNOMED CT:154735006	2014-08-07	0	0																																															
12	110221556	A	T	110221556	110221556	-	Haplotype	378057	RCV000435546	SCV000513422	472257	TRPV4	NM_021625.4:c.2486T>A	NP_067638.3:p.Val829Glu	NM_021625.4:c.2486T>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 03, 2017	OMIM	OMIM	Avascular necrosis of femoral head, primary, 2;AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 2 (1 family)	27330106					germline	MedGen:CN240839;OMIM:617383	2017-03-03	0	0																																															
12	110221557	CGCGG	C	110221558	110221561	-	Haplotype	378057	RCV000435546	SCV000513422	380146	TRPV4	NM_021625.4:c.2481_2484delCCGC	NP_067638.3:p.Arg828Trpfs	NM_021625.4:c.2481_2484delCCGC:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 03, 2017	OMIM	OMIM	Avascular necrosis of femoral head, primary, 2;AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 2 (1 family)	27330106					germline	MedGen:CN240839;OMIM:617383	2017-03-03	0	0																																															
13	20763313	G	T	20763313	20763313	-	Haplotype	267367;446728	RCV000258130;RCV000516165	SCV000599732;SCV000328260	186856	GJB2	NM_004004.5:c.408C>A	NP_003995.2:p.Tyr136Ter	NM_004004.5:c.408C>A:nonsense	Likely pathogenic	pathogenic	2	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter;no assertion criteria provided	May 09, 2017	Division of Genomic Diagnostics,The Children's Hospital of Philadelphia;OMIM	Division of Genomic Diagnostics,The Children's Hospital of Philadelphia;OMIM	Deafness, autosomal recessive 1A;DEAFNESS, AUTOSOMAL RECESSIVE 1A	1;20301449;20301607;20497192;12560944;15633193;24785414					germline	GeneReviews:NBK1272;Genetic Alliance:Deafness%2C+autosomal+recessive+1A/8159;MedGen:C2673759;OMIM:220290;Office of Rare Diseases:1697;Orphanet:90636	2017-05-09;2010-11-01	0	0																																															
13	20763380	T	C	20763380	20763380	-	Haplotype	177819	RCV000154452	SCV000204121	53906	GJB2	NM_004004.5:c.341A>G	NP_003995.2:p.Glu114Gly	NM_004004.5:c.341A>G:missense variant	Conflicting interpretations of pathogenicity	likely benign	0	0	0	1	0	criteria provided, conflicting interpretations	criteria provided, single submitter	May 09, 2017	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	10607953;10983956;12746422;15070423;17041943;17666888;20083784;20201936;20668687;21298213;23826813;24033266;9529365					germline	MedGen:CN169374	2015-07-28	1	1	PASS	1768	1482	142	1766	121412	121066	0.015	0	3	1619	0	93	7	44	10326	11540	8616	6610	66570	904	16500	2100866	0	3	1341	0	91	5	42	0	0	139	0	1	1	1	854	912	67212	53854	3	2164	0	1619	8616	EAS
13	20763587	C	T	20763587	20763587	-	Haplotype	267367;446728	RCV000258130;RCV000516165	SCV000599732;SCV000328260	32072	GJB2	NM_004004.5:c.134G>A	NP_003995.2:p.Gly45Glu	NM_004004.5:c.134G>A:missense variant	Pathogenic/Likely pathogenic	pathogenic	2	0	0	0	0	criteria provided, single submitter	criteria provided, single submitter;no assertion criteria provided	May 09, 2017	Division of Genomic Diagnostics,The Children's Hospital of Philadelphia;OMIM	Division of Genomic Diagnostics,The Children's Hospital of Philadelphia;OMIM	Deafness, autosomal recessive 1A;DEAFNESS, AUTOSOMAL RECESSIVE 1A	1;20301449;20301607;20497192;12560944;15633193;24785414					germline	GeneReviews:NBK1272;Genetic Alliance:Deafness%2C+autosomal+recessive+1A/8159;MedGen:C2673759;OMIM:220290;Office of Rare Diseases:1697;Orphanet:90636	2017-05-09;2010-11-01	1	0																																															
13	20763642	C	T	20763642	20763642	-	Haplotype	177819	RCV000154452	SCV000204121	44943	GJB2	NM_004004.5:c.79G>A	NP_003995.2:p.Val27Ile	NM_004004.5:c.79G>A:missense variant	Conflicting interpretations of pathogenicity	likely benign	0	0	0	1	0	criteria provided, conflicting interpretations	criteria provided, single submitter	May 09, 2017	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	10607953;10983956;12746422;15070423;17041943;17666888;20083784;20201936;20668687;21298213;23826813;24033266;9529365					germline	MedGen:CN169374	2015-07-28	1	1	PASS	5509	3971	768	5507	121412	121350	0.045	40	2674	2518	0	155	30	90	10404	11576	8632	6614	66706	908	16510	2357620	40	1954	1708	0	153	28	88	0	360	405	0	1	1	1	2380	3127	67256	54094	9	2164	0	2518	8632	EAS
13	23929111	G	A	23929111	23929111	-	Haplotype	424657	RCV000515975	SCV000574461	327819	SACS	NM_014363.5:c.1640C>T	NP_055178.3:p.Pro547Leu	NM_014363.5:c.1640C>T:missense variant	Uncertain significance	likely pathogenic	0	1	0	0	0	criteria provided, single submitter	criteria provided, single submitter	Mar 07, 2017	Unit for Genetic & Epidemiological Research on Neurological Disorders,Instituto de Investigação e Inovação em Saúde	Unit for Genetic & Epidemiological Research on Neurological Disorders,Instituto de Investigação e Inovação em Saúde	Hereditary spastic paraplegia	20301682;28832565				loss of function	inherited	GeneReviews:NBK1509;Genetic Alliance:Hereditary+spastic+paraplegia/3383;Genetic Testing Registry (GTR):GTR000500041;Genetic Testing Registry (GTR):GTR000500218;Genetic Testing Registry (GTR):GTR000500428;Genetic Testing Registry (GTR):GTR000508756;Genetic Testing Registry (GTR):GTR000525862;Genetic Testing Registry (GTR):GTR000525863;Genetic Testing Registry (GTR):GTR000528277;Genetic Testing Registry (GTR):GTR000529007;MedGen:C0037773;OMIM:PS303350;Office of Rare Diseases:6637;Orphanet:ORPHA685;SNOMED CT:39912006	2017-03-07	1	0	PASS	5	5	0	5	121412	121244	4.118e-05	0	1	0	0	2	0	2	10372	11576	8654	6614	66612	906	16510	1894098	0	1	0	0	2	0	2	0	0	0	0	0	0	0	2	3	67258	53986	0	2164	0	2	16510	SAS
13	23929117	C	A	23929117	23929117	-	Haplotype	424657	RCV000515975	SCV000574461	411584	SACS	NM_014363.5:c.1634G>T	NP_055178.3:p.Trp545Leu	NM_014363.5:c.1634G>T:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Mar 07, 2017	Unit for Genetic & Epidemiological Research on Neurological Disorders,Instituto de Investigação e Inovação em Saúde	Unit for Genetic & Epidemiological Research on Neurological Disorders,Instituto de Investigação e Inovação em Saúde	Hereditary spastic paraplegia	20301682;28832565				loss of function	inherited	GeneReviews:NBK1509;Genetic Alliance:Hereditary+spastic+paraplegia/3383;Genetic Testing Registry (GTR):GTR000500041;Genetic Testing Registry (GTR):GTR000500218;Genetic Testing Registry (GTR):GTR000500428;Genetic Testing Registry (GTR):GTR000508756;Genetic Testing Registry (GTR):GTR000525862;Genetic Testing Registry (GTR):GTR000525863;Genetic Testing Registry (GTR):GTR000528277;Genetic Testing Registry (GTR):GTR000529007;MedGen:C0037773;OMIM:PS303350;Office of Rare Diseases:6637;Orphanet:ORPHA685;SNOMED CT:39912006	2017-03-07	0	0																																															
13	52515247	C	T	52515247	52515247	-	Haplotype	3863	RCV000004067	SCV000024233	38430	ATP7B	NM_000053.3:c.3526G>A	NP_000044.2:p.Gly1176Arg	NM_000053.3:c.3526G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 2005	OMIM	OMIM	Wilson disease;WILSON DISEASE	15845031;18506894;20301685;20482602;27854360				loss of function	germline	GeneReviews:NBK1512;Genetic Alliance:Wilson+disease/7506;Genetic Testing Registry (GTR):GTR000260623;Genetic Testing Registry (GTR):GTR000501125;Genetic Testing Registry (GTR):GTR000503091;Genetic Testing Registry (GTR):GTR000507952;Genetic Testing Registry (GTR):GTR000508735;Genetic Testing Registry (GTR):GTR000509712;Genetic Testing Registry (GTR):GTR000515523;Genetic Testing Registry (GTR):GTR000520457;Genetic Testing Registry (GTR):GTR000521900;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000528632;Genetic Testing Registry (GTR):GTR000528928;Genetic Testing Registry (GTR):GTR000530035;Genetic Testing Registry (GTR):GTR000530097;Genetic Testing Registry (GTR):GTR000552345;Genetic Testing Registry (GTR):GTR000553937;Genetics Home Reference:wilson-disease;MedGen:C0019202;OMIM:277900;Office of Rare Diseases:7893;Orphanet:905;SNOMED CT:88518009	2005-05-01	0	0																																															
13	52515330	A	G	52515330	52515330	-	Haplotype	3863	RCV000004067	SCV000024233	18902	ATP7B	NM_000053.3:c.3443T>C	NP_000044.2:p.Ile1148Thr	NM_000053.3:c.3443T>C:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Sep 10, 2014	OMIM	OMIM	Wilson disease;WILSON DISEASE	15845031;18506894;20301685;20482602;27854360				loss of function	germline	GeneReviews:NBK1512;Genetic Alliance:Wilson+disease/7506;Genetic Testing Registry (GTR):GTR000260623;Genetic Testing Registry (GTR):GTR000501125;Genetic Testing Registry (GTR):GTR000503091;Genetic Testing Registry (GTR):GTR000507952;Genetic Testing Registry (GTR):GTR000508735;Genetic Testing Registry (GTR):GTR000509712;Genetic Testing Registry (GTR):GTR000515523;Genetic Testing Registry (GTR):GTR000520457;Genetic Testing Registry (GTR):GTR000521900;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000528632;Genetic Testing Registry (GTR):GTR000528928;Genetic Testing Registry (GTR):GTR000530035;Genetic Testing Registry (GTR):GTR000530097;Genetic Testing Registry (GTR):GTR000552345;Genetic Testing Registry (GTR):GTR000553937;Genetics Home Reference:wilson-disease;MedGen:C0019202;OMIM:277900;Office of Rare Diseases:7893;Orphanet:905;SNOMED CT:88518009	2005-05-01	1	0	PASS	5	5	0	5	120882	120772	4.136e-05	0	0	4	0	1	0	0	9806	11576	8624	6614	66740	900	16512	3816301	0	0	4	0	1	0	0	0	0	0	0	0	0	0	3	2	67262	53510	0	2164	0	4	8624	EAS
13	103701773	G	A	103701773	103701773	-	Haplotype	8241	RCV000008724	SCV000028933	38442	SLC10A2	NM_000452.2:c.785C>T	NP_000443.1:p.Thr262Met	NM_000452.2:c.785C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 15, 1997	OMIM	OMIM	Bile acid malabsorption, primary;BILE ACID MALABSORPTION, PRIMARY	9109432					germline	Genetic Alliance:Bile+acid+malabsorption%2C+primary/7818;MedGen:C2750087;OMIM:613291	1997-04-15	0	0	PASS	62	62	0	62	121412	121262	0.0005107	1	4	3	0	53	0	1	10402	11544	8602	6610	66688	906	16510	2110385	1	4	3	0	53	0	1	0	0	0	0	0	0	0	36	26	67228	54034	0	2164	0	53	66688	NFE
13	103703640	A	G	103703640	103703640	-	Haplotype	8241	RCV000008724	SCV000028933	23280	SLC10A2	NM_000452.2:c.728T>C	NP_000443.1:p.Leu243Pro	NM_000452.2:c.728T>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 15, 1997	OMIM	OMIM	Bile acid malabsorption, primary;BILE ACID MALABSORPTION, PRIMARY	9109432					germline	Genetic Alliance:Bile+acid+malabsorption%2C+primary/7818;MedGen:C2750087;OMIM:613291	1997-04-15	0	0																																															
14	23895007	G	A	23895007	23895007	-	Haplotype	487487	RCV000015167	SCV000035424	29150	MYH7	NM_000257.3:c.2183C>T	NP_000248.2:p.Ala728Val	NM_000257.3:c.2183C>T:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jun 27, 2017	OMIM	OMIM	Familial hypertrophic cardiomyopathy 1;CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	11424919;20301559;20301725;21267010;23788249;25173338;25356965;27854360					germline	GeneReviews:NBK1768;Genetic Alliance:Familial+hypertrophic+cardiomyopathy+1/8382;MedGen:C3495498;OMIM:192600	2001-06-01	2	0	VQSRTrancheSNP99.60to99.80	19	18	0	18	121412	121400	0.0001565	2	3	0	0	11	0	2	10406	11574	8652	6614	66736	906	16512	3296745	2	3	0	0	11	0	2	0	0	0	0	0	0	0	12	6	67284	54116	0	2164	0	3	11574	AMR
14	23896866	C	T	23896866	23896866	-	Haplotype	487487	RCV000015167	SCV000035424	29130	MYH7	NM_000257.3:c.1816G>A	NP_000248.2:p.Val606Met	NM_000257.3:c.1816G>A:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Mar 13, 2017	OMIM	OMIM	Familial hypertrophic cardiomyopathy 1;CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	11424919;20301559;20301725;21267010;23788249;25173338;25356965;27854360					germline	GeneReviews:NBK1768;Genetic Alliance:Familial+hypertrophic+cardiomyopathy+1/8382;MedGen:C3495498;OMIM:192600	2001-06-01	2	0																																															
14	29237048	C	G	29237048	29237048	+	Phase unknown	189607	RCV000170068	SCV000222377	169055	FOXG1	NM_005249.4:c.563C>G	NP_005240.3:p.Ala188Gly	NM_005249.4:c.563C>G:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Feb 08, 2013	RettBASE	RettBASE	not provided;Not provided						de novo	MedGen:CN517202	2011-02-15	1	0																																															
14	29237129	TC	CT	29237129	29237130	+	Phase unknown	189607	RCV000170068	SCV000222377	187407	FOXG1	NM_005249.4:c.644_645delTCinsCT	NP_005240.3:p.Phe215Ser	NM_005249.4:c.644_645delTCinsCT:missense variant	Likely pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 08, 2013	RettBASE	RettBASE	not provided;Not provided						de novo	MedGen:CN517202	2011-02-15	0	0																																															
14	32031331	G	A	32031331	32031331	+	Haplotype	7	RCV000000017	SCV000020160;SCV000245520	15046	NUBPL	NM_025152.2:c.166G>A	NP_079428.2:p.Gly56Arg	NM_025152.2:c.166G>A:missense variant;NR_120408.1:n.221G>A:non-coding transcript variant	Uncertain significance	pathogenic;pathogenic	2	0	0	0	0	criteria provided, single submitter	no assertion criteria provided;criteria provided, single submitter	Feb 22, 2017	OMIM;Baylor Miraca Genetics Laboratories	OMIM;Baylor Miraca Genetics Laboratories	Mitochondrial complex I deficiency;MITOCHONDRIAL COMPLEX I DEFICIENCY;Mitochondrial complex I deficiency	20818383;22072591;23553477;24088041;26633545					germline;maternal;paternal	Genetic Alliance:Mitochondrial+complex+I+deficiency/4823;MedGen:C1838979;OMIM:252010;Office of Rare Diseases:3908;Orphanet:2609	2013-04-23;2014-04-09	1	0	PASS	17	17	0	17	120806	109420	0.0001407	1	0	0	0	16	0	0	8962	10896	7580	6342	59636	836	15168	1320845	1	0	0	0	16	0	0	0	0	0	0	0	0	0	7	10	61292	48128	0	2050	0	16	59636	NFE
14	32319298	T	C	32319298	32319298	+	Haplotype	7	RCV000000017	SCV000020160;SCV000245520	59458	NUBPL	NM_025152.2:c.815-27T>C		NM_025152.2:c.815-27T>C:intron variant	Conflicting interpretations of pathogenicity	pathogenic;pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided;criteria provided, single submitter	Aug 14, 2017	OMIM;Baylor Miraca Genetics Laboratories	OMIM;Baylor Miraca Genetics Laboratories	Mitochondrial complex I deficiency;MITOCHONDRIAL COMPLEX I DEFICIENCY;Mitochondrial complex I deficiency	20818383;22072591;23553477;24088041;26633545					germline;maternal;paternal	Genetic Alliance:Mitochondrial+complex+I+deficiency/4823;MedGen:C1838979;OMIM:252010;Office of Rare Diseases:3908;Orphanet:2609	2013-04-23;2014-04-09	0	1	PASS	436	430	3	436	120786	117040	0.00361	7	6	0	82	320	5	16	9462	11158	8332	6534	64716	858	15980	1967338	7	6	0	80	316	5	16	0	0	0	1	2	0	0	255	181	65232	51808	1	2118	0	320	64716	NFE
14	51378443	AGTAC	A	51378444	51378447	-	Haplotype	38368	RCV000020505	SCV000040956	46929	PYGL	NM_002863.4:c.1969+1_1969+4delGTAC		NM_002863.4:c.1969+1_1969+4delGTAC:intron variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 17, 2011	GeneReviews	GeneReviews	Glycogen storage disease, type VI;Glycogen Storage Disease Type VI	17705025;20301760					not provided	GeneReviews:NBK5941;Genetic Alliance:Glycogen+Storage+Disease+Type+6/3126;MedGen:C0017925;OMIM:232700;Office of Rare Diseases:6529;Orphanet:369;SNOMED CT:237971004;SNOMED CT:29291001	2011-05-17	0	0																																															
14	51378448	CTTTTT	AAAAAG	51378448	51378453	-	Haplotype	38368	RCV000020505	SCV000040956	46930	PYGL	NM_002863.4:c.1964_1969invAAAAAG	NP_002854.3:p.Glu655_Lys656del		-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 17, 2011	GeneReviews	GeneReviews	Glycogen storage disease, type VI;Glycogen Storage Disease Type VI	17705025;20301760					not provided	GeneReviews:NBK5941;Genetic Alliance:Glycogen+Storage+Disease+Type+6/3126;MedGen:C0017925;OMIM:232700;Office of Rare Diseases:6529;Orphanet:369;SNOMED CT:237971004;SNOMED CT:29291001	2011-05-17	0	0																																															
14	75570544	C	A	75570544	75570544	-	Haplotype	242987	RCV000234965	SCV000292296	248590	NEK9	NM_033116.5:c.1731+1G>T		NM_033116.5:c.1731+1G>T:splice donor variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 11, 2016	OMIM	OMIM	Nevus comedonicus;NEVUS COMEDONICUS, SOMATIC	27153399					somatic	MedGen:C0265987;OMIM:617025	2016-07-11	0	0																																															
14	75570561	C	A	75570561	75570561	-	Haplotype	242987	RCV000234965	SCV000292296	244069	NEK9	NM_033116.5:c.1715G>T	NP_149107.4:p.Gly572Val	NM_033116.5:c.1715G>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 11, 2016	OMIM	OMIM	Nevus comedonicus;NEVUS COMEDONICUS, SOMATIC	27153399					somatic	MedGen:C0265987;OMIM:617025	2016-07-11	0	0																																															
14	94847262	T	A	94847262	94847262	-	Haplotype	440500;440501	RCV000508742;RCV000508836	SCV000605935;SCV000605936	33008	SERPINA1	NM_001127701.1:c.863A>T	NP_001121173.1:p.Glu288Val	NM_001127701.1:c.863A>T:missense variant	Pathogenic, other	pathogenic	2	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Oct 23, 2017	HerediLab, Inc.	HerediLab, Inc.	Alpha-1-antitrypsin deficiency;Alpha-1 Antitrypsin Deficiency	15685488;20301692;24121147					germline	GeneReviews:NBK1519;Genetic Alliance:Alpha+1-Antitrypsin+Deficiency/325;MedGen:C0221757;OMIM:613490;Office of Rare Diseases:5784;Orphanet:60;SNOMED CT:30188007	2016-07-12;2015-11-13	0	0	PASS	2437	2341	48	2437	121412	121410	0.02	81	253	1	59	2026	17	0	10406	11578	8654	6614	66738	908	16512	2612939	81	241	1	59	1942	17	0	0	6	0	0	42	0	0	1345	1092	67288	54122	0	2164	0	2026	66738	NFE
14	94847386	G	A	94847386	94847386	-	Haplotype	219354	RCV000205893	SCV000259189	33000	SERPINA1	NM_001127707.1:c.739C>T	NP_001121179.1:p.Arg247Cys	NM_001127701.1:c.739C>T:missense variant	Conflicting interpretations of pathogenicity, other	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	criteria provided, single submitter	Jul 15, 2016	HerediLab, Inc.	HerediLab, Inc.	Alpha-1-antitrypsin deficiency	15685488;20301692;24121147					germline	GeneReviews:NBK1519;Genetic Alliance:Alpha+1-Antitrypsin+Deficiency/325;MedGen:C0221757;OMIM:613490;Office of Rare Diseases:5784;Orphanet:60;SNOMED CT:30188007	2015-07-23	1	1	PASS	349	347	1	349	121412	121292	0.002875	13	2	0	2	330	2	0	10384	11548	8648	6604	66708	904	16496	2280717	13	2	0	2	328	2	0	0	0	0	0	1	0	0	198	151	67240	54052	0	2164	0	330	66708	NFE
14	94848973	T	C	94848973	94848973	-	Haplotype	440500	RCV000508742	SCV000605935	434125	SERPINA1	NM_001127701.1:c.602A>G	NP_001121173.1:p.Asp201Gly	NM_001127701.1:c.602A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jul 12, 2016	HerediLab, Inc.	HerediLab, Inc.	Alpha-1-antitrypsin deficiency;Alpha-1 Antitrypsin Deficiency	15685488;20301692;24121147					germline	GeneReviews:NBK1519;Genetic Alliance:Alpha+1-Antitrypsin+Deficiency/325;MedGen:C0221757;OMIM:613490;Office of Rare Diseases:5784;Orphanet:60;SNOMED CT:30188007	2016-07-12	0	0																																															
14	94849061	C	T	94849061	94849061	-	Haplotype	17972	RCV000019572	SCV000039869	33011	SERPINA1	NM_001127701.1:c.514G>A	NP_001121173.1:p.Gly172Arg	NM_001127701.1:c.514G>A:missense variant	Uncertain significance	other	0	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Jul 15, 2016	OMIM	OMIM	PI M(NICHINAN);PI M(NICHINAN)	2309708;6162902					germline	OMIM:107400.0017	2016-07-15	0	0	PASS	52	52	0	52	121412	121412	0.0004283	18	2	1	0	29	2	0	10406	11578	8654	6614	66740	908	16512	2194510	18,1,0	2,1,0	1,0,0	0,1,0	29,71,0	2,2,0	0,38,0	0	0	0	0	0	0	0	24	28	67288	54124	0	2164	0	18	10406	AFR
14	94849345	GAGA	G	94849346	94849348	-	Haplotype	17972	RCV000019572	SCV000039869	321860	SERPINA1	NM_001127701.1:c.227_229delTCT	NP_001121173.1:p.Phe76del	NM_001127701.1:c.227_229delTCT:inframe_variant	Pathogenic, other	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 15, 2016	OMIM	OMIM	PI M(NICHINAN);PI M(NICHINAN)	2309708;6162902					germline	OMIM:107400.0017	2016-07-15	0	0	PASS	22	22	0	22	121412	120586	0.0001812	1	7	6	0	8	0	0	10404	11576	8648	6614	66478	896	15970	1676692	1	7	6	0	8	0	0	0	0	0	0	0	0	0	9	13	66720	53866	0	2058	0	6	8648	EAS
14	94849385	G	T	94849385	94849385	-	Haplotype	440501	RCV000508836	SCV000605936	434128	SERPINA1	NM_001127701.1:c.190C>A	NP_001121173.1:p.Gln64Lys	NM_001127701.1:c.190C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Nov 13, 2015	HerediLab, Inc.	HerediLab, Inc.	Alpha-1-antitrypsin deficiency;Alpha-1 Antitrypsin Deficiency	15685488;20301692;24121147					germline	GeneReviews:NBK1519;Genetic Alliance:Alpha+1-Antitrypsin+Deficiency/325;MedGen:C0221757;OMIM:613490;Office of Rare Diseases:5784;Orphanet:60;SNOMED CT:30188007	2015-11-13	0	0																																															
14	94849388	G	A	94849388	94849388	-	Haplotype	219354	RCV000205893	SCV000259189	33013	SERPINA1	NM_001127701.1:c.187C>T	NP_001121173.1:p.Arg63Cys	NM_001127701.1:c.187C>T:missense variant	Conflicting interpretations of pathogenicity, other	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	criteria provided, single submitter	Oct 11, 2016	HerediLab, Inc.	HerediLab, Inc.	Alpha-1-antitrypsin deficiency	15685488;20301692;24121147					germline	GeneReviews:NBK1519;Genetic Alliance:Alpha+1-Antitrypsin+Deficiency/325;MedGen:C0221757;OMIM:613490;Office of Rare Diseases:5784;Orphanet:60;SNOMED CT:30188007	2015-07-23	1	1	PASS	118	118	0	118	121412	121316	0.0009719	2	4	3	0	108	0	1	10406	11578	8654	6614	66670	906	16488	1707609	2	4	3	0	108	0	1	0	0	0	0	0	0	0	70	48	67234	54082	0	2154	0	108	66670	NFE
15	40763815	C	G	40763815	40763815	+	Haplotype	446172	RCV000002428	SCV000022586	439519	CHST14	NM_130468.3:c.403C>G	NP_569735.1:p.Arg135Gly	NM_130468.3:c.403C>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 01, 2009	OMIM	OMIM	Ehlers-Danlos syndrome, musculocontractural type;EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1	11666007;20004762					germline	Genetic Alliance:Adducted+Thumb+and+Clubfoot+Syndrome/216;Genetics Home Reference:ehlers-danlos-syndrome;MedGen:C1866294;OMIM:601776;Orphanet:2953	2009-12-01	0	0																																															
15	40763822	T	A	40763822	40763822	+	Haplotype	446172	RCV000002428	SCV000022586	439520	CHST14	NM_130468.3:c.410T>A	NP_569735.1:p.Leu137Gln	NM_130468.3:c.410T>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 01, 2009	OMIM	OMIM	Ehlers-Danlos syndrome, musculocontractural type;EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1	11666007;20004762					germline	Genetic Alliance:Adducted+Thumb+and+Clubfoot+Syndrome/216;Genetics Home Reference:ehlers-danlos-syndrome;MedGen:C1866294;OMIM:601776;Orphanet:2953	2009-12-01	0	0																																															
15	49037145	CGTT	C	49037146	49037148	-	Haplotype	446758	RCV000077752	SCV000109558	97524	CEP152				-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 2013	OMIM	OMIM	Primary autosomal recessive microcephaly 9;MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE	20301772;22775483					germline	GeneReviews:NBK9587;GeneTests:279904;MedGen:C3553886;OMIM:614852;Orphanet:2512	2013-05-01	0	0																																															
15	49048296	A	G	49048296	49048296	-	Haplotype	446758	RCV000077752	SCV000109558	97321	CEP152	NM_001194998.1:c.3149T>C	NP_001181927.1:p.Leu1050Pro	NM_001194998.1:c.3149T>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 2013	OMIM	OMIM	Primary autosomal recessive microcephaly 9;MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE	20301772;22775483					germline	GeneReviews:NBK9587;GeneTests:279904;MedGen:C3553886;OMIM:614852;Orphanet:2512	2013-05-01	0	0	PASS	2	2	0	2	120856	120740	1.655e-05	0	0	0	0	0	0	2	9802	11558	8626	6612	66732	900	16510	1837576	0	0	0	0	0	0	2	0	0	0	0	0	0	0	2	0	67244	53496	0	2164	0	2	16510	SAS
15	50782626	T	G	50782626	50782626	+	Haplotype	161994	RCV000149419	SCV000192010	171716	USP8	NM_005154.4:c.2138T>G	NP_005145.3:p.Leu713Arg	NM_001128610.2:c.2138T>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 18, 2014	Institute of Human Genetics, Klinikum rechts der Isar	Institute of Human Genetics, Klinikum rechts der Isar	Pituitary dependent hypercortisolism;Pituitary dependent hypercortisolism	22720333					somatic	GeneReviews:NBK97965;Genetic Alliance:Pituitary+dependent+hypercortisolism/9118;MedGen:C0221406;OMIM:219090;Orphanet:96253;SNOMED CT:190502001	2014-11-18	0	0																																															
15	50782638	A	G	50782638	50782638	+	Haplotype	161994	RCV000149419	SCV000192010	171717	USP8	NM_005154.4:c.2150A>G	NP_005145.3:p.Tyr717Cys	NM_001128610.2:c.2150A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 18, 2014	Institute of Human Genetics, Klinikum rechts der Isar	Institute of Human Genetics, Klinikum rechts der Isar	Pituitary dependent hypercortisolism;Pituitary dependent hypercortisolism	22720333					somatic	GeneReviews:NBK97965;Genetic Alliance:Pituitary+dependent+hypercortisolism/9118;MedGen:C0221406;OMIM:219090;Orphanet:96253;SNOMED CT:190502001	2014-11-18	0	0	PASS	1	1	0	1	121412	121152	8.236e-06	0	0	0	0	1	0	0	10338	11552	8634	6610	66618	902	16498	3084563	0,0,0	0,0,0	0,0,0	0,0,0	1,0,0	0,0,0	0,1,0	0	0	0	0	0	0	0	1	0	67234	53918	0	2164	0	1	66618	NFE
15	51250689	G	A	51250689	51250689	+	Haplotype	224506	RCV000210065	SCV000265991	226246	AP4E1	NM_007347.4:c.1549G>A	NP_031373.2:p.Val517Ile	NM_007347.4:c.1549G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 16, 2016	OMIM	OMIM	Stuttering, familial persistent 1;STUTTERING, FAMILIAL PERSISTENT, 1	23239121;26544806					germline	Gene:100049541;MedGen:C3489627;OMIM:184450	2016-03-16	0	0	PASS	2	2	0	2	121326	87814	1.648e-05	0	0	0	0	2	0	0	7740	8746	6572	5594	44290	728	14144	1144251	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1	1	49304	38510	0	2054	0	2	44290	NFE
15	51289577	G	A	51289577	51289577	+	Haplotype	224506	RCV000210065	SCV000265991	226245	AP4E1	NM_007347.4:c.2401G>A	NP_031373.2:p.Glu801Lys	NM_007347.4:c.2401G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 16, 2016	OMIM	OMIM	Stuttering, familial persistent 1;STUTTERING, FAMILIAL PERSISTENT, 1	23239121;26544806					germline	Gene:100049541;MedGen:C3489627;OMIM:184450	2016-03-16	0	0	PASS	3	3	0	3	121408	118512	2.471e-05	3	0	0	0	0	0	0	10302	11410	8512	6558	65750	890	15090	1377171	3	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	65420	53092	0	1880	0	3	10302	AFR
15	72643548	C	T	72643548	72643548	-	Haplotype	446267	RCV000004129	SCV000024295	38431	HEXA	NM_000520.5:c.598G>A	NP_000511.2:p.Val200Met	NM_000520.5:c.598G>A:missense variant;NR_134869.1:n.1099G>A:non-coding transcript variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 1996	OMIM	OMIM	Tay-Sachs disease, B1 variant;TAY-SACHS DISEASE, B1 VARIANT	1415222;2976595;8198136;8659543					germline	MedGen:C1848916	1996-07-01	0	0	PASS	4	4	0	4	121412	121382	3.295e-05	1	2	0	0	1	0	0	10402	11570	8654	6614	66726	908	16508	2005114	1	2	0	0	1	0	0	0	0	0	0	0	0	0	1	3	67278	54104	0	2164	0	2	11570	AMR
15	72643572	C	G	72643572	72643572	-	Haplotype	446267	RCV000004129	SCV000024295	18962	HEXA	NM_000520.5:c.574G>C	NP_000511.2:p.Val192Leu	NM_000520.5:c.574G>C:missense variant;NR_134869.1:n.1075G>C:non-coding transcript variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 1996	OMIM	OMIM	Tay-Sachs disease, B1 variant;TAY-SACHS DISEASE, B1 VARIANT	1415222;2976595;8198136;8659543					germline	MedGen:C1848916	1996-07-01	0	0																																															
15	89866657	C	G	89866657	89866657	-	Phase unknown	157526	RCV000144870	SCV000172142	28546	POLG	NM_002693.2:c.2243G>C	NP_002684.1:p.Trp748Ser	NM_002693.2:c.2243G>C:missense variant	Conflicting interpretations of pathogenicity	uncertain significance	0	0	1	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Jul 14, 2017	Section of Medical Genetics, Telemark Hospital	Section of Medical Genetics, Telemark Hospital	Charcot-Marie-Tooth disease;axonal type;Charcot-Marie-Tooth disease	15477547;15824347;20301532;22189570;25025039;28812649					not applicable	GeneReviews:NBK1358;Genetic Alliance:Charcot-Marie-Tooth+Disease/1276;Genetics Home Reference:charcot-marie-tooth-disease;MedGen:C0007959;OMIM:PS118220;Office of Rare Diseases:6034;SNOMED CT:50548001	2013-11-01	1	1	PASS	101	101	0	101	121412	119838	0.0008319	1	0	0	36	62	1	1	10252	11376	8604	6362	66130	884	16230	1817103	1	0	0	36	62	1	1	0	0	0	0	0	0	0	57	44	66484	53354	1	2140	0	62	66130	NFE
15	89870237	C	G	89870237	89870237	-	Phase unknown	157526	RCV000144870	SCV000172142	28549	POLG	NM_002693.2:c.1491G>C	NP_002684.1:p.Gln497His	NM_002693.2:c.1491G>C:missense variant	Conflicting interpretations of pathogenicity	uncertain significance	0	0	1	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Jul 21, 2017	Section of Medical Genetics, Telemark Hospital	Section of Medical Genetics, Telemark Hospital	Charcot-Marie-Tooth disease;axonal type;Charcot-Marie-Tooth disease	15477547;15824347;20301532;22189570;25025039;28812649					not applicable	GeneReviews:NBK1358;Genetic Alliance:Charcot-Marie-Tooth+Disease/1276;Genetics Home Reference:charcot-marie-tooth-disease;MedGen:C0007959;OMIM:PS118220;Office of Rare Diseases:6034;SNOMED CT:50548001	2013-11-01	1	1	PASS	29	29	0	29	121412	121404	0.0002389	0	0	0	0	29	0	0	10406	11578	8654	6614	66732	908	16512	2426645	0,0,0	0,0,0	0,0,0	0,0,0	29,0,0	0,0,0	0,1,0	0	0	0	0	0	0	0	12	17	67288	54116	0	2164	0	29	66732	NFE
16	223509	C	G	223509	223509	+	Haplotype	375745	RCV000417222	SCV000503054	362631	HBA2	NM_000517.4:c.339C>G	NP_000508.1:p.His113Gln	NM_000517.4:c.339C>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 29, 2016	GeneReviews	GeneReviews	alpha Thalassemia	20301608;25052315;8735302					germline	GeneReviews:NBK1435;Genetic Alliance:Alpha-Thalassemia/333;MedGen:C0002312;OMIM:604131;Orphanet:846;SNOMED CT:68913001	2016-12-29	0	0																																															
16	223509	CCTCCCCGCCGAG	C	223510	223521	+	Haplotype	375745	RCV000417222	SCV000503054	362632	HBA2	NM_000517.4:c.340_351delCTCCCCGCCGAG	NP_000508.1:p.Leu114_Glu117del		-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 29, 2016	GeneReviews	GeneReviews	alpha Thalassemia	20301608;25052315;8735302					germline	GeneReviews:NBK1435;Genetic Alliance:Alpha-Thalassemia/333;MedGen:C0002312;OMIM:604131;Orphanet:846;SNOMED CT:68913001	2016-12-29	0	0																																															
16	227067	A	G	227067	227067	+	Haplotype	15762	RCV000017073	SCV000037345	30800	HBA1	NM_000558.4:c.235A>G	NP_000549.1:p.Asn79Asp	NM_000558.4:c.235A>G:missense variant	other	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN J (SINGAPORE);HEMOGLOBIN J (SINGAPORE)	5085670					germline	OMIM:141800.0075	2016-07-20	0	0																																															
16	227071	C	G	227071	227071	+	Haplotype	15762	RCV000017073	SCV000037345	38474	HBA1	NM_000558.4:c.239C>G	NP_000549.1:p.Ala80Gly	NM_000558.4:c.239C>G:missense variant	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN J (SINGAPORE);HEMOGLOBIN J (SINGAPORE)	5085670					germline	OMIM:141800.0075	2016-07-20	0	0																																															
16	1254325	G	A	1254325	1254325	+	Haplotype	2704	RCV000002823	SCV000022981	17743	CACNA1H	NM_021098.2:c.2318G>A	NP_066921.2:p.Gly773Asp	NM_021098.2:c.2318G>A:missense variant	-	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 11, 2005	OMIM	OMIM	Epilepsy, childhood absence 6;EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6	12891677;15888660					germline	Genetic Alliance:Epilepsy%2C+childhood+absence+6/8325;MedGen:C2749872;OMIM:611942;Orphanet:64280	2005-05-11	0	0	PASS	32	31	0	31	119812	96232	0.0002671	0	0	30	0	1	0	0	7188	9922	7482	5078	54046	674	11842	1051406	0	0	30	0	1	0	0	0	0	0	0	0	0	0	21	10	55276	40956	0	1354	0	30	7482	EAS
16	1254369	C	T	1254369	1254369	+	Haplotype	2704	RCV000002823	SCV000022981	38427	CACNA1H	NM_021098.2:c.2362C>T	NP_066921.2:p.Arg788Cys	NM_021098.2:c.2362C>T:missense variant	Benign	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 03, 2013	OMIM	OMIM	Epilepsy, childhood absence 6;EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6	12891677;15888660					germline	Genetic Alliance:Epilepsy%2C+childhood+absence+6/8325;MedGen:C2749872;OMIM:611942;Orphanet:64280	2005-05-11	0	0	PASS	9851	8498	525	9548	119926	107658	0.082	148	429	896	600	7226	63	186	9002	11300	8380	6528	61916	768	9764	1565098	146,0,0	401,0,0	814,1,0	542,0,0	6364,0,0	57,0,0	174,0,0	1	14	41	29	431	3	6	5267	4281	59528	48130	21	862	3	7226	61916	NFE
16	1545525	C	T	1545525	1545525	+	Haplotype	236230	RCV000225207	SCV000282071;SCV000298029	237798	TELO2	NM_016111.3:c.514C>T	NP_057195.2:p.Gln172Ter	NM_016111.3:c.514C>T:nonsense	-	pathogenic;pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided;criteria provided, single submitter	Jun 17, 2016	OMIM;Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	OMIM;Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	You-Hoover-Fong syndrome;YOU-HOOVER-FONG SYNDROME	27132593					germline	MedGen:C4310778;OMIM:616954	2016-06-17;0000-00-00	0	0																																															
16	1555603	G	A	1555603	1555603	+	Haplotype	236230	RCV000225207	SCV000282071;SCV000298029	237812	TELO2	NM_016111.3:c.2034+1G>A		NM_016111.3:c.2034+1G>A:splice donor variant	-	pathogenic;pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided;criteria provided, single submitter	Jun 17, 2016	OMIM;Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	OMIM;Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	You-Hoover-Fong syndrome;YOU-HOOVER-FONG SYNDROME	27132593					germline	MedGen:C4310778;OMIM:616954	2016-06-17;0000-00-00	0	0																																															
16	2110651	T	A	2110651	2110651	+	Haplotype	65347	RCV000055571	SCV000083795	76281	TSC2	NM_000548.4:c.976-20T>A		NM_000548.4:c.976-20T>A:intron variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Tuberous sclerosis database (TSC2)	Tuberous sclerosis database (TSC2)	Tuberous sclerosis syndrome;TSC	20301399;23519317;23788249;27854360					germline	GeneReviews:NBK1220;MedGen:C0041341;OMIM:191100;OMIM:PS191100;SNOMED CT:7199000	0000-00-00	0	0																																															
16	2131729	C	CCTGTACAAGTCA	2131730	2131741	+	Haplotype	64881	RCV000055081	SCV000083299	75810	TSC2	NM_000548.4:c.3745_3756dupCTGTACAAGTCA	NP_000539.2:p.Leu1253_Ser1254insTyrLysSerLeu	NM_000548.4:c.3745_3756dupCTGTACAAGTCA:inframe_variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Tuberous sclerosis database (TSC2)	Tuberous sclerosis database (TSC2)	Tuberous sclerosis syndrome;TSC	15798777;20301399;23519317;23788249;27854360					germline	GeneReviews:NBK1220;MedGen:C0041341;OMIM:191100;OMIM:PS191100;SNOMED CT:7199000	0000-00-00	0	0																																															
16	2134579	GCC	G	2134581	2134582	+	Haplotype	65324	RCV000055548	SCV000083772	76256	TSC2	NM_000548.4:c.4358_4359delCC	NP_000539.2:p.Pro1453Glnfs	NM_000548.4:c.4358_4359delCC:frameshift variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Tuberous sclerosis database (TSC2)	Tuberous sclerosis database (TSC2)	Tuberous sclerosis syndrome;TSC	11468687;20301399;23519317;23788249;27854360					germline	GeneReviews:NBK1220;MedGen:C0041341;OMIM:191100;OMIM:PS191100;SNOMED CT:7199000	0000-00-00	0	0																																															
16	2134583	AGTGGCCTCCGGC	A	2134584	2134595	+	Haplotype	65324	RCV000055548	SCV000083772	76257	TSC2	NM_000548.4:c.4361_4372delGTGGCCTCCGGC	NP_000539.2:p.Ser1454_Pro1458delinsThr	NM_000548.4:c.4361_4372delGTGGCCTCCGGC:inframe_variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Tuberous sclerosis database (TSC2)	Tuberous sclerosis database (TSC2)	Tuberous sclerosis syndrome;TSC	11468687;20301399;23519317;23788249;27854360					germline	GeneReviews:NBK1220;MedGen:C0041341;OMIM:191100;OMIM:PS191100;SNOMED CT:7199000	0000-00-00	0	0																																															
16	2135279	TACGACACCC	T	2135282	2135290		Haplotype	65183	RCV000055400	SCV000083621	76115		NM_000548.4:c.4621_4629delGACACCCAC	NP_000539.2:p.Asp1541_His1543del	NM_000548.4:c.4621_4629delGACACCCAC:inframe_variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Tuberous sclerosis database (TSC2)	Tuberous sclerosis database (TSC2)	Tuberous sclerosis syndrome;TSC	20301399;23519317;23788249;27854360					germline	GeneReviews:NBK1220;MedGen:C0041341;OMIM:191100;OMIM:PS191100;SNOMED CT:7199000	0000-00-00	0	0																																															
16	3293405	C	T	3293405	3293405	-	Haplotype	2555	RCV000002664	SCV000022822	17578	MEFV	NM_000243.2:c.2082G>A	NP_000234.1:p.Met694Ile	NM_000243.2:c.2082G>A:missense variant;NM_001198536.1:c.*286G>A:3 prime UTR variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 06, 2017	OMIM	OMIM	Familial mediterranean fever, autosomal dominant;FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT	10024914;10090880;10364520;10612841;10787449;10980540;11484206;11938447;12401847;12929299;12955725;15942916;16255051;17331080;18097735;19967574;20041150;20301405;20534143;9668175					germline	GeneReviews:NBK1227;Genetic Alliance:Familial+mediterranean+fever%2C+autosomal+dominant/8401;MedGen:C1851347;OMIM:134610;Orphanet:342	2000-04-01	0	0	PASS	18	18	0	18	121412	121410	0.0001483	0	7	0	0	11	0	0	10406	11576	8654	6614	66740	908	16512	2139217	0	7	0	0	11	0	0	0	0	0	0	0	0	0	8	10	67286	54124	0	2164	0	7	11576	AMR
16	3304626	C	G	3304626	3304626	-	Haplotype	2555	RCV000002664	SCV000022822	17581	MEFV	NM_000243.2:c.442G>C	NP_000234.1:p.Glu148Gln	NM_000243.2:c.442G>C:missense variant;NM_001198536.1:c.277+1685G>C:intron variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Sep 29, 2017	OMIM	OMIM	Familial mediterranean fever, autosomal dominant;FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT	10024914;10090880;10364520;10612841;10787449;10980540;11484206;11938447;12401847;12929299;12955725;15942916;16255051;17331080;18097735;19967574;20041150;20301405;20534143;9668175					germline	GeneReviews:NBK1227;Genetic Alliance:Familial+mediterranean+fever%2C+autosomal+dominant/8401;MedGen:C1851347;OMIM:134610;Orphanet:342	2000-04-01	1	1	PASS	8561	6211	1038	8287	119630	92068	0.072	124	184	2275	6	961	49	4688	6734	8460	7222	4668	48764	684	15536	1177769	122	180	1645	6	927	45	3286	1	2	315	0	17	2	701	5377	2910	54234	37834	548	2116	92	2275	7222	EAS
16	14687212	A	AT	14687213	14687213	-	Phase unknown	180663	RCV000162315	SCV000206799	178829	PARN	NM_002582.3:c.863dupA	NP_002573.1:p.Asn288Lysfs	NM_002582.3:c.863dupA:frameshift variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	May 13, 2015	Bone Marrow Failure laboratory,Queen Mary University London	Bone Marrow Failure laboratory,Queen Mary University London	Dyskeratosis congenita;Dyskeratosis congenita	20301779					germline	GeneReviews:NBK22301;Genetic Alliance:Dyskeratosis+congenita/9566;MedGen:C0265965;OMIM:PS127550;SNOMED CT:74911008	2015-02-04	0	0																																															
16	14702130	ATACT	A	14702131	14702134	-	Phase unknown	180663	RCV000162315	SCV000206799	178830	PARN	NM_002582.3:c.659+4_659+7delAGTA		NM_002582.3:c.659+4_659+7delAGTA:intron variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 12, 2015	Bone Marrow Failure laboratory,Queen Mary University London	Bone Marrow Failure laboratory,Queen Mary University London	Dyskeratosis congenita;Dyskeratosis congenita	20301779					germline	GeneReviews:NBK22301;Genetic Alliance:Dyskeratosis+congenita/9566;MedGen:C0265965;OMIM:PS127550;SNOMED CT:74911008	2015-02-04	0	0	PASS	1	1	0	1	29502	20136	3.39e-05	0	0	0	0	0	0	1	2168	410	620	34	8800	190	7914	448031	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	10858	9278	0	1460	0	1	7914	SAS
16	15812194	C	T	15812194	15812194	-	Haplotype	14131	RCV000015192	SCV000035449	29170	MYH11	NM_001040113.1:c.5294G>A	NP_001035202.1:p.Arg1765Gln	NM_001040113.1:c.5294G>A:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 03, 2016	OMIM	OMIM	Aortic aneurysm, familial thoracic 4;AORTIC ANEURYSM, FAMILIAL THORACIC 4	14722581;16444274;20301299;23788249;24882528;25173340;25356965;27854360					germline	Genetic Alliance:Aortic+Aneurysm%2C+Familial+Thoracic+4/532;Genetic Testing Registry (GTR):GTR000330980;Genetics Home Reference:familial-thoracic-aortic-aneurysm-and-dissection;MedGen:C1851504;OMIM:132900;Office of Rare Diseases:9876	2006-03-01	0	1	PASS	25	25	0	25	121410	116672	0.0002059	2	0	0	0	23	0	0	9922	11278	8604	5934	64220	872	15842	1628442	2	0	0	0	23	0	0	0	0	0	0	0	0	0	11	14	64824	51848	0	2156	0	23	64220	NFE
16	15815278	C	A	15815278	15815278	-	Haplotype	14131	RCV000015192	SCV000035449	75290	MYH11	NM_001040113.1:c.4599+1G>T		NM_001040113.1:c.4599+1G>T:splice donor variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 01, 2006	OMIM	OMIM	Aortic aneurysm, familial thoracic 4;AORTIC ANEURYSM, FAMILIAL THORACIC 4	14722581;16444274;20301299;23788249;24882528;25173340;25356965;27854360					germline	Genetic Alliance:Aortic+Aneurysm%2C+Familial+Thoracic+4/532;Genetic Testing Registry (GTR):GTR000330980;Genetics Home Reference:familial-thoracic-aortic-aneurysm-and-dissection;MedGen:C1851504;OMIM:132900;Office of Rare Diseases:9876	2006-03-01	0	0																																															
16	15820739	C	A	15820739	15820739	-	Haplotype	440783	RCV000015194	SCV000035451	29173	MYH11	NM_001040114.1:c.3845G>T	NP_001035203.1:p.Arg1282Leu	NM_001040113.1:c.3845G>T:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Oct 29, 2013	OMIM	OMIM	Aortic aneurysm, familial thoracic 4;AORTIC ANEURYSM, FAMILIAL THORACIC 4	17666408;20301299;23788249;24882528;25173340;25356965;27854360					germline	Genetic Alliance:Aortic+Aneurysm%2C+Familial+Thoracic+4/532;Genetic Testing Registry (GTR):GTR000330980;Genetics Home Reference:familial-thoracic-aortic-aneurysm-and-dissection;MedGen:C1851504;OMIM:132900;Office of Rare Diseases:9876	2007-10-15	1	0																																															
16	15820772	A	G	15820772	15820772	-	Haplotype	440783	RCV000015194	SCV000035451	94510	MYH11	NM_001040113.1:c.3812T>C	NP_001035202.1:p.Leu1271Pro	NM_001040113.1:c.3812T>C:missense variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Aug 28, 2015	OMIM	OMIM	Aortic aneurysm, familial thoracic 4;AORTIC ANEURYSM, FAMILIAL THORACIC 4	17666408;20301299;23788249;24882528;25173340;25356965;27854360					germline	Genetic Alliance:Aortic+Aneurysm%2C+Familial+Thoracic+4/532;Genetic Testing Registry (GTR):GTR000330980;Genetics Home Reference:familial-thoracic-aortic-aneurysm-and-dissection;MedGen:C1851504;OMIM:132900;Office of Rare Diseases:9876	2007-10-15	2	0																																															
16	30097630	C	T	30097630	30097630	-	Haplotype	188053	RCV000167863	SCV000218510	255673	TBX6	NM_004608.3:c.1227G>A	NP_004599.2:p.Pro409=	NM_004608.3:c.1227G>A:synonymous variant	Benign	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Mar 28, 2016	OMIM	OMIM	Spondylocostal dysostosis 5;SPONDYLOCOSTAL DYSOSTOSIS 5	20301771;25564734					germline	GeneReviews:NBK8828;Genetics Home Reference:spondylocostal-dysostosis;MedGen:C1852521;OMIM:122600	2015-01-22	2	0	PASS	39036	24897	6843	38584	121326	118406	0.322	663	4003	3987	2821	23007	307	3796	9822	11418	8548	6398	64898	880	16442	2471351	613,0,0	2671,0,0	2112,1,1	1567,0,0	14855,0,0	209,0,0	2870,0,0	25	666	937	627	4076	49	463	21566	17018	66480	51926	503	2158	77	3987	8548	EAS
16	30102802	T	C	30102802	30102802	-	Haplotype	188053	RCV000167863	SCV000218510	418555	TBX6	NM_004608.3:c.-48-240A>G		NM_004608.3:c.-48-240A>G:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 22, 2015	OMIM	OMIM	Spondylocostal dysostosis 5;SPONDYLOCOSTAL DYSOSTOSIS 5	20301771;25564734					germline	GeneReviews:NBK8828;Genetics Home Reference:spondylocostal-dysostosis;MedGen:C1852521;OMIM:122600	2015-01-22	0	0																																															
16	30103160	C	A	30103160	30103160	-	Haplotype	188053	RCV000167863	SCV000218510	185945	TBX6	NM_004608.3:c.-49+34G>T		NM_004608.3:c.-49+34G>T:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 22, 2015	OMIM	OMIM	Spondylocostal dysostosis 5;SPONDYLOCOSTAL DYSOSTOSIS 5	20301771;25564734					germline	GeneReviews:NBK8828;Genetics Home Reference:spondylocostal-dysostosis;MedGen:C1852521;OMIM:122600	2015-01-22	0	0																																															
16	47730319	T	C	47730319	47730319	+	Haplotype	13621	RCV000014591	SCV000034845	28660	PHKB	NM_000293.2:c.2923T>C	NP_000284.1:p.Tyr975His	NM_000293.2:c.2923T>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 1997	OMIM	OMIM	Glycogen storage disease IXb;GLYCOGEN STORAGE DISEASE IXb	21634085;9215682					germline	GeneReviews:NBK55061;Genetic Alliance:Glycogen+storage+disease+IXb/8483;MedGen:C0543514;OMIM:261750;Orphanet:79240	1997-07-01	0	0	PASS	5	5	0	5	121408	121184	4.118e-05	0	0	0	1	4	0	0	10402	11510	8642	6592	66624	908	16506	2090936	0,0,0	0,0,0	0,0,0	0,1,0	1,4,0	0,0,0	0,0,0	0	0	0	0	0	0	0	3	2	67170	54014	0	2164	0	4	66624	NFE
16	47730322	G	T	47730322	47730322	+	Haplotype	13621	RCV000014591	SCV000034845	38463	PHKB	NM_000293.2:c.2926G>T	NP_000284.1:p.Glu976Ter	NM_000293.2:c.2926G>T:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 1997	OMIM	OMIM	Glycogen storage disease IXb;GLYCOGEN STORAGE DISEASE IXb	21634085;9215682					germline	GeneReviews:NBK55061;Genetic Alliance:Glycogen+storage+disease+IXb/8483;MedGen:C0543514;OMIM:261750;Orphanet:79240	1997-07-01	0	0	PASS	5	5	0	5	121410	121200	4.118e-05	0	0	0	1	4	0	0	10402	11512	8644	6592	66632	908	16510	2091212	0	0	0	1	4	0	0	0	0	0	0	0	0	0	3	2	67180	54020	0	2164	0	4	66632	NFE
16	56902267	C	T	56902267	56902267	+	Haplotype	8596	RCV000009127	SCV000029344	23635	SLC12A3	NM_000339.2:c.488C>T	NP_000330.2:p.Thr163Met	NM_000339.2:c.488C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 26, 2006	OMIM	OMIM	Familial hypokalemia-hypomagnesemia;GITELMAN SYNDROME	17000984;21343949					germline	Genetic Alliance:Familial+hypokalemia-hypomagnesemia/8399;MedGen:C0268450;OMIM:263800;Orphanet:358;SNOMED CT:3188003	2006-09-26	0	0	PASS	2	1	0	1	121406	105806	1.647e-05	0	0	1	0	0	0	0	8934	10152	7794	5240	58588	774	14324	1484941	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	58838	46968	0	2004	0	1	7794	EAS
16	56928506	G	A	56928506	56928506	+	Haplotype	8596	RCV000009127	SCV000029344	38443	SLC12A3	NM_000339.2:c.2612G>A	NP_000330.2:p.Arg871His	NM_000339.2:c.2612G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 26, 2006	OMIM	OMIM	Familial hypokalemia-hypomagnesemia;GITELMAN SYNDROME	17000984;21343949					germline	Genetic Alliance:Familial+hypokalemia-hypomagnesemia/8399;MedGen:C0268450;OMIM:263800;Orphanet:358;SNOMED CT:3188003	2006-09-26	0	0	PASS	3	3	0	3	121412	120228	2.471e-05	1	0	1	0	0	0	1	10242	11432	8642	6440	66318	894	16260	1737030	1	0	1	0	0	0	1	0	0	0	0	0	0	0	1	2	66686	53542	0	2148	0	1	8642	EAS
16	67976470	G	A	67976470	67976470	-	Haplotype	3667	RCV000003852	SCV000024017	38429	LCAT	NM_000229.1:c.544C>T	NP_000220.1:p.Arg182Cys	NM_000229.1:c.544C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 01, 1993	OMIM	OMIM	Norum disease;LCAT DEFICIENCY	8432868					germline	Genetic Alliance:Norum+disease/5271;MedGen:C0023195;OMIM:245900;Office of Rare Diseases:4011;Orphanet:650;Orphanet:79293	1993-02-01	0	0	PASS	2	2	0	2	121410	119980	1.647e-05	0	0	0	0	2	0	0	10210	11548	8600	6612	65620	882	16508	1681526	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	67064	52916	0	2164	0	2	65620	NFE
16	67976842	C	T	67976842	67976842	-	Haplotype	3667	RCV000003852	SCV000024017	18706	LCAT	NM_000229.1:c.349G>A	NP_000220.1:p.Ala117Thr	NM_000229.1:c.349G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 01, 1993	OMIM	OMIM	Norum disease;LCAT DEFICIENCY	8432868					germline	Genetic Alliance:Norum+disease/5271;MedGen:C0023195;OMIM:245900;Office of Rare Diseases:4011;Orphanet:650;Orphanet:79293	1993-02-01	0	0	PASS	1	1	0	1	121412	120788	8.236e-06	0	0	0	0	1	0	0	10304	11542	8602	6606	66334	902	16498	1711473	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	67106	53682	0	2164	0	1	66334	NFE
16	88786582	G	A	88786582	88786582	-	Haplotype	55809	RCV000049235	SCV000077488	70465	PIEZO1	NM_001142864.3:c.6059C>T	NP_001136336.2:p.Ala2020Val	NM_001142864.3:c.6059C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 09, 2013	OMIM	OMIM	Xerocytosis;DEHYDRATED HEREDITARY STOMATOCYTOSIS	23479567;9718354					germline	Gene:10774;Genetic Alliance:Dehydrated+Hereditary+Stomatocytosis+Pseudohyperkalemia+and+Peri;Genetic Alliance:Stomatocytosis+II/6894;MedGen:C0272051;OMIM:177720;OMIM:194380;OMIM:611184.0003;OMIM:611184.0005;OMIM:611184.0008;Orphanet:3202;SNOMED CT:87994004	2013-05-09	0	0																																															
16	88793552	G	A	88793552	88793552	-	Haplotype	55809	RCV000049235	SCV000077488	70466	PIEZO1	NM_001142864.3:c.3350C>T	NP_001136336.2:p.Ser1117Leu	NM_001142864.3:c.3350C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 09, 2013	OMIM	OMIM	Xerocytosis;DEHYDRATED HEREDITARY STOMATOCYTOSIS	23479567;9718354					germline	Gene:10774;Genetic Alliance:Dehydrated+Hereditary+Stomatocytosis+Pseudohyperkalemia+and+Peri;Genetic Alliance:Stomatocytosis+II/6894;MedGen:C0272051;OMIM:177720;OMIM:194380;OMIM:611184.0003;OMIM:611184.0005;OMIM:611184.0008;Orphanet:3202;SNOMED CT:87994004	2013-05-09	0	0																																															
16	88800060	C	T	88800060	88800060	-	Haplotype	55813	RCV000049238	SCV000077491	70476	PIEZO1	NM_001142864.3:c.2423G>A	NP_001136336.2:p.Arg808Gln	NM_001142864.3:c.2423G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 09, 2013	OMIM	OMIM	Xerocytosis;DEHYDRATED HEREDITARY STOMATOCYTOSIS WITH PSEUDOHYPERKALEMIA AND PERINATAL EDEMA	11001917;23479567;9827909					germline	Gene:10774;Genetic Alliance:Dehydrated+Hereditary+Stomatocytosis+Pseudohyperkalemia+and+Peri;Genetic Alliance:Stomatocytosis+II/6894;MedGen:C0272051;OMIM:177720;OMIM:194380;OMIM:611184.0003;OMIM:611184.0005;OMIM:611184.0008;Orphanet:3202;SNOMED CT:87994004	2013-05-09	0	0	PASS	64	37	1	39	26748	15256	0.002393	1	0	0	1	29	0	8	1260	316	484	104	5530	152	7410	202532	1	0	0	1	27	0	8	0	0	0	0	1	0	0	20	19	9550	5706	1	1396	0	29	5530	NFE
16	88800139	C	T	88800139	88800139	-	Haplotype	55813	RCV000049238	SCV000077491	70475	PIEZO1	NM_001142864.3:c.2344G>A	NP_001136336.2:p.Gly782Ser	NM_001142864.3:c.2344G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 09, 2013	OMIM	OMIM	Xerocytosis;DEHYDRATED HEREDITARY STOMATOCYTOSIS WITH PSEUDOHYPERKALEMIA AND PERINATAL EDEMA	11001917;23479567;9827909					germline	Gene:10774;Genetic Alliance:Dehydrated+Hereditary+Stomatocytosis+Pseudohyperkalemia+and+Peri;Genetic Alliance:Stomatocytosis+II/6894;MedGen:C0272051;OMIM:177720;OMIM:194380;OMIM:611184.0003;OMIM:611184.0005;OMIM:611184.0008;Orphanet:3202;SNOMED CT:87994004	2013-05-09	0	0	PASS	54	35	1	37	27326	11196	0.001976	1	0	0	3	27	0	6	904	226	342	100	4164	104	5356	138009	1	0	0	3	25	0	6	0	0	0	0	1	0	0	16	21	6882	4314	0	980	0	27	4164	NFE
16	88801252	G	C	88801252	88801252	-	Haplotype	55813	RCV000049238	SCV000077491	70469	PIEZO1	NM_001142864.3:c.1848+31C>G		NM_001142864.3:c.1848+31C>G:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 09, 2013	OMIM	OMIM	Xerocytosis;DEHYDRATED HEREDITARY STOMATOCYTOSIS WITH PSEUDOHYPERKALEMIA AND PERINATAL EDEMA	11001917;23479567;9827909					germline	Gene:10774;Genetic Alliance:Dehydrated+Hereditary+Stomatocytosis+Pseudohyperkalemia+and+Peri;Genetic Alliance:Stomatocytosis+II/6894;MedGen:C0272051;OMIM:177720;OMIM:194380;OMIM:611184.0003;OMIM:611184.0005;OMIM:611184.0008;Orphanet:3202;SNOMED CT:87994004	2013-05-09	0	0																																															
17	7123838	C	T	7123838	7123838	+	Haplotype	441528	RCV000001698	SCV000021854	16670	ACADVL	NM_000018.3:c.194C>T	NP_000009.1:p.Pro65Leu	NM_000018.3:c.194C>T:missense variant;NM_001033859.2:c.139-85C>T:intron variant;NM_001270448.1:c.-35C>T:5 prime UTR variant	Benign/Likely benign	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Aug 04, 2017	OMIM	OMIM	Very long chain acyl-CoA dehydrogenase deficiency;VLCAD DEFICIENCY	10790204;20301763					germline	GeneReviews:NBK6816;Genetic Alliance:VLCAD+deficiency/7410;MedGen:C3887523;OMIM:201475;Office of Rare Diseases:5508;Orphanet:26793;SNOMED CT:237996001;SNOMED CT:237997005	2000-01-01	2	0	PASS	1273	1136	68	1272	121410	121338	0.01	1180	61	0	0	18	5	8	10394	11574	8652	6614	66688	906	16510	2639990	1046	59	0	0	18	5	8	67	1	0	0	0	0	0	456	816	67276	54062	1	2164	0	1180	10394	AFR
17	7125387	A	C	7125387	7125387	+	Haplotype	441528	RCV000001698	SCV000021854	38417	ACADVL	NM_000018.3:c.739A>C	NP_000009.1:p.Lys247Gln	NM_000018.3:c.739A>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 2000	OMIM	OMIM	Very long chain acyl-CoA dehydrogenase deficiency;VLCAD DEFICIENCY	10790204;20301763					germline	GeneReviews:NBK6816;Genetic Alliance:VLCAD+deficiency/7410;MedGen:C3887523;OMIM:201475;Office of Rare Diseases:5508;Orphanet:26793;SNOMED CT:237996001;SNOMED CT:237997005	2000-01-01	0	0																																															
17	7918017	G	C	7918017	7918017	+	Haplotype	453243;453244	RCV000009948;RCV000009950	SCV000030169;SCV000030171	24393	GUCY2D	NM_000180.3:c.2511G>C	NP_000171.1:p.Glu837Asp	NM_000180.3:c.2511G>C:missense variant	not provided	pathogenic	2	0	0	0	0	no assertion provided	no assertion criteria provided	Dec 15, 2017	OMIM	OMIM	Cone-rod dystrophy 6;CONE-ROD DYSTROPHY 6	10647719;11565546;9097965;9618177;10951519					germline	Genetic Alliance:Cone-Rod+Dystrophy+6/1771;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1866293;OMIM:601777;Office of Rare Diseases:10117;Office of Rare Diseases:10656;Orphanet:1872	2000-01-01;2017-12-15	0	0																																															
17	7918018	C	A	7918018	7918018	+	Haplotype	453243	RCV000009948	SCV000030169	38445	GUCY2D	NM_000180.3:c.2512C>A	NP_000171.1:p.Arg838Ser	NM_000180.3:c.2512C>A:missense variant	not provided	pathogenic	1	0	0	0	0	no assertion provided	no assertion criteria provided	Jan 01, 2000	OMIM	OMIM	Cone-rod dystrophy 6;CONE-ROD DYSTROPHY 6	10647719;11565546;9097965;9618177					germline	Genetic Alliance:Cone-Rod+Dystrophy+6/1771;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1866293;OMIM:601777;Office of Rare Diseases:10117;Office of Rare Diseases:10656;Orphanet:1872	2000-01-01	0	0																																															
17	7918018	C	T	7918018	7918018	+	Haplotype	453244	RCV000009950	SCV000030171	24394	GUCY2D	NM_000180.3:c.2512C>T	NP_000171.1:p.Arg838Cys	NM_000180.3:c.2512C>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Dec 15, 2017	OMIM	OMIM	Cone-rod dystrophy 6;CONE-ROD DYSTROPHY 6	10951519					germline	Genetic Alliance:Cone-Rod+Dystrophy+6/1771;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1866293;OMIM:601777;Office of Rare Diseases:10117;Office of Rare Diseases:10656;Orphanet:1872	2017-12-15	0	0																																															
17	7918022	C	T	7918022	7918022	+	Haplotype	453244	RCV000009950	SCV000030171	38391	GUCY2D	NM_000180.3:c.2516C>T	NP_000171.1:p.Thr839Met	NM_000180.3:c.2516C>T:missense variant	not provided	pathogenic	1	0	0	0	0	no assertion provided	no assertion criteria provided	Dec 15, 2017	OMIM	OMIM	Cone-rod dystrophy 6;CONE-ROD DYSTROPHY 6	10951519					germline	Genetic Alliance:Cone-Rod+Dystrophy+6/1771;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1866293;OMIM:601777;Office of Rare Diseases:10117;Office of Rare Diseases:10656;Orphanet:1872	2017-12-15	0	0	PASS	1	1	0	1	121412	121072	8.236e-06	0	0	0	0	1	0	0	10362	11556	8630	6614	66500	904	16506	2048255	0,0,0	0,0,0	0,0,0	0,0,0	3,1,0	0,0,0	0,0,0	0	0	0	0	0	0	0	0	1	67240	53832	0	2164	0	1	66500	NFE
17	17118608	G	TC	17118608	17118608	-	Haplotype	3377	RCV000003544	SCV000023702	243924	FLCN	NM_144997.5:c.1323delCinsGA	NP_659434.2:p.His442Thrfs	NM_144997.5:c.1323delCinsGA:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 01, 2009	OMIM	OMIM	Multiple fibrofolliculomas;BIRT-HOGG-DUBE SYNDROME	19320655;19562744;20301695;24319509;25394175					germline	GeneReviews:NBK1522;Genetic Alliance:Multiple+fibrofolliculomas/8920;Genetics Home Reference:birt-hogg-dube-syndrome;MedGen:C0346010;OMIM:135150;Office of Rare Diseases:2322;Orphanet:122;SNOMED CT:110985001	2009-09-01	0	0																																															
17	17118626	AAACTCTGTAAC	A	17118627	17118637	-	Haplotype	3377	RCV000003544	SCV000023702	18416	FLCN	NM_144997.5:c.1301-7_1304delGTTACAGAGTT		NM_144997.5:c.1301-7_1304delGTTACAGAGTT:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 01, 2009	OMIM	OMIM	Multiple fibrofolliculomas;BIRT-HOGG-DUBE SYNDROME	19320655;19562744;20301695;24319509;25394175					germline	GeneReviews:NBK1522;Genetic Alliance:Multiple+fibrofolliculomas/8920;Genetics Home Reference:birt-hogg-dube-syndrome;MedGen:C0346010;OMIM:135150;Office of Rare Diseases:2322;Orphanet:122;SNOMED CT:110985001	2009-09-01	0	0																																															
17	19561110	G	A	19561110	19561110	+	Haplotype	438264	RCV000504796	SCV000598618	260161	ALDH3A2	NM_000382.2:c.733G>A	NP_000373.1:p.Asp245Asn	NM_000382.2:c.733G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jun 01, 2017	Rizzo Lab,University of Nebraska Medical Center	Rizzo Lab,University of Nebraska Medical Center	Sjögren-Larsson syndrome;Ichthyosis;Spasticity;Intellectual disability;Sjogren-Larsson syndrome	10577908					germline	Genetic Alliance:Sjogren-Larsson+syndrome/6627;Genetics Home Reference:sjogren-larsson-syndrome;MedGen:C0037231;OMIM:270200;Office of Rare Diseases:7654;Orphanet:816;SNOMED CT:111303009	2017-06-01	0	0	PASS	1	1	0	1	121412	121312	8.236e-06	0	0	0	0	1	0	0	10390	11558	8650	6614	66690	908	16502	1886863	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	67240	54072	0	2162	0	1	66690	NFE
17	19564542	G	C	19564542	19564542	+	Haplotype	438264	RCV000504796	SCV000598618	431886	ALDH3A2	NM_000382.2:c.901G>C	NP_000373.1:p.Ala301Pro	NM_000382.2:c.901G>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jun 01, 2017	Rizzo Lab,University of Nebraska Medical Center	Rizzo Lab,University of Nebraska Medical Center	Sjögren-Larsson syndrome;Ichthyosis;Spasticity;Intellectual disability;Sjogren-Larsson syndrome	10577908					germline	Genetic Alliance:Sjogren-Larsson+syndrome/6627;Genetics Home Reference:sjogren-larsson-syndrome;MedGen:C0037231;OMIM:270200;Office of Rare Diseases:7654;Orphanet:816;SNOMED CT:111303009	2017-06-01	0	0																																															
17	19564543	CT	C	19564547	19564547	+	Haplotype	438264	RCV000504796	SCV000598618	431887	ALDH3A2	NM_000382.2:c.906delT	NP_000373.1:p.Phe302Leufs	NM_000382.2:c.906delT:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jun 01, 2017	Rizzo Lab,University of Nebraska Medical Center	Rizzo Lab,University of Nebraska Medical Center	Sjögren-Larsson syndrome;Ichthyosis;Spasticity;Intellectual disability;Sjogren-Larsson syndrome	10577908					germline	Genetic Alliance:Sjogren-Larsson+syndrome/6627;Genetics Home Reference:sjogren-larsson-syndrome;MedGen:C0037231;OMIM:270200;Office of Rare Diseases:7654;Orphanet:816;SNOMED CT:111303009	2017-06-01	0	0																																															
17	19564550	T	G	19564550	19564550	+	Haplotype	438264	RCV000504796	SCV000598618	431888	ALDH3A2	NM_000382.2:c.909T>G	NP_000373.1:p.Gly303=	NM_000382.2:c.909T>G:synonymous variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jun 01, 2017	Rizzo Lab,University of Nebraska Medical Center	Rizzo Lab,University of Nebraska Medical Center	Sjögren-Larsson syndrome;Ichthyosis;Spasticity;Intellectual disability;Sjogren-Larsson syndrome	10577908					germline	Genetic Alliance:Sjogren-Larsson+syndrome/6627;Genetics Home Reference:sjogren-larsson-syndrome;MedGen:C0037231;OMIM:270200;Office of Rare Diseases:7654;Orphanet:816;SNOMED CT:111303009	2017-06-01	0	0	PASS	1	1	0	1	121412	121238	8.236e-06	0	0	0	0	1	0	0	10394	11562	8654	6612	66598	908	16510	1672213	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	67268	53970	0	2164	0	1	66598	NFE
17	29577934	TA	T	29577935	29577935	+	Haplotype	217112	RCV000200907	SCV000255592	213715	NF1	NM_001042492.2:c.4110+1798del		NM_000267.3:c.4110+1798del:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Medical Genomics Laboratory,Department of Genetics UAB	Medical Genomics Laboratory,Department of Genetics UAB	Neurofibromatosis, type 1;Neurofibromatosis, type 1	15604628;17636453;20065170;20301288;20301471;24893135;26189818				loss of function	unknown	GeneReviews:NBK1109;Genetic Alliance:Neurofibromatosis+type+1/5174;Genetic Testing Registry (GTR):GTR000260605;Genetic Testing Registry (GTR):GTR000335545;Genetic Testing Registry (GTR):GTR000500115;Genetic Testing Registry (GTR):GTR000500672;Genetic Testing Registry (GTR):GTR000500881;Genetic Testing Registry (GTR):GTR000500970;Genetic Testing Registry (GTR):GTR000500971;Genetic Testing Registry (GTR):GTR000500972;Genetic Testing Registry (GTR):GTR000501087;Genetic Testing Registry (GTR):GTR000501088;Genetic Testing Registry (GTR):GTR000509686;Genetic Testing Registry (GTR):GTR000510677;Genetic Testing Registry (GTR):GTR000510679;Genetic Testing Registry (GTR):GTR000511186;Genetic Testing Registry (GTR):GTR000511188;Genetic Testing Registry (GTR):GTR000514608;Genetic Testing Registry (GTR):GTR000514913;Genetic Testing Registry (GTR):GTR000514981;Genetic Testing Registry (GTR):GTR000515566;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520393;Genetic Testing Registry (GTR):GTR000520410;Genetic Testing Registry (GTR):GTR000521399;Genetic Testing Registry (GTR):GTR000521505;Genetic Testing Registry (GTR):GTR000521546;Genetic Testing Registry (GTR):GTR000522322;Genetic Testing Registry (GTR):GTR000528459;Genetic Testing Registry (GTR):GTR000528529;Genetic Testing Registry (GTR):GTR000528533;Genetic Testing Registry (GTR):GTR000528913;Genetic Testing Registry (GTR):GTR000528930;Genetic Testing Registry (GTR):GTR000529017;Genetic Testing Registry (GTR):GTR000529068;Genetic Testing Registry (GTR):GTR000551630;Genetic Testing Registry (GTR):GTR000552183;Genetic Testing Registry (GTR):GTR000552305;Genetic Testing Registry (GTR):GTR000556576;MedGen:C0027831;OMIM:162200;OMIM:613113.0001;OMIM:613113.0002;OMIM:613113.0003;OMIM:613113.0004;OMIM:613113.0005;OMIM:613113.0006;OMIM:613113.0007;OMIM:613113.0008;OMIM:613113.0009;OMIM:613113.0012;OMIM:613113.0013;OMIM:613113.0014;OMIM:613113.0015;OMIM:613113.0016;OMIM:613113.0021;OMIM:613113.0022;OMIM:613113.0023;OMIM:613113.0024;OMIM:613113.0025;OMIM:613113.0026;OMIM:613113.0027;OMIM:613113.0029;OMIM:613113.0030;OMIM:613113.0031;OMIM:613113.0032;OMIM:613113.0037;OMIM:613113.0038;OMIM:613113.0040;OMIM:613113.0041;OMIM:613113.0042;OMIM:613113.0043;OMIM:613113.0044;OMIM:613113.0046;Office of Rare Diseases:7866;Orphanet:636;Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia,Universidade Católica de Brasília:R34;SNOMED CT:92824003	0000-00-00	0	0																																															
17	41247892	T	C	41247892	41247892	-	Haplotype	236265	RCV000225499	SCV000282252	46245	BRCA1	NM_007294.3:c.641A>G	NP_009225.1:p.Asp214Gly	NM_007294.3:c.641A>G:missense variant;NR_027676.1:n.777A>G:non-coding transcript variant	Benign	benign	0	0	0	0	1	no assertion for the individual variant	reviewed by expert panel	Jul 19, 2017	Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)	Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)	Breast-ovarian cancer, familial 1	1;10;15604628;17392385;17508274;17924331;19305347;20;20065170;20301425;23188549;23788249;23918944;24366376;24366402;24432435;24493721;25356965;25394175;27008870;27854360;3;548;70				loss of function	germline	GeneReviews:NBK1247;Genetic Alliance:Breast-ovarian+cancer%2C+familial+1/7865;Genetic Testing Registry (GTR):GTR000017876;Genetic Testing Registry (GTR):GTR000021517;Genetic Testing Registry (GTR):GTR000320777;Genetic Testing Registry (GTR):GTR000325409;Genetic Testing Registry (GTR):GTR000330054;Genetic Testing Registry (GTR):GTR000501196;Genetic Testing Registry (GTR):GTR000501743;Genetic Testing Registry (GTR):GTR000501746;Genetic Testing Registry (GTR):GTR000501817;Genetic Testing Registry (GTR):GTR000505644;Genetic Testing Registry (GTR):GTR000507653;Genetic Testing Registry (GTR):GTR000507764;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507913;Genetic Testing Registry (GTR):GTR000507930;Genetic Testing Registry (GTR):GTR000509001;Genetic Testing Registry (GTR):GTR000509002;Genetic Testing Registry (GTR):GTR000509348;Genetic Testing Registry (GTR):GTR000509349;Genetic Testing Registry (GTR):GTR000509363;Genetic Testing Registry (GTR):GTR000509450;Genetic Testing Registry (GTR):GTR000509451;Genetic Testing Registry (GTR):GTR000509692;Genetic Testing Registry (GTR):GTR000509980;Genetic Testing Registry (GTR):GTR000509982;Genetic Testing Registry (GTR):GTR000509983;Genetic Testing Registry (GTR):GTR000512320;Genetic Testing Registry (GTR):GTR000512644;Genetic Testing Registry (GTR):GTR000512645;Genetic Testing Registry (GTR):GTR000512816;Genetic Testing Registry (GTR):GTR000514601;Genetic Testing Registry (GTR):GTR000519030;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520071;Genetic Testing Registry (GTR):GTR000520072;Genetic Testing Registry (GTR):GTR000520394;Genetic Testing Registry (GTR):GTR000520410;Genetic Testing Registry (GTR):GTR000520865;Genetic Testing Registry (GTR):GTR000520866;Genetic Testing Registry (GTR):GTR000520867;Genetic Testing Registry (GTR):GTR000520869;Genetic Testing Registry (GTR):GTR000520870;Genetic Testing Registry (GTR):GTR000520871;Genetic Testing Registry (GTR):GTR000520872;Genetic Testing Registry (GTR):GTR000521908;Genetic Testing Registry (GTR):GTR000522159;Genetic Testing Registry (GTR):GTR000522160;Genetic Testing Registry (GTR):GTR000522161;Genetic Testing Registry (GTR):GTR000522162;Genetic Testing Registry (GTR):GTR000522243;Genetic Testing Registry (GTR):GTR000527942;Genetic Testing Registry (GTR):GTR000528915;Genetic Testing Registry (GTR):GTR000528916;Genetic Testing Registry (GTR):GTR000530120;Genetic Testing Registry (GTR):GTR000530202;Genetic Testing Registry (GTR):GTR000531275;Genetic Testing Registry (GTR):GTR000551440;Genetic Testing Registry (GTR):GTR000552245;Genetic Testing Registry (GTR):GTR000552304;MedGen:C2676676;OMIM:113705.0001;OMIM:113705.0002;OMIM:113705.0003;OMIM:113705.0004;OMIM:113705.0005;OMIM:113705.0006;OMIM:113705.0007;OMIM:113705.0008;OMIM:113705.0009;OMIM:113705.0010;OMIM:113705.0012;OMIM:113705.0013;OMIM:113705.0014;OMIM:113705.0015;OMIM:113705.0016;OMIM:113705.0017;OMIM:113705.0018;OMIM:113705.0019;OMIM:113705.0020;OMIM:113705.0021;OMIM:113705.0023;OMIM:113705.0024;OMIM:113705.0025;OMIM:113705.0026;OMIM:113705.0027;OMIM:113705.0028;OMIM:113705.0029;OMIM:113705.0030;OMIM:113705.0031;OMIM:113705.0032;OMIM:113705.0033;OMIM:113705.0034;OMIM:113705.0035;OMIM:113705.0036;OMIM:113705.0037;OMIM:602667.0001;OMIM:604370;Orphanet:145	2016-04-15	0	0	PASS	2	2	0	2	121408	115540	1.647e-05	0	0	0	0	2	0	0	9832	10936	8434	6330	63548	870	15590	1810047	0	0	0	0	2	0	0	0	0	0	0	0	0	0	0	2	64020	51520	0	2108	0	2	63548	NFE
17	41247941	T	G	41247941	41247941	-	Haplotype	236265	RCV000225499	SCV000282252	46242	BRCA1	NM_007294.3:c.594-2A>C		NM_007294.3:c.594-2A>C:splice acceptor variant	Benign	benign	0	0	0	0	1	reviewed by expert panel	reviewed by expert panel	Jul 19, 2017	Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)	Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)	Breast-ovarian cancer, familial 1	1;10;15604628;17392385;17508274;17924331;19305347;20;20065170;20301425;23188549;23788249;23918944;24366376;24366402;24432435;24493721;25356965;25394175;27008870;27854360;3;548;70				loss of function	germline	GeneReviews:NBK1247;Genetic Alliance:Breast-ovarian+cancer%2C+familial+1/7865;Genetic Testing Registry (GTR):GTR000017876;Genetic Testing Registry (GTR):GTR000021517;Genetic Testing Registry (GTR):GTR000320777;Genetic Testing Registry (GTR):GTR000325409;Genetic Testing Registry (GTR):GTR000330054;Genetic Testing Registry (GTR):GTR000501196;Genetic Testing Registry (GTR):GTR000501743;Genetic Testing Registry (GTR):GTR000501746;Genetic Testing Registry (GTR):GTR000501817;Genetic Testing Registry (GTR):GTR000505644;Genetic Testing Registry (GTR):GTR000507653;Genetic Testing Registry (GTR):GTR000507764;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507913;Genetic Testing Registry (GTR):GTR000507930;Genetic Testing Registry (GTR):GTR000509001;Genetic Testing Registry (GTR):GTR000509002;Genetic Testing Registry (GTR):GTR000509348;Genetic Testing Registry (GTR):GTR000509349;Genetic Testing Registry (GTR):GTR000509363;Genetic Testing Registry (GTR):GTR000509450;Genetic Testing Registry (GTR):GTR000509451;Genetic Testing Registry (GTR):GTR000509692;Genetic Testing Registry (GTR):GTR000509980;Genetic Testing Registry (GTR):GTR000509982;Genetic Testing Registry (GTR):GTR000509983;Genetic Testing Registry (GTR):GTR000512320;Genetic Testing Registry (GTR):GTR000512644;Genetic Testing Registry (GTR):GTR000512645;Genetic Testing Registry (GTR):GTR000512816;Genetic Testing Registry (GTR):GTR000514601;Genetic Testing Registry (GTR):GTR000519030;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520071;Genetic Testing Registry (GTR):GTR000520072;Genetic Testing Registry (GTR):GTR000520394;Genetic Testing Registry (GTR):GTR000520410;Genetic Testing Registry (GTR):GTR000520865;Genetic Testing Registry (GTR):GTR000520866;Genetic Testing Registry (GTR):GTR000520867;Genetic Testing Registry (GTR):GTR000520869;Genetic Testing Registry (GTR):GTR000520870;Genetic Testing Registry (GTR):GTR000520871;Genetic Testing Registry (GTR):GTR000520872;Genetic Testing Registry (GTR):GTR000521908;Genetic Testing Registry (GTR):GTR000522159;Genetic Testing Registry (GTR):GTR000522160;Genetic Testing Registry (GTR):GTR000522161;Genetic Testing Registry (GTR):GTR000522162;Genetic Testing Registry (GTR):GTR000522243;Genetic Testing Registry (GTR):GTR000527942;Genetic Testing Registry (GTR):GTR000528915;Genetic Testing Registry (GTR):GTR000528916;Genetic Testing Registry (GTR):GTR000530120;Genetic Testing Registry (GTR):GTR000530202;Genetic Testing Registry (GTR):GTR000531275;Genetic Testing Registry (GTR):GTR000551440;Genetic Testing Registry (GTR):GTR000552245;Genetic Testing Registry (GTR):GTR000552304;MedGen:C2676676;OMIM:113705.0001;OMIM:113705.0002;OMIM:113705.0003;OMIM:113705.0004;OMIM:113705.0005;OMIM:113705.0006;OMIM:113705.0007;OMIM:113705.0008;OMIM:113705.0009;OMIM:113705.0010;OMIM:113705.0012;OMIM:113705.0013;OMIM:113705.0014;OMIM:113705.0015;OMIM:113705.0016;OMIM:113705.0017;OMIM:113705.0018;OMIM:113705.0019;OMIM:113705.0020;OMIM:113705.0021;OMIM:113705.0023;OMIM:113705.0024;OMIM:113705.0025;OMIM:113705.0026;OMIM:113705.0027;OMIM:113705.0028;OMIM:113705.0029;OMIM:113705.0030;OMIM:113705.0031;OMIM:113705.0032;OMIM:113705.0033;OMIM:113705.0034;OMIM:113705.0035;OMIM:113705.0036;OMIM:113705.0037;OMIM:602667.0001;OMIM:604370;Orphanet:145	2016-04-15	3	0	PASS	2	2	0	2	121404	109096	1.647e-05	0	0	0	0	2	0	0	9588	10094	7982	6154	59486	834	14958	1683551	0,0,0	0,0,0	0,0,0	0,0,0	1,2,0	0,0,0	0,0,0	0	0	0	0	0	0	0	0	2	60388	48708	0	2052	0	2	59486	NFE
17	41276111	C	T	41276111	41276111	-	Haplotype	487432	RCV000576499	SCV000677891	424868	BRCA1	NM_007294.3:c.3G>A	NP_009225.1:p.Met1Ile	NM_007294.3:c.3G>A:missense variant	Conflicting interpretations of pathogenicity	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Apr 05, 2017	Counsyl	Counsyl	Breast-ovarian cancer, familial 1	15604628;16267036;16941470;17392385;17508274;19305347;20065170;20301425;23188549;23788249;23918944;24366376;24366402;24432435;24493721;25356965;25394175;27854360				loss of function	unknown	GeneReviews:NBK1247;Genetic Alliance:Breast-ovarian+cancer%2C+familial+1/7865;Genetic Testing Registry (GTR):GTR000017876;Genetic Testing Registry (GTR):GTR000021517;Genetic Testing Registry (GTR):GTR000320777;Genetic Testing Registry (GTR):GTR000325409;Genetic Testing Registry (GTR):GTR000330054;Genetic Testing Registry (GTR):GTR000501196;Genetic Testing Registry (GTR):GTR000501743;Genetic Testing Registry (GTR):GTR000501746;Genetic Testing Registry (GTR):GTR000501817;Genetic Testing Registry (GTR):GTR000505644;Genetic Testing Registry (GTR):GTR000507653;Genetic Testing Registry (GTR):GTR000507764;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507913;Genetic Testing Registry (GTR):GTR000507930;Genetic Testing Registry (GTR):GTR000509001;Genetic Testing Registry (GTR):GTR000509002;Genetic Testing Registry (GTR):GTR000509348;Genetic Testing Registry (GTR):GTR000509349;Genetic Testing Registry (GTR):GTR000509363;Genetic Testing Registry (GTR):GTR000509450;Genetic Testing Registry (GTR):GTR000509451;Genetic Testing Registry (GTR):GTR000509692;Genetic Testing Registry (GTR):GTR000509980;Genetic Testing Registry (GTR):GTR000509982;Genetic Testing Registry (GTR):GTR000509983;Genetic Testing Registry (GTR):GTR000512320;Genetic Testing Registry (GTR):GTR000512644;Genetic Testing Registry (GTR):GTR000512645;Genetic Testing Registry (GTR):GTR000512816;Genetic Testing Registry (GTR):GTR000514601;Genetic Testing Registry (GTR):GTR000519030;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520071;Genetic Testing Registry (GTR):GTR000520072;Genetic Testing Registry (GTR):GTR000520394;Genetic Testing Registry (GTR):GTR000520410;Genetic Testing Registry (GTR):GTR000520865;Genetic Testing Registry (GTR):GTR000520866;Genetic Testing Registry (GTR):GTR000520867;Genetic Testing Registry (GTR):GTR000520869;Genetic Testing Registry (GTR):GTR000520870;Genetic Testing Registry (GTR):GTR000520871;Genetic Testing Registry (GTR):GTR000520872;Genetic Testing Registry (GTR):GTR000521908;Genetic Testing Registry (GTR):GTR000522159;Genetic Testing Registry (GTR):GTR000522160;Genetic Testing Registry (GTR):GTR000522161;Genetic Testing Registry (GTR):GTR000522162;Genetic Testing Registry (GTR):GTR000522243;Genetic Testing Registry (GTR):GTR000527942;Genetic Testing Registry (GTR):GTR000528915;Genetic Testing Registry (GTR):GTR000528916;Genetic Testing Registry (GTR):GTR000530120;Genetic Testing Registry (GTR):GTR000530202;Genetic Testing Registry (GTR):GTR000531275;Genetic Testing Registry (GTR):GTR000551440;Genetic Testing Registry (GTR):GTR000552245;Genetic Testing Registry (GTR):GTR000552304;MedGen:C2676676;OMIM:113705.0001;OMIM:113705.0002;OMIM:113705.0003;OMIM:113705.0004;OMIM:113705.0005;OMIM:113705.0006;OMIM:113705.0007;OMIM:113705.0008;OMIM:113705.0009;OMIM:113705.0010;OMIM:113705.0012;OMIM:113705.0013;OMIM:113705.0014;OMIM:113705.0015;OMIM:113705.0016;OMIM:113705.0017;OMIM:113705.0018;OMIM:113705.0019;OMIM:113705.0020;OMIM:113705.0021;OMIM:113705.0023;OMIM:113705.0024;OMIM:113705.0025;OMIM:113705.0026;OMIM:113705.0027;OMIM:113705.0028;OMIM:113705.0029;OMIM:113705.0030;OMIM:113705.0031;OMIM:113705.0032;OMIM:113705.0033;OMIM:113705.0034;OMIM:113705.0035;OMIM:113705.0036;OMIM:113705.0037;OMIM:602667.0001;OMIM:604370;Orphanet:145	2017-04-05	0	1																																															
17	41276114	T	C	41276114	41276114	-	Haplotype	487432	RCV000576499	SCV000677891	480485	BRCA1	NM_007294.3:c.-1A>G			-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Apr 05, 2017	Counsyl	Counsyl	Breast-ovarian cancer, familial 1	15604628;16267036;16941470;17392385;17508274;19305347;20065170;20301425;23188549;23788249;23918944;24366376;24366402;24432435;24493721;25356965;25394175;27854360				loss of function	unknown	GeneReviews:NBK1247;Genetic Alliance:Breast-ovarian+cancer%2C+familial+1/7865;Genetic Testing Registry (GTR):GTR000017876;Genetic Testing Registry (GTR):GTR000021517;Genetic Testing Registry (GTR):GTR000320777;Genetic Testing Registry (GTR):GTR000325409;Genetic Testing Registry (GTR):GTR000330054;Genetic Testing Registry (GTR):GTR000501196;Genetic Testing Registry (GTR):GTR000501743;Genetic Testing Registry (GTR):GTR000501746;Genetic Testing Registry (GTR):GTR000501817;Genetic Testing Registry (GTR):GTR000505644;Genetic Testing Registry (GTR):GTR000507653;Genetic Testing Registry (GTR):GTR000507764;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507913;Genetic Testing Registry (GTR):GTR000507930;Genetic Testing Registry (GTR):GTR000509001;Genetic Testing Registry (GTR):GTR000509002;Genetic Testing Registry (GTR):GTR000509348;Genetic Testing Registry (GTR):GTR000509349;Genetic Testing Registry (GTR):GTR000509363;Genetic Testing Registry (GTR):GTR000509450;Genetic Testing Registry (GTR):GTR000509451;Genetic Testing Registry (GTR):GTR000509692;Genetic Testing Registry (GTR):GTR000509980;Genetic Testing Registry (GTR):GTR000509982;Genetic Testing Registry (GTR):GTR000509983;Genetic Testing Registry (GTR):GTR000512320;Genetic Testing Registry (GTR):GTR000512644;Genetic Testing Registry (GTR):GTR000512645;Genetic Testing Registry (GTR):GTR000512816;Genetic Testing Registry (GTR):GTR000514601;Genetic Testing Registry (GTR):GTR000519030;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520071;Genetic Testing Registry (GTR):GTR000520072;Genetic Testing Registry (GTR):GTR000520394;Genetic Testing Registry (GTR):GTR000520410;Genetic Testing Registry (GTR):GTR000520865;Genetic Testing Registry (GTR):GTR000520866;Genetic Testing Registry (GTR):GTR000520867;Genetic Testing Registry (GTR):GTR000520869;Genetic Testing Registry (GTR):GTR000520870;Genetic Testing Registry (GTR):GTR000520871;Genetic Testing Registry (GTR):GTR000520872;Genetic Testing Registry (GTR):GTR000521908;Genetic Testing Registry (GTR):GTR000522159;Genetic Testing Registry (GTR):GTR000522160;Genetic Testing Registry (GTR):GTR000522161;Genetic Testing Registry (GTR):GTR000522162;Genetic Testing Registry (GTR):GTR000522243;Genetic Testing Registry (GTR):GTR000527942;Genetic Testing Registry (GTR):GTR000528915;Genetic Testing Registry (GTR):GTR000528916;Genetic Testing Registry (GTR):GTR000530120;Genetic Testing Registry (GTR):GTR000530202;Genetic Testing Registry (GTR):GTR000531275;Genetic Testing Registry (GTR):GTR000551440;Genetic Testing Registry (GTR):GTR000552245;Genetic Testing Registry (GTR):GTR000552304;MedGen:C2676676;OMIM:113705.0001;OMIM:113705.0002;OMIM:113705.0003;OMIM:113705.0004;OMIM:113705.0005;OMIM:113705.0006;OMIM:113705.0007;OMIM:113705.0008;OMIM:113705.0009;OMIM:113705.0010;OMIM:113705.0012;OMIM:113705.0013;OMIM:113705.0014;OMIM:113705.0015;OMIM:113705.0016;OMIM:113705.0017;OMIM:113705.0018;OMIM:113705.0019;OMIM:113705.0020;OMIM:113705.0021;OMIM:113705.0023;OMIM:113705.0024;OMIM:113705.0025;OMIM:113705.0026;OMIM:113705.0027;OMIM:113705.0028;OMIM:113705.0029;OMIM:113705.0030;OMIM:113705.0031;OMIM:113705.0032;OMIM:113705.0033;OMIM:113705.0034;OMIM:113705.0035;OMIM:113705.0036;OMIM:113705.0037;OMIM:602667.0001;OMIM:604370;Orphanet:145	2017-04-05	0	0																																															
17	42988737	C	T	42988737	42988737	-	Haplotype	190352	RCV000192152	SCV000223016	77412	GFAP	NM_002055.4:c.994G>A	NP_002046.1:p.Glu332Lys	NM_002055.4:c.994G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Jan 08, 2015	GeneReviews	GeneReviews	Alexander's disease;Alexander's disease	18004641;20301351;21533827					germline	GeneReviews:NBK1172;Genetic Alliance:Alexander+Disease/302;MedGen:C0270726;OMIM:203450;Orphanet:58;SNOMED CT:81854007	2015-01-08	0	0																																															
17	42988743	G	C	42988743	42988743	-	Haplotype	190352	RCV000192152	SCV000223016	77410	GFAP	NM_002055.4:c.988C>G	NP_002046.1:p.Arg330Gly	NM_002055.4:c.988C>G:missense variant	not provided	pathogenic	1	0	0	0	0	no assertion provided	no assertion criteria provided	Jan 08, 2015	GeneReviews	GeneReviews	Alexander's disease;Alexander's disease	18004641;20301351;21533827					germline	GeneReviews:NBK1172;Genetic Alliance:Alexander+Disease/302;MedGen:C0270726;OMIM:203450;Orphanet:58;SNOMED CT:81854007	2015-01-08	0	0																																															
17	42990750	C	G	42990750	42990750	-	Haplotype	190336	RCV000192110	SCV000222969	77391	GFAP	NM_002055.4:c.667G>C	NP_002046.1:p.Glu223Gln	NM_002055.4:c.667G>C:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Jan 08, 2015	GeneReviews	GeneReviews	Alexander's disease;Alexander's disease	14707518;15060693;19444543;20301351;21533827					germline	GeneReviews:NBK1172;Genetic Alliance:Alexander+Disease/302;MedGen:C0270726;OMIM:203450;Orphanet:58;SNOMED CT:81854007	2015-01-08	0	0	PASS	43	43	0	43	121412	121174	0.0003542	0	5	0	0	28	0	10	10380	11566	8648	6556	66622	900	16502	2013105	0	5	0	0	28	0	10	0	0	0	0	0	0	0	24	19	67226	53948	1	2164	0	10	16502	SAS
17	42992619	C	T	42992619	42992619	-	Haplotype	190336	RCV000192110	SCV000222969	31209	GFAP	NM_002055.4:c.236G>A	NP_002046.1:p.Arg79His	NM_002055.4:c.236G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Nov 08, 2016	GeneReviews	GeneReviews	Alexander's disease;Alexander's disease	14707518;15060693;19444543;20301351;21533827					germline	GeneReviews:NBK1172;Genetic Alliance:Alexander+Disease/302;MedGen:C0270726;OMIM:203450;Orphanet:58;SNOMED CT:81854007	2015-01-08	1	0																																															
17	62019163	C	T	62019163	62019163	-	Haplotype	21158	RCV000020275	SCV000040630	34011	SCN4A	NM_000334.4:c.4479G>A	NP_000325.4:p.Met1493Ile	NM_000334.4:c.4479G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 28, 2016	GeneReviews	GeneReviews	Hyperkalemic Periodic Paralysis Type 1	10930446;20298421;20301669					germline	GeneReviews:NBK1496;GeneTests:2133;Genetic Alliance:Hyperkalemic+Periodic+Paralysis+Type+1/8591;MedGen:CN074266;OMIM:170500;Orphanet:682	2016-01-28	0	0																																															
17	62019174	A	G	62019174	62019174	-	Haplotype	21158	RCV000020275	SCV000040630	34010	SCN4A	NM_000334.4:c.4468T>C	NP_000325.4:p.Phe1490Leu	NM_000334.4:c.4468T>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 28, 2016	GeneReviews	GeneReviews	Hyperkalemic Periodic Paralysis Type 1	10930446;20298421;20301669					germline	GeneReviews:NBK1496;GeneTests:2133;Genetic Alliance:Hyperkalemic+Periodic+Paralysis+Type+1/8591;MedGen:CN074266;OMIM:170500;Orphanet:682	2016-01-28	0	0																																															
17	73513145	T	C	73513145	73513145	+	Haplotype	2121	RCV000002203	SCV000022361	38422	TSEN54	NM_207346.2:c.277T>C	NP_997229.2:p.Ser93Pro	NM_207346.2:c.277T>C:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Sep 08, 2009	OMIM	OMIM	Pontocerebellar hypoplasia type 4;PONTOCEREBELLAR HYPOPLASIA, TYPE 4	18711368;20301773					germline	GeneReviews:NBK9673;Genetic Alliance:Pontocerebellar+hypoplasia+type+4/5866;MedGen:C1856974;OMIM:225753;Office of Rare Diseases:343;Orphanet:166063	2008-09-01	0	0																																															
17	73518081	G	T	73518081	73518081	+	Haplotype	2121	RCV000002203	SCV000022361	17159	TSEN54	NM_207346.2:c.919G>T	NP_997229.2:p.Ala307Ser	NM_207346.2:c.919G>T:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Nov 01, 2017	OMIM	OMIM	Pontocerebellar hypoplasia type 4;PONTOCEREBELLAR HYPOPLASIA, TYPE 4	18711368;20301773					germline	GeneReviews:NBK9673;Genetic Alliance:Pontocerebellar+hypoplasia+type+4/5866;MedGen:C1856974;OMIM:225753;Office of Rare Diseases:343;Orphanet:166063	2008-09-01	2	0	PASS	98	75	0	75	119856	61012	0.0008176	2	0	0	3	69	1	0	4510	5454	4118	1724	33364	420	11422	745811	2	0	0	3	69	1	0	0	0	0	0	0	0	0	44	31	35964	25048	0	1826	0	69	33364	NFE
17	79684843	C	T	79684843	79684843	+	Haplotype	446176	RCV000516170	SCV000611120	439524	SLC25A10	NM_001270888.1:c.684C>T	NP_001257817.1:p.Pro228=	NM_001270888.1:c.684C>T:synonymous variant;NM_001270953.1:c.574C>T:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	-	Computational Biology Unit,University of Bari	Computational Biology Unit,University of Bari	Mitochondrial complex I deficiency;Epileptic encephalopathy;Decreased activity of mitochondrial complex I;Infantile muscular hypotonia	29211846					not applicable;paternal	Genetic Alliance:Mitochondrial+complex+I+deficiency/4823;HP:HP:0008947;HP:HP:0011923;HP:HP:0200134;MedGen:C1838979;OMIM:252010;Office of Rare Diseases:3908;Orphanet:2609	0000-00-00	0	0	PASS	146	144	1	146	121218	101782	0.001204	6	25	0	1	74	5	35	8368	9932	7378	5446	56198	764	13696	1264684	6	25	0	1	74	5	33	0	0	0	0	0	0	1	89	57	57320	44462	3	1978	0	35	13696	SAS
17	79686969	G	A	79686969	79686969	+	Haplotype	446176	RCV000516170	SCV000611120	439525	SLC25A10	NM_001270888.1:c.790-37G>A		NM_001270888.1:c.790-37G>A:intron variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	-	Computational Biology Unit,University of Bari	Computational Biology Unit,University of Bari	Mitochondrial complex I deficiency;Epileptic encephalopathy;Decreased activity of mitochondrial complex I;Infantile muscular hypotonia	29211846					not applicable;paternal	Genetic Alliance:Mitochondrial+complex+I+deficiency/4823;HP:HP:0008947;HP:HP:0011923;HP:HP:0200134;MedGen:C1838979;OMIM:252010;Office of Rare Diseases:3908;Orphanet:2609	0000-00-00	0	0	PASS	131	129	1	131	121412	120932	0.001079	3	21	0	1	66	5	35	10358	11566	8648	6614	66344	898	16504	2015130	3	21	0	1	66	5	33	0	0	0	0	0	0	1	78	53	67248	53684	3	2162	0	35	16504	SAS
18	3215156	CAC	GAG	3215156	3215158	-	Haplotype	229030	RCV000221703	SCV000272178	230906	MYOM1	NM_003803.3:c.64_66delGTGinsCTC	NP_003794.3:p.Val22Leu	NM_003803.3:c.64_66delGTGinsCTC:missense variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	criteria provided, single submitter	Jul 08, 2015	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-07-08	0	0																																															
18	3215157	A	C	3215157	3215157	-	Haplotype	229030	RCV000221703	SCV000272178	230904	MYOM1	NM_003803.3:c.65T>G	NP_003794.3:p.Val22Gly	NM_003803.3:c.65T>G:missense variant	Uncertain significance	uncertain significance	0	0	1	0	0	no assertion for the individual variant	criteria provided, single submitter	Mar 26, 2017	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-07-08	0	0	PASS	15	15	0	15	121098	114132	0.0001239	3	0	0	0	7	0	5	8998	10696	8284	6254	63468	848	15584	1585175	3,0,0,0,0,0,0,0,0,0	0,0,0,1,0,0,0,0,0,0	0,0,3,0,0,0,0,0,0,0	0,0,0,0,0,0,0,0,0,0	7,1,0,0,0,0,0,0,0,0	0,0,0,0,0,0,0,0,0,0	5,0,0,0,0,0,0,0,0,0	0	0	0	0	0	0	0	9	6	63908	50224	3	2082	0	3	8998	AFR
18	43445579	C	G	43445579	43445579	-	Haplotype	267449	RCV000496979	SCV000328418	262702	EPG5	NM_020964.2:c.6766+1G>C		NM_020964.2:c.6766+1G>C:splice donor variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0																																															
18	43459054	CA	C	43459055	43459055	-	Haplotype	267444	RCV000496982	SCV000328413	262703	EPG5	NM_020964.2:c.5792delT	NP_066015.2:p.Leu1931Trpfs	NM_020964.2:c.5792delT:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0																																															
18	43488022	C	T	43488022	43488022	-	Haplotype	267445	RCV000496976	SCV000328414	262704	EPG5	NM_020964.2:c.4230G>A	NP_066015.2:p.Trp1410Ter	NM_020964.2:c.4230G>A:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0																																															
18	43490582	AG	A	43490583	43490583	-	Haplotype	267447	RCV000496985	SCV000328416	262705	EPG5	NM_020964.2:c.4108delC	NP_066015.2:p.Leu1370Serfs	NM_020964.2:c.4108delC:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0																																															
18	43495974	C	T	43495974	43495974	-	Haplotype	267446	RCV000496981	SCV000328415	262712	EPG5	NM_020964.2:c.3582G>A	NP_066015.2:p.Lys1194=	NM_020964.2:c.3582G>A:synonymous variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0																																															
18	43497731	G	C	43497731	43497731	-	Haplotype	267445	RCV000496976	SCV000328414	262706	EPG5	NM_020964.2:c.3152C>G	NP_066015.2:p.Ser1051Ter	NM_020964.2:c.3152C>G:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0																																															
18	43502361	G	A	43502361	43502361	-	Haplotype	267449	RCV000496979	SCV000328418	262707	EPG5	NM_020964.2:c.3044C>T	NP_066015.2:p.Ala1015Val	NM_020964.2:c.3044C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0																																															
18	43505824	T	C	43505824	43505824	-	Haplotype	267448	RCV000496977	SCV000328417	262708	EPG5	NM_020964.2:c.2598A>G	NP_066015.2:p.Gln866=	NM_020964.2:c.2598A>G:synonymous variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0																																															
18	43508927	G	A	43508927	43508927	-	Haplotype	267446	RCV000496981	SCV000328415	262711	EPG5	NM_020964.2:c.2461C>T	NP_066015.2:p.Arg821Ter	NM_020964.2:c.2461C>T:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0	PASS	1	1	0	1	120818	120694	8.277e-06	0	0	0	0	1	0	0	9800	11570	8622	6612	66686	900	16504	2050026	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	67234	53460	0	2164	0	1	66686	NFE
18	43532429	TG	T	43532430	43532430	-	Haplotype	267448	RCV000496977	SCV000328417	262709	EPG5	NM_020964.2:c.1188delC	NP_066015.2:p.Tyr396Terfs	NM_020964.2:c.1188delC:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0																																															
18	43547204	A	G	43547204	43547204	-	Haplotype	267444	RCV000496982	SCV000328413	262710	EPG5	NM_020964.2:c.2T>C	NP_066015.2:p.Met1Thr	NM_020964.2:c.2T>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0																																															
18	43547205	T	C	43547205	43547205	-	Haplotype	267447	RCV000496985	SCV000328416	262713	EPG5	NM_020964.2:c.1A>G	NP_066015.2:p.Met1Val	NM_020964.2:c.1A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0																																															
18	50994293	A	G	50994293	50994293	+	Haplotype	375288	RCV000416369	SCV000485060	362059	DCC	NM_005215.3:c.3649A>G	NP_005206.2:p.Met1217Val	NM_005215.3:c.3649A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 2016	Neurogenetics Research, Murdoch Childrens Research Institute	Neurogenetics Research, Murdoch Childrens Research Institute	Corpus callosum agenesis						germline	Genetic Alliance:Agenesis+of+the+Corpus+Callosum/263;MedGen:C0175754;OMIM:217990;Office of Rare Diseases:1535;Orphanet:200	2016-01-01	0	0																																															
18	51013178	G	A	51013178	51013178	+	Haplotype	375288	RCV000416369	SCV000485060	362060	DCC	NM_005215.3:c.3748G>A	NP_005206.2:p.Ala1250Thr	NM_005215.3:c.3748G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 2016	Neurogenetics Research, Murdoch Childrens Research Institute	Neurogenetics Research, Murdoch Childrens Research Institute	Corpus callosum agenesis						germline	Genetic Alliance:Agenesis+of+the+Corpus+Callosum/263;MedGen:C0175754;OMIM:217990;Office of Rare Diseases:1535;Orphanet:200	2016-01-01	0	0	PASS	2	2	0	2	121412	121388	1.647e-05	0	0	0	0	2	0	0	10406	11578	8644	6614	66726	908	16512	2176765	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	67280	54108	0	2164	0	2	66726	NFE
18	55217985	A	C	55217985	55217985	-	Haplotype	561	RCV000000591	SCV000020740	38381	FECH	NM_001012515.2:c.1249T>G	NP_001012533.1:p.Cys417Gly	NM_000140.3:c.1231T>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 15, 2000	OMIM	OMIM	Erythropoietic protoporphyria;PROTOPORPHYRIA, ERYTHROPOIETIC	10942404;23016163					germline	GeneReviews:NBK100826;Genetic Alliance:Erythropoietic+Protoporphyria/2648;MedGen:C0162568;OMIM:177000;Office of Rare Diseases:4527;Orphanet:79278;SNOMED CT:51022005	2000-08-15	0	0	PASS	2	2	0	2	121412	121100	1.647e-05	0	0	0	0	2	0	0	10378	11566	8614	6612	66516	904	16510	2174775	0	0	0	0	2	0	0	0	0	0	0	0	0	0	1	1	67230	53870	0	2164	0	2	66516	NFE
18	55217991	G	A	55217991	55217991	-	Haplotype	561	RCV000000591	SCV000020740	38382	FECH	NM_001012515.2:c.1243C>T	NP_001012533.1:p.Pro415Ser	NM_000140.3:c.1225C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 15, 2000	OMIM	OMIM	Erythropoietic protoporphyria;PROTOPORPHYRIA, ERYTHROPOIETIC	10942404;23016163					germline	GeneReviews:NBK100826;Genetic Alliance:Erythropoietic+Protoporphyria/2648;MedGen:C0162568;OMIM:177000;Office of Rare Diseases:4527;Orphanet:79278;SNOMED CT:51022005	2000-08-15	0	0																																															
18	55217992	A	T	55217992	55217992	-	Haplotype	561	RCV000000591	SCV000020740	15600	FECH	NM_001012515.2:c.1242T>A	NP_001012533.1:p.Asn414Lys	NM_000140.3:c.1224T>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 15, 2000	OMIM	OMIM	Erythropoietic protoporphyria;PROTOPORPHYRIA, ERYTHROPOIETIC	10942404;23016163					germline	GeneReviews:NBK100826;Genetic Alliance:Erythropoietic+Protoporphyria/2648;MedGen:C0162568;OMIM:177000;Office of Rare Diseases:4527;Orphanet:79278;SNOMED CT:51022005	2000-08-15	0	0																																															
19	853329	G	T	853329	853329	+	Haplotype	16747	RCV000018231	SCV000038510	31786	ELANE	NM_001972.3:c.292G>T	NP_001963.1:p.Val98Leu	NM_001972.3:c.292G>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 01, 2007	OMIM	OMIM	Severe congenital neutropenia autosomal dominant;NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT	17436313;20301705					germline	GeneReviews:NBK1533;Genetic Alliance:Severe+congenital+neutropenia+autosomal+dominant/6527;MedGen:C1859966;OMIM:130130.0006;OMIM:130130.0007;OMIM:130130.0008;OMIM:130130.0009;OMIM:130130.0010;OMIM:130130.0011;OMIM:202700;Office of Rare Diseases:9558;Orphanet:486	2007-09-01	0	0																																															
19	853338	G	T	853338	853338	+	Haplotype	16747	RCV000018231	SCV000038510	38480	ELANE	NM_001972.3:c.301G>T	NP_001963.1:p.Val101Leu	NM_001972.3:c.301G>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 01, 2007	OMIM	OMIM	Severe congenital neutropenia autosomal dominant;NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT	17436313;20301705					germline	GeneReviews:NBK1533;Genetic Alliance:Severe+congenital+neutropenia+autosomal+dominant/6527;MedGen:C1859966;OMIM:130130.0006;OMIM:130130.0007;OMIM:130130.0008;OMIM:130130.0009;OMIM:130130.0010;OMIM:130130.0011;OMIM:202700;Office of Rare Diseases:9558;Orphanet:486	2007-09-01	0	0																																															
19	863114	T	G	863114	863114	+	Haplotype	16565	RCV000018033	SCV000038312	31604	CFD	NM_001928.3:c.638T>G	NP_001919.2:p.Val213Gly	NM_001928.3:c.638T>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 15, 2006	OMIM	OMIM	Complement factor d deficiency;COMPLEMENT FACTOR D DEFICIENCY	16527897					germline	Genetic Alliance:Complement+factor+d+deficiency/8033;MedGen:C1851396;OMIM:613912	2006-06-15	0	0																																															
19	863116	T	C	863116	863116	+	Haplotype	16565	RCV000018033	SCV000038312	38479	CFD	NM_001928.3:c.640T>C	NP_001919.2:p.Cys214Arg	NM_001928.3:c.640T>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 15, 2006	OMIM	OMIM	Complement factor d deficiency;COMPLEMENT FACTOR D DEFICIENCY	16527897					germline	Genetic Alliance:Complement+factor+d+deficiency/8033;MedGen:C1851396;OMIM:613912	2006-06-15	0	0																																															
19	5844343	C	T	5844343	5844343	-	Haplotype	17716	RCV000019289	SCV000039578	38486	FUT3	NM_000149.3:c.508G>A	NP_000140.1:p.Gly170Ser	NM_000149.3:c.508G>A:missense variant	-	association	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 18, 2015	OMIM	OMIM	Le(-) PHENOTYPE;Le(-) PHENOTYPE	8219240					germline	OMIM:111100.0001	2015-05-18	0	0	PASS	9889	7929	905	9739	121306	117892	0.082	2482	2885	1535	396	1491	57	893	9484	11480	8582	6526	64432	882	16506	1962068	1850	2139	1235	372	1463	53	817	316	373	150	12	14	2	38	4537	5202	66006	51886	107	2164	11	2482	9484	AFR
19	5844792	A	C	5844792	5844792	-	Haplotype	17716	RCV000019289	SCV000039578	32755	FUT3	NM_000149.3:c.59T>G	NP_000140.1:p.Leu20Arg	NM_000149.3:c.59T>G:missense variant	-	association	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 18, 2015	OMIM	OMIM	Le(-) PHENOTYPE;Le(-) PHENOTYPE	8219240					germline	OMIM:111100.0001	2015-05-18	0	0	PASS	21065	16356	2262	20881	121404	119156	0.174	3009	3400	2611	911	6792	154	4004	10088	11396	8538	6538	65286	876	16434	2272545	2110,0,1	2436,0,0	1801,0,0	771,0,0	6170,0,0	122,0,0	2946,0,0	449	482	405	70	311	16	529	11263	9618	66580	52576	480	2158	75	2611	8538	EAS
19	7125392	C	T	7125392	7125392	-	Haplotype	377384	RCV000496626	SCV000503037	364259	INSR	NM_000208.3:c.3160G>A	NP_000199.2:p.Val1054Met	NM_000208.3:c.3160G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 02, 2014	Medical Research Institute,Tokyo Medical and Dental University	Medical Research Institute,Tokyo Medical and Dental University	Insulin-resistant diabetes mellitus AND acanthosis nigricans	28765322					germline	Genetic Alliance:Insulin-resistant+diabetes+mellitus+AND+acanthosis+nigricans/8675;Genetics Home Reference:type-a-insulin-resistance-syndrome;MedGen:C0271690;OMIM:610549;Orphanet:2297;SNOMED CT:9859006	2014-06-02	0	0																																															
19	7126611	A	C	7126611	7126611	-	Haplotype	377383	RCV000496343	SCV000503036	364260	INSR	NM_000208.3:c.2997T>G	NP_000199.2:p.Tyr999Ter	NM_000208.3:c.2997T>G:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 02, 2014	Medical Research Institute,Tokyo Medical and Dental University	Medical Research Institute,Tokyo Medical and Dental University	Pineal hyperplasia AND diabetes mellitus syndrome	28765322					germline	Genetic Alliance:Pineal+hyperplasia+AND+diabetes+mellitus+syndrome/9115;Genetics Home Reference:rabson-mendenhall-syndrome;MedGen:C0271695;OMIM:262190;Orphanet:769;SNOMED CT:33559001	2014-06-02	0	0																																															
19	7142844	G	A	7142844	7142844	-	Haplotype	377382	RCV000496805	SCV000503035	364261	INSR	NM_000208.3:c.2525C>T	NP_000199.2:p.Ala842Val	NM_000208.3:c.2525C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 02, 2014	Medical Research Institute,Tokyo Medical and Dental University	Medical Research Institute,Tokyo Medical and Dental University	Pineal hyperplasia AND diabetes mellitus syndrome	28765322					germline	Genetic Alliance:Pineal+hyperplasia+AND+diabetes+mellitus+syndrome/9115;Genetics Home Reference:rabson-mendenhall-syndrome;MedGen:C0271695;OMIM:262190;Orphanet:769;SNOMED CT:33559001	2014-06-02	0	0																																															
19	7142865	C	A	7142865	7142865	-	Haplotype	377382	RCV000496805	SCV000503035	364262	INSR	NM_000208.3:c.2504G>T	NP_000199.2:p.Ser835Ile	NM_000208.3:c.2504G>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 02, 2014	Medical Research Institute,Tokyo Medical and Dental University	Medical Research Institute,Tokyo Medical and Dental University	Pineal hyperplasia AND diabetes mellitus syndrome	28765322					germline	Genetic Alliance:Pineal+hyperplasia+AND+diabetes+mellitus+syndrome/9115;Genetics Home Reference:rabson-mendenhall-syndrome;MedGen:C0271695;OMIM:262190;Orphanet:769;SNOMED CT:33559001	2014-06-02	0	0																																															
19	7163103	C	A	7163103	7163103	-	Haplotype	377381	RCV000496605	SCV000503034	364263	INSR	NM_000208.3:c.1969G>T	NP_000199.2:p.Val657Phe	NM_000208.3:c.1969G>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 02, 2014	Medical Research Institute,Tokyo Medical and Dental University	Medical Research Institute,Tokyo Medical and Dental University	Leprechaunism syndrome	28765322					germline	Genetic Alliance:Leprechaunism+syndrome/8731;Genetics Home Reference:donohue-syndrome;MedGen:C0265344;OMIM:246200;Orphanet:508;SNOMED CT:111307005	2014-06-02	0	0																																															
19	7170566	T	C	7170566	7170566	-	Haplotype	377384	RCV000496626	SCV000503037	364264	INSR	NM_000208.3:c.1465A>G	NP_000199.2:p.Asn489Asp	NM_000208.3:c.1465A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 02, 2014	Medical Research Institute,Tokyo Medical and Dental University	Medical Research Institute,Tokyo Medical and Dental University	Insulin-resistant diabetes mellitus AND acanthosis nigricans	28765322					germline	Genetic Alliance:Insulin-resistant+diabetes+mellitus+AND+acanthosis+nigricans/8675;Genetics Home Reference:type-a-insulin-resistance-syndrome;MedGen:C0271690;OMIM:610549;Orphanet:2297;SNOMED CT:9859006	2014-06-02	0	0																																															
19	7184535	G	A	7184535	7184535	-	Haplotype	377383	RCV000496343	SCV000503036	364265	INSR	NM_000208.3:c.766C>T	NP_000199.2:p.Arg256Cys	NM_000208.3:c.766C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 02, 2014	Medical Research Institute,Tokyo Medical and Dental University	Medical Research Institute,Tokyo Medical and Dental University	Pineal hyperplasia AND diabetes mellitus syndrome	28765322					germline	Genetic Alliance:Pineal+hyperplasia+AND+diabetes+mellitus+syndrome/9115;Genetics Home Reference:rabson-mendenhall-syndrome;MedGen:C0271695;OMIM:262190;Orphanet:769;SNOMED CT:33559001	2014-06-02	0	0	PASS	2	2	0	2	121412	119178	1.647e-05	0	0	0	0	2	0	0	9994	11482	8596	6490	65232	890	16494	1632521	0	0	0	0	2	0	0	0	0	0	0	0	0	0	2	0	66730	52448	0	2162	0	2	65232	NFE
19	10491186	C	T	10491186	10491186	-	Haplotype	440728	RCV000508928	SCV000606721	434354	TYK2	NM_003331.4:c.-316G>A			Uncertain significance	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Division of Host Defense,Kyushu University	Division of Host Defense,Kyushu University	Virus-induced diabetes;Virus-induced diabetes	26288847					inherited		0000-00-00	0	0																																															
19	10491187	C	T	10491187	10491187	-	Haplotype	440728	RCV000508928	SCV000606721	434355	TYK2	NM_003331.4:c.-317G>A			Uncertain significance	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Division of Host Defense,Kyushu University	Division of Host Defense,Kyushu University	Virus-induced diabetes;Virus-induced diabetes	26288847					inherited		0000-00-00	0	0																																															
19	10491248	T	C	10491248	10491248	-	Haplotype	440728	RCV000508928	SCV000606721	342540	TYK2	NM_003331.4:c.-378A>G		NM_003331.4:c.-378A>G:5 prime UTR variant	Uncertain significance	risk factor	0	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jun 14, 2016	Division of Host Defense,Kyushu University	Division of Host Defense,Kyushu University	Virus-induced diabetes;Virus-induced diabetes	26288847					inherited		0000-00-00	1	0																																															
19	10491352	T	G	10491352	10491352	-	Haplotype	440728	RCV000508928	SCV000606721	434356	TYK2	NM_003331.4:c.-482A>C			Uncertain significance	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Division of Host Defense,Kyushu University	Division of Host Defense,Kyushu University	Virus-induced diabetes;Virus-induced diabetes	26288847					inherited		0000-00-00	0	0																																															
19	10492177	A	T	10492177	10492177	-	Haplotype	440728	RCV000508928	SCV000606721	434357	TYK2	NM_003331.4:c.-1307T>A			Uncertain significance	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Division of Host Defense,Kyushu University	Division of Host Defense,Kyushu University	Virus-induced diabetes;Virus-induced diabetes	26288847					inherited		0000-00-00	0	0																																															
19	10492178	C	T	10492178	10492178	-	Haplotype	440728	RCV000508928	SCV000606721	434358	TYK2	NM_003331.4:c.-1308G>A			Uncertain significance	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Division of Host Defense,Kyushu University	Division of Host Defense,Kyushu University	Virus-induced diabetes;Virus-induced diabetes	26288847					inherited		0000-00-00	0	0																																															
19	11216228	T	TGTGATG	11216231	11216236	+	Haplotype	250923	RCV000238362	SCV000294356	245688	LDLR	NM_000527.4:c.649_654dupGATGGT	NP_000518.1:p.Gly218_Gly219insAspGly	NM_000527.4:c.649_654dupGATGGT:inframe_variant;NM_001195800.1:c.314-1837_314-1832dup:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Mar 25, 2016	LDLR-LOVD, British Heart Foundation	LDLR-LOVD, British Heart Foundation	Familial hypercholesterolemia	15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;27854360;7649546					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	2016-03-25	0	0																																															
19	11218079	G	A	11218079	11218079	+	Haplotype	430765	RCV000495914	SCV000583747	181238	LDLR	NM_000527.4:c.829G>A	NP_000518.1:p.Glu277Lys	NM_000527.4:c.829G>A:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	criteria provided, single submitter	Apr 24, 2017	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;25741868;27854360;28145427					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	2017-03-30	1	1	PASS	61	61	0	61	121412	121372	0.0005024	4	10	0	0	22	0	25	10404	11570	8654	6614	66712	906	16512	2939801	4	10	0	0	22	0	25	0	0	0	0	0	0	0	44	17	67282	54090	2	2164	0	25	16512	SAS
19	11218182	A	G	11218182	11218182	+	Haplotype	430769	RCV000495938	SCV000583762	245864	LDLR	NM_000527.4:c.932A>G	NP_000518.1:p.Lys311Arg	NM_000527.4:c.932A>G:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	criteria provided, single submitter	Mar 30, 2017	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;25741868;27854360					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	2017-03-30	1	1																																															
19	11218189	C	G	11218189	11218189	+	Haplotype	430769	RCV000495938	SCV000583762	245873	LDLR	NM_000527.4:c.939C>G	NP_000518.1:p.Cys313Trp	NM_000527.4:c.939C>G:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Mar 30, 2017	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;25741868;27854360					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	2017-03-30	0	0	PASS	1	1	0	1	121412	121132	8.236e-06	1	0	0	0	0	0	0	10332	11544	8644	6600	66602	908	16502	2932149	0,1,0	0,0,0	1,0,0	0,0,0	0,0,0	0,0,0	0,0,0	0	0	0	0	0	0	0	0	1	67248	53884	0	2162	0	1	10332	AFR
19	11224035	T	C	11224035	11224035	+	Haplotype	430765	RCV000495914	SCV000583747	246074	LDLR	NM_000527.4:c.1268T>C	NP_000518.1:p.Ile423Thr	NM_000527.4:c.1268T>C:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Mar 30, 2017	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;25741868;27854360;28145427					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	2017-03-30	0	0																																															
19	11226873	A	C	11226873	11226873	+	Haplotype	3737	RCV000003935	SCV000024100;SCV000583862	18776	LDLR	NM_000527.4:c.1690A>C	NP_000518.1:p.Asn564His	NM_000527.4:c.1690A>C:missense variant	Conflicting interpretations of pathogenicity	pathogenic;pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided;criteria provided, single submitter	Mar 30, 2017	OMIM;U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	OMIM;U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;FH AARHUS;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	1439789;15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;25741868;27854360;8528204;9143924					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	1997-01-01;2017-03-30	0	1																																															
19	11230901	A	C	11230901	11230901	+	Haplotype	430800	RCV000495898	SCV000583944	424334	LDLR	NM_000527.4:c.1979A>C	NP_000518.1:p.Gln660Pro	NM_000527.4:c.1979A>C:missense variant	Likely pathogenic	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Mar 30, 2017	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;25741868;27854360					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	2017-03-30	0	0																																															
19	11238731	G	A	11238731	11238731	+	Haplotype	430800	RCV000495898	SCV000583944	424344	LDLR	NM_000527.4:c.2359G>A	NP_000518.1:p.Val787Met	NM_000527.4:c.2359G>A:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Mar 30, 2017	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;25741868;27854360					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	2017-03-30	0	0																																															
19	11240191	CTCCTCGTCT	C	11240196	11240204	+	Haplotype	3737	RCV000003935	SCV000024100;SCV000583862	71434	LDLR	NM_000527.4:c.2397_2405delCGTCTTCCT	NP_000518.1:p.Val800_Leu802del	NM_000527.4:c.2397_2405delCGTCTTCCT:inframe_variant	Pathogenic/Likely pathogenic	pathogenic;pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided;criteria provided, single submitter	Mar 30, 2017	OMIM;U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	OMIM;U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;FH AARHUS;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	1439789;15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;25741868;27854360;8528204;9143924					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	1997-01-01;2017-03-30	0	0																																															
19	18705148	A	C	18705148	18705148	-	Haplotype	5706	RCV000006060	SCV000026242	34280	CRLF1	NM_004750.4:c.1121T>G	NP_004741.1:p.Leu374Arg	NM_004750.4:c.1121T>G:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 03, 2011	OMIM	OMIM	Cold-induced sweating syndrome 1;COLD-INDUCED SWEATING SYNDROME 1	12509788;21370513					germline	GeneReviews:NBK52917;Genetic Alliance:Cold-induced+sweating+syndrome+1/8000;Genetic Alliance:Crisponi+Syndrome/2012;MedGen:C1848947;OMIM:272430;Orphanet:157820	2003-02-01	0	0																																															
19	18710530	C	T	18710530	18710530	-	Haplotype	5706	RCV000006060	SCV000026242	20745	CRLF1	NM_004750.4:c.242G>A	NP_004741.1:p.Arg81His	NM_004750.4:c.242G>A:missense variant	Benign	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Mar 03, 2011	OMIM	OMIM	Cold-induced sweating syndrome 1;COLD-INDUCED SWEATING SYNDROME 1	12509788;21370513					germline	GeneReviews:NBK52917;Genetic Alliance:Cold-induced+sweating+syndrome+1/8000;Genetic Alliance:Crisponi+Syndrome/2012;MedGen:C1848947;OMIM:272430;Orphanet:157820	2003-02-01	0	0	PASS	5	5	0	5	121130	91230	4.128e-05	4	0	0	0	1	0	0	7514	8318	6848	3790	50312	624	13824	1006358	4	0	0	0	1	0	0	0	0	0	0	0	0	0	4	1	51636	39594	0	1868	0	4	7514	AFR
19	36333331	T	A	36333331	36333331	-	Haplotype	6872	RCV000007275	SCV000027471	38439	NPHS1	NM_004646.3:c.2456A>T	NP_004637.1:p.Asp819Val	NM_004646.3:c.2456A>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 01, 2000	OMIM	OMIM	Finnish congenital nephrotic syndrome;NEPHROTIC SYNDROME, TYPE 1	10652016					germline	Genetic Alliance:Congenital+Nephrotic+Syndrome+Finnish+Type/1861;MedGen:C0403399;OMIM:256300;OMIM:602716.0001;OMIM:602716.0002;OMIM:602716.0003;OMIM:602716.0004;OMIM:602716.0005;OMIM:602716.0006;OMIM:602716.0007;OMIM:602716.0008;OMIM:602716.0009;OMIM:602716.0010;Office of Rare Diseases:1500;Orphanet:839;SNOMED CT:197601003	2000-02-01	0	0																																															
19	36339044	C	T	36339044	36339044	-	Haplotype	6872	RCV000007275	SCV000027471	21911	NPHS1	NM_004646.3:c.1339G>A	NP_004637.1:p.Glu447Lys	NM_004646.3:c.1339G>A:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 18, 2016	OMIM	OMIM	Finnish congenital nephrotic syndrome;NEPHROTIC SYNDROME, TYPE 1	10652016					germline	Genetic Alliance:Congenital+Nephrotic+Syndrome+Finnish+Type/1861;MedGen:C0403399;OMIM:256300;OMIM:602716.0001;OMIM:602716.0002;OMIM:602716.0003;OMIM:602716.0004;OMIM:602716.0005;OMIM:602716.0006;OMIM:602716.0007;OMIM:602716.0008;OMIM:602716.0009;OMIM:602716.0010;Office of Rare Diseases:1500;Orphanet:839;SNOMED CT:197601003	2000-02-01	0	1	PASS	348	327	10	347	121412	119744	0.002866	0	1	334	0	3	1	8	9808	11524	8558	6596	65880	900	16478	2005864	0,0,0	1,0,0	314,1,0	0,0,0	3,0,0	1,0,0	8,0,0	0	0	10	0	0	0	0	171	176	66760	52984	1	2164	0	334	8558	EAS
19	38979992	AAG	A	38979995	38979996	+	Haplotype	29876	RCV000022757	SCV000044046	38831	RYR1	NM_000540.2:c.5726_5727delAG	NP_000531.2:p.Glu1909Glyfs	NM_000540.2:c.5726_5727delAG:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 2010	OMIM	OMIM	Minicore myopathy with external ophthalmoplegia;MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	20301467;20839240;22009146;23788249;27854360					germline	GeneReviews:NBK1290;Genetic Alliance:Minicore+myopathy+with+external+ophthalmoplegia/4818;MedGen:C1850674;OMIM:255320;Office of Rare Diseases:10316;Orphanet:598	2010-11-01	0	0																																															
19	38994959	C	T	38994959	38994959	+	Haplotype	12985	RCV000013857	SCV000034104	28024	RYR1	NM_000540.2:c.8026C>T	NP_000531.2:p.Arg2676Trp	NM_000540.2:c.8026C>T:missense variant	Uncertain significance	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 02, 2013	OMIM	OMIM	Malignant hyperthermia, susceptibility to, 1;MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1	14732627;14870754;16163667;16917943;20301325;23788249;25356965;27854360					germline	GeneReviews:NBK1146;MedGen:CN031421;OMIM:145600;Office of Rare Diseases:3363;Orphanet:423	2004-01-01	0	0	PASS	1	1	0	1	121412	121162	8.236e-06	0	0	0	0	1	0	0	10386	11554	8650	6594	66588	902	16488	1712878	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	67210	53952	0	2162	0	1	66588	NFE
19	38995998	C	G	38995998	38995998	+	Haplotype	12985	RCV000013857	SCV000034104	38459	RYR1	NM_000540.2:c.8360C>G	NP_000531.2:p.Thr2787Ser	NM_000540.2:c.8360C>G:missense variant	Benign/Likely benign	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 10, 2017	OMIM	OMIM	Malignant hyperthermia, susceptibility to, 1;MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1	14732627;14870754;16163667;16917943;20301325;23788249;25356965;27854360					germline	GeneReviews:NBK1146;MedGen:CN031421;OMIM:145600;Office of Rare Diseases:3363;Orphanet:423	2004-01-01	0	0	PASS	373	349	5	359	121402	108448	0.003072	299	19	0	0	39	2	0	9026	10420	8332	5456	59610	784	14820	1560619	289	19	0	0	39	2	0	5	0	0	0	0	0	0	151	208	60278	48170	0	2060	0	299	9026	AFR
19	39002893	T	C	39002893	39002893	+	Haplotype	29876	RCV000022757	SCV000044046	51078	RYR1	NM_000540.2:c.9242T>C	NP_000531.2:p.Met3081Thr	NM_000540.2:c.9242T>C:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Aug 08, 2017	OMIM	OMIM	Minicore myopathy with external ophthalmoplegia;MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	20301467;20839240;22009146;23788249;27854360					germline	GeneReviews:NBK1290;Genetic Alliance:Minicore+myopathy+with+external+ophthalmoplegia/4818;MedGen:C1850674;OMIM:255320;Office of Rare Diseases:10316;Orphanet:598	2010-11-01	1	1	PASS	80	80	0	80	121412	121222	0.0006589	76	4	0	0	0	0	0	10384	11576	8652	6614	66578	906	16512	3294191	76	4	0	0	0	0	0	0	0	0	0	0	0	0	27	53	67276	53946	0	2164	0	76	10384	AFR
19	39013851	C	G	39013851	39013851	+	Haplotype	65396	RCV000022758	SCV000044047	70540	RYR1	NM_000540.2:c.10348-6C>G		NM_000540.2:c.10348-6C>G:intron variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 11, 2017	OMIM	OMIM	Minicore myopathy with external ophthalmoplegia;MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	18253926;20301467;20839240;22009146;23788249;27854218;27854360					germline	GeneReviews:NBK1290;Genetic Alliance:Minicore+myopathy+with+external+ophthalmoplegia/4818;MedGen:C1850674;OMIM:255320;Office of Rare Diseases:10316;Orphanet:598	2010-11-01	0	0	PASS	3	3	0	3	121412	121204	2.471e-05	2	1	0	0	0	0	0	10342	11560	8646	6612	66630	908	16506	1581433	2	1	0	0	0	0	0	0	0	0	0	0	0	0	1	2	67266	53938	0	2164	0	2	10342	AFR
19	39071022	G	A	39071022	39071022	+	Haplotype	65396	RCV000022758	SCV000044047	38832	RYR1	NM_000540.2:c.14524G>A	NP_000531.2:p.Val4842Met	NM_000540.2:c.14524G>A:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 11, 2017	OMIM	OMIM	Minicore myopathy with external ophthalmoplegia;MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	18253926;20301467;20839240;22009146;23788249;27854218;27854360					germline	GeneReviews:NBK1290;Genetic Alliance:Minicore+myopathy+with+external+ophthalmoplegia/4818;MedGen:C1850674;OMIM:255320;Office of Rare Diseases:10316;Orphanet:598	2010-11-01	0	0	PASS	7	6	0	6	121412	120564	5.765e-05	2	1	0	0	3	0	0	10334	11462	8636	6386	66436	896	16414	1936532	2	1	0	0	3	0	0	0	0	0	0	0	0	0	1	5	66904	53660	0	2156	0	2	10334	AFR
19	42364887	G	T	42364887	42364887	+	Haplotype	6319	RCV000033188	SCV000057024	21358	RPS19	NM_001022.3:c.43G>T	NP_001013.1:p.Val15Phe	NM_001022.3:c.43G>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 03, 2015	OMIM	OMIM	Diamond-Blackfan anemia 1;DIAMOND-BLACKFAN ANEMIA 1	12586610;20301769					germline	GeneReviews:NBK7047;Genetic Alliance:Diamond-Blackfan+anemia+1/8226;MedGen:C2676137;OMIM:105650;Orphanet:124	2003-06-15	0	0																																															
19	42365273	C	T	42365273	42365273	+	Haplotype	6319	RCV000033188	SCV000057024	38387	RPS19	NM_001022.3:c.164C>T	NP_001013.1:p.Thr55Met	NM_001022.3:c.164C>T:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 13, 2017	OMIM	OMIM	Diamond-Blackfan anemia 1;DIAMOND-BLACKFAN ANEMIA 1	12586610;20301769					germline	GeneReviews:NBK7047;Genetic Alliance:Diamond-Blackfan+anemia+1/8226;MedGen:C2676137;OMIM:105650;Orphanet:124	2003-06-15	0	0	PASS	33	33	0	33	121412	120704	0.0002718	3	0	0	1	29	0	0	10328	11510	8618	6584	66298	900	16466	1808411	3	0	0	1	29	0	0	0	0	0	0	0	0	0	19	14	66972	53732	0	2164	0	29	66298	NFE
19	45411064	G	A	45411064	45411064	+	Haplotype	441264	RCV000019443	SCV000039733	32899	APOE	NM_000041.3:c.91G>A	NP_000032.1:p.Glu31Lys	NM_000041.3:c.91G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 1992	OMIM	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, DUE TO APOE4-PHILADELPHIA	1361196;1674745;22962670					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005	1992-11-01	0	0	PASS	18	18	0	18	121394	113212	0.0001483	2	3	0	4	7	0	2	9360	10972	8354	5432	62446	828	15820	1541505	2	3	0	4	7	0	2	0	0	0	0	0	0	0	13	5	63870	49342	1	2116	0	3	10972	AMR
19	45411110	T	C	45411110	45411110	+	Haplotype	441268	RCV000019456	SCV000039746	32909	APOE	NM_000041.3:c.137T>C	NP_000032.1:p.Leu46Pro	NM_000041.3:c.137T>C:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 15, 2017	OMIM	OMIM	APOE4(-)-FREIBURG;APOE4(-)-FREIBURG	21500874					germline	OMIM:107741.0023	2017-02-15	0	0	PASS	292	284	2	288	121410	118874	0.002405	0	5	0	39	238	5	1	10048	11476	8572	6176	65278	872	16452	1621988	0	5	0	37	236	5	1	0	0	0	1	1	0	0	154	134	66576	52298	0	2154	0	238	65278	NFE
19	45411858	C	G	45411858	45411858	+	Haplotype	441269	RCV000019458	SCV000039748	32911	APOE	NM_000041.3:c.305C>G	NP_000032.1:p.Pro102Arg	NM_000041.3:c.305C>G:missense variant	-	association	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 10, 2018	OMIM	OMIM	APOE4 VARIANT;APOE4 VARIANT	18583979;21500874;2341812;3585172					germline	OMIM:107741.0025;OMIM:107741.0028	2018-01-10	0	0	PASS	1	1	0	1	121378	97892	8.239e-06	0	0	0	0	1	0	0	8098	9064	6906	4536	54552	702	14034	1215837	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	55520	42372	0	1972	0	1	54552	NFE
19	45411902	G	A	45411902	45411902	+	Haplotype	441270	RCV000019459	SCV000039749	32912	APOE	NM_000041.3:c.349G>A	NP_000032.1:p.Ala117Thr	NM_000041.3:c.349G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 2008	OMIM	OMIM	APOE3 VARIANT;APOE3 VARIANT	18583979;6327682					germline	OMIM:107741.0026	2008-07-01	0	0																																															
19	45411941	T	C	45411941	45411941	+	Haplotype	440870;441267;441268;441269	RCV000019438;RCV000019455;RCV000019456;RCV000019458	SCV000039727;SCV000039745;SCV000039746;SCV000039748	32903	APOE	NM_000041.3:c.388T>C	NP_000032.1:p.Cys130Arg	NM_000041.3:c.388T>C:missense variant	Pathogenic, other	pathogenic;association	3	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 10, 2018	OMIM	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, AUTOSOMAL DOMINANT;HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE4;APOE4(-)-FREIBURG;APOE4 VARIANT	1730728;21500874;22962670;25333069;2539388;6860421;8488843;18583979;2341812;3585172					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005;OMIM:107741.0023;OMIM:107741.0025;OMIM:107741.0028	2017-02-14;1993-05-01;2017-02-15;2018-01-10	0	0	PASS	11382	4692	320	5332	113556	28926	0.1	682	233	157	211	3039	43	967	2496	1086	1044	646	14626	252	8776	652483	550	225	145	167	2717	41	847	66	4	6	22	161	1	60	3029	2303	17564	11362	151	1576	14	682	2496	AFR
19	45411987	G	A	45411987	45411987	+	Haplotype	441262	RCV000019439	SCV000039729	32895	APOE	NM_000041.3:c.434G>A	NP_000032.1:p.Gly145Asp	NM_000041.3:c.434G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 01, 1984	OMIM	OMIM	Apolipoproteinemia E1;APOLIPOPROTEINEMIA E1	6323533					germline		1984-04-01	0	0	PASS	13	6	0	6	113484	15904	0.0001146	0	0	0	0	5	0	1	766	308	530	96	6332	158	7714	434567	0	0	0	0	5	0	1	0	0	0	0	0	0	0	5	1	10664	5240	0	1468	0	5	6332	NFE
19	45412031	C	T	45412031	45412031	+	Haplotype	440870	RCV000019438	SCV000039727	38488	APOE	NM_000041.3:c.478C>T	NP_000032.1:p.Arg160Cys	NM_000041.3:c.478C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 14, 2017	OMIM	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, AUTOSOMAL DOMINANT	1730728;21500874;22962670;25333069;2539388;6860421					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005	2017-02-14	0	0																																															
19	45412040	C	T	45412040	45412040	+	Haplotype	441264	RCV000019443	SCV000039733	32890	APOE	NM_000041.3:c.487C>T	NP_000032.1:p.Arg163Cys	NM_000041.3:c.487C>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Nov 01, 1992	OMIM	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, DUE TO APOE4-PHILADELPHIA	1361196;1674745;22962670					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005	1992-11-01	0	0	PASS	134	37	1	39	109156	14800	0.001228	37	2	0	0	0	0	0	608	272	584	74	5474	142	7646	414826	35	2	0	0	0	0	0	1	0	0	0	0	0	0	18	21	10222	4578	0	1460	0	37	608	AFR
19	45412061	G	C	45412061	45412061	+	Haplotype	441270	RCV000019459	SCV000039749	38495	APOE	NM_000041.3:c.508G>C	NP_000032.1:p.Ala170Pro	NM_000041.3:c.508G>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 2008	OMIM	OMIM	APOE3 VARIANT;APOE3 VARIANT	18583979;6327682					germline	OMIM:107741.0026	2008-07-01	0	0																																															
19	45412079	C	T	45412079	45412079	+	Haplotype	441262;441265;441266	RCV000019439;RCV000019452;RCV000019454	SCV000039729;SCV000039741;SCV000039744	32887	APOE	NM_000041.3:c.526C>T	NP_000032.1:p.Arg176Cys	NM_000041.3:c.526C>T:missense variant	drug response	pathogenic	3	0	0	0	0	reviewed by expert panel	no assertion criteria provided	Feb 21, 2017	OMIM	OMIM	Apolipoproteinemia E1;APOLIPOPROTEINEMIA E1;Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III;HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE2	6323533;22962670;8664327;8488843					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005	1984-04-01;2017-02-21;1993-05-01	3	0	PASS	3513	910	31	972	97640	13534	0.036	85	8	34	4	498	14	329	460	204	418	54	4700	142	7556	382015	73	8	34	4	464	14	313	6	0	0	0	17	0	8	617	355	9448	4086	70	1456	6	85	460	AFR
19	45412278	G	A	45412278	45412278	+	Haplotype	441265	RCV000019452	SCV000039741	38490	APOE	NM_000041.3:c.725G>A	NP_000032.1:p.Arg242Gln	NM_000041.3:c.725G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 21, 2017	OMIM	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III	22962670;8664327					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005	2017-02-21	0	0																																															
19	45412314	T	A	45412314	45412314	+	Haplotype	441266	RCV000019454	SCV000039744	38491	APOE	NM_000041.3:c.761T>A	NP_000032.1:p.Val254Glu	NM_000041.3:c.761T>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 1993	OMIM	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE2	22962670;8488843					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005	1993-05-01	0	0	PASS	51	25	0	25	118360	18518	0.0004309	1	0	0	1	23	0	0	1172	470	716	204	7810	176	7970	461367	1	0	0	1	23	0	0	0	0	0	0	0	0	0	17	8	12066	6452	0	1502	0	23	7810	NFE
19	45412337	G	A	45412337	45412337	+	Haplotype	441263	RCV000019435	SCV000039725	32893	APOE	NM_000041.3:c.784G>A	NP_000032.1:p.Glu262Lys	NM_000041.3:c.784G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 01, 1995	OMIM	OMIM	HYPERLIPOPROTEINEMIA, TYPE III, AND ATHEROSCLEROSIS ASSOCIATED WITH APOE7;HYPERLIPOPROTEINEMIA, TYPE III, AND ATHEROSCLEROSIS ASSOCIATED WITH APOE7	2470732;2738044;6480826;7586659					germline	OMIM:107741.0007	1995-08-01	0	0	PASS	19	13	0	13	119978	29070	0.0001584	0	0	13	0	0	0	0	1986	1258	1550	610	14742	228	8696	561593	0	0	13	0	0	0	0	0	0	0	0	0	0	0	6	7	18044	11026	0	1566	0	13	1550	EAS
19	45412340	G	A	45412340	45412340	+	Haplotype	441263	RCV000019435	SCV000039725	38487	APOE	NM_000041.3:c.787G>A	NP_000032.1:p.Glu263Lys	NM_000041.3:c.787G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 01, 1995	OMIM	OMIM	HYPERLIPOPROTEINEMIA, TYPE III, AND ATHEROSCLEROSIS ASSOCIATED WITH APOE7;HYPERLIPOPROTEINEMIA, TYPE III, AND ATHEROSCLEROSIS ASSOCIATED WITH APOE7	2470732;2738044;6480826;7586659					germline	OMIM:107741.0007	1995-08-01	0	0	PASS	19	13	0	13	120006	30224	0.0001583	0	0	13	0	0	0	0	2060	1340	1654	672	15450	244	8804	571574	0	0	13	0	0	0	0	0	0	0	0	0	0	0	6	7	18710	11514	0	1586	0	13	1654	EAS
19	45412358	C	G	45412358	45412358	+	Haplotype	441267	RCV000019455	SCV000039745	38492	APOE	NM_000041.3:c.805C>G	NP_000032.1:p.Arg269Gly	NM_000041.3:c.805C>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 1993	OMIM	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE4	21500874;22962670;8488843					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005	1993-05-01	0	0	PASS	24	16	0	16	120090	37774	0.0001999	0	1	0	0	14	0	1	2536	2058	2226	1000	20290	286	9378	625322	0,0,0	1,0,0	0,0,0	0,0,0	14,0,0	0,0,0	1,1,0	0	0	0	0	0	0	0	9	7	23188	14586	0	1624	0	14	20290	NFE
19	47258781	C	A	47258781	47258781	+	Phase unknown	224674	RCV000226653	SCV000265787	226485	FKRP	NM_024301.4:c.74C>A	NP_077277.1:p.Ser25Ter	NM_024301.4:c.74C>A:nonsense	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Dec 01, 2015	Center for Genetic Medicine Research,Children's National Medical Center	Center for Genetic Medicine Research,Children's National Medical Center	Limb-girdle muscular dystrophy-dystroglycanopathy, type C5	27854218					unknown	Genetic Alliance:Limb-girdle+muscular+dystrophy-dystroglycanopathy%2C+type+C5/8754;MedGen:C1846672;OMIM:606596.0004;OMIM:606596.0005;OMIM:606596.0006;OMIM:606596.0011;OMIM:606596.0012;OMIM:606596.0013;OMIM:606596.0014;OMIM:606596.0015;OMIM:606596.0016;OMIM:607155;Orphanet:34515	2015-12-01	0	0																																															
19	47258781	CGT	C	47258783	47258784	+	Phase unknown	224674	RCV000226653	SCV000265787	226486	FKRP	NM_024301.4:c.76_77delTG	NP_077277.1:p.Trp26Alafs	NM_024301.4:c.76_77delTG:frameshift variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Dec 01, 2015	Center for Genetic Medicine Research,Children's National Medical Center	Center for Genetic Medicine Research,Children's National Medical Center	Limb-girdle muscular dystrophy-dystroglycanopathy, type C5	27854218					unknown	Genetic Alliance:Limb-girdle+muscular+dystrophy-dystroglycanopathy%2C+type+C5/8754;MedGen:C1846672;OMIM:606596.0004;OMIM:606596.0005;OMIM:606596.0006;OMIM:606596.0011;OMIM:606596.0012;OMIM:606596.0013;OMIM:606596.0014;OMIM:606596.0015;OMIM:606596.0016;OMIM:607155;Orphanet:34515	2015-12-01	0	0																																															
19	47259533	C	A	47259533	47259533	+	Phase unknown	224674	RCV000226653	SCV000265787	19260	FKRP	NM_024301.4:c.826C>A	NP_077277.1:p.Leu276Ile	NM_024301.4:c.826C>A:missense variant	Pathogenic	likely pathogenic	0	1	0	0	0	criteria provided, multiple submitters, no conflicts	criteria provided, single submitter	Aug 07, 2017	Center for Genetic Medicine Research,Children's National Medical Center	Center for Genetic Medicine Research,Children's National Medical Center	Limb-girdle muscular dystrophy-dystroglycanopathy, type C5	27854218					unknown	Genetic Alliance:Limb-girdle+muscular+dystrophy-dystroglycanopathy%2C+type+C5/8754;MedGen:C1846672;OMIM:606596.0004;OMIM:606596.0005;OMIM:606596.0006;OMIM:606596.0011;OMIM:606596.0012;OMIM:606596.0013;OMIM:606596.0014;OMIM:606596.0015;OMIM:606596.0016;OMIM:607155;Orphanet:34515	2015-12-01	2	0	PASS	92	13	0	13	99474	3282	0.0009249	0	0	0	0	13	0	0	86	28	124	10	772	36	2226	200663	0	0	0	0	13	0	0	0	0	0	0	0	0	0	9	4	2458	824	0	458	0	13	772	NFE
19	49468583	C	T	49468583	49468583	+	Haplotype	441527	RCV000017941	SCV000038220	31516	FTL	NM_000146.3:c.-182C>T		NM_000146.3:c.-182C>T:5 prime UTR variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 19, 2013	OMIM	OMIM	Hyperferritinemia cataract syndrome;HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	23421845;9226182					germline	Genetic Alliance:Hyperferritinemia+cataract+syndrome/3553;Genetics Home Reference:hyperferritinemia-cataract-syndrome;MedGen:C1833213;OMIM:134790.0001;OMIM:134790.0002;OMIM:134790.0003;OMIM:134790.0004;OMIM:134790.0005;OMIM:134790.0006;OMIM:134790.0007;OMIM:134790.0008;OMIM:134790.0009;OMIM:134790.0011;OMIM:134790.0012;OMIM:134790.0017;OMIM:134790.0020;OMIM:600886;Office of Rare Diseases:2806;Orphanet:163	2013-02-19	0	0																																															
19	49468587	T	G	49468587	49468587	+	Haplotype	441527	RCV000017941	SCV000038220	260732	FTL	NM_000146.3:c.-178T>G		NM_000146.3:c.-178T>G:5 prime UTR variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 19, 2013	OMIM	OMIM	Hyperferritinemia cataract syndrome;HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	23421845;9226182					germline	Genetic Alliance:Hyperferritinemia+cataract+syndrome/3553;Genetics Home Reference:hyperferritinemia-cataract-syndrome;MedGen:C1833213;OMIM:134790.0001;OMIM:134790.0002;OMIM:134790.0003;OMIM:134790.0004;OMIM:134790.0005;OMIM:134790.0006;OMIM:134790.0007;OMIM:134790.0008;OMIM:134790.0009;OMIM:134790.0011;OMIM:134790.0012;OMIM:134790.0017;OMIM:134790.0020;OMIM:600886;Office of Rare Diseases:2806;Orphanet:163	2013-02-19	0	0																																															
19	49519883	A	G	49519883	49519883	-	Haplotype	441529	RCV000015495	SCV000035760	38465	LHB	NM_000894.2:c.104T>C	NP_000885.1:p.Ile35Thr	NM_000894.2:c.104T>C:missense variant	-	benign	0	0	0	0	1	no assertion for the individual variant	no assertion criteria provided	Mar 01, 2003	OMIM	OMIM	LUTEINIZING HORMONE POLYMORPHISM;LUTEINIZING HORMONE POLYMORPHISM	10199775;10323405;10468997;12620433;1727817;7714098;7904610;8784083					germline	OMIM:152780.0002	2003-03-01	0	0	VQSRTrancheSNP99.60to99.80	8297	7577	277	8131	121404	120498	0.068	572	442	503	865	5218	80	451	10304	11544	8600	6540	66108	898	16504	3377263	530	418	487	771	4870	66	435	21	12	8	47	174	7	8	4527	3604	67010	53488	58	2164	2	5218	66108	NFE
19	49519905	A	G	49519905	49519905	-	Haplotype	441529	RCV000015495	SCV000035760	29453	LHB	NM_000894.2:c.82T>C	NP_000885.1:p.Trp28Arg	NM_000894.2:c.82T>C:missense variant	-	benign	0	0	0	0	1	no assertion for the individual variant	no assertion criteria provided	Mar 01, 2003	OMIM	OMIM	LUTEINIZING HORMONE POLYMORPHISM;LUTEINIZING HORMONE POLYMORPHISM	10199775;10323405;10468997;12620433;1727817;7714098;7904610;8784083					germline	OMIM:152780.0002	2003-03-01	0	0	PASS	8558	7804	332	8468	121406	120758	0.07	573	453	526	900	5480	83	453	10314	11558	8620	6576	66278	900	16512	3493173	533	429	508	798	5030	69	437	20	12	9	51	225	7	8	4688	3780	67150	53608	58	2164	2	5480	66278	NFE
20	4680251	A	G	4680251	4680251	+	Haplotype	13399;453225;453226	RCV000014337;RCV000032588;RCV000014336	SCV000034586;SCV000034587;SCV000034585	28436	PRNP	NM_000311.4:c.385A>G	NP_000302.1:p.Met129Val	NM_000311.4:c.385A>G:missense variant;NM_001271561.1:c.*74A>G:3 prime UTR variant	Benign/Likely benign, risk factor	pathogenic	3	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jun 14, 2016	OMIM	OMIM	Fatal familial insomnia;FATAL FAMILIAL INSOMNIA;Jakob-Creutzfeldt disease;CREUTZFELDT-JAKOB DISEASE	10581230;12205650;1353341;1353342;1469441;16227536;1671440;1671983;1684756;19038218;20301407;7709737;9751723;1347910;1357594;14732629;15623717;15806397;20038778;7630420;7783865;8105681;20298421					germline	GeneReviews:NBK1229;Genetic Alliance:Fatal+Familial+Insomnia/2793;MedGen:C0206042;OMIM:600072;Orphanet:466;SNOMED CT:83157008;Genetic Alliance:Creutzfeldt-Jakob+Disease/2006;MedGen:C0022336;OMIM:123400;Office of Rare Diseases:6956;Orphanet:204;Orphanet:282166;Orphanet:454700;SNOMED CT:792004	2008-11-26;2010-01-05	1	0	PASS	37316	24879	6205	37289	121410	121156	0.307	3559	4793	208	2023	22281	251	4174	10360	11554	8638	6606	66584	904	16510	3525588	2365	2777	200	1407	14839	181	3110	597	1008	4	308	3721	35	532	20510	16779	67212	53944	597	2164	99	4793	11554	AMR
20	4680398	G	A	4680398	4680398	+	Haplotype	13399;453225;453226	RCV000014337;RCV000032588;RCV000014336	SCV000034586;SCV000034587;SCV000034585	28438	PRNP	NM_000311.4:c.532G>A	NP_000302.1:p.Asp178Asn	NM_000311.4:c.532G>A:missense variant;NM_001271561.1:c.*221G>A:3 prime UTR variant	Pathogenic	pathogenic	3	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 05, 2010	OMIM	OMIM	Fatal familial insomnia;FATAL FAMILIAL INSOMNIA;Jakob-Creutzfeldt disease;CREUTZFELDT-JAKOB DISEASE	10581230;12205650;1353341;1353342;1469441;16227536;1671440;1671983;1684756;19038218;20301407;7709737;9751723;1347910;1357594;14732629;15623717;15806397;20038778;7630420;7783865;8105681;20298421					germline	GeneReviews:NBK1229;Genetic Alliance:Fatal+Familial+Insomnia/2793;MedGen:C0206042;OMIM:600072;Orphanet:466;SNOMED CT:83157008;Genetic Alliance:Creutzfeldt-Jakob+Disease/2006;MedGen:C0022336;OMIM:123400;Office of Rare Diseases:6956;Orphanet:204;Orphanet:282166;Orphanet:454700;SNOMED CT:792004	2008-11-26;2010-01-05	0	0																																															
20	10393439	C	A	10393439	10393439	-	Haplotype	448914	RCV000005632	SCV000025814	38435	MKKS	NM_170784.2:c.724G>T	NP_740754.1:p.Ala242Ser	NM_170784.2:c.724G>T:missense variant;NR_072977.1:n.364-3988G>T:intron variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Aug 15, 2017	OMIM	OMIM	McKusick Kaufman syndrome;MCKUSICK-KAUFMAN SYNDROME	10802661;16104012;20301675					germline	GeneReviews:NBK1502;Genetic Alliance:McKusick+Kaufman+syndrome/4529;MedGen:C0948368;OMIM:236700;Office of Rare Diseases:3427;Orphanet:2473	2005-09-15	1	1	PASS	675	658	8	674	121412	121282	0.00556	16	18	0	34	604	2	0	10320	11568	8652	6610	66716	906	16510	3027834	16	18	0	34	588	2	0	0	0	0	0	8	0	0	379	295	67268	54014	0	2164	0	604	66716	NFE
20	10393913	G	A	10393913	10393913	-	Haplotype	448914	RCV000005632	SCV000025814	20347	MKKS	NM_170784.2:c.250C>T	NP_740754.1:p.His84Tyr	NM_170784.2:c.250C>T:missense variant;NR_072977.1:n.364-4462C>T:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 15, 2005	OMIM	OMIM	McKusick Kaufman syndrome;MCKUSICK-KAUFMAN SYNDROME	10802661;16104012;20301675					germline	GeneReviews:NBK1502;Genetic Alliance:McKusick+Kaufman+syndrome/4529;MedGen:C0948368;OMIM:236700;Office of Rare Diseases:3427;Orphanet:2473	2005-09-15	0	0																																															
20	39742755	A	G	39742755	39742755	+	Haplotype	16773	RCV000018261	SCV000038540	31812	TOP1	NM_003286.3:c.1598A>G	NP_003277.1:p.Asp533Gly	NM_003286.3:c.1598A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 11, 1991	OMIM	OMIM	DNA topoisomerase I, camptothecin-resistant;DNA TOPOISOMERASE I, CAMPTOTHECIN-RESISTANT	1849260					germline	MedGen:C4016020	1991-01-11	0	0																																															
20	43255143	G	C	43255143	43255143	-	Haplotype	1981	RCV000002058	SCV000022216	38420	ADA	NM_000022.3:c.316C>G	NP_001308979.1:p.Thr9=	NM_000022.3:c.316C>G:missense variant;NM_001322050.1:c.27C>G:synonymous variant;NR_136160.1:n.467C>G:non-coding transcript variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 01, 1997	OMIM	OMIM	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency;SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	3304460;9361033					germline	MedGen:C0392607	1997-12-01	0	0																																															
20	43255169	T	C	43255169	43255169	-	Haplotype	1981	RCV000002058	SCV000022216	17020	ADA	NM_000022.3:c.290A>G	NP_000013.2:p.Tyr97Cys	NM_000022.3:c.290A>G:missense variant;NR_136160.1:n.441A>G:non-coding transcript variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 01, 1997	OMIM	OMIM	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency;SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	3304460;9361033					germline	MedGen:C0392607	1997-12-01	0	0	PASS	1	1	0	1	121412	121402	8.236e-06	0	0	0	0	1	0	0	10406	11576	8654	6614	66734	906	16512	2282908	0,0,0	0,0,0	0,0,0	0,0,0	1,1,0	0,0,0	0,0,0	0	0	0	0	0	0	0	1	0	67288	54114	0	2164	0	1	66734	NFE
20	62044831	G	T	62044831	62044831	-	Haplotype	369808	RCV000408720	SCV000484644	390693	KCNQ2	NM_172107.3:c.1735C>A	NP_742105.1:p.Leu579Met	NM_172107.3:c.1735C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 31, 2016	GeneReviews	GeneReviews	Early infantile epileptic encephalopathy 7	20437616;25818041					germline	GeneReviews:NBK32534;Genetic Alliance:Epileptic+encephalopathy%2C+early+infantile%2C+7/8345;MedGen:C3150986;OMIM:613720;Orphanet:439218	2016-03-31	0	0																																															
20	62044831	GC	TT	62044831	62044832	-	Haplotype	369808	RCV000408720	SCV000484644	203721	KCNQ2	NM_172107.3:c.1734_1735delGCinsAA	NP_742105.1:p.Met578_Leu579delinsIleMet	NM_172107.3:c.1734_1735delGCinsAA:missense variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Mar 31, 2016	GeneReviews	GeneReviews	Early infantile epileptic encephalopathy 7	20437616;25818041					germline	GeneReviews:NBK32534;Genetic Alliance:Epileptic+encephalopathy%2C+early+infantile%2C+7/8345;MedGen:C3150986;OMIM:613720;Orphanet:439218	2016-03-31	1	0																																															
20	62044832	C	T	62044832	62044832	-	Haplotype	369808	RCV000408720	SCV000484644	390692	KCNQ2	NM_172107.3:c.1734G>A	NP_742105.1:p.Met578Ile	NM_172107.3:c.1734G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 31, 2016	GeneReviews	GeneReviews	Early infantile epileptic encephalopathy 7	20437616;25818041					germline	GeneReviews:NBK32534;Genetic Alliance:Epileptic+encephalopathy%2C+early+infantile%2C+7/8345;MedGen:C3150986;OMIM:613720;Orphanet:439218	2016-03-31	0	0																																															
21	34951753	T	G	34951753	34951753	-	Haplotype	431417	RCV000496974	SCV000588191	424961	DONSON	NM_017613.3:c.1466A>C	NP_060083.1:p.Lys489Thr	NM_017613.3:c.1466A>C:missense variant	Likely pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 16, 2017	OMIM	OMIM	MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES;MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES	28191891					germline	MedGen:CN373593;OMIM:611428.0001;OMIM:611428.0002;OMIM:611428.0003;OMIM:611428.0004;OMIM:611428.0005;OMIM:611428.0006;OMIM:611428.0007;OMIM:617604	2017-08-04	0	0	PASS	120	118	1	120	121412	121394	0.0009884	4	11	2	0	91	2	10	10406	11578	8654	6614	66724	908	16510	1944831	0,4,0	0,11,0	104,2,0	0,0,0	1,91,0	0,2,0	1,8,0	0	0	0	0	0	0	1	68	52	67278	54116	3	2164	1	91	66724	NFE
21	34956005	T	C	34956005	34956005	-	Haplotype	431417	RCV000496974	SCV000588191	424940	DONSON	NM_017613.3:c.786-33A>G		NM_017613.3:c.786-33A>G:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 04, 2017	OMIM	OMIM	MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES;MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES	28191891					germline	MedGen:CN373593;OMIM:611428.0001;OMIM:611428.0002;OMIM:611428.0003;OMIM:611428.0004;OMIM:611428.0005;OMIM:611428.0006;OMIM:611428.0007;OMIM:617604	2017-08-04	0	0	PASS	57	53	0	53	121232	108098	0.0004702	4	9	0	0	37	1	2	8834	11090	7894	6398	59338	832	13712	1201470	4	9	0	0	37	1	2	0	0	0	0	0	0	0	29	24	60414	47684	0	1748	0	9	11090	AMR
21	34960866	T	G	34960866	34960866	-	Haplotype	431417	RCV000496974	SCV000588191	424962	DONSON	NM_017613.3:c.82A>C	NP_060083.1:p.Ser28Arg	NM_017613.3:c.82A>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 04, 2017	OMIM	OMIM	MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES;MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES	28191891					germline	MedGen:CN373593;OMIM:611428.0001;OMIM:611428.0002;OMIM:611428.0003;OMIM:611428.0004;OMIM:611428.0005;OMIM:611428.0006;OMIM:611428.0007;OMIM:617604	2017-08-04	0	0	AC_Adj0_Filter	12	0	0	0	13326	12	0.0009005	0	0	0	0	0	0	0	0	0	2	0	0	0	10	16596	0	0	0	0	0	0	0	0	0	0	0	0	0	0	.	.	12	0	.	2	.	NA	NA	NA
21	37833740	A	T	37833740	37833740	-	Haplotype	375673	RCV000417144	SCV000494729	19890	CLDN14	NM_012130.3:c.254T>A	NP_036262.1:p.Val85Asp	NM_001146077.1:c.254T>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Aug 30, 2016	Laboratory of Molecular Genetics,National Institutes of Health	Laboratory of Molecular Genetics,National Institutes of Health	Perrault Syndrome;Deafness;Primary ovarian insufficiency;Perrault Syndrome						germline	Illumina Clinical Services Laboratory,Illumina:37522;MedGen:CN239459	2016-08-30	0	0	PASS	1	1	0	1	121392	119264	8.238e-06	0	0	0	0	0	0	1	10112	11492	8560	6492	65230	880	16498	1910969	0	0	0	0	0	0	1	0	0	0	0	0	0	0	1	0	66828	52436	0	2164	0	1	16498	SAS
21	47551895	G	A	47551895	47551895	+	Haplotype	29642	RCV000022490	SCV000043779	38596	COL6A2	NM_001849.3:c.2489G>A	NP_001840.3:p.Arg830Gln	NM_001849.3:c.2489G>A:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 08, 2015	OMIM	OMIM	BETHLEM MYOPATHY 1, AUTOSOMAL RECESSIVE;BETHLEM MYOPATHY 1, AUTOSOMAL RECESSIVE	18852439;19949035					germline	OMIM:120240.0011;OMIM:120240.0017;OMIM:120240.0018;OMIM:120240.0019	2009-12-01	0	1	PASS	5	5	0	5	120554	84194	4.148e-05	1	1	0	0	3	0	0	6142	8772	6054	2964	47046	590	12626	1146718	1	1	0	0	3	0	0	0	0	0	0	0	0	0	2	3	49166	35028	0	1892	0	1	6142	AFR
21	47551933	C	T	47551933	47551933	+	Haplotype	29642	RCV000022490	SCV000043779	38597	COL6A2	NM_001849.3:c.2527C>T	NP_001840.3:p.Arg843Trp	NM_001849.3:c.2527C>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 13, 2016	OMIM	OMIM	BETHLEM MYOPATHY 1, AUTOSOMAL RECESSIVE;BETHLEM MYOPATHY 1, AUTOSOMAL RECESSIVE	18852439;19949035					germline	OMIM:120240.0011;OMIM:120240.0017;OMIM:120240.0018;OMIM:120240.0019	2009-12-01	0	0	PASS	5	5	0	5	120486	97870	4.15e-05	1	0	1	0	2	0	1	7526	10100	7338	3908	53782	672	14544	1277263	1	0	1	0	2	0	1	0	0	0	0	0	0	0	3	2	56752	41118	0	2026	0	1	7338	EAS
22	24109650	C	G	24109650	24109650	-	Haplotype	180222;204293	RCV000157071;RCV000192234	SCV000206796;SCV000239873	178410	CHCHD10	NM_213720.2:c.172G>C	NP_998885.1:p.Gly58Arg	NM_213720.2:c.172G>C:missense variant;NR_125755.1:n.217G>C:non-coding transcript variant;NR_125756.1:n.139+371G>C:intron variant	-	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 14, 2015	OMIM;GeneReviews	OMIM;GeneReviews	Myopathy, isolated mitochondrial, autosomal dominant;MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT (1 family)	25193783;26131548;9324076;2519378					germline	GeneReviews:NBK304142;MedGen:C4015513;OMIM:616209;Orphanet:457050	2015-01-01;2015-04-14	0	0																																															
22	24109779	G	C	24109779	24109779	-	Haplotype	204293	RCV000192234	SCV000239873	200690	CHCHD10	NM_213720.2:c.43C>G	NP_998885.1:p.Arg15Gly	NM_213720.2:c.43C>G:missense variant;NR_125755.1:n.140-52C>G:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 14, 2015	GeneReviews	GeneReviews	Myopathy, isolated mitochondrial, autosomal dominant;Myopathy, isolated mitochondrial, autosomal dominant	2519378;26131548					germline	GeneReviews:NBK304142;MedGen:C4015513;OMIM:616209;Orphanet:457050	2015-04-14	0	0																																															
22	24109779	G	T	24109779	24109779	-	Haplotype	180222	RCV000157071	SCV000206796	178409	CHCHD10	NM_213720.2:c.43C>A	NP_998885.1:p.Arg15Ser	NM_213720.2:c.43C>A:missense variant;NR_125755.1:n.140-52C>A:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 02, 2015	OMIM	OMIM	Myopathy, isolated mitochondrial, autosomal dominant;MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT (1 family)	25193783;26131548;9324076					germline	GeneReviews:NBK304142;MedGen:C4015513;OMIM:616209;Orphanet:457050	2015-01-01	0	0																																															
22	25625439	C	A	25625439	25625439	+	Haplotype	217348	RCV000203383	SCV000256031	214001	CRYBB2	NM_000496.2:c.343C>A	NP_000487.1:p.Pro115Thr	NM_000496.2:c.343C>A:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 09, 2015	Eye Genetics Research Group,Children's Medical Research Institute	Eye Genetics Research Group,Children's Medical Research Institute	Congenital cataract	26694549					de novo	Human Phenotype Ontology:HP:0000519;Human Phenotype Ontology:HP:0001108;Human Phenotype Ontology:HP:0007679;Human Phenotype Ontology:HP:0007726;Human Phenotype Ontology:HP:0007788;MedGen:C1842324	2015-01-09	0	0																																															
22	25625451	G	A	25625451	25625451	+	Haplotype	217348	RCV000203383	SCV000256031	214002	CRYBB2	NM_000496.2:c.355G>A	NP_000487.1:p.Gly119Arg	NM_000496.2:c.355G>A:missense variant	Pathogenic	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 10, 2017	Eye Genetics Research Group,Children's Medical Research Institute	Eye Genetics Research Group,Children's Medical Research Institute	Congenital cataract	26694549					de novo	Human Phenotype Ontology:HP:0000519;Human Phenotype Ontology:HP:0001108;Human Phenotype Ontology:HP:0007679;Human Phenotype Ontology:HP:0007726;Human Phenotype Ontology:HP:0007788;MedGen:C1842324	2015-01-09	0	0																																															
22	36661906	A	G	36661906	36661906	+	Haplotype	6080	RCV000006453	SCV000026636	21119	APOL1	NM_145343.2:c.1072A>G	NP_663318.1:p.Ser358Gly	NM_145343.2:c.1072A>G:missense variant	not provided	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 09, 2014	OMIM	OMIM	Focal segmental glomerulosclerosis 4, susceptibility to;FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO	20647424;24206458					germline	Genetic Alliance:Focal+segmental+glomerulosclerosis+4%2C+susceptibility+to/8438;MedGen:C2675525;OMIM:612551;Orphanet:84271	2010-08-13	0	0	PASS	2496	1899	297	2493	121412	121236	0.021	2413	67	0	0	7	5	1	10362	11576	8654	6614	66614	906	16510	2575022	1821	65	0	0	7	5	1	296	1	0	0	0	0	0	920	1573	67236	54000	0	2164	0	2413	10362	AFR
22	36662034	T	G	36662034	36662034	+	Haplotype	6080	RCV000006453	SCV000026636	76004	APOL1	NM_145343.2:c.1200T>G	NP_663318.1:p.Ile400Met	NM_145343.2:c.1200T>G:missense variant	not provided	risk factor	0	0	0	0	0	no assertion provided	no assertion criteria provided	Dec 09, 2014	OMIM	OMIM	Focal segmental glomerulosclerosis 4, susceptibility to;FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO	20647424;24206458					germline	Genetic Alliance:Focal+segmental+glomerulosclerosis+4%2C+susceptibility+to/8438;MedGen:C2675525;OMIM:612551;Orphanet:84271	2010-08-13	0	0	PASS	2432	1818	286	2390	121378	118060	0.02	2316	63	0	0	5	5	1	9852	11550	8634	6614	65358	886	15166	2467056	1746	61	0	0	5	5	1	285	1	0	0	0	0	0	900	1490	65510	52550	0	1884	0	2316	9852	AFR
22	40757623	G	C	40757623	40757623	+	Haplotype	208488	RCV000190501	SCV000245387	205025	ADSL	NM_000026.3:c.994G>C	NP_000017.1:p.Asp332His	NM_000026.3:c.994G>C:missense variant;NR_134256.1:n.1053G>C:non-coding transcript variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 17, 2014	Mendelics Analise Genomica	Mendelics Analise Genomica	Adenylosuccinate lyase deficiency;Adenylosuccinate lyase deficiency	10090474;23519317					germline	Genetic Alliance:Adenylosuccinase+Deficiency/230;MedGen:C0268126;OMIM:103050;Office of Rare Diseases:550;Orphanet:46;SNOMED CT:15285008	2014-02-17	0	0	PASS	1	1	0	1	121412	121222	8.236e-06	0	0	0	0	1	0	0	10360	11562	8642	6614	66636	904	16504	2564903	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	67242	53980	0	2164	0	1	66636	NFE
22	40760969	G	A	40760969	40760969	+	Haplotype	208488	RCV000190501	SCV000245387	17501	ADSL	NM_000026.3:c.1277G>A	NP_000017.1:p.Arg426His	NM_000026.3:c.1277G>A:missense variant;NM_001123378.1:c.1191+600G>A:intron variant;NR_134256.1:n.1367G>A:non-coding transcript variant	Pathogenic	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 12, 2017	Mendelics Analise Genomica	Mendelics Analise Genomica	Adenylosuccinate lyase deficiency;Adenylosuccinate lyase deficiency	10090474;23519317					germline	Genetic Alliance:Adenylosuccinase+Deficiency/230;MedGen:C0268126;OMIM:103050;Office of Rare Diseases:550;Orphanet:46;SNOMED CT:15285008	2014-02-17	0	0	PASS	31	31	0	31	121412	121412	0.0002553	1	1	0	0	28	0	1	10406	11578	8654	6614	66740	908	16512	2776004	1	1	0	0	28	0	1	0	0	0	0	0	0	0	19	12	67288	54124	0	2164	0	28	66740	NFE
X	13768812	TCTCAAACACTTGGG	T	13768818	13768831		Haplotype	11542	RCV000012298	SCV000032532	76962		NM_003611.2:c.936-550_936-537delACACTTGGGCTCAA		NM_003611.2:c.936-550_936-537delACACTTGGGCTCAA:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 2004	OMIM	OMIM	Oral-facial-digital syndrome;OROFACIODIGITAL SYNDROME I	15221448;20301367					germline	GeneReviews:NBK1188;Genetic Alliance:Orofaciodigital+syndromes/5428;MedGen:C1510460;OMIM:311200;Office of Rare Diseases:4121;Orphanet:2750;SNOMED CT:52868006	2004-07-01	0	0																																															
X	22112123	T	C	22112123	22112123	+	Haplotype	10818	RCV000011565	SCV000031797	25857	PHEX	NM_000444.5:c.755T>C	NP_000435.3:p.Phe252Ser	NM_000444.5:c.755T>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 01, 1997	OMIM	OMIM	Familial X-linked hypophosphatemic vitamin D refractory rickets;HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT	22319799;7550339;9106524					germline	GeneReviews:NBK83985;Genetic Alliance:Familial+Hypophosphatemic+Rickets/2752;MedGen:C0733682;OMIM:307800;Office of Rare Diseases:6735;Orphanet:89936;SNOMED CT:82236004	1997-04-01	0	0																																															
X	22112127	G	A	22112127	22112127	+	Haplotype	10818	RCV000011565	SCV000031797	38453	PHEX	NM_000444.5:c.759G>A	NP_000435.3:p.Met253Ile	NM_000444.5:c.759G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 01, 1997	OMIM	OMIM	Familial X-linked hypophosphatemic vitamin D refractory rickets;HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT	22319799;7550339;9106524					germline	GeneReviews:NBK83985;Genetic Alliance:Familial+Hypophosphatemic+Rickets/2752;MedGen:C0733682;OMIM:307800;Office of Rare Diseases:6735;Orphanet:89936;SNOMED CT:82236004	1997-04-01	0	0																																															
X	100658834	G	A	100658834	100658834	-	Haplotype	10723	RCV000011470	SCV000031702	38452	GLA	NM_000169.2:c.334C>T	NP_000160.1:p.Arg112Cys	NM_000169.2:c.334C>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 09, 2017	OMIM	OMIM	Fabry disease;FABRY DISEASE	12735292;1315715;16980809;20301469;20505683;20610207;21934708;23788249;23860966;25173338;25355838;25356965;27854360				Fabry disease is due to inactivating mutations in the X-linked GLA gene resulting in deficiency of the enzyme Alpha Galactosidase-A.;loss of function	germline	GeneReviews:NBK1292;Genetic Alliance:Fabry+Disease/2690;Genetic Testing Registry (GTR):GTR000246735;Genetic Testing Registry (GTR):GTR000260631;Genetic Testing Registry (GTR):GTR000325415;Genetic Testing Registry (GTR):GTR000327665;Genetic Testing Registry (GTR):GTR000337467;Genetic Testing Registry (GTR):GTR000500007;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000505068;Genetic Testing Registry (GTR):GTR000507480;Genetic Testing Registry (GTR):GTR000507942;Genetic Testing Registry (GTR):GTR000512526;Genetic Testing Registry (GTR):GTR000514924;Genetic Testing Registry (GTR):GTR000519366;Genetic Testing Registry (GTR):GTR000519384;Genetic Testing Registry (GTR):GTR000520061;Genetic Testing Registry (GTR):GTR000520062;Genetic Testing Registry (GTR):GTR000520063;Genetic Testing Registry (GTR):GTR000520414;Genetic Testing Registry (GTR):GTR000520447;Genetic Testing Registry (GTR):GTR000522329;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528276;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000528500;Genetic Testing Registry (GTR):GTR000528516;Genetic Testing Registry (GTR):GTR000528528;Genetic Testing Registry (GTR):GTR000528536;Genetic Testing Registry (GTR):GTR000551442;Genetic Testing Registry (GTR):GTR000552214;Genetic Testing Registry (GTR):GTR000556501;Genetic Testing Registry (GTR):GTR000556520;Genetic Testing Registry (GTR):GTR000556725;Genetic Testing Registry (GTR):GTR000558532;Genetics Home Reference:fabry-disease;MedGen:C0002986;OMIM:301500;Office of Rare Diseases:6400;Orphanet:324;SNOMED CT:16652001	2010-08-01	0	0																																															
X	100658972	C	G	100658972	100658972	-	Haplotype	10723	RCV000011470	SCV000031702	25762	GLA	NM_000169.2:c.196G>C	NP_000160.1:p.Glu66Gln	NM_000169.2:c.196G>C:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Jan 24, 2013	OMIM	OMIM	Fabry disease;FABRY DISEASE	12735292;1315715;16980809;20301469;20505683;20610207;21934708;23788249;23860966;25173338;25355838;25356965;27854360				Fabry disease is due to inactivating mutations in the X-linked GLA gene resulting in deficiency of the enzyme Alpha Galactosidase-A.;loss of function	germline	GeneReviews:NBK1292;Genetic Alliance:Fabry+Disease/2690;Genetic Testing Registry (GTR):GTR000246735;Genetic Testing Registry (GTR):GTR000260631;Genetic Testing Registry (GTR):GTR000325415;Genetic Testing Registry (GTR):GTR000327665;Genetic Testing Registry (GTR):GTR000337467;Genetic Testing Registry (GTR):GTR000500007;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000505068;Genetic Testing Registry (GTR):GTR000507480;Genetic Testing Registry (GTR):GTR000507942;Genetic Testing Registry (GTR):GTR000512526;Genetic Testing Registry (GTR):GTR000514924;Genetic Testing Registry (GTR):GTR000519366;Genetic Testing Registry (GTR):GTR000519384;Genetic Testing Registry (GTR):GTR000520061;Genetic Testing Registry (GTR):GTR000520062;Genetic Testing Registry (GTR):GTR000520063;Genetic Testing Registry (GTR):GTR000520414;Genetic Testing Registry (GTR):GTR000520447;Genetic Testing Registry (GTR):GTR000522329;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528276;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000528500;Genetic Testing Registry (GTR):GTR000528516;Genetic Testing Registry (GTR):GTR000528528;Genetic Testing Registry (GTR):GTR000528536;Genetic Testing Registry (GTR):GTR000551442;Genetic Testing Registry (GTR):GTR000552214;Genetic Testing Registry (GTR):GTR000556501;Genetic Testing Registry (GTR):GTR000556520;Genetic Testing Registry (GTR):GTR000556725;Genetic Testing Registry (GTR):GTR000558532;Genetics Home Reference:fabry-disease;MedGen:C0002986;OMIM:301500;Office of Rare Diseases:6400;Orphanet:324;SNOMED CT:16652001	2010-08-01	0	0	PASS	13	8	0	11	121410	87593	0.0001071	0	0	11	0	0	0	0	8479	9306	6625	4528	47913	633	10109	2132809	0	0	8	0	0	0	0	0	0	0	0	0	0	0	2	8	33524	54068	0	2164	0	11	6625	EAS
X	107823943	G	T	107823943	107823943	+	Haplotype	10464	RCV000011210	SCV000031437	35671	COL4A5	NM_033380.2:c.866G>T	NP_203699.1:p.Gly289Val	NM_000495.4:c.866G>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 04, 2012	OMIM	OMIM	Alport syndrome, X-linked recessive;ALPORT SYNDROME, X-LINKED	20301386;22166944;7706490;9195222					germline	GeneReviews:NBK1207;Genetic Alliance:Alport+Syndrome/335;MedGen:C1567742;OMIM:301050;Orphanet:63;Orphanet:88917	1995-04-01	0	0																																															
X	107929326	C	T	107929326	107929326	+	Haplotype	10464	RCV000011210	SCV000031437	38451	COL4A5	NM_033380.2:c.4282C>T	NP_203699.1:p.Arg1428Cys	NM_000495.4:c.4264C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 01, 1995	OMIM	OMIM	Alport syndrome, X-linked recessive;ALPORT SYNDROME, X-LINKED	20301386;22166944;7706490;9195222					germline	GeneReviews:NBK1207;Genetic Alliance:Alport+Syndrome/335;MedGen:C1567742;OMIM:301050;Orphanet:63;Orphanet:88917	1995-04-01	0	0	PASS	40	19	0	27	121402	81515	0.0003295	2	0	0	0	25	0	0	8237	8810	6307	4001	44698	571	8891	1434370	2	0	0	0	17	0	0	0	0	0	0	0	0	0	7	19	27788	53726	0	1904	0	25	44698	NFE
X	135738552	T	A	135738552	135738552	+	Haplotype	11158	RCV000011908	SCV000032141	26197	CD40LG	NM_000074.2:c.384T>A	NP_000065.1:p.Ser128Arg	NM_000074.2:c.384T>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 29, 1993	OMIM	OMIM	Immunodeficiency with hyper IgM type 1;IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	20301576;7678782					germline	GeneReviews:NBK1402;Genetic Alliance:Immunodeficiency+with+hyper+IgM+type+1/3776;MedGen:C0398689;OMIM:308230;Office of Rare Diseases:73	1993-01-29	0	0																																															
X	135738554	A	G	135738554	135738554	+	Haplotype	11158	RCV000011908	SCV000032141	38454	CD40LG	NM_000074.2:c.386A>G	NP_000065.1:p.Glu129Gly	NM_000074.2:c.386A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 29, 1993	OMIM	OMIM	Immunodeficiency with hyper IgM type 1;IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	20301576;7678782					germline	GeneReviews:NBK1402;Genetic Alliance:Immunodeficiency+with+hyper+IgM+type+1/3776;MedGen:C0398689;OMIM:308230;Office of Rare Diseases:73	1993-01-29	0	0																																															
X	148564464	C	G	148564464	148564464	-	Haplotype	10502	RCV000011248	SCV000031475	25541	IDS	NM_000202.7:c.1466G>C	NP_000193.1:p.Gly489Ala	NM_000202.7:c.1466G>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 2003	OMIM	OMIM	Mucopolysaccharidosis, MPS-II;MUCOPOLYSACCHARIDOSIS, TYPE II	12794697;20301451;21863056;25071396					germline	GeneReviews:NBK1274;Genetic Alliance:Mucopolysaccharidosis+type+II/4913;MedGen:C0026705;OMIM:309900;Orphanet:580;SNOMED CT:70737009	2003-07-01	0	0																																															
X	148564466	C	A	148564466	148564466	-	Haplotype	10502	RCV000011248	SCV000031475	38394	IDS	NM_000202.7:c.1464G>T	NP_000193.1:p.Met488Ile	NM_000202.7:c.1464G>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 2003	OMIM	OMIM	Mucopolysaccharidosis, MPS-II;MUCOPOLYSACCHARIDOSIS, TYPE II	12794697;20301451;21863056;25071396					germline	GeneReviews:NBK1274;Genetic Alliance:Mucopolysaccharidosis+type+II/4913;MedGen:C0026705;OMIM:309900;Orphanet:580;SNOMED CT:70737009	2003-07-01	0	0																																															
X	148564527	C	T	148564527	148564527	-	Haplotype	221203	RCV000204179	SCV000262516	25537	IDS	NM_000202.7:c.1403G>A	NP_000193.1:p.Arg468Gln	NM_000202.7:c.1403G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	criteria provided, single submitter	Sep 25, 2013	LISIN Facultad de Ciencias Exactas, Universidad Nacional de La Plata	LISIN Facultad de Ciencias Exactas, Universidad Nacional de La Plata	Mucopolysaccharidosis, MPS-II	18414213;20301451;21863056;25071396					maternal	GeneReviews:NBK1274;Genetic Alliance:Mucopolysaccharidosis+type+II/4913;MedGen:C0026705;OMIM:309900;Orphanet:580;SNOMED CT:70737009	2007-05-16	2	0																																															
X	148564536	T	A	148564536	148564536	-	Haplotype	221203	RCV000204179	SCV000262516	222899	IDS	NM_000202.7:c.1394A>T	NP_000193.1:p.Gln465Leu	NM_000202.7:c.1394A>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	May 16, 2007	LISIN Facultad de Ciencias Exactas, Universidad Nacional de La Plata	LISIN Facultad de Ciencias Exactas, Universidad Nacional de La Plata	Mucopolysaccharidosis, MPS-II	18414213;20301451;21863056;25071396					maternal	GeneReviews:NBK1274;Genetic Alliance:Mucopolysaccharidosis+type+II/4913;MedGen:C0026705;OMIM:309900;Orphanet:580;SNOMED CT:70737009	2007-05-16	0	0																																															
X	153762605	G	A	153762605	153762605	-	Haplotype	10392	RCV000011127	SCV000031354	25430	G6PD	NM_000402.4:c.682C>T	NP_000393.4:p.Arg228Cys	NM_001042351.2:c.592C>T:missense variant	other	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	May 24, 2017	OMIM	OMIM	Chronic granuloma and hemolytic anemia;CHRONIC GRANULOMA AND HEMOLYTIC ANEMIA	1353664;4125296					germline	MedGen:C4016535	1992-08-01	0	0	PASS	5	1	0	3	121410	87419	4.118e-05	0	0	1	0	0	0	2	8492	9298	6631	4473	47794	627	10104	1831519	0	0	1	0	0	0	0	0	0	0	0	0	0	0	2	1	33443	53976	0	2162	0	2	10104	SAS
X	153762653	G	A	153762653	153762653	-	Haplotype	10392	RCV000011127	SCV000031354	38393	G6PD	NM_000402.4:c.634C>T	NP_000393.4:p.Arg212Trp	NM_001042351.2:c.544C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 01, 1992	OMIM	OMIM	Chronic granuloma and hemolytic anemia;CHRONIC GRANULOMA AND HEMOLYTIC ANEMIA	1353664;4125296					germline	MedGen:C4016535	1992-08-01	0	0	PASS	2	0	0	1	121410	87377	1.647e-05	0	0	1	0	0	0	0	8488	9297	6631	4455	47782	622	10102	1830167	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	33407	53970	0	2162	0	1	6631	EAS
X	153762655	T	A	153762655	153762655	-	Haplotype	10382	RCV000011109	SCV000031336	25421	G6PD	NM_000402.4:c.632A>T	NP_000393.4:p.Asp211Val	NM_000402.4:c.632A>T:missense variant	Pathogenic, other	other	0	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	May 24, 2017	OMIM	OMIM	G6PD SANTAMARIA;G6PD SANTAMARIA	1978554;1999409;6433630;8956035					germline	OMIM:305900.0023	2017-05-24	2	0	PASS	17	9	0	13	121410	87382	0.00014	11	1	0	0	1	0	0	8489	9296	6630	4457	47784	622	10104	1829814	8	1	0	0	0	0	0	0	0	0	0	0	0	0	4	9	33414	53968	0	2162	0	11	8489	AFR
X	153763492	T	C	153763492	153763492	-	Haplotype	10361;10382	RCV000011075;RCV000011109	SCV000031301;SCV000031336	25399	G6PD	NM_000402.4:c.466A>G	NP_000393.4:p.Asn156Asp	NM_001042351.2:c.376A>G:missense variant	Conflicting interpretations of pathogenicity, other	pathogenic;other	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 18, 2017	OMIM	OMIM	Glucose 6 phosphate dehydrogenase deficiency;G6PD A-;G6PD SANTAMARIA	10734064;1303173;1978554;2253938;2503817;2572288;2836867;2912886;3393536;4388132;5448;5492291;669721;7106752;7291768;903703;1999409;6433630;8956035					germline	Genetic Alliance:G6pd+a-/8448;Genetic Alliance:Glucose+6+Phosphate+Dehydrogenase+Deficiency/3096;Genetics Home Reference:glucose-6-phosphate-dehydrogenase-deficiency;MedGen:C0017758;OMIM:305900.0002;OMIM:305900.0027;OMIM:305900.0028;Office of Rare Diseases:6520;OMIM:305900.0023	2000-03-31;2017-05-24	0	1	PASS	3471	1519	354	2840	121410	87435	0.029	2691	103	0	0	36	5	5	8489	9305	6633	4469	47793	628	10118	1924342	1414,0,0	77,8,0	0,0,0	0,0,0	24,0,0	3,0,0	1,0,0	353	1	0	0	0	0	0	612	2227	33479	53954	0	2164	0	2691	8489	AFR
X	153763551	G	C	153763551	153763551	-	Haplotype	10392	RCV000011127	SCV000031354	25431	G6PD	NM_000402.4:c.407C>G	NP_000393.4:p.Ser136Cys	NM_001042351.2:c.317C>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 01, 1992	OMIM	OMIM	Chronic granuloma and hemolytic anemia;CHRONIC GRANULOMA AND HEMOLYTIC ANEMIA	1353664;4125296					germline	MedGen:C4016535	1992-08-01	0	0																																															
X	153764217	C	T	153764217	153764217	-	Haplotype	10361	RCV000011075	SCV000031301	25400	G6PD	NM_000402.4:c.292G>A	NP_000393.4:p.Val98Met	NM_001042351.2:c.202G>A:missense variant	drug response	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 18, 2017	OMIM	OMIM	Glucose 6 phosphate dehydrogenase deficiency;G6PD A-	10734064;1303173;1978554;2253938;2503817;2572288;2836867;2912886;3393536;4388132;5448;5492291;669721;7106752;7291768;903703					germline	Genetic Alliance:G6pd+a-/8448;Genetic Alliance:Glucose+6+Phosphate+Dehydrogenase+Deficiency/3096;Genetics Home Reference:glucose-6-phosphate-dehydrogenase-deficiency;MedGen:C0017758;OMIM:305900.0002;OMIM:305900.0027;OMIM:305900.0028;Office of Rare Diseases:6520	2000-03-31	0	0	PASS	1211	699	44	997	121410	86653	0.009974	955	27	0	0	10	1	4	8415	9269	6613	4315	47413	612	10016	1559835	670	21	0	0	6	1	1	44	0	0	0	0	0	0	202	787	32808	53836	0	2156	0	955	8415	AFR
